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ABSTRACT
Driver sleepiness is known to be a major contributor to road traffic incidents (RTIs). An 
initial literature review identified many studies reporting untreated obstructive sleep 
apnoea (OSA) sufferers as having impaired driving performance and increased RTI risk. 
It is consistently reported that treatment with continuous positive air pressure (CPAP) 
improves driving performance and decreases RTI risk, although most of these studies 
are conducted less than one year after starting treatment. UK law allows treated OSA 
patients to continue driving if their doctor states that treatment has been successful.
Despite the wealth of publications surrounding OSA and driving, 6 key areas were 
identified from the literature review as not fully investigated, the: (i) prevalence of 
undiagnosed OSA in heavy goods vehicle (HGV) drivers in the UK; (ii) impact of sleep 
restriction on long term CPAP treated OSA compared with healthy controls; (iii) ability 
of treated OSA participants to identify sleepiness when driving; (iv) impact of one night 
CPAP withdrawal on driving performance; (v) individual difference in driving 
performance of long term CPAP treated OSA participants; (vi) choice of 
countermeasures to driver sleepiness by two groups susceptible to driver sleepiness, 
OSA and HGV drivers.
Key areas (i) and (vi) were assessed using questionnaires. 148 HGV drivers were 
surveyed to assess OSA symptoms and preference of countermeasures to driver 
sleepiness. All participants completing the driving simulator study were also surveyed. 
9.5% of HGV drivers were found to have symptoms of suspected undiagnosed OSA. 
Additionally the OSA risk factors were more prevalent for HGV drivers than reported in 
national statistics reports for the general population. The most effective 
countermeasures to driver sleepiness (caffeine and a nap) were not the most popular. 
Being part of a susceptible group (OSA or HGV driver) and prior experience of driver 
sleepiness did not promote effective choice of countermeasure. 
Key areas (ii) to (v) were assessed using a driving simulator. Driving simulators present 
a safe environment to test participants in a scenario where they may experience 
sleepiness without endangering other road users. Initially, in a repeated measures 
counterbalanced design, 19 CPAP treated OSA participants, recruited from an OSA 
iii
patients association group and 20 healthy controls, recruited by adverts in the local 
area, completed a two hour afternoon drive following a normal night’s sleep (with 
treatment) and following sleep restriction to 5 hours. OSA participants were then 
invited to complete a 3rd study day following a normal length of sleep but without 
CPAP. The control groups was matched to the OSA group for age and driving 
experience. All drives were recorded and assessed for sleep related incidents, EEG 
activity was continuously monitored and subjective sleepiness ratings recorded at 
regular intervals. 
Following a normal night’s sleep there was no significant difference between driving 
performance for CPAP treated OSA participants and controls. Both the healthy 
controls and the OSA participants could safely drive for approximately 90 min. Sleep 
restriction had a greater impact on OSA than control participants resulting in 
significantly more driving incidents and shorter safe driving time. 
OSA participants were more likely to report sleepiness prior to a major driving incident 
than control participants. On average, OSA participants experienced 19 minutes of 
feeling sleepy prior to incident compared with 65 minutes for controls. 
Without CPAP, participants started the drive feeling sleepier and therefore 
experienced incidents earlier than following sleep restriction to 5 h. Participants were 
less likely to report sleepiness prior to first major incident compared with following 
sleep restriction.
Approximately a quarter of OSA participants were severely affected by sleep 
restriction; others showed no significant difference to controls. These affected OSA 
participants were more likely to report sleepiness prior to major incident than those 
not affected.
Following the completion of the driving simulator work, it became apparent that when 
compared with younger participants studied in previous publications, older 
participants; (1) had fewer driving incidents; (2) were less likely to report sleepiness 
prior to a major incident.
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In summary, approximately 10% of HGV drivers surveyed were suspected of having 
OSA. Survey of countermeasures to driver sleepiness suggests experienced drivers do 
not make effective choices. Long term CPAP treated OSA patients appear not have 
driving impairment compared with healthy controls of a similar age, as long as 
treatment is adhered to and adequate sleep obtained. OSA patients can identify when 
they are sleepy, although older people appear less able to do this while driving than 
younger people.
An effective education program is needed to facilitate diagnosis of OSA in HGV drivers,
for all drivers to improve choice of countermeasures to driver sleepiness and to 
promote the importance of a full night’s sleep and treatment adherence to OSA 
patients. Further research is needed to investigate ability to identify sleepiness and 
individual difference in susceptibility to sleep restriction in treated OSA patients. 
Key words
Driving performance, driver sleepiness, obstructive sleep apnoea, perception of 
sleepiness, countermeasures, individual difference, continuous positive air pressure 
(CPAP) 
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1PREFACE
CASES OF SLEEP-RELATED ROAD TRAFFIC INCIDENTS CAUSED BY DRIVERS 
WITH OBSTRUCTIVE SLEEP APNOEA 
2To establish the real world context for research in this thesis it is important to 
appreciate the human impact of road traffic incidents (RTIs) caused by obstructive 
sleep apnoea (OSA) drivers. As set out in the UK Public Records Acts 1958 and 1967, 
court files are closed to the public until they are a minimum of thirty years old. 
Therefore it is not possible to assess the prevalence of RTIs where OSA has been 
identified as a causal factor. However, it is possible to appreciate the situation through 
newspaper articles. 
A search of UK newspapers was conducted using the search terms “sleep apnoea” and 
“traffic accident”. Presented here is a summary of 4 cases that were identified from 
the newspaper search, with varying court outcomes. It is recognised that the 
information may be subjective as it is obtained from newspapers rather than court 
documents and that these are likely to be higher profile cases considered to be 
newsworthy.
All 4 of the cases detailed below resulted in fatalities and all were caused by heavy 
goods vehicle (HGV) drivers and in 3 cases OSA was diagnosed after the crash. This is 
not intended to be analyses of all cases of OSA sleep related road traffic incidents 
(srRTIs), but, this information does illustrate the severity of srRTIs, occurrence in both 
diagnosed and undiagnosed OSA sufferers and demonstrates the varied outcomes of 
court cases. 
Case 1
In 2006 on an A road in Oxfordshire a 61 year old HGV driver fell asleep at the wheel of 
his 30 tonne truck killing a couple and their two sons aged 16 and 11 years. The HGV 
driver had been awake since 4.30am and driving from 7am when the incident 
happened at 3:30pm. The HGV drove into the back of a queue of traffic, the first 
vehicle it hit was pushed out of the way, the second lifted into the top deck of a car 
transporter before the HGV drove over the top of the third car crushing the family 
inside. 
Following the incident the driver was diagnosed with OSA. The defence stated that the 
driver did not remember the incident and that OSA had caused him to pass out 
3suddenly. Medical experts for the prosecution testified that OSA would not result in 
being unable to identify increasing sleepiness and that the driver could have taken 
appropriate measures to avoid falling asleep at the wheel. 
The court found the driver guilty and sentenced him to 3 years and 9 months in prison.  
Source: A Dawar (2007), Driver who fell asleep, killing family of four, will go to jail .The 
Times (London),December 8, 2007, p. 35.
A Topping (2007), Lorry driver who fell asleep faces jail for killing family. The Guardian 
(London), December 8, 2007,  p. 19.
Case 2
In 2006 on a motorway in Merseyside a 54 year old HGV driver fell asleep at the wheel 
of his HGV killing a 25 year old man. The HGV drove into the back of a queue of traffic 
crushing the victims car and writing off 9 other vehicles. 
The driver was initially charged with dangerous driving due to falling asleep at the 
wheel. OSA was diagnosed after the incident. The defence stated that the driver had 
sought help from his GP about feeling tired four months before hand and that on the 
day of the incident he had been feeling fine then started to feel faint and fuzzy before 
having no memory of events. 
The court gave a verdict of accidental death and no sentence was given. 
Source: J Narain (2008), Death crash trucker’s sleeping illness. Daily Mail (London), 
August 6, 2008, p. 29.
Case 3
In 2005 on an A road in Scotland a 36 year old HGV driver fell asleep at the wheel of 
his HGV killing three people aged 25, 44 and 36 years. The HGV drove into the back of 
a queue of traffic at approximately 50 mph hitting 5 vehicles. 
Following the incident the driver was diagnosed with OSA. The expert witness for the 
defence stated that the driver would not have known that he had a sleep disorder or 
4how severe it was before hand. The driver stated that he had “blacked out” prior to 
the incident. An expert witness for the prosecution stated that the driver would have 
known that he was sleepy even though he didn’t know he had a disorder.
The court found the driver to have no proven guilt and no sentence was given. 
Source: R Moore (2007), ‘Sleepy’ driver on death rap. The Mirror (Scots Ed) October 
10, 2007, p. 15.
Case 4
In 2000 on a motorway in Kent a 44 year old HGV driver fell asleep at the wheel of his 
HGV tractor unit killing 2 people aged 24 and 25. The HGV tractor unit first hit a broken 
down van on the hard shoulder before veering across three lanes and into the 
oncoming traffic hitting the car carrying both victims.
In court the driver admitted to falling asleep at the wheel 15 times before causing 
several minor accidents. The driver had been diagnosed with OSA in 1999 at which 
time the doctor advised him not to drive. Despite the diagnosis he continued to work 
as a lorry driver and took a second job as a cleaner working 3 hours per night. On the 
night of the incident he had finished work at 1am having had no more than 4 hours 
sleep. The driver told the court that he had lied to his doctor about feeling sleepy in 
1999 as he wanted to be signed of work to deal with family problems. He stated that 
as far as he knew he had nothing wrong with him apart from a snoring problem.
The court found the driver guilty and sentenced him to 8 years in prison. 
Source: H Studd (2002), Eight years for sleepy lorry driver who killed. The Times 
(London), January 19, 2002.
Photo. Unaccredited (2002), Driver jailed for couples death. BBC news 18 January 2002
5CHAPTER ONE
A REVIEW OF LITERATURE ON DRIVER SLEEPINSS AND OBSTRUCTIVE 
SLEEP APNOEA
61.1 Introduction 
Falling asleep whilst driving can result in serious accidents. Road traffic injuries 
account for 2.1% of all global deaths, which is the 11th greatest cause of deaths in the 
world (Peden 2004). With over 34 million licensed vehicles on UK roads in June 2009 
(Department for Transport 2009) driver sleepiness has the potential to be a major
problem. Driver tiredness has been recognised by the UK Department for Transport 
THINK campaign as being responsible for around 300 deaths per year. One group of 
people susceptible to excessive daytime sleepiness are untreated Obstructive Sleep 
Apnoea (OSA) sufferers. Research into obstructive sleep apnoea (OSA) has increased 
greatly over the last 30 years reflecting the increased importance in this area of 
research (Lavie 2008). OSA is important in driver sleepiness as one of the symptoms is 
excessive daytime sleepiness (EDS) (Phillips 2004). If an OSA sufferer is driving it is 
possible they may suffer driver sleepiness as a result of their pre-existing condition. 
Successfully treated OSA patients are usually free to drive, as daytime sleepiness 
returns to normal levels. However, little is known about OSA patients and their ability 
to cope in the long term: How they react to a shorter night’s sleep than usual? What 
happens if they miss a night’s treatment? If undiagnosed OSA is prevalent in people 
driving heavy goods vehicles (HGVs) for work? This thesis aims to address these 
questions.
To define the context of the problem of OSA driver sleepiness the following chapter 
uses existing work to explain the disorder OSA, detail the nature of sleep-related road 
traffic incidents (srRTIs) and discuss the impact of OSA on driving. Finally this chapter 
contains a review of OSA and driving studies conducted using surveys and simulators, 
enabling identification of gaps in the literature and research questions to be 
addressed.  
1.2 Obstructive sleep apnoea 
OSA is a sleep disorder resulting in the repeated collapse of the airway during sleep. As 
the airway collapses it blocks the air flow so the body and brain do not get sufficient 
oxygen (Hardinge 2008). During the collapse the body becomes starved of oxygen, the 
low oxygen levels are recognised by the brain which responds by waking the person in 
7order to resume breathing. Sufferers do not always fully wake as breathing can 
resume in light sleep. However, this repetitive interruption of deep sleep can result in 
EDS (Hardinge 2008). 
An apnoea occurs when air flow ceases for 10 seconds or more, anything less than 10
seconds or a partial reduction in air flow is a hypopnoea (Hardinge 2008). Severity of 
OSA is quantified by the Apnoea Hypopnoea Index (AHI) which is the average number 
of apnoeas and hypopnoeas which occur per hour of sleep. It is generally accepted 
that to be classed as an OSA patient the AHI must be greater than 5 (American
Academy of Sleep Medicine Task Force 1999). Respiratory Disturbance Index (RDI) may 
also be used; this is average respiratory arousal events per hour, which may include 
more than just apnoeas and hypopnoeas e.g. snoring arousals. Sleep disordered 
breathing (SDB) describes any disorder characterised by abnormal respiratory 
patterns; the most common is OSA. 
1.2.1 Epidemiology
The exact prevalence of OSA is not known as it is suspected many people have the 
condition and do not realise. Estimations of prevalence depend on the population 
assessed and the definition of OSA used. Due to time and money constraints it is often 
not suitable to use a full polysomnography (PSG) for diagnoses (Bresnitz et al. 1994). 
Prevalence estimations are important in order to estimate the expected health care 
cost to an area (Young et al.
The most comprehensive study to day of prevalence found 4% of men and 2% of 
women have OSA (Young et al. 1993). This formed part of the Wisconsin Sleep Cohort 
Study, a large population based study. In this case an initial sleep patterns 
questionnaire was completed by participants including questions on snoring. A high 
return rate of 82% (3513 participants) returned questionnaires, all respondents who 
habitually snored and 25% of the sample who were not snorers completed overnight 
PSG. Participants were considered to have OSA if they had an AHI 5 or over. The 
prevalence rate within the population was based on having a combination of AHI>5 
and reporting daytime sleepiness.  A sample of participants completed a repeat PSG to 
check for consistency. This was a major study covering a large population size, the 
8only minor limitation is that they did not distinguish true OSA events from possible 
central events; central events being defined as lack of airflow and cessation of 
respiratory effort, with obstructive apnoea being lack of airflow with continued 
respiratory effort (Bresnitz et al. 1994).   
Several population studies have shown prevalence to be between 0.3% and 10%,
though it should be noted that these studies have predominantly been on Caucasian 
subjects (Stradling et al. 1991, Bearpark et al. 1995, Bixler et al. 2001). It is likely that 
somewhere around 5% of a Caucasian middle aged adults would be suffering from 
OSA (Young et al. 2002). There have been few studies in non Caucasian populations so 
it is not possible to say with certainty if prevalence varies, however it has been 
reported that prevalence is higher in African Americans than Caucasians (Ancoli-Israel 
et al. 1995). In that study all participants were over 65 years and had sleep recordings 
completed at home, the odds of having an AHI ≥30 were 2.5 times higher in African-
Americans, this was controlling for BMI.   
The prevalence of OSA increases with age and is most common in men aged 40 – 60 
years (Hardinge 2008) increasing to a possible prevalence of 24% in over 65s, as 
measured using a portable home monitoring system on 420 participants (Ancoli-Israel 
2009). However, it should be noted that presence of sleep disordered breathing in the 
elderly does not necessarily mean the person has OSA (Hoch et al. 1990). 
Research suggests that there is a gender split of between 2:1 and 3:1 prevalence in 
males compared to females (Redline et al. 1994, Bixler et al. 2001, Wahner-Roedler et 
al. 2007). OSA is strongly linked to obesity so it is suggested that as the prevalence of 
obesity is increasing so will prevalence of OSA (Gibson 2004). 
1.2.2 Pathogenesis
OSA occurs in individuals where the airway collapses completely and repeatedly, often 
causing oxygen desaturation. The pharynx is a soft, the small muscles (pharyngeal 
dilators) contract during inspiration. During sleep all muscles relax, thus the structure 
of the pharynx is weaker and liable to collapse (Klawe et al. 2003). OSA will occur in 
some individuals but not other, this will depend on the initial size of the pharynx, if it is 
larger partial collapse with muscle weakening can occur with it closing (Fogel et al. 
92004). Additional factors also contribute predominantly caused by obesity as excess 
adipose tissue is excess weight the pharyngeal dilators have to act against (Gibson et 
al. 2004). The narrowing of the airway impedes ventilation and results in full or partial 
arousal. 
OSA is more likely to occur in men and in people aged over 40, additionally obesity, 
central body fat distribution and large neck size have been consistently shown to be 
high risk factors of OSA (Shigeta et al. 2008, Young et al. 2002, Peppard et al 2000, 
Young et al 2004). A collar size of 43cm (17”) in men and 40cm (16”) in women has 
been shown to be highly indicative of OSA (Davies et al. 1992). Smoking is considered 
to be a possible risk factor as the airway may become inflamed. In the Wisconsin 
cohort mentioned earlier current smokers were 3 times more likely to have OSA than 
people who did not smoke at the time of data collection (Wetter et al.1994), 
association between smoking and OSA  is also reported by (Stradling and Crosby 1991).
Although there is suggestion of association between smoking and OSA there is less 
evidence than for obesity (Young et al. 2002).
1.2.3 Diagnosis 
Polysomnography (PSG) involves the measurement of brain activity by EEG, eye 
movements by Electrooculogram (EOG) and muscle activity by Electromyogram (EMG).  
Electrodes are attached to specific locations on a participant’s scalp in accordance with 
the Rechtschaffen and Kales (1968) international 10-20 system and recorded over a 
night. The output can be scored using Rechtschaffen and Kales (1968) standard scoring 
to show each stage of sleep and wakefulness, demonstrating the transition from wake
to sleep and distinctive stages during sleep. 
PSG is used for the recording of brain activity in sleep, this technique is the gold 
standard for diagnosing OSA as it can be used to sleep stage and monitor arousals 
from sleep as well as monitoring air flow at the noise/mouth and blood oxygen 
concentrations. However, in practice it costly to complete a full over night recording to 
all patients presenting in clinic. In the UK the most commonly used diagnostic tool is a 
partial sleep study including oximetry, (which can be set up at a sleep clinic), the 
patient will then sleep at home in their own bed and come back to the clinic the 
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following day for diagnosis (Hardinge 2008).  At some clinics (or in cases where the 
home recording is inconclusive, often because of detachment of the equipment at 
night) a full polysomnography (PSG) is carried out over night in hospital (Gibson 2004). 
People with an AHI greater than 5 are diagnosed as OSA sufferers.
Overnight recordings are expensive and time consuming, so before they are carried 
out doctors may assess determine if any reported day time sleepiness is excessive. 
The most common way to asses EDS is by using the Epworth Sleepiness Scale (ESS). 
Those scoring over 12 are said to have EDS, as healthy people have been shown to 
score an average of 5 (Johns 1991, Johns et al. 1997). The ESS measures average sleep 
propensity, an individual’s general level of sleepiness independent of the current 
situation (Shen et al. 2006). OSA patients usually suffer from various other medical 
conditions, so when identifying EDS it is important to note if the patient has other 
conditions which may exacerbate this i.e. depression or diabetes (Koutsourelakis et al. 
2008).   ESS is a valid tool for assessing sleepiness in OSA patients as it improves once 
treatment is started (Engleman et al. 1996). However, some studies have not found 
significant correlation between ESS and OSA severity as measured by AHI and how 
quickly they can fall asleep (Chervin et al. 1997, Olson et al. 1998). A full explanation of 
the ESS can be found in section 3.5.3.1.
1.2.4 Symptoms
The presenting symptom of OSA is often first reported by the bed partner of the 
sufferer, most commonly loud snoring and “holding their breath” while asleep (Phillips 
2004). In contrast, the most common complaint from the patient is excessive day time 
sleepiness (EDS) interfering with daytime activities, this is extreme, often unexplained 
sleepiness during the day which is frequently quantified by an ESS over 12. However, 
not all sufferers will have EDS (Gibson 2004). OSA patients who have EDS are often 
referred to as having obstructive sleep apnoea syndrome (OSAS). Patients may be 
unaware of the apnoeas, believing they are getting a full night’s sleep (Hardinge 2008). 
They may report feeling un-rested when they wake but will not know why. Sufferers 
also report morning headaches and a dry mouth on waking (Bresnitz et al. 1994). 
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1.2.5 Complications and associations with OSA
Beyond the symptoms reported specifically to OSA;
Stopping breathing in their sleep
EDS
Loud snoring
Morning headaches
Dry mouth on waking
There are other complications with have been associated with OSA, where links have 
been shown although not conclusively proven. Outlined below are those complications 
and associated risks not relevant to driving. Possible cognitive function decline and the 
symptom of day time sleepiness are relevant to driving and are detailed in section 1.4.  
1.2.5.1 Mortality 
OSA is a chronic disease which is now routinely treated, as such no recent study has 
followed patients without treatment. He et al. (1988) monitored 385 male patients 
with OSA over 8 years, 22 died in this period giving a 0.78 probability of survival. The 
authors report that in untreated patients aged over 50 the probability of death was 
significantly higher among those with an AHI ≥20. Although this study is limited to one 
sleep centre in Canada which limits the generalisation of the findings, it does 
demonstrate mortality rates to be higher in sufferers with elevated AHI. 
1.2.5.2 Type 2 diabetes
It is possible that OSA is associated with diabetes, as many OSA patients also suffer 
from diabetes, however, as yet there has been no firm evidence that OSA causes 
diabetes as most studies are observational rather than experimental (Punjabi et al. 
2009). A suggested mechanism is that the repeated arousals during the period before 
treatment decrease insulin sensitivity (Stamatakis and Punjabi 2010). CPAP treatment 
does not appear to reverse the associated adverse effects with diabetes as reviewed 
by Punjabi et al. (2009), they suggest a strong confounding factor is BMI as CPAP can 
treat OSA without the patient being required to lose weight. However, it is then not 
clear if the diabetes is a risk factor for OSA or if OSA is a risk factor for diabetes (West 
et al. 2006).  
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1.2.5.3 Cardiovascular disease and stroke
Apnoea episodes result in the body being exposed to hypoxia and negative 
intrathoracic pressures on the cardiovascular system. The added pressure to the hear 
can result in raised blood pressure, heart rate and impair function. There is an 
independent association between OSA and hypertension, coronary artery disease, 
arrhythmias, heart failure and stroke, as reviewed in Bradley and Floras (2009), Young 
et al (2002) and Malhotra and White (2002). In particular there is strong evidence that 
OSA is a risk factor for stroke (Yaggi and Mosenin 2004). CPAP treatment has been 
shown by randomised control trials to lower blood pressure and improve cardiac 
function, however, as yet large trials have not been conducted (Bradley and Floras 
2009).  
1.2.5.4 Quality of life
The SF-36 health related quality of life measure has been used in OSA samples. The 
two largest are the Wisconsin Sleep Cohort Study (Finn et al 1998) and the Sleep Heart 
Health Study (Baldwin et al. 2001). Both studies show a linear association of OSA 
severity and decline in the SF-36 scales, although not always significantly so. In 
Baldwin et al. (2001) the association was significant for all scales if OSA was defined as 
AHI>30, so it appears that severe OSA is highly likely to have an impact on quality of 
life. Co-morbidities present a confounding factor is any OSA and quality of life study as 
OSA is common in older adults and has been linked to cardiovascular disease. It can be 
difficult to clearly distinguish what is the cause of any reduced quality of life. 
Treatment with CPAP has been found to improve health related quality of life (Moyer 
et al. 2001). Literature on quality of life and OSA is reviewed by Moyer et al. (2001) 
and Young et al. (2002).
1.2.6 Treatment
In the UK the National Institute for Health and Clinical Excellence (NICE) guidelines for 
treatment available on the NHS state that moderate to severe OSA patients are to be 
treated with continuous positive air pressure (CPAP). This treatment is also 
recommended for mild sufferers if life style advice (losing weight) has not been 
effective (NICE 2008). Other possible treatments include oral appliances and 
uvulopalatopharyngoplasty surgery; these were evaluated by the NICE 2008 report 
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along with CPAP, the report concluded CPAP to be the most effective treatment. As 
CPAP is the recommended treatment in the UK the other two treatment options will 
not be considered in this work. 
CPAP works as the increased air pressure prevents the airway collapse (Phillips 2004,
Abbey et al. 1989). CPAP treatment entails wearing a mask over the nose and (if 
needed) mouth during sleep, through which a constant pressure of air is pumped from 
an electrical box which sits at the side of the bed (Hardinge 2008).  The pressure 
required to maintain the airway varies between individuals so the machine has to be 
calibrated for each patient (Gibson 2004). 
Figure 1.2-1 CPAP machine. ResMed (2008)
CPAP treatment should be used for more than 7 hours each night to ensure maximum 
reduction in OSA symptoms (Phillips 2004) but in practice compliance is a problem. 
One study found only 46% of CPAP users used the machine for at least 4h on 70% of 
days (Kribbs et al. 1993b). Common complaints with the machine are that air can 
sometimes leak through the mouth which results in the patient having a dry mouth 
which can feel uncomfortable (Phillips 2004). Claustrophobia with the mask over the 
face at night and the noise of the machine inhibiting sleep are also reported causes of 
non compliance with treatment. Generally level of adherence is determined in the 
early stages of treatment but it is important to follow up after 6 months as some 
patients will increase or decrease adherence (Aloia et al. 2008). Patients with severe 
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cases of OSA have been shown to be more compliant than patients with moderate 
OSA (Yetkin et al. 2008).
CPAP has been shown to improve ESS and MWT scores (Jenkinson et al. 1999, McDaid 
et al. 2009), however, MSLT do not improve, suggesting OSA patients may retain high 
sleep ability. It has generally been shown that CPAP improved both objective and 
subjective sleepiness in moderate to severe cases of OSA (Davies et al. 2000). Not all 
research supports the use of CPAP; compliance rates are so low that it is more 
effective to recommend weight loss (Wright et al. 2000). In the case of mild OSA the 
NICE guidelines state that CPAP should only be used if weight loss fails (NICE 2008).
CPAP treatment has been shown to be cost effective (NICE 2008).  One study 
compared 181 OSA patients and 181 matched controls looking at health care services 
used in the 10 years prior to OSA diagnosis. They found that OSA patients use 
approximately twice as many health care services during this time than the controls 
(Ronald et al. 1999) and results in decreased hospitalisation costs (Bahammam et al. 
1999). There is also the decreased cost to society in road traffic incidents (George 
2001) and improved quality of life resulting in increased work performance (Findley et 
al. 2001). Within the NICE guidelines CPAP is recognised as the most cost effective
method of treatment for OSA, where it was compared to oral appliances and lifestyle 
management. Subjects were monitored for 1 year and monitored for health events, 
RTI, ESS and quality of life by the assessment group. Additionally a CPAP manufacturer 
also submitted a report on cost effectiveness. Very few participants had an RTI in the 
year so the impact on RTIs was not firmly established and some of the evidence came 
from a CPAP manufacturer, however, it remains that the NHS acknowledged CPAP as 
the most cost effective treatment. Cost effectiveness is very important to the NHS who 
work from a limited budget (NICE 2008). 
1.3 Driver sleepiness
Driver sleepiness is feeling sleepy or drowsy while in control of a motor vehicle. This 
will result in impaired driving performance and is as a result or inadequate prior sleep, 
one possible cause of inadequate prior sleep is OSA. 
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1.3.1 Prevalence of road traffic incidents 
Traffic injuries were the 9th leading cause of death and disability in the world in 1990, 
and have been predicted to be the 3rd leading cause by 2020 (Murray et al. 1997). In 
2007 there were 247 780 road casualties and 2 946 people killed on roads in Great 
Britain (GB) (Department for Transport 2008). 
Research has shown that 16 - 20% of road traffic incidents (RTIs) on major roads are as 
a result of sleep-related crashes (Horne et al. 1995). In the UK Horne et al. (1995) 
found sleep related road traffic incidents (srRTI) to be more likely to result in fatality, 
here 23% of fall asleep incidents to result in death or serious injury compared with 
15% of all other road incidents police were called to in Devon, Cornwall, Leicestershire, 
Staffordshire, Northamptonshire, Warwickshire, and West Mercia on motorways and A 
roads over a 5 year period. This is likely in part due to the high speed of such incidents, 
an American study found 62% of srRTIs to be at excess of 50mph (Pack et al. 1995).  In 
the American study of 4333 RTIs judged to be caused by the driver falling asleep 1.4% 
resulted in fatality which is less than the 2.3% of alcohol related RTIs reported as 
resulting in fatality (Pack et al. 1995). It is not possible to compare the numbers in the 
UK and USA study as the UK study does not separate for death and serious injury, also 
the USA study reports in comparison to fatality in alcohol related RTIs only whereas 
the UK study compares with all other causes of RTI. Also in America using logistic 
regression driver sleepiness has been reported to directly increase the odds that a RTIs 
will be fatal (Bunn et al. 2005).
It is likely srRTIs have high fatality and injury rates because drivers who are asleep 
make no correction to their direction of travel which usually results in head on 
collisions or running off the road (Pack et al. 1995). If the driver wakes before a crash 
has occurred it is possible they will suddenly try to correct the direction of travel which 
could cause them to lose control of the vehicle (Hancock et al. 1997). This has been 
demonstrated in a driving simulator, where sleepy drivers were less likely to correct 
steering but their movements were of high amplitude (Thiffault et al. 2003). 
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1.3.2 Characteristics of sleep-related road traffic incidents 
In a suspected drink or drug related RTIs there are definitive tests which will conclude 
if a driver is under the influence of either. However, with sleep-related RTIs (srRTIs) 
following the event the drivers are likely to become alert, therefore showing no signs 
of prior sleepiness. In the UK the following criteria are used by the police and 
consequently court system to identify srRTIs, this criteria are derived from Horne et al. 
(1995):
Main Criteria
1. No mechanical defects
2. Good weather and driving conditions
3. Speeding and ‘driving too close’ excluded
4. Alcohol excluded
5. Medical disorder/medications excluded
6. Vehicle runs off the road or into another vehicle
7. No evidence of breaking beforehand
8. Driver could see the impact point clearly for over 7 seconds before the crash
i.e. prolonged inattention, not momentary distraction
Other points:
A) More likely to occur 02:00h- 06:00 and 14:00 – 16:00h
B) Usually on a dull road
C) Driver usually denies sleep/sleepiness 
Using the above criteria Horne and Reyner (1995) assessed those RTIs likely to be 
sleep-related in comparison to the volume of traffic on the roads at the time, reported 
in figure 1.3-1.
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Figure 1.3-1 Number of sleep-related accidents and traffic density, (J. A. Horne et al. 1995)
A clear circadian affect can be seen (solid line of figure 1.3-1); with sleep-related 
accidents peaking in the early hours of the morning and in the early afternoon in line 
with circadian rhythm. Traffic density (circles in figure 1.3-1) peaks during the rush 
hour times of 8-9am and 5-6pm and is at its lowest during the early hours of the 
morning. Sleep-related RTIs appeared less common at times of the day when traffic 
density is high. 
There is a general trend for younger adults to have sleep crashes in the early hours of 
the morning and older adults in the afternoon (Summala et al. 1994, Flatley et al. 
2004), this is probably due to younger drivers being more likely to be on the roads in 
the early hours of the morning than older drivers. Research has shown that younger 
people are more affected by sleep deprivation than older people (Brendel et al. 1990, 
Lowden et al. 2009), though this does not mean that older people are not affected by 
sleep deprivation (Sagaspe et al. 2007); added to this inexperienced drivers are more 
impaired by sleep deprivation than experienced drivers (Lenne et al. 1998).
Additionally, women are less likely to have a srRTI than men (Horne et al. 1995). 
Research has shown that women are better at realising they are sleepy and that their 
driving is impaired by sleep restriction (Barrett et al. 2004b) and they act on this 
information. 
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With all real roads srRTI data there is a strong possibility of under reporting as It can 
be hard to conclusively identify an RTI as being sleep-related (Horne et al. 1999). As 
there is no clear test of driver sleepiness the attending police officer may not be willing 
to report driver sleepiness as a cause of an accident. Therefore, when studying 
accident data it can be necessary to re-evaluate police reports in order to obtain a 
more accurate estimate the number of srRTIs (Horne et al. 1995). 
1.3.3 Are sleep-related road traffic accidents preventable?
There is now a wealth of research demonstrating that healthy people do not fall asleep 
whilst driving without experiencing a period of increasing sleepiness beforehand 
(Reyner and Horne 1998b, Lisper et al. 1986, Otmani et al. 2005, Horne et al. 2004) . 
However, the problem comes when drivers fail to take signs of sleepiness as signs of 
increasing risk of falling asleep (Kaplan et al. 2007). The following section discusses if 
people are aware of sleepiness and therefore able to stop driving before an incident 
occurs, the implicating factors resulting in srRTIs. 
1.3.3.1 Insight into sleepiness
It has long been recognised that people have a legal responsibility to be fit to drive; 
but opinion on falling asleep at the wheel has changed over the years. McCutcheon 
(1998) reports a case in Scottish law of H.M. Advocate v. Ritchie (a driver who fell 
asleep) in 1926, which stated “that a person is obliged to take account of the risk of 
falling asleep when driving”. The same paper reports this decision being rejected in 
1963, and then approved in 1991. From the legal perspective it makes a lot of 
difference whether a driver is able to fall asleep without any warning or if drivers 
consciously decide to continue driving while knowing that they are sleepy. Examples of 
different court outcomes are reported in the preface of this thesis. 
There is evidence that people are aware of sleepiness prior to having a srRTI as If 
people who have fallen asleep while driving are asked what happened prior to the 
incident they are able to identify and recognise known warning behaviours. These 
behaviours include: struggling to keep eyes open, yawning, difficulty connecting to 
driving, slower response to traffic change and an increased variation in speed (Lisper 
et al. 1986, Nordbakke et al. 2007).
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Further evidence of ability to recognise sleepiness is apparent in the correlation 
between subjective sleepiness scores and driving simulator performance. Here, when 
sleep restricted participants rate themselves feeling sleepy at times when srRTIs
occurred (Horne et al. 2004, Biggs et al. 2007). In a study of young healthy drivers it 
was found that participants had an average of 45 minutes from when they felt sleepy 
until a driving incident occurred (Reyner and Horne 1998b). This time interval would 
be sufficient to implement a countermeasure before a RTI occurs. However, it was 
found that some drivers although knowing they were sleepy did not feel they were 
likely to fall asleep and therefore may not use a countermeasure.  The correlation 
between subjective sleepiness ratings and driving performance has also been noted in 
healthy participants during 24h sleep deprivation (Baranski 2007).
Additionally subjective (KSS) scores have also been shown to correlate to EEG 
measures of sleepiness (Horne et al. 2004, Kaida et al. 2006), demonstrating that 
participants have awareness of their underlying sleepiness. As it has been shown 
experimentally that subjective sleepiness as rated on the KSS is linked driving incidents 
it can also be expected to do so on real roads. When reporting KSS 9 participants 
report they are fighting sleep; if someone is fighting sleep it is likely they will be doing 
something to “fight” it using a countermeasure such as open a window. If a person has 
taken any action in this manner it can be said that they knew they were sleepy (Horne 
et al. 2004).
All studies of awareness of sleepiness reported above have been conducted under 
laboratory conditions, where participants are repeatedly asked to report a subjective 
sleepiness rating. It should be acknowledged that when on real roads, without this 
prompt drivers may not regularly assess how sleepy they are so could miss early signs 
of sleepiness and continue to drive. 
The research reported here has been completed using healthy participants; similar 
research has not been conducted with older drivers or OSA participants, consequently 
there is no evidence of awareness of sleepiness in these groups. 
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1.3.3.2 Factors affecting sleep related incidents
Below is a brief outline of the factors which can contribute to srRTIs this is to 
demonstrate that despite one underlying cause (the driver being to sleepy to drive) 
there are many contributing factors resulting in increased likelihood of a srRTI 
occurring. 
Prior sleep
Having inadequate sleep prior to driving has been shown to be a major cause of sleep-
related accidents (Fell et al. 1997, Connor et al. 2002). 
Time of day
As detailed in section 1.2.2 a greater number of sleep-related accidents happen in the 
early hours of the morning and in the early afternoon when sleep pressure is at its 
highest (Horne et al. 1995, Pack et al. 1995). The effect of time of day is exacerbated in 
shift workers driving home in the early hours of the morning (Horne et al. 1999, 
Akerstedt et al. 2005).
Type of road
Analysis of RTI data has shown sleep-related accidents to be more common on major 
roads, such as motorways (Horne et al. 1995). It is likely that the monotonous 
conditions of this type of road facilitate sleepiness (Horne et al. 1999). It is thought 
that a road with little variation leads to lower arousal and therefore increased 
sleepiness (Thiffault et al. 2003). In line with this, traffic density also has an effect, as 
sleep-related accidents on motorways are more likely when there is low traffic density 
(Flatley et al. 2004), in situations with greater traffic density drivers may be able to 
maintain alertness. 
General sleepiness levels
Using the Epworth sleepiness scale as a measure of general sleepiness, it has been 
shown that people who are generally sleepier are more likely to fall asleep while 
driving (Maycock 1996). 
Driving duration
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It may be hypothesised that the longer a person drives the more likely they are to fall 
asleep. However, evidence is conflicting, as using a simulator it has been shown that in 
healthy participants there is no significant effect of time on task to driving incidents, 
but that driving performance is worsened by prior sleep restriction (P. Philip et al. 
2005). In another study, driving impairment over time was reported and the authors 
suggested that 80 min is the safe limit for monotonous driving (Ting et al. 2008).
Individual difference
Ability to maintain performance when sleep deprived varies greatly between 
individuals (Van Dongen et al. 2004). Whilst driving a significant difference in ability to 
cope with sleep deprivation has been found between individuals (Philip et al. 2006). 
Driving experience
It is possible that those drivers who often drive at night or when sleep deprived will be 
at higher risk of falling asleep at the wheel due to greater exposure. However, there is 
some evidence to show that it is possible for people to adapt to this situation, such as 
professional drivers adapting to night time driving (Dalziel et al. 1997). Similarly it has 
been suggested that inexperienced drivers (holding a licence for less than three years) 
have greater impairment at a driving task following sleep deprivation than 
experienced drivers (Lenne et al. 1998). 
Sleep disorders
Accident surveys have been used to show obstructive sleep apnoea sufferers to be 
more likely to have srRTIs than healthy people.
1.3.4 Countermeasures to driver sleepiness
Driver sleepiness is a phenomenon that can affect anyone; not just those with sleep 
disorders (though the propensity may be higher). A key factor in whether a person falls 
asleep at the wheel is the nature of the aversive action that they take. If a person feels 
sleepy when driving the choices they make on how to deal with this can determine the 
outcome of the journey: arriving safely at their destination or having an RTI. 
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Countermeasures to driver sleepiness are aversive actions taken by the driver in the
hope to maintain alertness; these can be classified as two types; pre-journey and in-
transit. Pre-journey countermeasures are activities undertaken to reduce sleepiness 
on a future journey, an example of a pre-journey countermeasures is getting a good 
night’s sleep. In-transit countermeasures are used at the time sleepiness occurs, for 
example stopping for a nap. Within both types of countermeasure some options are 
more effective than others and a driver must have accurate knowledge of what is most 
effective to make the correct choice based on their current situation to avoid a RTI.  
1.3.4.1 Effective counter measures to driver sleepiness
Nordbakke and Sagberg (2007) provide a fairly comprehensive list of possible 
countermeasures drivers use to combat sleepiness.
Pre-journey countermeasures In-transit countermeasures
Avoid heavy meal right before the drive
Plan starting time/sleeping habits
Sufficient sleep over a long period
Plan stop during the drive
Sufficient sleep the night before
Avoid/be moderate with alcohol
Opening the window
Stopping and getting out of the car 
(stretch legs)
Put on music
Talk to yourself 
Eat sweets/drink sodas
Drink coffee (caffeine containing drink)
Ask passenger(s) to talk to you
Drink water
Stop and have a nap
Stop to eat
Drive faster or overtake
Talking on mobile phone (not applicable 
in the UK)
Table 1.3-1 Counter measures to driver sleepiness Nordbakke and Sagberg (2007)
Planning for a long journey could reduce the chance of driver sleepiness. It is 
important to get adequate sleep prior to a journey. For instance it has been shown 
that in cases of drivers who had had a RTI, those who had had 5 hours or less sleep the 
previous night had significantly greater risk of injury or death as a result of the RTI 
(Connor et al. 2002). Drivers involved in sleep-related crashes also report shorter 
average sleep per night than drivers involved in non sleep-related crashes (Stutts et al. 
2003). 
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Circadian rhythm affects how sleepy a person feels at different times of day, 
consequently there are times during circadian dip that sleep-related RTIs are more 
likely to occur, these are between 2am to 5am and 2pm to 4pm (Horne et al. 1995, 
Connor et al. 2002) as discussed in section 1.3.2 Choosing to complete a long journey 
in these vulnerable time periods could result in driver sleepiness (Lenne et al. 1997). 
Time on task is also a factor in RTIs (Folkard 1997), planning regular breaks reduces 
time spent driving and therefore risk of a RTI. 
With pre-journey countermeasures it seems obvious to avoid night driving and get
adequate sleep prior to a long journey (Anund et al. 2008). However, choosing an
effective in-transit countermeasure may be more difficult as some prior knowledge is 
required.  The two effective in-transit countermeasure are caffeine consumption and 
having a nap, both significantly improve driving performance, subjective sleepiness 
and objective sleepiness measured by EEG in sleep restricted drivers and more so in 
combination (Horne et al. 1996, Reyner et al. 2000, De Valck et al. 2001, Reyner et al. 
2002, Biggs et al. 2007, Hayashi et al. 2008). In addition to the experimental work RTI 
risk has also been shown to be reduced for drivers who have had coffee within the last 
2 hours (Cummings et al. 2001). Caffeine has also been shown to improve driving 
performance in individuals who were not sleep restricted in the first place, thus 
demonstrating a counteracting effect to a monotonous environment as well as 
improved alertness in cases of sleepiness (Brice et al. 2001, De Valck et al. 2001).
Countermeasures shown to be ineffective include; exercise/stretching legs during a 
break from driving (Lisper et al. 1980, Horne et al. 1996). Cold air on the face and loud 
music have also been shown to have little effect on driving performance at a simulator 
task and make no significant improvement to objective sleepiness as measured by EEG 
(Reyner, Horne 1998a). As a result of this increasing body of evidence into effective 
countermeasures UK Highway Code was changed in 1999, where it previously advised 
sleepy drivers to stop and stretch their legs it now states drivers should have a high 
caffeine content drink and a 20 minute nap (Highway Code 2008). Consequently, all UK 
drivers have access to accurate information in the Highway Code, Figure 1.3-1.
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A study of UK drivers prior to the highway code change, reported the most popular 
countermeasure to be opening a window (68%) followed by stop for a walk (57%), only 
14% said to drink coffee (Maycock 1996). This is reflective of the advice at the time 
however, no similar research has been conducted since the change in advice. All
drivers passing their test since 1999 will have learnt to have caffeine and a 20 minute 
nap if they feel sleepy when driving, to plan their journey not to coincide with the 
circadian dip and to take a break every 2 hours as part of their theory learning from 
the Highway Code (Highway code 2008). People who passed their test before 1999 
would only be aware of this if they keep up to date with Highway Code changes.
Although, it is a requirement to keep up to date with changes in the Highway Code this 
is done at drivers volition, consequently, their maybe UK drivers who still think if they 
feel sleepy when driving they should stop and stretch their legs. 
1.3.4.2 Preference for countermeasures
It is important to note that knowledge and action are two different things. In order to 
choose an effective countermeasure a person needs to have the knowledge of which 
measures work and additionally the motivation to act on this knowledge.
Although it may seem obvious to get a good night’s sleep before a long drive to a sleep 
researcher, it is not necessarily the case for the general public. A Norwegian survey of 
Figure 1.3-2 The Highway Code rule 91
The Highway code - Fitness to drive
91
Driving when you are tired greatly increases your risk of collision. To minimise this risk
 make sure you are fit to drive. Do not begin a journey if 
you are tired. Get a good night’s sleep before 
embarking on a long journey 
 avoid undertaking long journeys between midnight and
6 am, when natural alertness is at a minimum 
 plan your journey to take sufficient breaks. A minimum 
break of at least 15 minutes after every two hours of 
driving is recommended 
 if you feel at all sleepy, stop in a safe place. Do not 
stop on the hard shoulder of a motorway 
 the most effective ways to counter sleepiness are to 
drink, for example, two cups of caffeinated coffee and 
to take a short nap (at least 15 minutes).
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1513 drivers asked respondents what puts them at risk of driver sleepiness, 79% said 
several nights bad sleep but only 43% felt one night of bad sleep prior to a drive would 
have an effect (Nordbakke et al. 2007).   The circadian effect was even less 
acknowledged in the Norwegian survey as only 20% of the respondents thought that 
the time of day they started a journey would have an effect on driver sleepiness. 
Length of driving time is also not always recognised as a problem; in a UK study only 
35.1% of respondents would take a break every 2 hours or less, 23.9% of people being 
happy to drive for 4 hours or more (Maycock 1996). Those who are happy to drive for 
longer were more likely to have fallen asleep while driving (Maycock 1996, Nordbakke 
et al. 2007). If people do not have accurate information about causes of driver 
sleepiness it is unlikely they will take appropriate pre-transit precautions. 
Training in effective countermeasures could be aimed at new drivers and high risk 
drivers, such as those with sleep disorders and professional drivers. Providing such 
training has been shown to improve knowledge (Gander et al. 2005). In this case 
professional heavy vehicle and light vehicle drivers were trained to improve awareness 
of driver sleepiness and effective countermeasures. In a 2 year follow up participants 
were asked if they had changed their driving and choices as a result of the training.
Approximately half the drivers had done so, highlighting that individual choice plays a 
large part in countermeasure use, not just knowledge. 
When asked which in-transit countermeasures are most effective 70% of people in the 
Norwegian study said stop and have a nap and 34% said open a window. But when 
asked which countermeasure they would use the most popular choice was open a 
window (52%) with stop and nap chosen by only 8% (Nordbakke et al. 2007). This is a 
clear example of people having accurate knowledge of an affective countermeasure 
and choosing to ignore it. Though not all knowledge was accurate as 80% of people 
thought stretching their legs was a highly effective countermeasure whereas only 22% 
chose drinking coffee.  
Age has been shown to be a factor in choice of countermeasure, older drivers have 
been shown to be more likely to use an effective countermeasure (Anund et al. 2008). 
In particular, older drivers have been found more likely to stop driving to stretch their 
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legs or have a nap, whereas young drivers are more likely to continue their journey 
and use in-car countermeasures such as opening a window (Nordbakke et al. 2007). 
In a Swedish survey of 1886 drivers, logistic regression showed that people who had 
experienced driver sleepiness and professional drivers were more likely to choose 
having a nap and having caffeine (both effective countermeasures) (Anund et al. 
2008).  The same survey found that snorers and people with disturbed sleep were no 
more likely to choose an effective countermeasure than non snorers and people with 
good sleep. This is surprising as it would be expected that this subgroup of people 
would be likely to experience some driver sleepiness and therefore have some sort 
information on how to cope with this. Nordbakke and Sagberg (2007) asked people in 
Norway who had fallen asleep while driving what they did afterwards: 26% continued 
to drive without having a break while only 23% stopped for a nap (Nordbakke et al. 
2007). It is possible that as these people did not crash when they fell asleep they did 
not perceive themselves to be in danger so continued to drive. 
Use of countermeasures depends on an individual and their perception of the risk of 
driver sleepiness. If a driver does not feel they are at risk of becoming sleepy they may 
not feel the need to get a good night’s sleep prior to a long drive. UK motorway drivers 
are likely to have come across “Tiredness kills take a break” signs, which aim to 
promote awareness amongst drivers of the advice in the Highway Code. If these are 
effective it could be expected that UK drivers know that driving when tired is 
dangerous and would therefore seek out effective countermeasures. 
1.4 OSA and driver sleepiness
1.4.1 OSA and driving Law
Certain medical conditions impact a person’s legal entitlement to hold a driving 
licence. In the UK there are two categories of driving licence group 1 car drivers and 
group 2 HGV drivers. This section outlines the law in regards to both types of licence 
and suffering from OSA. 
27
1.4.1.1 Car drivers Law
The UK law must follow the European Union (EU) directive 91/439/EEC annex III 
(European Union 1991) which details the minimum standards of physical and mental 
fitness for holding a driving licence in the EU, in which there is no mention of 
sleepiness or sleep apnoea. The final paragraph states:
Figure 1.4-1 Paragraph 18 EU Directive 91/439/EEC
This gives some scope for other conditions such as OSA which are not mentioned to 
result in sufferers being deemed ‘unfit to drive’. 
The majority of the EU countries driving licence laws state the EU directive. However, 
10 out of 25 surveyed countries do mention sleepiness or OSA in their local law; this 
includes the UK (Alonderis et al. 2008). Across the EU countries which mention OSA all 
agree that if untreated patients should stop driving, but once successfully treated 
driving may resume. 
In practice in the UK most patients diagnosed with OSA receive treatment very soon 
after diagnosis. They will then inform the Driver and Vehicle Licensing Agency (DVLA) 
that they have the condition and present a letter from their doctor saying they are 
receiving satisfactory treatment, as such there is rarely a period of time when driving 
ceases.  
1.4.1.2 Heavy goods vehicle law
EU law governs working practice for all HGV drivers across the EU. The law states that: 
 Driving time is limited to 9 h per 24h (this may be extended twice a week to 10 
h per 24h period).
 Drivers may be on duty for a maximum of 11 h per 24h.
“As a general rule, where applicants or drivers suffer from any disorder
which is not mentioned in the preceding paragraph but is liable to be, or
to result in, a functional incapacity affecting safety at the wheel, driving
licences shall not be issued or renewed unless the application is supported
by authorized medical opinion and, if necessary, subject to regular
medical check-ups”
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 Maximum weekly drive time is 56 h but must not exceed 90 h in a two week 
period.
 Drivers can drive a maximum of 4.5 h without a break. For every 4.5 h driving a 
driver must have 45 min break. 
(Official Journal of the European Union 2006) (EC) 561/2006 
In the UK, to drive a HGV, a group two, large goods vehicle (LGV) licence is required; 
applicants for this licence must be aged 18 or over. From the granting of the licence 
until the licence holder is 45 no medical checks are required. When the licence holder 
is aged 45 to 65 they must pass medical examinations every 5 years, and when over 65
pass a medical every year. The DVLA issues information regarding the medical which 
includes a description of symptoms of OSA and advises applicants to contact a doctor 
if they feel they have any of the symptoms. The information clearly states “Even if a 
medical condition is the cause of falling asleep at the wheel, it is not an excuse in law” 
(DVLA 2009). So holders of group two licences receive some, all be it not much, 
information about OSA and the dangers of driving whilst sleepy when they reach the 
age of 45. 
As with car driving licence holders it is the duty of the licence holder to report any 
medical conditions to DVLA, this includes OSA. To continue holding a licence group 
two licence holders must visit a medical practitioner who is required to both confirm 
receipt of treatment and confirm ongoing compliance with treatment.  It is therefore 
possible that a diagnosed HGV driver may have to stop professional driving for 
approximately three months during treatment in order to prove compliance.
1.4.2 Risks associated with OSA
In sections 1.2.4 and 1.2.5 the symptoms and risk factors associated with OSA were 
presented. The risk factor of impaired cognitive function and the symptom of 
excessive daytime sleepiness both may have a direct impact on driving, because of this 
these two have been further discussed below. 
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1.4.2.1 Impaired cognitive function
There are many studies investigating the impact of OSA on cognitive function, but 
there are no definitive conclusions to the question ‘do OSA patients have impaired 
cognitive function?’, and ‘does CPAP treatment improve cognitive performance?’ In 
general review papers have suggested that it is likely that there is some cognitive 
impairment in OSA participants and often some improvement in some areas is seen 
with CPAP treatment (Aloia et al. 2004, Decary et al. 2000, Engleman and Joffe 1999, 
Saunamaki et al 2007). Due to the conflicting nature of findings a summary of the 
studies referenced can be found in Table 1.4-1 to greater detail than other reference 
tables in the current work. Here follows a discussion of the major points.
In papers reporting impaired cognitive performance in OSA patients the most 
commonly reported areas of deficit are working memory, phonological fluency, 
cognitive flexibly and planning (Saunamaki et al. 2007). It has been suggested that this 
impairment is linked to intelligence: one study showed that cognitive impairment 
measured by attention tasks compared to healthy controls is only seen in OSA patients 
with normal intelligence, those with high intelligence show no impairment compared 
to healthy controls also of high intelligence. Quan et al. (2006) compared 67 untreated 
OSA participants and 74 controls at a battery of cognitive tests and found no 
significant difference between the groups. The authors do note that the participants 
had mild to moderate OSA and that impairment maybe apparent in more severe cases 
of OSA, none the less, no significant differences were found. 
In general CPAP treatment has been shown to improve the specific areas of attention 
and vigilance as reviewed by Aloia et al. (2004).  For example, Bardwell et al. (2001) 
studied 36 OSA participants receiving 1 week of real or sham CPAP the authors report 
overall cognitive improvement with the real CPAP. However, this study only compared 
treatment for 1 week, this is not long enough as participants would not have had time 
to get used to using the mask. Also performance at the specific tasks did not 
significantly improve with real CPAP it was only when results for all were combined 
that the improvement was concluded. CPAP has also been found to improve cognitive 
performance by Barnes et al. (2002) who report an improvement in cognitive function 
with 28 OSA participants receiving treatment for 8 weeks. In this case it is not clear 
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how much improvement is due to the CPAP or placebo effect as in some tests there 
was significant improvement under the placebo condition. In another treatment 
intervention study 20 OSA participants were found to have significantly improved 
cognitive function after 3 months of treatment which was still apparent 1 year into 
treatment (Bork et al. 1996). Although CPAP may improve cognitive impairment it has 
been reported that it does not normalise it, in a review Engleman and Joffe (1999) 
identified that even in cases of improvement treated patients did not always reach 
baseline levels of controls. 
Although on the whole improved cognitive performance is reported following 
treatment of OSA participants it is not the case for all studies. Testing 47 OSA 
participants at baseline and following one year of CPAP treatment no change in
cognitive impairment was found by Alchanatis et al. (2005). Barbe et al. (2001) tested 
55 OSA participants at baseline and following 6 weeks of either CPAP or sham CPAP 
and found no significant difference of any cognitive measure between groups post 
treatment. This particular study was with OSA participants who did not have EDS so 
that maybe a confounding factor as the majority of OSA patients will have EDS.  Henke 
et al. (2001) completed a randomised control trial with 46 OSA patents using CPAP and 
sham CPAP in this case both groups showed some improvement following treatment 
but the real CPAP did not result in greater improvement than the sham CPAP. 
Although still not conclusive, increasingly papers are reporting that some degree of 
cognitive impairment is apparent in OSA patients. Additionally authors are stating 
theories as to what is the cause of this impairment. Two strong hypotheses are i) 
impairment is caused by sleep deprivation ii) impairment is caused by permanent 
brain damage as a result of hypoxia.    
If there is impairment in cognitive ability in OSA patients which is due to sleep 
deprivation it would be expected that following successful CPAP treatment cognitive 
ability will improve because sleep deprivation has been removed. This has been shown 
by Borak et al. (1996), and even at adherence to CPAP of only 3.4 hours per night
improvement is reported (Engleman et al. 1994). 
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In their highly controlled study of cognitive function across the day Lis et al. (2008) 
demonstrated untreated OSA patients to be slower and less accurate at cognitive tasks 
and that performance deteriorated as daytime sleepiness increased. The authors 
equate performance to be similar to that of healthy people who have been sleep 
deprived, suggesting it is the sleep fragmentation causing the impairment rather than 
hypoxia. These findings are supported by Verstraeten et al. (2004) who compared 36 
OSA participants with 32 controls they reported significantly worse performance at 
tasks by the OSA participants but noted it to be similar to the cognitive decline found 
after sleep loss in healthy people. Both sleep fragmentation and hypoxia are 
correlated to RDI so it might be expected that those with greater sleep disturbance i.e. 
a higher RDI would have a greater impairment of cognitive function, but RDI has been 
shown to be unrelated to cognitive function (Boland et al. 2002, Lojander et al. 1999).  
Similarly, decreased brain activation has been seen using fMRI on a ‘Go no Go’ task 
with untreated OSA patients compared with controls. Here, higher AHI was associated 
with slower reaction time, however, AHI was not related to changes in cerebral 
response. Suggesting that impairment was due to the sleep disruption caused by 
increased AHI rather than hypoxia (Ayalon et al. 2009). It should be noted that there 
was greater variability between OSA participants than between control participants, a 
larger sample size than 14 in each group may be necessary for a firm conclusion. 
Changes in grey matter are also reported between untreated OSA and control 
participants however, this has not been linked to any impairment in cognitive function 
(Yaouhi et al 2009). 
Not all studies show significant improvement following CPAP treatment (Knoepke and 
Aloia 2009, Henke et al. 2001), suggesting the underlying cause of impairment may not
be due to sleep deprivation itself. Comparing pre and post treatment patients, Aloia et 
al. (2004) found psychomotor to be the most likely cognitive function to still be 
impaired following treatment. The authors hypothesise this to be due to permanent 
damage of the brain caused as a result of hypoxemia. Noting that the brain regions 
associated with fine motor control may be more susceptible to hypoxemia, whereas 
attention, which is impaired by both sleep fragmentation and hypoxemia generally 
improve when sleep fragmentation is eliminated. 
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A further suggestion is that cognitive impairment is caused due to a decline in white 
matter. Brain imaging studies have shown structural abnormalities in white matter in 
untreated OSA patients (Macey et al. 2008) which could affect performance at 
cognitive tasks. In this study Macey et al. (2008) made a direct comparison between 
brain scans of 41 untreated OSA patients and 69 controls. Untreated OSA patients 
suffer sleep deprivation as a result of a fragmented night’s sleep. In healthy subjects 
white matter has been implicated in a person’s ability to function when sleep deprived 
(Rocklage et al. 2009). As such OSA participants who may have damaged white matter 
due to hypoxia may have a reduced capacity to cope with the sleep deprivation they 
experience due to fragmented, this may explain reduced cognitive function. 
A major problem when deciding if CPAP treatment reverses any cognitive impairment 
is variation in compliance to treatment and treatment duration (Decary et al. 2000, 
Yaouhi et al. 2009). Additionally lack of standardised testing makes it hard to compare 
results between studies (Decarey et al. 2000). It has also been suggested that tests of 
higher sensitivity are needed (Lee et al. 1999). 
In cases where no improvement has been seen it is possible that patients are not using 
their machine for long enough and therefore still have some sleep deprivation 
problems resulting in conflicting findings. For example, when comparing real and sham 
CPAP Barbe et al. (2001) found no improvement in cognitive performance; whereas 
Bardwell et al. (2001) reported improvements after just one week’s treatment for real 
compared with sham CPAP. Additionally, not controlling for learning effect is 
particularly key problem if you consider improvement can be found with sham CPAP as 
well as real CPAP (Henke et al. 2001) and with placebo tablet as well as CPAP (Barnes 
et al. 2002).
Alternatively, apparent cognitive difficulty may in fact be an adaptation to new tasks 
problem rather than a genuine cognitive deficit. In a procedural learning task a sub 
group of OSA patients were found to have marked difficulty with the task initially 
when compared to controls and other OSA patients, suggesting adaptive skills 
problems. After practice there was no significant difference between the OSA 
participants as a whole and the control group suggesting OSA participants don’t have 
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general cognitive impairment but do struggle with novel tasks, showing normal 
learning following initial adaptation difficulties (Rouleau et al. 2002). It is also noted 
that all OSA patients showing this initial impairment were aged over 40 years old, so 
perhaps age of participant should also be considered when comparing findings.
There has been a large individual difference in cognitive ability reported in untreated 
OSA participants; however, when considering these results it is important to 
determine if any deficit is clinically important. It has been suggested that improvement 
in cognitive performance following CPAP can only be assessed if people are below 
average to start with; otherwise tests are not of sufficiently sensitivity (Lojander et al. 
1999, Alchanatis et al. 2005). Alchanatis et al. (2005) found no difference in cognitive 
ability between OSA and control participants of high intelligence however, those with 
normal intelligence did show impairment in comparison to controls. The authors 
conclude that high intelligence by protect against cognitive decline. No other studies 
distinguishing IQ were identified so it is not possible to know if this was a one off 
finding.  This suggests that not all OSA patients will experience cognitive impairment. 
In summary, it is highly likely that some untreated OSA patients will have some degree 
of cognitive impairment though the underlining cause of this is not yet known. CPAP 
has been shown to improve some cognitive functions but not all; it is unclear whether 
this would be due to permanent brain damage or poor treatment compliance. There is 
also the possibility of insufficient sensitivity of cognitive measures, and that small 
sample sizes may be affected by high degrees of individual difference. No studies were 
identified directly assessing cognitive function and driving ability, however, it is 
possible that impaired cognitive function may affect driving ability and is an area of 
research that should be investigated.
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Table 1.4 – 1 Summary of cognitive function in OSA patients’ studies
Author Year Type of study Sample Measures Results Conclusions
Alchanatis 
et al.
2005 Case control 47 OSA before 
treatment and 
after 1 year of 
CPAP
36 controls 
Neuropsychological 
battery test 
assessing attention 
and alertness. All 
participants were 
divided into high-
intelligence group 
(IQ ‡ 90th 
percentile) and a 
normal-intelligence 
group (50≤ IQ < 90 
percentile).
No significant difference between 
patient groups by IQ regarding 
OSA severity or sleepiness. High-
intelligence patients
showed the same 
attention/alertness performance 
compared with the high-
intelligence
controls. Patients with normal-
intelligence showed 
attention/alertness
decline compared with the 
normal-intelligence control 
group. Neither group of patients 
showed any difference with 1 
year of CPAP
High-intelligence may 
have a protective 
effect against OSA-
related cognitive 
decline. Cognitive 
function does not 
improve with CPAP. 
Aloia et al. 2004 Review 37 articles Articles published 
from 1985 – 2002 
findings were vague for most 
cognitive domains. Treatment, 
however, was noted to improve 
attention, vigilance
in most studies and consistently 
did not improve constructional 
abilities or psychomotor 
functioning
Potential cognitive 
impairment in OSA 
patients has not been 
conclusively proven.  
Treatment can 
improve the specific 
areas of attention 
and vigilance. 
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Author Year Type of study Sample Measures Results Conclusions
Ayalon et 
al. 
2009 Case control 14 OSA
14 Control 
Go no go task 
completed in an 
fMRI scanner. 
Patients with OSA showed 
decreased brain activation in 
cingulate, frontal, and parietal 
regions which are typically in-
volved in attention tasks. 
Increasing AHI was associated 
with slower mean reaction time 
and with decreased brain 
activation in areas involved in 
arousal and attention, response
The association of 
AHI with slow 
reaction times and 
brain activation 
suggests that 
alertness and 
reaction times show 
greater correlations 
with measures of 
sleep disruption than 
with measures of 
hypoxia.
Barbe et al. 2001 Randomised 
control trail
55 OSA 
patients 
without EDS
Patients received 
real or sham CPAP 
for 6 weeks post 
diagnosis. Quality 
of life, cognitive 
function, MSLT and 
blood pressure 
were recorded. 
All variables were similar (nsd) 
between groups at the start. 
There was no significant different 
to any variables following 
treatment or sham. 
In patients who do 
not have EDS CPAP 
does not
modify quality of life, 
objective sleepiness, 
vigilance, attention,
memory, information 
processing, 
visuomotor 
coordination, or 
arterial
blood pressure.
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Author Year Type of study Sample Measures Results Conclusions
Bardwell et 
al. 
2001 Random 
control trail
36 OSA 
patients 
Patients received 1 
week of CPAP or 
sham CPAP. Tests 
completed pre-
and post treatment
Digit Vigilance-Time significantly 
improved with real CPAP.  All 
results were rank summed 
together The rank-sum test 
revealed that the CPAP group had 
significantly better
overall cognitive functioning post
treatment than the placebo 
group 
There is suggestion 
that overall cognitive 
improvement may be 
due to CPAP, no 
beneficial effects in
any specific cognitive 
domain were found
Barnes et 
al.
2002 Random 
control trail –
repeated 
measures
28 Mild OSA 
(AHI 5 – 30) 
Measures were 
taken at base line 
then after 8 wk of 
treatment with 
CPAP, and after 8 
wk
of treatment with 
an oral placebo 
tablet
CPAP improved self-reported 
symptoms of OSA, including
snoring, restless sleep, daytime 
sleepiness, and irritability more 
than did placebo However, the 
placebo
tablet resulted in a significant 
improvement in a wide range of 
functional variables compared 
with baseline
Placebo effect
may account for 
some of the 
treatment responses 
to CPAP observed 
previously in patients 
with mild OSA. 
Boland et 
al.
2002 Case control 1700 
participants 
not diagnosed 
with OSA 
PSG completed and 
RDI scored and 
cognitive measures 
taken
There was no consistent 
association between the RDI and 
any of the cognitive function 
measures.
There is no evidence 
of a dose response 
relationship between 
the RDI and cognitive 
function scores. 
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Author Year Type of study Sample Measures Results Conclusions
Borak et al. 1996 Treatment 
intervention
20 severe OSA Psychological
tests were 
performed before, 
after three, and 
after twelve 
months of CPAP 
treatment.
At baseline the most disturbed 
cognitive functions were 
concentration and recent 
memory. CPAP treatment 
resulted in significant 
improvement in cognitive 
function;
concentration, recent verbal, 
visual and spatial memory were 
already seen at three
months.
In  patients with 
severe OSA CPAP
treatment results in a 
significant early 
improvement in 
cognitive function 
but not in emotional 
status.
Decary et 
al.
2000 Review NA review
paper is to propose 
a standardized test 
battery for the 
neuropsychological
evaluation of OSAS 
patients
Overall performance is found to 
be impaired in OSA participants 
but it is hard to compare between 
studies due to a variety of tests 
used. 
A standard test 
battery is proposed 
to cover attentional
and executive 
functioning, short-
term and long-term 
memory,
and provide a global 
evaluation of 
intellectual 
functioning. 
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Author Year Type of study Sample Measures Results Conclusions
Engleman 
et al.
1994 Randomised 
control trail 
34 mild OSA 
patients  
4 weeks on CPAP, 4 
weeks on placebo 
tablet in a 
randomised order
Compared with placebo, CPAP 
improved
ESS  but not objective MWT 
performances on 2 of 7 cognitive 
tasks  and, depression score.
Confirms benefits
for daytime function 
after CPAP treatment 
for mild SAHS, but 
highlight poor 
compliance y of CPAP 
in many such patients
Engleman 
and Joffe
1999 review 10 selected 
articles 
Review cognitive 
impairment in OSA 
from selected 
relevant articles. 
Cognitive
performance on tests of attention 
and concentration ability, visual 
motor and constructional skills, 
verbal fluency, planning and 
problem solving, memory and 
executive function may be mildly 
to moderately impaired  in OSA 
patients. The daytime 
impairments associated with OSA 
are improved by CPAP, although 
it does not normalise The severity 
of sleepiness and cognitive 
impairments show weak and 
moderate correlations with 
frequency of sleep-disordered 
breathing in clinical and 
epidemiological studies.
Experimental and 
clinical evidence
supports a role for 
nocturnal 
physiological events 
of OSA, arousals and 
hypoxaemia, in 
directly or
indirectly producing 
neuropsychological 
deficits, particularly 
those of sleepiness 
and cognitive 
deterioration.
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Author Year Type of study Sample Measures Results Conclusions
Henke et 
al.
2001 Randomised 
control trial 
46 OSA 
patients
Therapeutic and 
sub therapeutic 
CPAP. Tested 
before and after 
treatment 
Significant
improvements in Digit Symbol, 
Digit Span Backward, and 
Complex
Figure tests. However, there were 
no group differences in changes
in test results during the period 
when one group was on effective
CPAP and the other on ineffective 
CPAP
No difference in 
improvement 
depending on if on 
real or sham CPAP. 
Knoepke 
and Aloia
2009 Review NA Review of 
literature to 
propose a model 
for cause of 
cognitive 
impairment in OSA 
Evidence indicates that hypoxia is 
partially responsible for this 
impairment and that its effects 
are not responsive to treatments 
for OSA.
Cognitive impairment 
is apparent in OSA 
patients. A
proportion of the 
clinical impairment 
seen can be 
attributed sleep 
fragmentation. There 
is some evidence that 
some is caused by 
hypoxia 
Lee et al. 1999 Case control 17 OSA 
patients
16 controls 
neuropsychological 
tests of executive 
functions
OSA had greater deficits in the 
retrieval of information from 
semantic memory and in shifting 
responses in the face
of error but differences in 
working memory were not.
More sensitive 
measures than are 
typically used in 
neuropsychiatric 
research are 
required.
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Lojander et 
al.
1999 Randomised 
control trial
27 OSA 
participants 
with CPAP 23 
OSA 
participants 
had UPPP 
surgery
Cognitive function 
tested at baseline, 
month 3 and 1 year 
after treatment
Cognitive function did not 
correlate importantly with
daytime sleepiness or severity of 
OSAS Success in treatment of 
OSAS
did not affect neuropsychological 
outcome.
The standard 
cognitive
test battery is 
insufficiently 
sensitive to identify 
positive changes in 
patients with
OSAS,
Macey et 
al.
2008 Case control 41 untreated 
OSA patients  
69 controls
Brain scan White matter is extensively 
affected in OSA patients
Alterations in white 
matter include axons 
linking major 
structures within the 
limbic system, pons, 
frontal, temporal and 
parietal cortices, and 
projections to and 
from the cerebellum.
Quan et al. 2006 Case control 67 OSA 
participants 74 
controls
A battery of 
neuropsychological 
tests 
No significant differences in any 
individual neuropsychological test 
or composite variable between 
the OSA and control groups
Mild to moderate 
OSA has little impact 
on the selected 
measures of 
attention, executive 
function, motor 
speed and processing
speed.
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Rocklage et 
al.
2009 Case control 32 students 
aged 19 – 25 
separated to 
those affected 
by sleep 
deprivation 
and those not
Total sleep 
deprivation, visual 
motor task and 
MRI scan
Participant susceptibility to sleep 
deprivation  was correlated with 
lower fractional anisotropy values 
in multiple regions of white 
matter, Significantly higher values 
in those less vulnerable to sleep 
deprivation. 
Differences in 
distributed white 
matter pathways 
reflect, and may 
contribute to, a 
person’s ability to 
function effectively 
when sleep deprived.
Rouleau et 
al.
2002 Case control 28 OSA 18 
controls 
Mirror Tracing and
Rotary Pursuit skill 
learning tasks. 
Subjects also 
completed a 
comprehensive
neuropsychological 
test battery
No significant differences in 
learning rates
were observed between the 
groups However, there was a 
subgroup of OSAS subjects (n=11) 
who
showed marked difficulties in the 
initial acquisition of the Mirror 
Tracing Performance of subjects 
who had difficulty with
initial adaptation on the Mirror 
Tracing was also significantly 
lower on tests of frontal 
executive function but not in 
those <40 years.
OSAS patients did not 
show procedural skill 
learning deficits 
however, did show 
deficits in initial skill 
adaptation and
difficulties on other 
neuropsychological 
tests
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Author Year Type of study Sample Measures Results Conclusions
Saunamaki
et al.
2007 Review 40 articles Review of papers 
from 1990 to 2005
The most defected domains of
executive functions were working 
memory, phonological fluency,
cognitive flexibility, and planning. 
CPAP improved  performance 
times, cognitive flexibility,
and planning. Deficits in working 
memory and phonological fluency
persisted.
Performance 
impaired Executive 
functions in OSAS 
should be assessed
with a standardized 
neuropsychological 
test battery More 
research is
needed on the 
efficiency of CPAP 
treatment on 
executive 
dysfunctions
Verstraeten
et al.
2004 Case control 36 OSA 
patients 32 
controls 
Neuropsychological 
tests included Trail
Making part A and 
B, Symbol Digit 
Modalities (SDMT), 
Digit Span forward
and backward, 
Stroop Color-Word, 
Five-Point design 
fluency, and an
Attention Flexibility 
task
Performance was significantly
reduced on the SDMT, the Digit 
Span forward
task , the number of errors on the 
basic 2-choice reaction time
subtest of the Attentional 
Flexibility task and the mean RT 
on the actual Attentional 
Flexibility subtest. No other 
performance differences were
found between patients and 
healthy controls.
No specific clinical 
indications for
executive attention 
deficits  or
an impaired central 
executive of working 
memory are found in 
patients. Cognitive 
performance seems 
very similar
to the cognitive 
decline found after 
sleep loss 
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Author Year Type of study Sample Measures Results Conclusions
Yaouhi et 
al.
2009 Case control 16 OSA 
untreated
14 controls
Neuropsychological 
test battery to 
investigate
attention and 
vigilance, executive 
functions, episodic 
memory and motor 
domains and brain 
imaging by MRI. 
Little impairment in memory and 
motor domains. No impairment 
at all other tests. Gray matter loss 
in the frontal and temporo–
parieto–occipital cortices
Not impaired
despite the presence 
of only minor 
memory and motor
impairments, 
patients displayed 
significant cerebral 
changes in terms of 
both gray
matter density and 
metabolic levels
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1.4.2.2   Excessive Daytime Sleepiness and sleep restriction
As EDS is a known symptom of OSA, it is the EDS which can result in OSA sufferers 
having difficulty to maintain alertness during a monotonous task such as long distance 
driving. EDS can lead to poor memory, poor sustained attention, irritability, learning 
problems, cognitive difficulty and ultimately depression (Engleman and Joffe 1999, 
Engleman et al. 1999), all of which could contribute to increase risk of RTI. The most 
widely used measure of EDS is the Epworth Sleepiness Scale (ESS) (Johns 2001), this is 
shown in section 3.5.3. The key papers discussing excessive daytime sleepiness and the 
few investigation the impact of sleep restriction can be found in table 1.4-2.
Specifically it has been demonstrated that OSA patients have a reduced ability to 
maintain concentration during monotonous situations (Mazza et al. 2005). It is 
therefore plausible that if faced with a monotonous motorway drive OSA patients may 
find it harder than non sufferers to remain alert.  Using ESS in the context of driver 
sleepiness is problematic because it is a subjective measure and people may be 
unwilling to answer truthfully in fear of having their licence revoked. Engleman et al. 
(1997) asked 99 OSA patients for ESS scores prior to starting CPAP. Once people were 
treated they were asked again to rate their ESS score from before treatment, 
prompting a retrospective assessment of sleepiness. They found that 67% of people 
gave a higher ESS the second time around. This would suggest that the problem of EDS 
in OSA is worse than most studies report due to the underreporting by the 
participants. However, it should be noted that patients were surveyed up to 70 weeks 
into treatment so some may have found it hard to recall how they were feeling over a 
year ago. 
Many studies have shown that CPAP treatment can improve the performance of OSA 
patients at various tasks, sometimes to the level of healthy individuals (Hack et al. 
2000, Munoz et al. 2000, Yamamoto et al. 2000, George 2001) and therefore it may be 
supposed that all treated OSA patients are fit to drive. Although, there are a few 
studies showing some evidence that CPAP does not relieve EDS (Dinges et al. 2003, 
Santamaria et al. 2007) which may mean driving could remain impaired, there is strong 
evidence that ESS of treated OSA patients is no worse than the general population.
Stradling et. al. (2007) have reviewed this by comparing ESS of over 500 patients with 
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500 controls, they found the prevalence of scores over 10 to be similar in both groups 
indicating the patients with EDS using CPAP are still within healthy norms. Another 
study points out that the range of estimates of increased accident rates due to EDS 
varies greatly, so more research is needed in this area. The author also states EDS in 
OSA patients is not a major public health risk (Douglas 2001).
It is generally accepted that treated OSA patients are fit to drive because EDS is 
controls and this is reflected in the laws of many countries (Alonderis et al. 2008). An 
area of interest examined in very few studies of OSA participants relating to driving is 
the effect of sleep deprivation. It is known that sleep deprivation of healthy individuals 
can impair driving performance (Horne et al. 2004) and that OSA patients on CPAP 
treatment can show driving performance the same as healthy individuals (e.g.Findley 
et al. 1989). So how does sleep deprivation affect the driving of these treated OSA 
patients? Only two studies which looked at the effect of sleep deprivation on 
untreated OSA patients were identified, they found that the lack of sleep created the 
same level of impairment for OSA patients as controls using the psychomotor vigilance 
task (PVT) (Desai et al. 2006). Interestingly the sleep deprivation did not increase the 
subjective sleepiness scores of the OSA patients as much as the controls (Desai et al. 
2006). This may suggest some impairment in self recognition of sleepiness. 
The only sleep restriction study in OSA participants when driving used a driving 
simulator. Vakulin et al. (2009) compared 38 untreated OSA sufferers with 20 controls 
at a 90min driving task. The OSA participants were found to have greater vulnerability 
to the sleep restriction (4h) resulting in larger standard deviation of lane position. 
Additionally OSA participants had a 40% greater impairment in recognising self 
sleepiness following sleep restriction than healthy controls. The greater susceptibility 
to sleep restriction is interesting, but as it is already generally accepted that untreated 
OSA sufferers are not fit to drive of greater interest is whether this increased 
vulnerability persists with treatment.
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Table 1.4 – 2 Summary of Excessive Day Time Sleepiness in OSA patients’ studies
Author Year Type of study Sample Measures Results Conclusions
Desai et al. 2003 Case control 13 OSA
16 controls
Full PSG after a 
normal sleep and 
after 36h sleep 
restriction.
OSA participants had lower 
minimum oxygen saturation 
following sleep deprivation but no 
difference in AHI.
Sleep deprivation does 
not worsen OSA 
parameters measured 
by PSG.
Desai et al. 2006 Case control 13 OSA
16 controls
Neurobehavioural 
assessment test 
after normal sleep 
and 36h sleep 
restriction.
OSA participants were less aware of 
their sleepiness and on 1 occasion 
showed greater impairment than 
controls.
OSA react the same to 
sleep deprivation as 
controls, but are less
able to perceive 
daytime sleepiness.
Dinges et 
al.
2003 Case control 77 CPAP treated 
OSA receive 
madafonil 80 
CPAP treated 
OSA  receive 
placebo
Reaction time and 
functional 
outcomes of sleep 
(FOS).
Those taking modafonil had better 
reaction times, less lapses and better 
FOS results.
Modafonil can help 
improve alertness in 
CPAP treated OSA 
patients. 
Douglas 2001 Review There is great variation in estimates 
of increase risk of RTI in OSA. Which 
can be used to suggest between 1% 
and 50% of RTI deaths are caused by 
OSA. 
Figures are very 
speculative and more 
research is needed, it 
has not been proven 
that EDS in OSA is a 
major public health 
risk. 
Engleman 
et al. 
1997 Intervention 99 OSA patients ESS and questions 
on driving 
impairment taken 
prior and post to 
CPAP treatment 
ESS significantly rose and more 
driving impairment was reported. 
Patients underestimate 
the problems 
associated with OSA 
prior to treatment. 
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Author Year Type of study Sample Measures Results Conclusions
Engleman 
et al.
1999 Randomised 
controlled trial
34 OSA patients 
4 weeks on 
CPAP, 4 weeks 
on oral placebo
ESS, MWT, 
psychological 
function and 
quality of life 
assessments. 
CPAP improved ESS but not MWT, 
psychological well being and quality 
of life also improved.
CPAP  improves 
daytime functioning 
but adherence can be 
low. 
Engleman 
and Joffe
1999 Review Daytime 
sleepiness, 
cognitive deficits, 
driving ability and 
psychosocial well 
being. 
OSA patients generally report severe 
daytime sleepiness; mild problems 
are identified with attention, 
concentration, verbal fluency and 
problem solving. 
Severe daytime 
sleepiness and mild 
cognitive function 
problems may 
contribute to RTIs 
making them 7 times 
more likely than in 
healthy people. In 
general CPAP improves 
all problems. 
Findley et 
al.
1989 Case control 6 untreated 
OSA 7 controls
Driving simulator OSA performed worse than controls. 
Following treatment OSA 
participants repeated the simulation 
and made less errors. 
Driving simulator 
performance is 
impaired in OSA 
patients and improves 
with CPAP treatment. 
George 2001 Case control 210 OSA treated 
with CPAP for 3 
years
Compared official 
accident reports 
for the 3 years 
before and after 
CPAP treatment 
and controls for 
same period
Untreated OSA had more RTIs than 
controls, following CPAP the number 
fell to normal. 
Risk of RTI due to OSA 
is removed by
treatment. 
Hack et al. 2000 Repeated 
measures
59 OSA on real 
and sham CPAP 
Driving simulator Standard deviation of steering 
improved with real CPAP, daytime 
sleepiness also improved.
OSA impairs driving and 
performance improves 
following treatment.
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Author Year Type of study Sample Measures Results Conclusions
Mazza et 
al.
2005 Case control 20 OSA
40 controls
MWT, sustained 
attention and 
divided attention 
tasks.
95% of patients had vigilance and/or 
attention impairment.
For OSA patients ability 
to remain awake in 
monotonous situations 
is impaired. Using only 
a single test may 
underestimate the 
problem. 
Munoz et 
al.
2000 Case control 80 OSA 
80 controls
ESS, anxiety, Steer 
clear simulator and 
PVT
Steer clear performance and mood 
improved with treatment. Reaction 
time showed little change.
CPAP is a good 
treatment for OSA.
Santamaria 
et al.
2007 Review CPAP is effective for most patients 
but some continue to complain 
about sleepiness after CPAP. 
CPAP compliance 
should be monitored 
and diagnosis checked. 
Modafinil could be 
tried. 
Stradling et 
al.
2007 Case control 572 OSA
525 Control
ESS No difference in the % of each group 
with an ESS>10.
Some people on CPAP 
will still be sleepy but 
no greater prevalence 
than the general 
population. 
Vakulin et 
al.
2009 Case control 38 OSA
20 controls
Driving simulator OSA had higher steering deviation 
than controls and greater 
deterioration over time. 
OSA are more 
vulnerable to sleep 
restriction.
Yamamoto 
et al.
2000 Retrospective 47 OSA Driving history, ESS 
and mood
Reports of more accidents prior to 
starting CPAP than once on 
treatment and improved ESS. 
CPAP reduces the rate 
of RTI and improves 
daytime sleepiness. 
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1.4.3 Heavy Goods Vehicles
The prevalence of OSA increases with age and is most common in men aged 40 to 60
years (Hardinge, 2008). It has been suggested that HGV drivers as a cohort may be at 
higher risk of OSA as a result of general characteristics associated with their work e.g. 
sedentary job and irregular meal patterns which may result in obesity.   There is no UK 
national screening for OSA in HGV drivers and therefore many people may be driving 
these large vehicles for prolonged periods over many miles whilst suffering from 
undiagnosed OSA.
1.4.3.1 HGV statistics
The number of HGV licensed drivers in GB in 2007 was 528 000, this is in comparison 
to over 28 million cars (Department for Transport 2008). In 2007, 461 HGVs were 
involved in fatal accidents compared to 3141 cars. However if this is looked at in rate 
per 100 million vehicle kilometres, HGVs have a fatal accident rate of 1.6 compared to 
0.8 for cars (Department for Transport 2008). That is to say there are fewer HGV
licensed drivers in GB than cars, yet the rate at which they are involved in fatal 
accidents is twice as high. It should be noted that these figures are for HGVs licensed 
in Great Britain and does not include foreign registered vehicles on GB roads, meaning 
that actual figure could be higher. 
In 2006 in the USA there were 8 819 000 large trucks registered, 4,732 of these were 
involved in fatal crashes resulting in a total of 4,995 deaths; this is despite the fact that 
large trucks only account for 4% of all registered vehicles (NHTSA’s National Center for 
Statistics and Analysis 2008). If this figure is calculated as rate per 100 million vehicle 
miles travelled there is a fatal accident rate of 2.12, far worse than in Great Britain. 
Two USA reports have suggested sleepiness accounts for 31 – 41% of major crashes of 
commercial vehicles (Transport Research Board 1985, National Transportation Safety 
Board 1990). This higher figure for HGV srRTIs is supported by a particularly worrying 
report from a roadside survey of truck drivers in the USA, stating 47.1% of drivers 
admitting to having fallen asleep at the wheel (McCartt et al. 2000). It is unclear if the 
problem is as severe in other countries; a study focusing on the Australian state of 
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Victoria estimated that fatigue of HGV drivers contributes to 9.8 % of fatal HGV 
crashes (Haworth et al. 1989).
An additional problem for HGV drivers is that in periods of time not driving, drivers 
may be engaged in loading and unloading of the vehicle. This means that time 
“resting” from driving is not actually spent at rest. 
1.4.3.2 HGV drivers and OSA
HGV drivers have been recognised as appropriate targets for OSA screening 
(Gurubhagavatula et al. 2004) as they have been identified as often being male, middle 
aged and obese (Caples et al. 2005), all factors which put people more at risk from 
OSA. HGV drivers as a population have been targeted in OSA research in order to 
estimate prevalence both objectively and subjectively. The key findings are 
summarised in table 1.4-3. 
1.4.3.2.1 Objective measures of OSA in HGV populations
The most accurate way to diagnose OSA is with over night polysomnography (PSG). 
Objective measures give definitive diagnosis of OSA but as they are costly to carry out 
there are very few studies of this nature. A large study of objective measures recorded 
truck drivers sleeping at a truck stop and reported 78% having sleep disordered 
breathing (Stoohs et al. 1995). This suggests the problem of undiagnosed OSA maybe 
very greatly within the HGV driver population. Overnight sleep recordings have also 
been completed on HGV drivers in Sweden and Australia, here undiagnosed OSA was 
less frequent at 17% and 15.8% respectively (Carter et al. 2003, Howard et al. 2004).
To get the most accurate picture of how many HGV drivers have undiagnosed OSA all 
HGV drivers would be required to undergo PSG. An American study has investigated 
the cost effectiveness of screening all HGV drivers for OSA and found that this was not 
cost effective, in comparison to the cost incurred from RTIs of undiagnosed OSA 
sufferers. However if drivers were first identified as high or low risk using BMI, gender 
and age and only the high risk drivers were tested with PSG the authors suggest it 
would cost 50% less than the cost that these drivers could incur on the road while at 
risk from their undiagnosed OSA (Gurubhagavatula et al. 2008). It must be noted that
these values were based on a mass mailing survey of truck drivers with only a 32%
51
response rate. But still results are promising and give strong argument to implement a 
basic screening process. 
1.4.3.2.2 Subjective measures
For research less accurate and cheaper methods are often used to investigate 
prevalence of OSA. The majority of research into HGV drivers and OSA uses some form 
of questionnaire, though there are a few driver simulator studies. Existing studies
using subjective measures have shown OSA to be highly prevalent among commercial 
drivers ranging from between 16% and 78% being affected; measures include
questionnaire, ESS, and BMI though none of these studies were conducted in the UK 
(Stoohs et al. 1995, Carter et al. 2003, Gurubhagavatula et al. 2004, Canani et al. 
2005). Questionnaire screening is cheaper than PSG, and recording BMI combined with 
OSA symptom reporting has been shown to be 81% sensitive at identifying 
undiagnosed OSA sufferers when checked with PSG (Gurubhagavatula et al. 2004). 
However, it will always be the case that not all OSA sufferers will be identified. 
Questionnaire studies have also been used to successfully assess driver sleepiness in 
HGV drivers, such as in Finland in which 20% of long haul drivers reported falling 
asleep at the wheel (Häkkänen et al. 2000). 
A road side questionnaire survey in the USA looked for predictors of falling asleep at 
the wheel in long distance drivers who were covering more than fifty thousand miles 
per year: they found that an arduous work schedule (> 10 hours driving), poor self 
reported sleep on work nights, daytime sleepiness, symptoms of OSA (snoring, BMI, 
stopping breathing), night time drowsiness and age were all significant predictors of 
falling asleep at the wheel (McCartt et al. 2000). However, in this study 47.1% 
reported falling asleep at the wheel so this is a particularly biased group when 
compared with the healthy population. Though it does demonstrate the vulnerability 
of this cohort and is strong evidence for the dangers of OSA.
An alternative approach to HGV driver survey is to question those who have had an 
accident regarding the hours leading up to it. One New Zealand postal survey asked 
HGV drivers recently involved in an RTI questions about the 72 hours preceding the 
incident (Gander et al. 2006). This study suggested that the number of hours of 
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previous driving is of greater significance than the number of hours prior wakefulness. 
Suggesting time on task to be a big influencing factor, this is controlled for in the EU as 
HGV drivers are only allowed to drive 4.5h without a break. It was estimated that 
17.6% of the crashes were fatigue related, adding to evidence from studies in many 
countries that driver sleepiness is a constant problem in this cohort.
A large proportion of HGV drivers recognise sleepiness as a problem in their industry, 
but the majority do not report this being a problem for them as an individual (Feyer et 
al. 1995, Arnold et al. 1997). This suggests that if voluntary screening for OSA was 
offered drivers would not take it up because they don’t perceive themselves to have a 
sleepiness problem. If screening is introduced it is likely to be most effective if it is 
enforced. 
The vast majority of research in this area has been conducted abroad, but there is one 
UK specific study from 1995; a postal survey of HGV drivers and male car drivers. This 
study found that there was no significant association between number of miles driven 
in a year and previous accidents for HGV drivers, although for car drivers people with 
higher annual millage were more likely to report having had an accident. In this study
the HGV drivers were not asked if they had ever fallen asleep at the wheel and the 
interviewer made a subjective decision as to whether each HGV driver was obese or 
had a large collar size. The study found that those categorised as obese or large collar 
size were more likely to have EDS, and those with high EDS who were also classed as 
having a large collar size were more likely to have had an accident in the last three 
years (Maycock 1995). This study does suggest that there may be a problem with 
undiagnosed OSA in UK HGV drivers similar to that identified in the studies about, but 
as the main classification measures were subjective it is possible not all obese drivers 
were recognised or some drivers were classified as obese when they were not. 
A further UK study has been conducted by a commercial CPAP provider. Their website 
gives details of a large survey of UK HGV drivers which found 16% percent to be 
suffering from OSA and needing immediate treatment. Obviously there is a conflict of 
interest in a CPAP manufacturer conducting this type of study, but to date no 
equivalent has been carried out (Moylan 2005).  Both UK studies would suggest that 
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there may be a problem with undiagnosed OSA in HGV drivers but the subjective 
classification of the Maycock study (1995) and the conflict of interest in Moylan (2005) 
mean that no firm conclusions can be reached. 
As a related side line, Edinburgh bus drivers have also been shown to have a high 
prevalence of driver sleepiness, with 12% of respondents reporting having fallen 
asleep at the wheel and 9% reporting falling asleep while at work at least once a 
month. Using a questionnaire assessment this study suggest that prevalence of OSA to 
be 10% in this population, the authors report inviting participants for a sleep study but 
with very low acceptance rate the results were not reported (Vennelle et al. 2010).  
This further demonstrates the difficulty in screening commercial drivers for OSA if it is 
not compulsory; it is probable that many participants will refuse the overnight sleep 
study for fear of implications about their legal driving status.
Within sleep research PSG is the accepted gold standard to diagnose OSA however, in 
the context of HGV driver screening, blanket PSG has been shown not to be cost 
effective (Gurubhagavatula et al. 2008). As such objective measures alone are not 
appropriate for this cohort. Instead target PSG recordings to those most at risk are 
desirable. However, before any government/company policy for targeted screening 
would be introduced research evidence is needed to prove that the problem of 
undiagnosed OSA is a large enough problem to be tackled. The best way to do this is 
anonymous subjective questionnaire and BMI calculation as drivers will be more likely 
to participate if it is anonymous as they will not fell their job is a risk. If BMI can be 
objectively calculated this would add strength to the potential diagnosis as BMI is 
strongly linked to OSA. However, as with all subjective measures it must then be 
recognised that this is an estimation as not all participants will answer honestly.  
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Table 1.4 – 3 Summary of Key HGV and OSA studies
Author Year Type of study Sample Measures Results Conclusions
Canani et al. 2005 Cross sectional 438 male HGV 
drivers
Questionnaire on 
sleep, driving 
habits and ESS
45% had loud snoring, 7.6% 
witnessed apnoeas. 22% had fallen 
asleep at the wheel . 39% had 
been involved in an RTI with 16.4% 
stating sleepiness as possible 
contributing factor. 
Sleepiness is a common 
problem probably 
relating to RTIs
Carter et al. 2003 Survey case 
control
40000 drivers
1389 
professional 
drivers
Survey and 161 
drivers had a 
sleepy study. 
Greater proportion of accidents in 
professional drivers. 17% of 
professional drivers having the 
sleep recording were diagnosed 
with OSA.
Professional drivers had a 
greater self perceived 
sleep debt. 
Gander et al. 2006 Survey 130 completed 
questionnaires 
which could be 
linked to a crash 
report. 
Anonymous 
questionnaire on 
sleep and duty 
history 72h before 
incident
17.6% of crashes were identified 
as fatigue related. In 511 official 
crash reports 5.1% were identified 
as fatigue related. 
Current methods of 
assessing fatigue crashes 
only identify 41-71%
Gurubhagavatula 
et al. 
2004 Survey 247 HGV drivers Predicting OSA 
from symptoms 
and BMI, 
confirmation by 
PSG
Using symptoms and BMi was 81% 
sensitive which is comparable to 
oximetry.
Two stage screening is 
viable to exclude OSA 
from commercial drivers. 
Gurubhagavatula 
et al.
2008 Case control 247 HGV drivers 
at high risk of 
OSA, 159 at low 
risk.
3 screening 
methods, PSG, PSG 
only of those at 
high risk, no 
screening
PSG is not cost effective as it is 
more expensive than cost incurred 
from OSA related crashes. 
Screening for age, gender and BMI 
prior to PSG is cost effective. 
Strategies to eliminate 
blanket PSG are more 
cost effective than not 
screening high treatment 
acceptance is needed.
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Author Year Type of study Sample Measures Results Conclusions
Häkkänen et al. 2000 Survey 184 long haul 
drivers, 133 
short haul 
drivers
Questions on OSA 
symptoms and 
driver sleepiness.
40% of long haul and 21% of short 
hall had difficulty staying alert on 
20% of driving occasions. 20% of 
long haul reported falling asleep 
while driving.  4% of long haul 
showed signs of OSA.
Driver sleepiness is 
common even if few 
drivers have OSA.
Haworth et al. 1989 Review 9.1% of fatal accidents involving 
trucks are sleep related.  Accident 
risk is highest during the night. In 
vehicle countermeasures are 
popular.
Sleep related crashes are 
a recognised problem and 
in vehicle alerting devices 
should be tested.
Howard et al. 2004 Survey 2342 HGV 
drivers, 161 
having PSG
Questions on 
daytime sleepiness 
and OSA symptoms
Of those having PSG 60% had SDB 
and 15.8% OSA. 24% of all drivers 
had EDS. The sleepiest 5% of 
drivers had increased accident 
risk. 
EDS and SDB are common 
in HGV drivers. Accident 
risk is related to 
sleepiness.
Maycock 1995 Survey 996 HGV drivers Questions on 
accidents in last 3y, 
ESS and OSA 
symptoms.
Accident rate was not linked to 
time spent driving. Over 55y had 
more accidents. 37%  snored  or 
were judged by the interviewer to 
have large collar size and had 
ESS>12. 
Those with signs of OSA 
had an accident liability 
twice that of the 
remainder. 
McCartt et al. 2000 Survey 593 HGV drivers Questionnaire on 
typical work and 
rest patterns, 
drowsiness and 
sleep disorders.
47.1% had ever fallen asleep while 
driving, 25.4% in the past year. 
Underlying independent factors of 
falling asleep while driving were, 
daytime sleepiness, arduous 
schedule, older, short and poor 
sleep and symptoms of sleep 
disorder.
Identifying drivers with 
sleep disorders would 
reduce sleep related 
driving incidents. 
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Author Year Type of study Sample Measures Results Conclusions
Stoohs et al. 1995 Survey 388 HGV drivers
159 had sleep 
monitored 
Oxygen 
desaturation index 
(ODI) , BMI
10% had ODI>30 per h. BMI was 
significantly different between 
those with ODI>30 and <5. 20% 
showed symptoms of regular sleep 
disturbance. 
The combination of 
potential OSA and 
difficult shift patterns 
impacts on daytime 
alertness. 
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1.4.4 Review of OSA research with survey/accident studies
Looking at accident records from the police or insurance companies and self reported 
accidents are also a good way to compare OSA patients and controls or to compare 
OSA patients’ pre and post treatment.  However, a major limitation of most of these 
studies in this area is that they are cross-sectional. 
A review of accident survey studies with non commercial drivers found in 23 out of 27 
papers untreated OSA drivers were at significantly higher risk of having had an 
accident than controls (this did include 8 simulator studies) with a median odds ratio 
of 3:1 (Ellen et al. 2006). In one retrospective study with a large sample size it was 
suggested that the difference between accident rate in untreated OSA and controls is 
largely due to those with an AHI over 40 (George et al. 1999). It appears that OSA 
drivers are at a significantly greater risk of RTI although the difference may be due to 
severe OSA sufferers being at particularly high risk. 
CPAP has been found to be very effective at reducing RTIs. One study surveyed CPAP 
users, of which 39.39% self reported RTIs in the 2 years prior to CPAP, yet none of 
them reported RTIs during the first 2 years of treatment (Yamamoto et al. 2000). 
Another study of CPAP patients in comparison to a control group found the patients 
were significantly more likely to have had an accident in the 3 years prior to treatment 
but in the first 3 years of CPAP the chance of an RTI occurring was the same as for 
controls (George 2001). 
In one accident survey study it was found that controls had more accidents than 
untreated OSA patents during a 3 year period, though the OSA patients self reported a 
greater percentage of their accidents to be sleep-related (Aldrich 1989). It has been 
shown that sleepy drivers have more RTIs but sleepy drivers are not necessarily 
suffering from undiagnosed OSA (Masa et al. 2000). Here respondents were classified 
in to subgroups by level of sleepiness, when assessed for OSA 24% of total 
respondents were positively diagnosed with 14% of these in the non sleepy driver’s 
category. Similarly in Horstmann et al. (2000) 32% of OSA patients had an ESS >15 but 
only 12% of the patients reported having had a sleep-related crash, suggesting EDS 
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does not necessarily result in a RTI. The same study did however, find that those with 
an AHI >34 had more accidents than the control, so severe OSA may lead to accidents.
Relying on self reported accidents means there may be some bias as participants may 
not want to admit to having had an accident. Another approach is to look at insurance 
company or government records of RTIs, though again any unreported RTIs will not 
appear. Several studies have found untreated OSA patients to have more accidents 
than controls to various odds ratios, 2.3 (Barbe et al. 1998), 3.4 (T. Young et al. 1997), 
6.3 (Teran-Santos et al. 1999). 
A different approach is to survey drivers who have had RTIs to look for commonalities. 
It has been found that OSA is more prevalent in RTI drivers than matched controls 
(Teran-Santos et al. 1999). Though in another study the prevalence of sleep disordered 
breathing (SDB) was found to be similar between the two groups (Kingshott et al. 
2004). Also of note in the latter study there was no correlation between ESS and RTI 
and those who answered yes to the question “Have you ever felt sleepy while 
driving?” were more likely to have had an RTI. Other studies have also demonstrated 
that self reported sleepiness while driving was a predictor of accidents (Young et al. 
1997, Lloberes et al. 2000, Masa et al. 2000).  However, it should be considered that 
the people who have had an RTI may be more aware of sleepiness while driving as 
they have experienced a crash; because of this they may have heightened awareness 
of anything which may result in RTI and over report it. 
It is acknowledged that not all OSA patients will have an RTI (George 2001) and 
although various methods have been tried, it has not been possible to identify a 
predictor of which patients are more likely to have an incident. Daytime sleepiness, 
anxiety, depression, level of vigilance and driving simulator performance have all been 
unsuccessful at predicting which patients will have accidents (Young et al. 1997, Barbe 
et al. 1998). 
1.4.5 Review of OSA and driving simulator studies
The current research to investigate the impact of OSA on driving will be conducted 
predominantly using a driving simulator. The following is a review of existing literature 
in the specific area of OSA and driver sleepiness (key findings are summarised in table 
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1.4-4), subdivided by the type of simulator used for the investigation. To aid
understanding, initially an introduction to driving simulators is included.  
1.4.5.1 Driving simulators
When experimentally assessing driver sleepiness the ethical implications of putting a 
known sleepy driver in charge of a vehicle on real roads means that in practice most 
research is carried out using a driving simulator.
1.4.5.1.1 Types of simulator
The simulators used in this type of research can be split by the three main sub groups; 
steer clear, divided attention driving task (DADT) and advanced simulators. 
 The steer clear task typically lasts for 20 minutes where subjects are shown a 
computer generated dual carriageway road, they are instructed that if they 
need to change lane because of an obstacle in the road they should press a 
computer key. The outcome of the test is measured by how many collisions 
occurred.  The steer clear is a vigilance test which has not been shown to relate 
to actual crashes (George 2004).
 DADT is more advanced than the steer clear task. This simulator typically has a 
steering wheel, brake and accelerator pedal, usually set up in front of a 
computer screen. Participants are asked to drive in the centre of a computer 
generated winding road. The test measures standard deviation from the centre 
of the road; and therefore ability to stay on course. In the corners of the screen 
numbers are shown, these change through the drive, before the start the 
participant is instructed which of these stimuli they should respond to, when 
they see this number they should press a button on the steering wheel as 
quickly as possible. Reaction times are calculated from this.
 Advance simulators vary greatly but all typically have a real immobilised car (or 
half a car) which the participant sits in to drive on a computer generated road. 
Some simulators vibrate to suggest movement; others play road noise into the 
car to give the illusion of movement. The road set up used varies between 
research centres, with some favouring a winding road similar to the DADT 
while others have a monotonous dual carriage way. Some have reaction time 
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tasks as in the DADT others do not. Advanced simulators provide the most 
lifelike driving experience.
 Real car on road driving. A few research centres conduct trials using 
instrumented dual controlled cars, such as those at Maastricht and Utrecht 
universities in the Netherlands. In these studies, participants drive on real 
roads with the investigator in the passenger seat to take over control of the car 
if required. Sensors within the car can monitor the real world environment and 
records deviation from central lane position on major roads. To date these cars 
have predominantly been used to investigate the effect of drugs and alcohol on 
driving and never in the area of OSA (e.g. Verster et al. 2004, Wingen et al. 
2005). 
1.4.5.1.2 Advantages and limitations to simulator studies
As well as being safer than on-road testing simulators also allow tight experimental 
control by reducing the number of uncontrolled variables (George 2004). It is also 
harder to monitor lane position on a real road than in a simulator. 
Using driving simulators to assess driver sleepiness have shown comparable results to 
real life driving, however, lane drifting is elevated in a simulator and participants may 
feel sleepier (Philip et al. 2005). Driving tasks have been shown to be highly correlated 
to the Maintenance of Wakefulness test (Philip et al. 2005, Pizza et al. 2009). 
Suggesting that the MWT could be used as an assessment of fitness to drive (Banks et 
al. 2005, Pizza et al. 2009). In the MWT subjects are required to stay awake as long as 
they can in an un-stimulating environment. 
It is acknowledged that motivation while driving a simulator is different than on the 
road as a crash does not have the same consequence; the driver has no need to fear 
for their safety or the safety of other road users (George 2004). It is possible to 
increase the suggestion of a “real life” situation particularly with sleepy participants by 
using a real car and recreating a standard driving environment such as wearing a seat 
belt.
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1.4.5.1.3 Performance measures
Various outcome measures can be used to assess driving ability: acceleration, 
breaking, following distance, maintaining speed, lane position, and maintain driving 
while completing a secondary task (George 2003). Sleep related road traffic incidents 
(srRTIs) are characterised by drivers drifting off the road or into another lane (Pack et 
al. 1995) so assessing lane drifting may provide the most accurate measure of sleep 
impaired driving performance. Driving simulators have shown that with sleepiness, 
deviation within a lane and collisions with lane demarcation lines increases (Philip et 
al. 2005). The other measures may also be affected by sleepiness so should be 
considered, however lane drifting is the primary outcome. 
Previous work at Loughborough University has used an advanced simulator, stationary 
real car simulator to assess driver sleepiness predominantly by inappropriate lane 
crossing as scored manually from video recordings of drives (Horne et al. 1996, Reyner 
and Horne 1998a, Reyner and Horne 1998b, Baulk et al. 2001, Horne et al. 2003, 
Barrett et al. 2004b). This simulator set up has been validated to real road conditions 
(Baulk et al. 1998), a full description of the simulator can be found in chapter 3. 
1.4.5.2 Obstructive sleep apnoea participants at steer clear task
The steer clear simulator is a simple design but has been demonstrated to effectively 
distinguish between OSA patients and a control group in various studies. It has also 
been shown that this impaired performance can be overcome by CPAP treatment. This 
suggests that prior to treatment OSA sufferers may pose a danger on the roads 
however with effective treatment this risk is reduced.  
The earliest of these studies was Findley et al. (1989). This American study compared 
performance in a steer clear simulator of untreated severe OSA patients with controls. 
The drive only lasted for 30 minutes so although it was monotonous it is possible that 
the participants may have been able to sustain attention for this time though would 
have impaired performance had the test been longer. The OSA patients hit 
significantly more road obstacles than the controls. After CPAP treatment 
performance improved and was no longer significantly different to the controls. 
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However, the small sample size of 12 in each and the fact that only 6 of these 
completed the task again after CPAP means only limited conclusions can be drawn.
Other driving simulator studies have also shown CPAP to improve performance of OSA 
sufferers at the steer clear task both in the UK (Kingshott et al. 2000)  and in Spain 
(Munoz et al. 2000). Amongst other tests, participants completed ESS, steer clear and 
PVT before treatment, 3 months and 12 months into CPAP treatment. ESS and steer 
clear performance had improved by 3 months and this was sustained up until the 12th
month of treatment at the end of this study. These studies all show that any 
impairment at a steer clear task which is present in OSA patients is greatly reduced 
and often eliminated after treatment with CPAP. 
It is important to note the great variability at steer clear performance amongst OSA 
patients. One study suggests that as many as 15% of untreated or undiagnosed OSA 
sufferers do not pose any greater risk on the roads when compared to people of a 
similar age without the condition (Findley et. al. 1995). The worst performers of the 
OSA group were significantly worse than the OSA participants who performed at the 
level of the control group, but nothing was attributed as the cause of this difference. It 
should be noted that participants only had one minute to practice before the task 
started so it is possible that a learning effect had an impact on the results of this 30 
minute drive.
It has to be questioned how accurate steer clear is at predicting real life situations, the 
task involves pressing a computer key when you see an obstacle in the road often over 
a short period of time. For example Findley et al. (1999) used a longer, one hour steer 
clear task in conjunction with a reaction time task (creating a divided attention driving 
task) they compared 31 untreated OSA patients and 14 controls over an hour drive. 
The OSA hit significantly more obstacles, as previous research would predict, but what 
is interesting is that there was a difference in the time on task effect. The OSA group 
showed a trend to increased incidents with time on task which was not apparent in 
the control group. This suggests that it may be appropriate to have a shorter 
recommended driving time for people with OSA. Another interesting finding of this 
study is the variability amongst people with OSA, the variability of performance within 
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the OSA group was 27 times greater than the variability within the control group. This 
difference may be partially attributed to the control group being smaller than the OSA 
group, but it is important to note that there may be a heightened difference in ability 
to drive within OSA patients and therefore it may not be appropriate to consider all 
OSA patients in the same way. Further investigation is needed to see if there are any 
predictors of driving performance and also if performance changes with increased
driving length
It is possible to describe the steer clear task as a reaction time test within the context 
of driving. When participants complete a driving simulator task it is important that it 
gives them the perception of driving. Pressing a button is not representative of driving 
so participants may not take the simulation as seriously as they would actual driving.
1.4.5.3 Obstructive sleep apnoea participants at a Divided attention driving tasks 
(DADT)
DADT can be considered more advanced than steer clear as they require participants 
to use a steering wheel to govern the direction of their vehicle, whilst performing a 
reaction time test. Participants are required to actively steer to keep the car on the 
road as well as respond to target numbers. The DADT is traditionally a winding road 
which participants have to actively steer to stay on, this is not typical of the roads 
where sleep crashes usually occur. The task is usually short, 20 or 30 minutes, which is 
not a long time when you consider that the UK Highway Code recommends drivers 
should take a break every 2 hours and therefore expects long drives to be in excess of 
this time. 
Despite its shortcomings the DADT has been used to show that OSA does cause some 
driving impairment and that CPAP treatment can reduce this. There is also the 
suggestion that OSA sufferers are aware of how tired they are so would be able to stop 
before an incident occurred. DADT have also been used to demonstrate that the ESS 
and AHI may not be sensitive enough measures to predict driving performance for OSA 
patients. 
The first DADT studies with OSA patients were conducted in Canada (George et al. 
1996a). They found that on average OSA patients were worse at staying on track than
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the control group, although in practice this was only half of the OSA group performing
at a lower level than the control.   The investigators took other measures to try to 
identify what could be causing the impairment in some of the OSA patients tracking
and not others. Linear regression analysis showed that less than 25% of the variance in 
tracking error could be accounted for by AHI or MSLT score. The steering was the main 
measure of sleepiness, it was assumed that no steering movement for 30 seconds was 
because of sleep, however, without EEG it is not possible to know if this was the case. 
More recently, in the UK a DADT was carried out (Juniper et al. 2000). The view of the 
road was varied to form three conditions, one when the total road was visible, one 
condition only the near road was visible and the final condition only the far road was 
visible. The untreated OSA group performed significantly worse on all conditions at 
tracking and reaction time in comparison to controls. They were particularly worse 
when only part of the road was visible, which may suggest that OSA patients need 
more visual cues to maintain driving performance. As with other studies the drive time 
was only 30 minutes so it is still not known what performance would be like with 
prolonged driving.
It is known that sleep deprivation and alcohol can impair driving performance (Horne 
et al. 2003). The impairment due to OSA has been shown to be similar to that of sleep 
deprivation and not like that of alcohol over three 30 minute drives (Hack et al. 2001). 
Alcohol impaired steering equally throughout the drive; sleep deprivation resulted in 
increased impairment as the drive went on. The OSA group showed steering 
impairment more characteristic of the sleep deprived group than the alcohol group. 
However, the OSA group were in their fifties and the other two groups were in their 
twenties so there may have been a degree of age related change not accounted for.  
Another limiting factor is that each group drove at a different time in the day so it is 
not fair to compare them as they would have been under different circadian 
influences. 
The DADT has also been compared to real life RTIs (Turkington et al. 2001) assessing
people who attended a hospital clinic with expected OSA who were tested on a 10 
minute DADT, they were also asked to report any accidents, near misses or sleeping at 
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the wheel in the last 3 years and fill in a questionnaire about driving habits such as 
miles driven a year. No predictor of accident in the previous 3 years was identified. 
Age, sex and alcohol consumption were the best predictors of simulator performance, 
ESS was related to the reported near misses and sleeping at the wheel but did not 
correlate to simulator performance. However, Turkington et al (2001) relied on self 
reporting accidents; people may have been unwilling to disclose this information, 
particularly in a hospital setting, if they felt their driving licence was at risk. 
Mazza et al (2005) looked at ability at reaction time tests, ability to remain awake and 
DADT. They found that OSA patients were more likely to fall asleep while trying to 
remain awake than the control group and that although reaction time was similar the 
patient group were more likely to make mistakes. They also noted that the OSA 
patents who remained awake during the task still showed impaired performance at 
the other tasks. This is a concerning conclusion as it suggests that even if OSA patients 
appear alert they may still have impaired performance at tasks such as driving. The 
question then is how to measure this alertness; it has been found that the ESS is not 
sensitive enough to detect impaired performance (Mazza et al. 2005, Walter et al. 
2002a, Kingshott et al. 1998, Orth et al. 2005). It is also of note that Mazza et al. (2005) 
had only 1 female in the patient group but 12 in the controls which may have affected 
the comparison. Another study comparing ability to stay awake and DADT 
performance found ability to stay awake was correlated with simulator performance 
but this was not significant (Sagaspe et al. 2007b). This study also found that ability to 
stay awake was linked to AHI which Mazza et al. (2005) did not. 
A further study found no difference in ability to remain awake between OSA patients 
and controls (Mazza et al. 2006). The results of this existing research suggest it is 
unclear whether OSA patients have an impaired ability to remain awake in 
monotonous situations or not. It is possible the conflicting results between studies are 
due to great individual variation between OSA patients. 
Recently the DADT has been developed by Pizza et al (2008) so that the drive is a dual 
carriageway, as this is more reflective of the type of road sleep crashes tend to occur 
on. In this study OSA patients were tested on the simulator and subjective (Stanford 
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Sleepiness Scale and ESS) and objective (MSLT) sleepiness measures were taken. These 
measures all correlated to driving errors, the authors suggest that OSA sufferers are 
aware of their tiredness so would be able to stop before an incident occurred.
However, the study does not state if the patients were receiving treatment or not, it is 
assumed that they were not in which case it would be interesting to see if the same 
results were found following CPAP. Secondly the SSS scores were taken before the 
drive was started but not monitored throughout the drive. It would be useful to know 
how this changed through the drive as a predictor of incidents to see if OSA patients 
were truly identifying when they were getting tired. Finally the drive itself was 
designed to be monotonous but the test was only 30 minutes long so it has to be 
questioned if this really simulates a monotonous drive. 
The most comprehensive investigation into the effects of CPAP using a DADT was a UK 
study conducted by Hack et al (2000). This study was a double blind randomised 
control trial with 59 males aged 30 to 75, participants either received a working CPAP 
machine or a machine which appeared to work but did not blow air out at a positive 
pressure. DADT was completed for 30 minutes before and after treatment. The real 
CPAP resulted in significantly improved steering performance and reaction time and 
the sham CPAP did not. ESS scores were also taken, these significantly improved under 
both real and sham CPAP though to a greater extent with real CPAP. This study clearly 
shows the effectiveness of CPAP as a treatment for OSA and also shows that untreated 
OSA sufferers have some driving impairment (Hack et al. 2000). This is supported by 
Turkington et al (2004), who tested severe OSA patients in a driving simulator; half 
were then given CPAP treatment and tested on day 1, 3, 7 and 14. Treatment was then 
stopped for 7 days but simulator testing continued. The results were compared to the 
other 18 patients who did not receive treatment. They found the CPAP improved both 
tracking position and reaction time, the same as Hack et al (2000). However,
interestingly Turkington et al (2004) found that stopping treatment did reduce 
performance but, 7 days after stopping treatment this group were still performing 
better than the OSA patients who had never received treatment. As performance was 
not sustained without the treatment it would not be wise to recommend breaks in 
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treatment though this suggests that if treatment is missed for unavoidable reason 
patients may still be able to drive safely.  
1.4.5.4 Obstructive sleep apnoea participants at advanced simulator studies
There are fewer advanced simulator studies than DADT or steer clear as they are more 
costly and time consuming to administer.  They also tend to be longer drives as they 
are usually the main focus of testing unlike Steer Clear which can be administered as 
part of a battery of tests. Advanced simulators have been used to show impairment in 
ability of OSA drivers compared to controls and improvement following CPAP 
treatment. As with simpler simulator designs, no predictor of driving ability has been 
identified. These studies tend to be of longer duration that the simpler simulations. 
This may increase reliability at identifying impairment during monotonous driving as it 
has been reported that testing OSA drivers for 30 minutes on a simulator cannot 
identify impairment shown on the same simulator after a 90 minute drive (Vakulin et 
al. 2009). Impaired ability to recognise sleepiness and a lower capacity to cope with 
sleep restriction have been demonstrated compared to control groups. 
Advanced simulators have been used to demonstrate the effectiveness of CPAP 
treatment (Orth et al. 2005). In this case OSA patients were tested before and after 
receiving CPAP treatment, the results of which found an improvement in driving 
performance after treatment. The investigators also looked for predictors of simulator 
performance, as doctors are required to state if they think people are unfit to drive it 
would be useful if a measure could be found on which to base this decision. A number 
of psychological tests including ESS were looked at as well as features of an overnight 
PSG recording, but no links were found. This simulator did have a driving ‘cab’ for 
participants to sit in but it was not a real car, the ‘cab’ appears similar to that of racing 
games found in arcades. The drive was for 60 minutes following the format of the 
DADT.
A 60 minute advanced driving simulation comparing OSA sufferers and controls found 
OSA sufferers had worse lane deviation than controls (Risser et al. 2000). This study 
also took continuous EEG recording to measure attention lapses – alpha or theta 
activity lasting 3 seconds was counted as an attention lapse. This study is one of only 2 
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driving simulator studies using EEG during the drive recording, the other being Vakulin 
et al. (2009), described below. The OSA group had more extended and an increased 
number of attention lapses. Subjective sleepiness on a VAS was taken immediately 
before and after the drive showing the control group to be more alert. The subjective 
scores did not increase as much for OSA sufferers as they did for control participants 
suggesting impairment in ability to recognise sleepiness. Subjective scores were not 
taken throughout the drive so it is unknown how the groups relate to each other at 
this time. The authors state there were 15 controls and 15 OSA patients who 
completed the drive but it is unclear how many participants were included in analysis. 
After the drive the OSA participants then completed over night PSG and if their AHI 
was below 20 they were excluded from the analysis. It is also not stated if the OSA 
participants were receiving CPAP or not (Risser et al. 2000).  
Vakulin et al. (2009) used a dual carriage way simulation for 90 min on 3 occasions 
with OSA sufferers and control drivers after, normal sleep, sleep restriction (4 hrs) and 
alcohol consumption. With main outcome measures of steering deviation and 
‘crashes’ the untreated OSA group were found to have more impairment at the driving 
task than the control group at base line. The OSA group had significantly more 
impaired driving than the control group after sleep restriction though not after alcohol 
consumption. Many studies have also shown untreated OSA participants to have 
impaired driving compared to controls but it is interesting that sleep restriction has a 
greater effect on OSA participants. Using untreated OSA participants means it is not 
clear if the sleep restriction itself is the cause of impairment or rather by restricting 
people who already have poor sleep it might be expected that they be sleepier than 
controls.
All the advanced simulator studies discussed here have been using monotonous road 
conditions in order to represent the type of road where sleep-related crashes are most 
likely to occur. However, if medium traffic density is presented it has been shown that 
untreated OSA drivers perform at the same level as controls (Tassi et al. 2008). 
Interestingly the authors report increased theta and beta activity in OSA participants
EEG and greater caution when overtaking than controls, suggesting possible 
compensation mechanisms to achieve the same performance outcome. 
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A real car study was used to investigate reaction times of OSA sufferers compared with 
controls (Mazza et al. 2006). Participants drove down a 150 metre track, when the car 
reached 40 km/hr a jet of water was pumped on to the road forming a wall about 40 
meters in front of the car. Participants then had to brake and reaction time was 
measured. There were three conditions, the participant didn’t know when the water 
would appear, the participant was distracted at the time the water appeared and the 
participant was told to put their foot over the brake pedal just before the water 
appeared. OSA patients had slower reaction times that controls in each condition, 
though on average this was only 0.5 seconds. Following CPAP treatment the average 
reaction time became the same as for the controls. 
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Table 1.4 – 4 Summary of OSA and driving simulator studies key findings
Author Year Type of study Sample Measures Results Conclusions
Findley et al. 1989 Case control 12 untreated 
OSA
12 controls
30min Steer 
clear, obstacle hit 
rate
OSA participants hit more 
obstacles than controls.  Follow 
up of 6 patients post treatment 
showed improved performance. 
Driving simulator 
performance is 
impaired in 
untreated OSA and 
improves with CPAP. 
Findley et al. 1995 Case control 62 untreated 
OSA, 12 
controls, 10 
patients with 
narcolepsy 
30min Steer clear Poor performance at steer clear 
was associated with higher 
accident rate in the preceding 5 y. 
Patients had worse performance 
than controls.
Impaired vigilance on 
Steer Clear is
associated with high 
automobile accident 
rate in OSA patients. 
Findley et al. 1999 Case control 31 untreated 
OSA, 14 
controls , 16 
narcolepsy 
6*4min Steer 
clear
Patients had significantly more 
collisions than controls. There 
was greater inter-participant 
variability between OSA then 
controls. OSA participants 
showed greater decrease in 
performance with time on task 
than controls. 
In participant 
assessment tasks 
need to be of long 
enough duration to 
show time on task 
effects. 
George et al. 1996a Case control 21 untreated 
OSA, 21 
controls, 16 
narcolepsy 
20min DADT and 
MSLT
Tracking error was worse for OSA 
than controls. But half the patient 
group were as good at tracking as 
controls. MSLT did not predict 
DADT performance.
OSA participants 
have worse DADT 
performance than 
controls, MSLT does 
not predict this. 
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Author Year Type of study Sample Measures Results Conclusions
Hack et al. 2000 Randomised 
control trial
59 OSA 1 
month of CPAP 
or sham CPAP
3*30min DADT DADT improved in both 
conditions but more in real CPAP. 
Reaction time was faster 
following real CPAP
CPAP improves 
steering and reaction 
time showing 
untreated OSA to 
have impaired driving 
performance. 
Hack et al. 2001 Case control 26 untreated 
OSA, 12 
control. 24h 
sleep deprived 
and alcohol 
consumption. 
3*30min DADT Untreated OSA performed 
between alcohol consuming 
controls and sleep deprived 
controls. OSA was more like sleep 
deprivation than alcohol 
consumption.  
OSA impairment is 
more comparable 
with sleep 
deprivation than 
abnormal cognitive 
or motor skills. 
Juniper et al. 2000 Case control 12 untreated 
OSA, 12 
control
3*30min DADT 
part of road 
visible
OSA performed worse than 
controls particularly when not the 
entire road was visible. 
OSA patients may be 
more disadvantaged 
than controls when 
the view of the road 
is limited such as in 
fog.
Kingshott et al. 2000 Intervention 62 OSA at 
baseline and 6 
months into 
CPAP
30min Steer clear Task performance improved with 
CPAP treatment.  AHI was a poor 
predictor of performance.
CPAP improves 
daytime functioning 
in OSA patients.
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Author Year Type of study Sample Measures Results Conclusions
Mazza et al. 2005 Case control 20 untreated 
OSA, 40 
control
DADT Vigilance was impaired in OSA 
compared with control at a range 
of vigilance tasks including DADT.
It is not just ability to 
remain awake in 
monotonous 
situations but also in 
for stimulating 
conditions.  A single 
test is not sufficient 
to identify impaired 
vigilance. 
Mazza et al. 2006 Case control OSA before 
and after 
CPAP, controls
Real car, reaction
time. 
OSA had slower reaction times 
than controls, with twice the 
number of collisions. Following 
CPAP there was no difference 
between OSA and controls. 
Driving ability is 
significantly impaired 
in OSA. After CPAP 
deficits normalise 
even in non sleepy 
patients. 
Munoz et al. 2000 Intervention, 
case control
80 OSA before 
and after 1y 
CPAP. 80 
Controls
Steer clear Prior to treatment task 
performance was significantly 
worse in OSA compared with 
controls. Performance improved 
with CPAP.
CPAP is a valid 
treatment for OSA 
patients. 
Orth et al. 2005 Intervention 31 OSA 
patients 
before and 
after 2 and 42 
days of CPAP. 
DADT advanced 
simulator
Attention and alertness improve 
with CPAP but vigilance remained 
the same. No relationship 
between ESS and DADT
DADT is a possible 
bench mark for 
driving performance 
in OSA patients. 
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Author Year Type of study Sample Measures Results Conclusions
Risser et al. 2000 Case control 15 untreated 
OSA, 15 
controls
1h Advanced 
simulator with 
EEG
OSA had impaired driving 
performance compared with 
controls and more EEG attention 
lapses. Attention lapses were 
correlated with driving 
performance. 
OSA driver 
impairment increases
over task duration. 
RTIs are not just due 
to sleep disturbance 
but also inattention 
due to sleepiness. 
Sagaspe et al. 2007b Cross 
sectional
30 untreated 
OSA
1h DADT, MWT MWT correlated with DADT 
performance. The sleepiest group 
had the worse performance. ESS 
and AHI did not predict DADT 
performance.  
MWT 0-19min is 
associated with DADT 
performance 
impairment. 
Turkington et 
al.
2001 Cross 
sectional 
150 untreated 
OSA
20min DADT Participant characteristics – older 
age, female and alcohol 
consumption had greatest 
influence on DADT performance. 
Self reported near miss accidents 
were also associated with DADT 
performance. ESS is associated 
with falling asleep at the wheel.
There is an 
independent 
relationship between 
DADT performance 
and driving ability in 
OSA patients. 
Turkington et 
al.
2004 Intervention 18 OSA tested 
at baseline, 
1,3,7 days and 
2 weeks into 
CPAP. Then 
discontinued 
for 7 days.
DADT At 7 days of treatment DADT 
performance was significantly 
better than baseline. Following 7 
days of stopping treatment 
significant improvement 
compared to baseline was still 
reported. 
DADT performance 
improves within the 
first few days of 
starting CPAP. 
Improvement is 
sustained for up to 
1week without 
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treatment. 
Author Year Type of study Sample Measures Results Conclusions
Vakulin et al. 2009 Case control 38 untreated 
OSA, 20 
controls
Advanced 
simulator, sleep 
restriction and 
alcohol condition
OSA had worse driving 
performance than controls. 
Increase in driving impairment 
was significantly greater in OSA 
than controls following sleep 
restriction and alcohol. Prolonged 
eye closure and microsleeps 
predicted driving performance.  
Untreated OSA are
more vulnerable to 
sleep restriction than 
healthy controls. 
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1.5 Research aims and hypotheses
The aim of this research is to investigate the impact of OSA on driving in two key 
subgroups. 
A) HGV drivers on UK roads
B) OSA patients treated long term with CPAP 
From the literature review 7 areas were identified as needing further investigation. 
The following aims and hypotheses were then developed. This thesis has been 
designed with the hope of addressing them.   
AIM 1: To evaluate the prevalence of undiagnosed OSA in HGV drivers on UK roads. 
The literature has shown that driver sleepiness is a problem to HGV drivers. It can be 
exacerbated by hours spent driving, lack of quality sleep, inadequate rest and sleep 
disorders. OSA has been shown to be more prevalent in HGV driver populations than 
in the general population (Stoohs et al. 1995, Carter et al. 2003, Gurubhagavatula et al.
2004, Canani et al. 2005). However, results have be conflicting as some studies use 
more robust assumptions for undiagnosed OSA than others, as it is not cost effective 
to screen every driver using PSG. The majority of HGV and OSA studies have been 
conducted outside of the UK. The key study in the UK was conducted 15 years ago and 
results were based on the investigators perception of if participants were obese 
(Maycock 1995) as such there is a gap in the research to investigate if international 
findings are also applicable in the UK.
Hypotheses addresses in Chapter 2:
To test the hypothesis that undiagnosed OSA will be prevalent in HGV drivers on UK 
roads.
To test the hypothesis that OSA risk factors and symptoms can be used to predict self 
reported likelihood of falling asleep at the wheel in HGV drivers on UK roads.
To test the hypothesis that those with suspected OSA will have greater EDS and fall 
asleep incidents.
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To test the hypothesis that high ESS will be associated with reports of falling asleep at 
the wheel and risk factors of OSA.
To test the hypothesis that OSA symptoms and risk factors will be of greater 
prevalence than in the general population.
AIM2: To evaluate the effect of sleep restriction in OSA-CPAP compliant patients 
compared with controls at a simulated driving task.
The literature has shown performance at driving tasks improves in OSA participants 
following up to 1 year of CPAP treatment also to levels comparable with controls, 
(Findley et al. 1989, George et al. 1997, Hack et al. 2000, Kingshott et al. 2000, Munoz 
et al. 2000, Mazza et al. 2006). However, the research showing improvement in 
performance following CPAP treatment has predominantly been conducted using 
short duration tests. It is unknown if CPAP treated patients will have similar 
performance to controls at a long monotonous task, such as simulated motorway 
driving.
With untreated OSA participants total sleep deprivation (Desai et al. 2006) and sleep 
restriction to 4 hours (Vakulin et al. 2009) have be found to cause greater impairment 
at driving tasks than in healthy controls
CPAP treatment has also been shown to improve daytime sleepiness in OSA patients 
(Hardinge et al. 1995, Ballester et al. 1999). It would therefore be expected that when 
OSA patients use their CPAP and have a full night’s sleep they would feel no sleepier 
than control participants at the start of a task and progress in sleepiness during the 
task in the same manner as controls.
Subjective driver sleepiness is most commonly investigated by recording subjective 
sleepiness before and after a driving task. However, this methodology means that 
sleepiness is not reported when the participant is completing the task, as such 
alertness may have improved or worsened since the task environment has been 
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removed. The current work will record sleepiness throughout the driving task to 
address this. 
In two studies investigating subjective sleepiness following sleep deprivation in 
untreated OSA participants and increase in subjective sleepiness has been reported, 
however not to the same magnitude as control participants despite the OSA group 
having worse task performance (Desai et al. 2006, Risser et al. 2000).
Combined alpha and theta power has been demonstrated to be most representative 
of the transition between wake and sleep in healthy young participants during a 
driving simulator task (Horne et al. 1996). Beta activity occurs with increased effort to 
remain alert and has been shown to decrease with prolonged attention tasks (Jap et 
al. 2009). 
Beta activity in untreated OSA participants has been reported to be higher during a 
driving task of medium traffic density compared with controls (Tassi et al. 2008). 
Higher activity in the beta and theta power spectrum has also been observed during 
total sleep deprivation in untreated OSA participants compared with controls, 
suggesting greater sleepiness and greater effort to remain alert (Greneche et al. 2008). 
Only one study was identified in the area of OSA and driver simulation. Risser et al. 
(2000) completed a driving simulator study for 60 min including EEG recording of 
untreated OSA participants compared with control participants. OSA participants were 
found to have more “attention lapses” in EEG activity than controls and these lapses 
became longer in duration as the task progressed for the OSA participants, compared 
with controls. This indicates that the EEG activity of untreated OSA participants differs 
to that of controls during a driving task, however, this driving task was only 60 minutes 
so it is unknown if the same result would be found with a longer task or treated OSA 
participants. 
No studies with treated OSA participants were identified to assess if the increased 
vulnerability to the effects of sleep restriction in relation to task performance, 
subjective sleepiness and EEG activity persists into treatment. 
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Hypotheses addressed in Chapter 5
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by increased lane deviation 
after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation and 
shorter time to first incident after sleep restriction to 5h of treated sleep.
Hypotheses addressed in Chapter 6
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by subjective sleepiness 
measures (KSS and LHoFA) after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by subjective sleepiness measures 
(KSS and LHoFA) after sleep restriction to 5h of treated sleep.
To test the hypothesis that in both groups subjective measures of sleepiness will be 
correlated to each other (KSS vs LHoFA and KSS vs ESS). 
Hypotheses addressed in Chapter 7
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by increased beta and 
combined alpha theta activity after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased beta and combined 
alpha theta activity after sleep restriction to 5h of treated sleep both overall and at the 
specific time of first incident for the OSA group.
AIM 3: To evaluate the ability of OSA-CPAP compliant patients compared with controls 
at recognising sleepiness during a simulated driving task.
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The literature shows that participants in their early twenties are able to recognise 
sleepiness while completing a driving task and do so with an average of 45.5 min 
notice before first major incident (Reyner and Horne 1998b, Horne et al. 2004). The 
current research allows for the same analysis to be completed on older healthy and 
OSA participants aged 50 to 75.  
Increase in sleepiness from the full night’s sleep of sleep deprivation has been 
reported to be significantly greater for controls than untreated OSA participants (Desai 
et al. 2006), from which the authors suggest the OSA participants are not as good at 
recognising sleepiness as controls. However, this may not be certain as in practice the 
difference was small, with an increase just of 1.3 (SSS) for OSA suffers, compared to 
1.9 for controls. Additionally, Pizza et al. (2008) used a divided attention driving task 
periodically through the day to demonstrate that times where task performance was 
most impaired coincided with when OSA participants rated themselves as most sleepy, 
therefore suggesting OSA participants can recognise sleepiness.  
A previous driving simulator study with young participants has found EEG activity to be 
correlated with subjective sleepiness (Horne et al. 2004). Greneche et al. (2008) also 
investigated correlation of EEG and subjective sleepiness; here during 24 h sustained 
wake in older participants. EEG was found to closely correlate to subjective sleepiness 
in control participants but not in untreated OSA participants, suggesting OSA 
participants do not know when they were sleepy. This study was not associated with a 
performance task, so is not directly comparable to the current work as the perception 
of task performance may influence perception of sleepiness. However, it is of interest 
that the correlation was not identified in OSA participants. 
No studies identifying perception of sleepiness during a performance task with treated 
OSA participants were identified. 
Hypotheses addressed in Chapter 8
To test the hypothesis if OSA CPAP compliant participants show impaired ability to 
subjectively identify sleepiness at a driving simulator task as reflected by greater 
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number of driving incidents while reporting not being sleepy, reporting feeling sleepy 
prior to first driving incident after sleep restriction to 5h.
To test the hypothesis that EEG will correlate to KSS in both treated OSA and control 
participants after sleep restriction to 5h.
To test the hypothesis that fleeing sleepy will be associated with being likely to fall 
asleep for OSA CPAP treated patients during a driving task following sleep restriction 
to 5h.
AIM 4: To evaluate the ability of OSA-CPAP compliant patients during a simulated 
driving task following CPAP withdrawal for one night compared with after a normal 
night on treatment and treated sleep restricted to 5h. 
The literature shows withdrawal of CPAP in compliant long term users results in 
immediate resumption of sleep disordered breathing and when treatment is resumed 
there is immediate recovery, as measured by PSG (Grunstein et al. 1996, Yang et al. 
2006a). 
Three previous studies were identified as investigating the impact of CPAP withdrawal 
on task performance and subjective sleepiness; all have been with participants on 
CPAP for one year or less and results are conflicting.  
Turkington et al. (2004) used a divided attention driving task, CPAP was found to 
improve task performance compared to prior treatment performance. Following two 
weeks of CPAP the treatment was stopped, although task performance decreased it 
never returned to the same level as before treatment. Yang et al. (2006) also withdrew 
CPAP from compliant users; here participants felt sleepier after one night of 
withdrawal but were able to maintain performance at a battery of cognitive tasks 
including PVT. The residual effect of treatment after it had been withdrawn is 
unexpected as sleep disordered breathing is likely to have returned. However, it is
possible that participants were able to maintain performance despite the increased 
sleepiness due to the simple nature of the task. The PVT is a short duration test and 
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the divided attention driving task used in Turkington et al. (2004) was only 20 minutes 
in duration. This is too short to give an indication of ability to drive.
In contrast Kribbs et al. (1993a) also withdrew CPAP treatment for 1 night but reported 
that all participants had impaired subjective sleepiness and PVT performance 
compared with when undergoing treatment. 
No studies investigating perception of sleepiness following CPAP withdrawal were 
identified. 
Hypotheses addressed in Chapter 9
To test the hypothesis that sleep quality will be impaired with CPAP withdrawal in OSA 
CPAP compliant participants.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation, 
subjective sleepiness, EEG activity, successful drive completion and shorter time to 
first incident after treatment withdrawal than either normal treated sleep or sleep 
restriction to 5h of treated sleep.
To test the hypothesis that treatment withdrawal from OSA CPAP compliant 
participants with not affect ability to recognise sleepiness as reflected by KSS at first 
major incident and reporting feeling sleepy prior to first driving incident (KSS6+, LHoFA 
4+).
AIM 5: To evaluate the individual difference of the effect of sleep restriction in OSA-
CPAP compliant patients at a simulated driving task.
The literature shows that ability to maintain performance when sleep deprived varies 
greatly between healthy individuals (Van Dongen et al. 2004). Some degree of 
variability at the driving simulator task, when sleep restricted, would therefore be
expected in both the control and treated OSA group.
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Driving simulator studies have shown there to be great individual difference between 
untreated OSA participants, with many studies showing an overlap with performance 
of the control group (George et al. 1996b, Findley et al. 1999, Juniper et al. 2000, 
Findley 1995, Ayalon et al. 2009). This greater variability appears to be maintained 
following CPAP treatment (Findley et al. 1989, Hack et al. 2001).
With large individual difference it is important to find out what the predictor of driving 
impairment is. So far this has not been achieved, ESS, AHI and MWT have all been 
unsuccessful at consistently predicting poor task performance (Mazza et al. 2005,
Kingshott et al. 1998, Orth et al. 2005, Sagaspe et al. 2007b, Turkington et al. 2001).  
Many of the studies mentioned use short duration driving performance tasks. It is 
therefore not known if the same variability cross over in performance level with 
controls will be apparent during a long duration driving task or in those OSA 
participants treated for a long period of time. 
Hypotheses addressed in Chapter 10
To test the hypothesis that there will be great individual difference in OSA CPAP 
compliant participants driver performance at a driving simulator task as reflected by 
lane deviation incidents in comparison to controls after sleep restriction to 5h. 
To test the hypothesis that those OSA CPAP compliant participants with greater 
vulnerability to sleep restriction will have impaired driver performance at a driving 
simulator task as reflected by land deviation incidents, time to first incident, greater 
subjective and EEG sleepiness in comparison to OSA CPAP complaint participants not 
vulnerable to sleep restriction. 
To test the hypothesis that those OSA CPAP compliant participants who are older and 
those with higher ESS will have greater impaired driver performance at a driving 
simulator task. 
To test the hypothesis that in those OSA CPAP compliant participants who have 
greater vulnerability to sleep restriction there will be no difference in insight into 
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sleepiness than those who are not vulnerable, as reflected by subjective score at first 
major incident. 
AIM 6: To evaluate the ability of OSA-CPAP compliant patients at a hazard perception 
test specifically related to driving compared with healthy controls.
The literature shows that experienced drivers perform better at hazard perception 
tests than inexperienced drivers (Smith et al. 2009), with age and annual mileage being 
strong predictors of hazard perception test performance (Grayson et al. 2002). 
Hazard perception will be presented as a novel task for all participants. Untreated OSA 
participants have been reported to have poorer cognitive task performance on initial 
exposure to a task (Rouleau et al. 2002); it is not known if this is still the cases when 
treated with CPAP. 
Hazard perception is cognitively demanding (Horswill et al. 2004, Smith et al. 2009).
OSA patients have been shown to be at greater risk of RTI (Ellen et al. 2006) and to 
have reduced cognitive function (Mathieu et al. 2008). It is therefore possible that one 
factor causing the increased RTI risk in OSA patients is poor hazard perception.  
Hypotheses addressed in Chapter 11
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
hazard perception performance at a computer based task compared with controls, 
following a normal treated night’s sleep, as reflected by test score and pass rate.
To test the hypothesis that ESS and Age will be negatively correlated with hazard 
perception score in both OSA CPAP compliant participants and controls. 
To test the hypothesis that driving experience will be positively correlated with hazard 
perception score in both OSA CPAP compliant participants and controls. 
AIM 7: To evaluate the choice of countermeasure to driver sleepiness in two groups 
susceptible to driver sleepiness, HGV drivers and OSA drivers. 
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The literature shows that in general people have reported good awareness of the 
dangers of driver sleepiness and generally good knowledge of effective 
countermeasures, however, despite this knowledge appropriate measures are not 
necessarily utilised (Nordbakke et al. 2007, Anund et al. 2008). The only similar UK 
study identified was conducted prior to the change in advice for sleepy drivers in the 
UK Highway Code, the survey results for “choice of countermeasure” reflected the 
advice published at the time (Maycock 1996).   
The UK Highway Code currently offers good advice in dealing with driver sleepiness
stating to take a break every 2 hours and if a driver feels sleepy to stop for a 
caffeinated drink and a nap, see Figure 1.3-1. Prior to 1999 stopping to stretch legs 
was advised.  All new drivers in the UK are required to be familiar with the Highway 
Code; however, experienced drivers are required to keep up to date on their own 
volition. It is possible therefore, that drivers passing their test before 1999 would 
choose to stretch their legs if they felt sleepy while driving as this was the advice at the 
time.  
As a subgroup, professional drivers and OSA may be more likely to experience driver 
sleepiness than control car licence holders. As these groups may have actively sought 
out advice on driver sleepiness countermeasures or received it from their employer or 
doctor, which may result in making effective choices.    
Hypotheses addressed in Chapter 12
To test the hypothesis that HGV and OSA drivers will be more likely to choose 
appropriate countermeasures to driver sleepiness than controls.
To test the hypothesis that participants who have prior experience of falling asleep at 
the wheel will be more likely to choose appropriate countermeasures than those that 
have not.  
To test the hypothesis that the countermeasures listed in the highway code (caffeine, 
nap and break from driving every 2h) will be most popular for all respondents.
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To test the hypothesis that OSA CPAP treated participants will be more likely to 
identify driver sleepiness as a problem than controls. 
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CHAPTER TWO
THE PROBLEM IN CONTEXT: A SURVEY OF HEAVY GOODS VEHICLE DRIVERS 
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2.1 Introduction
Recently the media have drawn attention to HGV drivers falling asleep at the wheel 
who have OSA or are later diagnosed with OSA. Awareness in this topic area may 
suggest that HGV drivers are a main problem group for OSA. The stereotype of a HGV
driver is one who is overweight and sedentary. If this is true it is suggestive of a sub-
population likely to have greater risk of OSA than the general population. Due to the 
nature of the job these drivers spend a lot of time on the road covering many miles, 
thus it could be hypothesised that there is an increased risk of an undiagnosed OSA 
srRTI in this sub-group of the population. The damage done by HGVs has greater 
consequences than a car if the driver falls asleep due to the vast difference in the mass
of the vehicle. As detailed in chapter one, untreated OSA drivers appear to be at a 
greater risk on the roads than healthy people. Therefore, HGV drivers are an important 
research group as the prevalence of undiagnosed OSA may be higher in HGV drivers 
than in the general population.
2.1.1 Key points from the literature review
A comprehensive literature review of HGV drivers and OSA can be found in section 
1.4.3; the main points are highlighted here. 
Studies of HGV drivers tend to focus either on looking for predictors of driver 
sleepiness; work demands, personal health, quality of prior sleep, OSA or recording an 
overview of HGV drivers characteristics; age, average hours driven.
Overall, existing research suggests that driver sleepiness is a problem to HGV drivers. It 
can be exacerbated by hours spent driving, lack of quality sleep, inadequate rest and 
sleep disorders. OSA has been shown to be more prevalent in HGV driver populations 
than in the general population (Stoohs et al. 1995, Carter et al. 2003, Gurubhagavatula 
et al. 2004, Canani et al. 2005). However, results can be conflicting as some studies use 
more robust assumptions for undiagnosed OSA than others, as it is not cost effective 
to screen every driver using PSG. 
Although there is a growing body of international research in OSA and HGV drivers 
only two studies have been carried out in the UK; one which was 15 years ago and 
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required the investigators to estimate if they thought participants were obese, rather 
than objective measures and the other was conducted by a CPAP manufacturer. 
2.1.2 Research Aim and Hypotheses
AIM : To evaluate the prevalence of undiagnosed OSA in HGV drivers on UK roads. 
Hypotheses :
To test the hypothesis that undiagnosed OSA will be prevalent in HGV drivers on UK 
roads.
To test the hypothesis that OSA risk factors and symptoms can be used to predict self 
reported likelihood of falling asleep at the wheel in HGV drivers on UK roads.
To test the hypothesis that those with suspected OSA will have greater EDS and fall 
asleep incidents.
To test the hypothesis that high ESS will be associated with reports of falling asleep at 
the wheel and risk factors of OSA.
To test the hypothesis that OSA symptoms and risk factors will be of greater 
prevalence than in the general population.
2.2 Methodology
Study design: Cross sectional questionnaire.
Setting: A UK HGV rest stop;
“J23 Truck Stop” Junction 23 Lorry Park Ltd, Ashby Road, Shepshed, Loughborough, 
Leicestershire, LE12 9BS
The HGV stop is a safe place for drivers to park and spend their break or to stop over 
night, facilities include a café and bar. Two investigators (the author and one other)
were based in the café between 6pm and 9pm (the busiest period) over several weeks
in June 2009.
89
2.2.1 Participants
148 HGV drivers completed the questionnaire, average age 47.25 years ranging from 
21 to 68 years. All participants were male. 
2.2.2 Protocol
Investigators set up anthropometric measurement apparatus in a quiet corner of the 
café. The investigators approached participants in the café, either after they had 
finished eating or while they were waiting for their food to arrive. An explanation of 
the purpose of the study was given to all participants before completing the 
questionnaire. Questionnaires were self-administered but the interviewers were 
present to answer questions if they arose. The only inclusion criterion was that 
participants had a HGV licence and were willing to take part.  This was regardless of 
any other variables such as age, race or sex etc.  The main reason given for drivers not 
participating was that they did not have enough time to complete it.
92 participants agreed to the anthropometric measurements being taken, 56 
participants provided an estimation of their own weight, height and collar size, all but 
one volunteered an estimation of each measurement.
This study was approved by the Loughborough University Ethics Committee.  
2.2.3 Measures
Three categories of measures were taken.
1. Anthropometric measurements
2. Questionnaire
3. Epworth sleepiness scale
Anthropometric measurements
Collar size and BMI are indicators of risk of OSA. People who have a BMI over 28 and a 
collar size greater than 43cm (men) are at greater risk of having undiagnosed OSA 
(NHS 2009). The below measures were taken from the HGV study population to assess 
prevalence of OSA risk.
Height and weight measures can be used calculate BMI using the following formula.
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BMI =
( kg/m² )
weight in kilograms
————————————
height in meters²
BMI is a widely used calculation to assess for obesity, as it assesses weight 
independently of height (Deurenberg et al. 2007). A BMI of 25 kg/m² is the overweight 
threshold, with obesity being classified from 30 kg/m². 
Height: This was recorded using a portable height measure attached to the wall. 
Participants were asked to remove their shoes and stand with their backs to the wall 
while the investigator took a height reading.
Weight: With shoes off, participants were asked to stand on portable scales (Hanson).
The portable scales were accurate to within 0.6 kg. No adjustments were made for 
clothing. Clothing was fairly constant with participants often wearing jeans and a T-
shirt. It is expected this clothing would weigh approximately 1.5 kg.
Height and weight measures were used by the investigator to calculate BMI.
Collar size:  A standard material tape measure was passed around the neck of each 
participant; the investigator recorded the measurement in centimetres.
Questionnaire
The questionnaire comprised of 18 questions over two pages. The questions were in 4
main themes. The full questionnaire can be seen in appendix 1. 
 Those relating to the professional information (Q 1, 2, 3, 10, 11)
Drivers were asked how long they had held a HGV licence, how many hours 
they drove for a week, how many miles they covered a year and how long they 
would drive for before taking a break.
 Those identifying risk factors or symptoms of OSA (Q 4, 5, 6, 7, 8, 18)
This included declaring previous diagnosis with OSA, smoking, caffeine 
consumption and if bed partners report any signs of OSA during sleep i.e. 
snoring or witnessed apnoeas.
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 Those relating to sleep habits ( Q 9, 16, 17)
These included information on napping, sleep onset latency and total sleep 
time on work and non work days.
 Those relating to driver sleepiness (Q 12, 13, 14, 15)
Drivers were asked had they ever felt sleepy while driving or if they had fallen 
asleep at the wheel. They were also asked if they felt being drowsy whilst 
driving was a problem and what countermeasures they would take to avoid 
this. These questions will be discussed in chapter 12.
Questionnaires were self administered and returned immediately to the investigator.
The majority of the questions had set answers with tick boxes, this reduced the time 
taken to complete the questionnaire. 
For the purpose of this study the following will be accepted as risk factors of OSA, as 
detailed by the NHS (NHS 2009): 
 Male sex
 Obesity
 Aged over 40
 Neck circumference of 43 cm or more
 Smoking (suspected risk factor)
For the purpose of the current study the following will be recognised as being 
associated with OSA
 Feeling excessively sleepy during the day (ESS 12 or over)
 Having to drink caffeine often with the sole purpose to remain alert
 Having a bed partner reporting witnessed apnoeas (either choking or holding 
breath)
 Having a bed partner report frequent loud snoring (suspected risk factor)
Questions relating to countermeasures to driver sleepiness will be discussed in chapter 
12.
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Epworth Sleepiness Scale
The Epworth Sleepiness Scale (ESS) (Johns 2000a) is a widely used and validated eight 
item self rating scale. Participants indicate the probably of them falling asleep under 
different set circumstances, see appendix 2. The resulting scores are totalled with a
range from 0 to 24. A score of below 10 is considered normal. Any participant scoring 
12 or higher is considered to have some degree of excessive daytime sleepiness (EDS). 
2.2.4 Statistical analysis
Analysis was completed using Statistical Package for Social Science (SPSS 16.02 for 
Windows, Rel 10/4/08. Chicago: SPSS Inc). Results are expressed as mean ± standard 
deviation or as percentages.
Chi-squared tests were used to assess for association between categorical data. In all 
cases the assumptions of independence of data and expected frequencies being about 
5 were met. In the event of a significant Chi-squared result the odds ratio was 
calculated by hand and reported.
Spearmans Rho was used to identify any significant correlations between risk factors 
of OSA and the ESS (scale data). 
2.3 Results
2.3.1 Prevalence of possible undiagnosed OSA 
Hypotheses:
To test the hypothesis that OSA risk factors and symptoms can be used to predict self 
reported likelihood of falling asleep at the wheel in HGV drivers on UK roads.
To test the hypothesis that those with suspected OSA will have greater EDS and fall 
asleep incidents.
9.46% of the study population are suspected of having OSA, 2.7% of the study
population reported previous diagnosis of OSA. The main criteria for suspected OSA 
was bed partner reports of holding breath or choking while asleep, 7.43% of 
participants fit this criteria. Additionally participants were suspected of having OSA if 
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they matched all of the risk criteria; ESS ≥ 12, obesity, collar size ≥ 43 cm, aged over 40 
years and occasional or frequent snoring, 2.03% of participants matched these criteria. 
43.86% of the suspected OSA cases consented to anthropometric measures being 
taken. Average age of these participants was 46.5 years with 35.71% of them under 
the age of required regular medicals (Figure 2.3-1). 71.43% were obese, with only one 
person in the normal weight category (Figure 2.3-2). All participants who consented to 
the anthropometric measurements were obese. 21.43% had fallen asleep at the wheel 
(Figure 2.3-3) with 57.14% having EDS (Figure 2.3-104).
Figure 2.3-1 Age distribution of participants with suspected OSA
0
5
10
15
20
25
35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56
Pe
rc
en
ta
ge
 (%
)
Age
35.71% do not 
require medicals
64.29% require 
medicals
94
Figure 2.3-2 BMI classification of participants with suspected OSA
Figure 2.3-3 Reports of falling asleep at the wheel for participants with suspected OSA
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Figure 2.3-4 Excessive daytime sleepiness in participants with suspected OSA
Chi-squared test compared characteristics of the suspected cases with the rest of the 
study population, see Table 2.3-1. The only significant finding was for EDS where 
57.1% of those with suspected OSA had EDS compared to 8.3% of those who were not 
suspected of having OSA. Based on the odds ratio, the odds of having EDS are 14.78 
times higher for the people with suspected OSA. 
Chi-Squared value Degrees of 
freedom
significance
BMI classification 3.641 2 0.162
Age ≥40 yrs 0.088 1 0.767
Neck ≥ 43 cm 1.587 1 0.208
Smoker 2.671 1 0.102
ESS ≥ 12 26.638 1 0.000*
Fallen asleep at the 
wheel
0.089 1 0.766
Table 2.3-1 Chi-squared results for those who reported apnoeas (* denotes significance)
2.3.2 Prevalence of OSA risk factors and symptoms in the whole study population 
Hypotheses:
To test the hypothesis that undiagnosed OSA will be prevalent in HGV drivers on UK 
roads.
No
43%
Yes
57%
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In the total sample all participants were male, 46.62% were obese, 82.43% were aged 
over 40, 41.89 % had a neck circumference of 43 cm or more and 31.08% were 
smokers, see Figure 2.3-5, Figure 2.3-6, Figure 2.3-7 and Figure 2.3-8. These are all risk 
factors which could contribute to OSA.
Figure 2.3-5 BMI classifications of the total study population 
Figure 2.3-6 Age distribution of the total study population
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Figure 2.3-7 Collar size distribution
Figure 2.3-8 Percent of smokers
22.3% of participants had an ESS score of 10 or over. An ESS of 10 indicates there may 
be some cause for concern. 12.85% of participants had an ESS of 12 or over, 
these people have excessive daytime sleepiness (EDS), 
caffeine to stay alert was not found and 72.11% said they never drink a caffeine 
content drink with the sole purpose to remain alert, 
frequent loud snoring and 41.89% reported occasional snoring. 7.43% reported a bed 
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witness reports were from those already diagnosed with OSA and who were 
presumably being treated at the time of the survey
Figure 2.3-9 Reports from bed partners of the whole study population
Figure 2.3-10 ESS distribution and Excessive daytime sleepiness
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Figure 2.3-11 Graph to show how often caffeine is used with the sole purpose to remain alert
2.3.3 Characteristics of the study sample and professional information
Hypotheses: To test the hypothesis that undiagnosed OSA will be prevalent in HGV 
drivers on UK roads.
On average, participants had held a HGV licence for 20.84 years (s.d. 11.12). Average 
BMI was 29.93 kg/m² (s.d. 4.64) and ranged from 20.60 kg/m² to 47.90 kg/m².  88.5% 
of participants were overweight or obese. Average collar size was 42.13 cm (s.d. 3.23), 
40.82% of participants having a collar size of 43 cm or more. They drove on average 
43.07 (s.d. 7.15) hours a week, (3 participants drove less than 30 hours per week) 
covering an average of 85,160 miles a year (s.d.40.70).  Participant characteristics are 
detailed in Table 2.3-2.
Mean S.d.
Age (years) 47.25 10.30 
Years held group 2 licence 20.84 11.12 
BMI (kg/m²) 29.93 4.64 
Collar size (cm) 42.13 3.23 
Hours driven per week 43.07 7.15
Miles driven per year 85 160 40 700 
Table 2.3-2 Participant characteristics
68.24% of participants reported no difference in the amount of time they actually 
drove for and how long they would be comfortable driving for. 6.08% said they drove 
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for longer than they were happy to and 25.68% would be happy to drive for longer 
than they currently do, see Figure 2.3-12. 33.11% of people slept for the same amount 
of time on work and non work nights. 8.58% slept for longer on work nights than non 
work nights.  Of the 58.12% getting less sleep than they would on a non work night the 
average sleep loss was 2.02 hours.
Figure 2.3-12 Number of hours participants would be happy to drive for before taking a break and 
number of hours participants actually drive for before taking a break
2.3.4 Associations falling asleep at the wheel and EDS
Hypotheses:
To test the hypothesis that OSA risk factors and symptoms can be used to predict self 
reported likelihood of falling asleep at the wheel in HGV drivers on UK roads.
To test the hypothesis that high ESS will be associated with reports of falling asleep at 
the wheel and risk factors of OSA.
BMI classification, age over 40 years, neck circumference of 43 cm or over, smoking 
and having EDS (ESS of 12 or over) were compared between those reporting having 
fallen asleep at the wheel and those not having fallen asleep at the wheel using Chi-
squared test. None were significantly different, see Table 2.3-3 Chi-squared results 
with having fallen asleep at the wheel, see Table 2.3-3.
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Chi-Squared value Degrees  of 
freedom
significance
BMI classification 0.804 2 0.669
Age ≥40 yrs 0.167 1 0.683
Neck ≥ 43 cm 2.147 1 0.143
Smoker 0.597 1 0.440
ESS ≥ 12 1.001 1 0.317
Table 2.3-3 Chi-squared results with having fallen asleep at the wheel
BMI classification, age over 40 years and neck circumference of 43 cm or over were 
compared between those having EDS and not having EDS using Chi-squared test. Only 
smoking showed a significant relationship with EDS. 23.9% of smokers scored an ESS 
suggestive of EDS compared to 7.8% of non smokers. 
Chi-Squared value Degrees of 
freedom
significance
BMI classification 0.319 2 0.853
Age ≥40 yrs 1.379 1 0.240
Neck ≥ 43 cm 0.388 1 0.533
Smoker 7.316 1 0.007*
Table 2.3-4 Chi-squared results with having excessive daytime sleepiness (* denotes statistical 
significance)
2.3.5 Correlation between risk factors and ESS
Hypotheses:
To test the hypothesis that OSA risk factors and symptoms can be used to predict self 
reported likelihood of falling asleep at the wheel in HGV drivers on UK roads.
To test the hypothesis that high ESS will be associated with reports of falling asleep at 
the wheel and risk factors of OSA.
Using Spearman’s Rho, BMI, age, collar size, weight, hours driven per week and miles 
driven per year were assessed for correlation to ESS. The only significant result was 
with age, this was a very slight negatively correlated. 
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Spearman’s rho N significance
BMI 0.700 148 0.199
Age ≥40 yrs -0.171 148 0.019*
Neck ≥ 43 cm 0.108 147 0.096
Weight 0.110 147 0.092
Hours driven per 
week
-0.107 146 0.100
Miles driven per year 0.028 141 0.373
Table 2.3-5 Spearman's rho correlations to ESS (* denotes statistical significance)
2.3.6 Opinions on drivers sleepiness 
62.56% reported having felt sleepy at some time whilst driving. 18.92% admitted 
having fallen asleep at the wheel, Figure 2.3-13. 12.84% of respondents didn’t feel that 
driving whilst drowsy affects their ability to drive safely, Figure 2.3-14. 
Figure 2.3-13 Percent of participants who have felt sleepy while driving and fallen asleep while driving
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Figure 2.3-14 Percept split of opinion on whether driving while drowsy affects ability to drive safely
2.3.7 Comparison of HGV results to population statistics 
Hypotheses:
To test the hypothesis that OSA symptoms and risk factors will be of greater 
prevalence than in the general population.
Study population General public
Male 100% 49.06% a
Obesity prevalence 46.62% 23.1%  b
Aged over 40 82.43% 56.14% c
Average neck 
circumference 
42.13 cm 38 cm d
Smoking prevalence 31.08% 21% e
Average ESS 6.7 4.6 f
Bed partner reporting 
witnessed apnoeas
7.43% 3.8% g
Bed partner reporting 
snoring
56.75% 40.3% g
Table 2.3-6 Comparison of HGV results and population statistics
a UK population as a whole 2007 (Office for National Statistics 2007)
b UK male adult population 2005 (NHS Information Centre 2006)
c UK adult males (aged 21 – 65) 2007 (Office for National Statistics 2007)
d UK male general population (Martin et al. 1997)
No
13%
Yes
87%
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e UK total population aged ≥16 2007 (National Statistics Online 2009)
f Australian 1997 general population (Johns et al. 1997)
g UK general population telephone interview (Ohayon et al. 1997)
Table 2.3-6 compares the prevalence of OSA risk factors in the HGV driver sample to 
the general population. Data for the general population were obtained from the office 
of national statistics were possible. Where this was not possible relevant published 
journal articles have been used.  Of the adult male population aged 21 – 65 in the UK 
56.14% are aged over 40 year olds (Office for National Statistics 2007), in the HGV 
sample 82.43% are aged 40 – 65 years. Smoking rates are also higher than the general 
public. ESS is found to be on average 2.1 higher than a sample of the general 
population. 56.75% of the HGV population reported snoring compared to 40.3% of the 
general population (Ohayon et al. 1997). 7.43% of HGV drivers reported apnoeas in 
comparison to 3.8% of the general public (Ohayon et al. 1997).
2.4 Discussion
This is the most recent study of its kind that we know of in the UK; similar studies have 
been conducted in the USA, Brazil, Australia, France, New Zealand and Greece. 
Previous UK studies have been conducted by a CPAP company, creating a conflict of 
interest (Moylan 2005) and a survey in which investigators classified BMI categories 
without taking measurements (Maycock 1995). 
A main aim of the current work was to identify what percentage of HGV drivers in a 
sample study population have suspected OSA and to see how they differed to the rest 
of the study population. 9.46% were identified as having suspected OSA. The 
suspected OSA cases are much than the estimated 4% prevalence in the general male 
population (Young et al. 1997), although less than in a Swedish and Australian studies
using overnight PSG in HGV drivers at 17% and 15.8% respectively (Carter et al. 2003,
Howard et al. 2004).The main basis for suspicion of OSA in the current study was 
reports of witnessed apnoeas by bed partners; however, 20.27% of drivers did not 
have a bed partner so cases of suspected OSA maybe under reported. 2.70% of the 
total sample reported prior diagnosis of OSA, as they were all currently employed as 
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professional HGV drivers and did not show EDS it is assumed they were all successfully 
treated. 
Those with suspected OSA were significantly more likely to be suffering from EDS than 
the remainder of the study population, the odds of having EDS being 14.78 times 
higher for this subgroup than the study population as a whole. Elevated EDS puts a 
person at greater risk of falling asleep at the wheel and suggests they should ideally be 
tested for OSA. Of those participants with suspected OSA, 35.7% were younger than
45 years old so will not yet require a medical examination to retain their licence. The 
remained were aged between 45 and 65 years so were subject to medical 
examinations every 5 years. It is possible that the current required medicals are not 
picking up all cases of OSA. 
One of the key risk factors for OSA is obesity, 88.5% of the study population were 
found to be either over-weight or obese, this is comparable with Gurubhagavatula et 
al. (2004) a USA study which found a prevalence of 88% overweight or obese HGV 
drivers. Additionally, overweight men have been found likely to underestimate their 
weight (Kuchler et al. 2003) as a result it is probable that the BMI maybe artificially 
lower than it would have been if all participants consented to anthropometric
measurements being taken. 
Overall it has been found that there is a higher prevalence of risk factors and 
symptoms of OSA in a sample of HGV drives on UK roads, than in the general 
population. In comparison to the general public population statistics this sample of 
HGV drivers demonstrate a male dominated environment (Office for National Statistics 
2007) with higher prevalence of obesity (NHS Information Centre 2006) and greater 
average neck circumference (Martin et al. 1997). EDS is a common symptom of OSA 
and although the average ESS for the HGV drivers surveyed was not at a critical level it 
is 2.1 higher than a sample of the general public (Johns et al 1997). Another common 
symptom of OSA is snoring and again this is more prevalent in HGV drivers than the 
general population (Ohayon et al. 1997), suggesting that OSA may be more prevalent 
in HGV drivers than the general public. However, not all snorers have OSA so this is 
only an indication of a likely higher prevalence. A more reliable indicator of OSA is 
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reports of witnessed apnoeas, which were reported almost twice as much as in a 
sample of the general population (Ohayon et al. 1997). The HGV driver population 
appears to be at greater risk of OSA than the general population.
From the survey completed none of the factors assessed were significantly associated 
with reports of drivers having falling asleep at the wheel. Smokers were significantly 
more likely to have an ESS ≥ 12 than non smokers, but no other factors were 
significantly associated with EDS. It is not possible to know if one causes the other as 
smoking may result in greater daytime sleepiness or it is possible that individuals may 
decide to smoke because they are sleepy and nicotine, as a stimulant, increases their 
alertness. 
Participants in the current study had an average age of 47.3 y which is older than 
found in similar studies in other countries where average age in late 30s is more 
common (Stoohs et al. 1995, Philip et al. 2002, Gurubhagavatula et al. 2004, Canani et 
al. 2005, Tzamalouka et al. 2005, Gander et al. 2006, Hanowski et al. 2007). Having an 
older HGV driving population in the UK may increase the number of HGV drivers 
suffering from OSA as the condition is more prevalent in those aged over 40. 
The majority of participants were driving for the maximum time period allowed under 
EU law before taking a break. These truck drivers appeared generally happy with the 
requirements of the job and the majority were not unwilling to drive these hours, 
25.68% even said they would be happy to drive for longer before taking a break.  The 
average driving week was reported as 43.07 hours which is less than the 56 hours per 
week allowed by law (EU law). 
In comparing self reported sleep time on work nights and non work nights almost 60% 
reported a difference. However, approximately 40% of those losing sleep only have an 
hour or less difference in sleep time between work and non work nights, so this is 
likely to have minimal impact. More worryingly approximately 13% those reporting 
sleep loss on work nights recorded a difference of 4 to 6 hours; this is a large 
difference in sleep time and may result in impairment at work.   
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HGV drivers cover approximately 81 489 miles more per year than the average car 
driver (comparing millage reports in the current study and car driving mileage 
(Department for Transport 2009). Additionally they appear to be at greater risk of OSA 
(as suggested by prevalence of symptoms and risk factors in this sample) than the 
general public. It is therefore very important that HGV drivers are able to recognise 
sleepiness as a hazard to driving and be able to take effective counter measures. The 
majority of the HGV drivers in this sample reported having felt sleepy whilst driving 
and the majority recognised that driving whilst drowsy could affect their ability to 
drive safely. However, 12.8% felt driving whilst drowsy did not affect their ability to 
drive safely and this was despite 36.8% of these drivers reporting that they had fallen 
asleep at the wheel. It is possible that they have this response because they have 
fallen asleep while driving in the past and there have been no consequences. 
18.9% of drivers admitted to having fallen asleep at the wheel in the past, this is a 
lower percentage than in some other studies which have found 22% (Canani et al. 
2005),  23% (Tzamalouka et al. 2005), and 47.1% (McCartt et al. 2000). However, 
admitting to falling asleep at the wheel is admitting to dangerous driving and even 
though the questionnaire is anonymous some drivers may have been unwilling to 
admit if they had fallen asleep at the wheel. 
This survey has shown that prevalence of undiagnosed OSA in a sample of UK HGV
drivers is potentially higher than in the general population. It suggests that there are 
HGV drivers who are driving long distances for prolonged periods of time whilst having 
undiagnosed OSA. This will predispose them to EDS which may increase the chance of 
them having an accident. Offering screening and treatment is likely not to be enough, 
the industry as a whole needs to show acceptance towards treated OSA drivers or 
people will not be willing to come forward and be tested. In order for the industry to
be accepting it is important to know that the treatment is effective and that driving 
performance is equivalent to healthy drivers both at the onset of treatment and in the 
long term. 
Screening for high risk factors of OSA then testing this subgroup of high risk drivers 
using PSG could be a cost effective way to identify patients (Gurubhagavatula et al. 
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2008). However, as we have found, drivers who are subject to medicals are still falling 
into the high risk group of suspected OSA. It is unclear if this is because GPs carrying 
out current medicals are not recognising the symptoms of OSA or that the frequency 
of medicals at five years is not sufficient. 
Another problem is even if drivers are diagnosed with OSA it can be difficult to get 
them to accept and regularly use treatment. One USA study surveyed 456 HGV drivers 
and identified 53 as showing signs of OSA, these were all invited for PSG but only 20 
turned up to be tested. All 20 had OSA but in a follow up only 1 patient reported using 
their treatment (Parks et al 2009).  There is a problem with adherence to CPAP 
treatment for all OSA patients (Weaver et al. 2008) but the issue of unwillingness to 
seek help may be exacerbated by fear of losing their driving licence and job. 
2.4.1 Limitations 
The sample size of 148 is adequate for the purpose of this study, however there are 
528, 000 licensed heavy goods vehicles in the UK, so to get a more detailed picture of 
the HGV drivers in the UK, a larger sample size would be required. In order to achieve 
this, more than one survey site would be needed. The current study was limited to one 
local survey site and data was collected over several weeks. It was noted that by the 
end of the data collection investigators were encountering customers of the café who
had already completed the survey on a previous occasion. Encompassing more HGV 
stops would allow a larger sample size to be collected; unfortunately the current study 
did not have the resources to do this. Another way to reach a larger potential study 
population would be to conduct a postal survey. However, this would mean that 
anthropometric measurements would not be taken by the investigator and results 
would be reliant on accurate reports from participants. 
The most feasible way to get contact details of large numbers of HGV drivers would be 
through large national employers. However, even if a questionnaire remained 
anonymous people may be unwilling to answer questions such as “Have you fallen 
asleep at the wheel?” honestly if they think that their employer may find out. A postal 
survey would allow participants to fill the questionnaire in at a time appropriate to 
them and would not impose on their meal time. Conducting research in a café may 
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also bias the type of person who fills in the survey as by nature of a truck stop anyone 
in it has “stopped” driving, those wishing to keep going will not be represented. Also 
any drivers who had brought their own meal may have been eating in their HGV and 
will not have been represented. 
The questionnaire was designed to take 5 minutes to complete in the hope that a large 
number of people would complete it. More accurate identification of suspected OSA 
could have been obtained by using additional questionnaires specifically designed for 
diagnosis of OSA. However, because drivers were there to eat, the focus was on 
keeping the survey short. An area of questioning not included was the pattern of 
working hours; it is not possible to tell from this survey if drivers worked at night or 
during the day. This may have an effect as sleep-related crashes are more likely to 
occur in the early hours of the morning than at any other time (Horne et al. 1995). PSG 
recordings were not carried out so a conclusive diagnosis of how many drivers had 
OSA is not known. Due to time and cost this was not feasible to complete. 
No questions were asked about drinks containing small amounts of caffeine such as 
tea and cola. In small quantities the amount of caffeine received in these drinks is not 
enough to promote alertness. It would have been useful to know if they had been 
consumed in quantities large enough that may have impacted alertness. 
The ethnicity and country the driving licence was not recorded. UK drivers are subject 
to medical checks from the age of 45 but foreign drivers may not be.  This meant it 
was not possible to distinguish if the OSA with suspected OSA had received a medical 
check or not. 
2.5 Conclusions
- Almost 10% of the HGV population have suspected undiagnosed OSA. These 
suspected OSA sufferers have significantly more EDS than the rest of the study 
population.
- The UK HGV driving population appears to be slightly older than in other 
countries and over half are old enough to require medicals in order to maintain 
their licence. 
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- The HGV driver population has higher incidence of both risk factors and 
symptoms of OSA than the general public, suggesting that occurrence of OSA 
maybe higher in this subgroup than the population as a whole. 
- The majority of HGV drivers have felt sleepy whilst they are driving 
- No identifier of which drivers would have EDS or have fallen asleep at the 
wheel was identified. 
2.6 Further work
The knowledge gained from this survey study provides a context for the problem of 
OSA and driver sleepiness on UK roads. As such it is important to determine if treated 
OSA drivers have any impairment compared to the general population. A driving 
simulator will be used so that this issue can be investigated further (chapters 3 – 10) in 
a safe environment.
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CHAPTER THREE
Methodology for driving simulator studies 
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The following chapter details the methodology for the driving simulator studies used 
to collect data presented in chapters 5 to 10. This chapter presents an overview of 
procedures applicable to recruiting participants; study protocol for both screening and 
test days; details of the driving simulator used and the different measures recorded. 
Specifics will be detailed in the relevant chapters. 
3.1 The Driving Simulator
The driving simulator comprised of a Ford Fiesta car with a fixed base (Figure 3.1-1). A 
large screen was located in front of the car so that it could be viewed through the 
windscreen, with a road projected onto the screen. A video camera with infra-red light 
was positioned to the side of the car to film the driver’s face. The camera could be 
seen by the driver but did not disrupt the view of the road. All mirrors in the car were 
blacked out. There was an unobtrusive microphone in the car to record participant’s 
responses to the subjective sleepiness questions. 
The steering, accelerator and brake were electronically connected to a computer 
system at the back of the lab, from which the road was generated. Changes in steering 
and speed were picked up by the computer which adjusted the position on the road 
accordingly. 
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Figure 3.1-1 Loughborough University Sleep Research Centre driving simulator
The road projected was a computer generated dual carriageway in the daytime, with a 
hard shoulder to the left and a central reservation in the middle (see Figure 3.1-2). 
Rumble strips were present either side of the carriageway resulting in a change of
audio if they were driven on. The road generated had no sharp corners but had gentle 
bends; there were an equal number of gentle bends to the right as to the left. The 
road was designed so that it must be ‘actively’ driven; there were sufficient bends so 
that participants would not be able to stay in the left hand lane unless they were 
driving attentively.  During the two hour drive three slow moving cars were presented 
in the left hand lane. Participants had to overtake the car then return to the left hand 
lane. The laboratory lights were switched off during testing. 
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Figure 3.1-2 Road view, seen by participants, showing a slow moving vehicle to be overtaken
During the drive the image from the video camera and the road as seen by the 
participant were recorded on to DVD with the road scene appearing in the top right 
hand corner (Figure 3.1-3). The recordings were later analysed to asses sleep-related 
incidents. 
Figure 3.1-3 Freeze frame from a recording of a participant driving
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A comparison of performance in this simulator with performance on a closed-circuit 
track in a dual controlled car following sleep restriction to 5 h demonstrated similar 
trends in driving performance and subjective sleepiness were found in both situations 
(Baulk 2002).
3.2 Participant Recruitment
As discussed in chapter 2 HGV drivers are a susceptible group to OSA and further 
research into their driving ability when treated for OSA is needed. However, the 
nature of simulator studies means that they are time consuming so it is unlikely that 
full time employed people would volunteer to take part, particularly HGV drivers who 
may often be away from home. A way of allowing HGV drivers to participate may have 
been to approach employers to ask for their drivers to be allowed to participate during 
work time. However, it was suspected that drivers would be unwilling to participate if 
their employers were involved for fear of jeopardising their jobs. 
Due to the suspected restricted availability of HGV drivers, simulator studies will be 
carried out on members of the general driving public with a group 1 licence.
3.2.1 OSA participants
All participants were recruited from Leicester Sleep Apnoea Patients Association 
(LSAPA). When people are diagnosed with OSA at Leicester General Hospital they 
receive CPAP treatment and are invited to join LSAPA, a voluntary support network. 
To maintain patient confidentiality letters detailing the study and questionnaires were 
sealed in unaddressed envelopes and delivered to LSAPA. The association mailed the 
letters to their members requesting completed questionnaire to be sent to the 
researchers. At the end of the questionnaire participants were invited to state if they 
would like to be contacted in regards to a driving simulator study. 
170 recruitment letters were sent out, 103 completed questionnaires were returned, 
of which 70 people were interested in the simulator studies. 32 participants were 
invited in for screening following exclusion of 38 potential participants due to reports 
of ill health, driving less than three hours a week or living more than 30 miles from 
Loughborough University. 20 participants were selected for the final study. 
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It was desirable that the OSA study population were reflective of the responses 
received from the questionnaire sent to the LSAPA. Only 14% of LSAPA respondents 
were female, due to this small number and the findings in chapter 2 where no HGV 
drivers were female, it was decided that the final study population would be all male. 
The average age of the male questionnaire respondents was 63.64 years. In order for 
the study population to represent this group those aged below 50 and over 75 were 
excluded. The control group were then recruited to fit the same criteria.
3.2.2 Control Participants
To compare the 20 OSA participants a healthy control group of the same sex and 
similar age were recruited. Advertisements for control participants were put up in the 
form of posters at Loughborough University notice boards, local community centres, 
leisure centres, bowls clubs, local libraries, churches and the town hall. An 
advertisement was placed in a local newspaper and a news story about the simulator 
studies was published in the following edition. Finally letters were sent to the 
secretaries of 5 local Rotary Clubs.
Following these advertisements and a screening phone conversation to exclude people 
with ill health, driving less than 3 hours a week or living more than 30 miles from 
Loughborough University, 30 people agreed to attend a screening day.
3.3 Screening
For both the OSA and control participants initial screening was conducted by 
telephone to ensured potential participants were only invited to the laboratory 
screening day if they met the following inclusion criteria:
 Held a current UK driving licence
 Not a commercial driver
 Drove for at least three hours a week
 Lived no further than 30 miles from the university (Due to budget limitations, 
as taxis were to be provided)
 Self reported general health as good to excellent (not suffering from epilepsy 
or severe migraines which may be affected by the simulator)
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 Male
 Aged 50 to 75
All participants were sent a participant information sheet (appendix 3) with details of 
the study prior to agreeing to participate. 
The same screening day protocol (seen in Table 3.3-1) was observed for both OSA and 
control participants. As well as to exclude people who were not suitable for the study, 
screening also introduced the participant to the researcher and the simulator in order 
to reduce anxiety on the study days. 
1000h – 1015h Explanation of studies and completion of consent forms
1015h – 1100h Completion of structured interview
1100h – 1110h Anthropometric measures taken
1110h – 11130h Hazard perception test completed
1130h – 1200h Test drive of simulator
Table 3.3-1 Screening day schedule
During the screening day the studies were explained in full to participants and an 
informed consent form (appendix 4) was completed. A media consent form (appendix 
5) was also completed stating whether or not participants agreed to their video or 
photograph being used for scientific or media purposes. 
All participants were interviewed when they attended a screening day. The interviews 
were conducted in the form of a structured questionnaire; the investigator read the 
questions aloud to enable the participant to expand on the answers if they felt there 
was more to say than could be conveyed in the questionnaire tick boxes. The interview 
consisted of 39 questions for the OSA participants (appendix 6) and 27 questions for 
the control participants (appendix 7) taking 45 to 60 minutes to complete.  This was 
followed by anthropometric measurements of height, weight and percentage body fat. 
Percentage body fat was calculated using TANITA body composition analyzer TBF-300.
Participants all completed a computer based hazard perception test (Driving Test 
Success 2007) designed to simulate the hazard perception test forming part of the 
current UK driving test. This test takes approximately 20 minutes to complete and 
consists of 14 video clips, requiring participants to press the mouse button as soon as 
they see a hazard in each clip. The test was explained to participants and they were 
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shown an example clip. The investigator remained in the room while participants 
completed the first clip to check that they understood the test. The investigator then 
left the room while participants completed the remaining video clips. 
Finally a 30 min test drive in the simulator was completed by each participant. During 
the test drive the car was set up in the same manner as the study days with the 
exclusion of EEG recording. 10 cars were presented in order for participants to practice 
overtaking. 
Participants were excluded from the main studies if they were found to have:
 Uncontrolled medical conditions
 Irregular sleep patterns
 Discomfort at driving the simulator
 A BMI over 28 (control participants only as this would put them in a high risk 
category for undiagnosed OSA)
3.4 Study Protocol
All studies were approved by Loughborough University Ethics Advisory Committee, 
and protocol established following advice from Dr C. Hanning, see appendix 7.
3.4.1 Sleep restriction study 
The sleep restriction study consists of two study days, completed in a counter 
balanced design. These were: 
1. Following normal sleep 
2. Following sleep restriction to 5 h
The protocol for both study days was the same except for the amount of sleep 
obtained the night before. Actimeters and sleep diaries (appendix 8) were sent out in 
advance to be worn/completed on the three nights prior to the study day. Participants 
were asked to refrain from drinking alcohol or caffeine from 2200h the night before 
the study day and to not eat anything after 1000h on the study day. 
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1200h – 1250h Taxi transports participant from home to the Sleep Research 
Centre
1300h Participant lunch
1300h Investigator checks actiwatch data for compliance
1315h – 1345h Electrodes applied
1345h – 1400h Participant settled in car
1400h – 1600h Simulator drive
1600h – 1615h Electrodes removed
1600h Taxi to take participant home
Table 3.4-1 Study day schedule
A taxi was provided to bring the participants to the laboratory. On arrival at 1300h 
participants were given a light lunch of two cheese rolls and a glass of water and the 
actimeter data was downloaded to check compliance. At 1315h electrodes were 
applied and driving commenced at 1400h. This time was chosen to coincide with the 
natural circadian dip.
Participants were instructed to drive in the left hand lane (unless overtaking), at a 
speed appropriate for the road and at which they were able to maintain control of the 
vehicle. During the drive the investigator was in the room at all times in case of a 
problem but there was no communication between investigator and participant once 
the drive began. Every 200 seconds subjective sleepiness was measured, a recorded 
voice would ask “sleep check?” and the investigator recorded the participant’s verbal 
response. During the two hours there were three cars to overtake at regular intervals. 
At 1600h the simulator program stopped so that participants did not have to pull over 
and stop the car. The electrodes were removed and participants went home in a 
prepaid taxi. Participants returned for the second of their study days at least three 
days later. 
3.4.2 CPAP withdrawal
Following completion of the sleep restriction study all OSA participants were invited to 
participate in a CPAP withdrawal study, 11 accepted. This study comprised of one 
study day. The night before this study day participants slept for their normal length of 
sleep but did not use their CPAP machine. All participants discussed the procedure for 
this study thoroughly with the investigator ensuring that participants were aware of 
the following:
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-  There was no obligation to participate in this study.
-  They should only agree if they were fully aware of the study protocol and participant 
requirements.
-  It was possible that they may feel some additional sleepiness in the day following 
not using the CPAP, so this study day is to be organised for a date convenient to them 
on which they have no other commitments. 
- If any problems occurred in the night as a result of not using CPAP they should 
resume CPAP use immediately and contact the investigator in the morning to cancel 
the afternoon simulator drive.
The protocol on the study day itself was exactly the same as for the sleep restriction 
study, Table 3.4-1. 
3.5 Measurements 
3.5.1 Screening day measures
On the screening day all participants completed a structured interview style 
questionnaire with the researcher detailing general health, general sleep, driving 
habits and OSA if applicable. The questionnaire (appendix 5 and 6) was used to 
exclude participants who were not suitable to participate and to determine participant 
characteristics. These are detailed in chapter 4. 
Anthropometric measurements, BMI and percentage body fat were also taken. BMI as 
a technique is detailed in section 2.2.3. BMI is highly correlated to percentage body fat 
so generally provides a good indication of obesity, however, in muscular people 
obesity can be over estimated as muscle mass is not distinguished from fat mass 
(Aronne 2002).  It is therefore preferable to calculate percentage body fat as well. A 
man of average weight would be expected to have 15 – 20 % body fat (Seidell et al. 
1997). It was not possible to calculate % body fat of HGV drivers as the survey was 
conducted outside of the University. For participants in the driving simulator study it 
was possible to take this measure the TANITA body composition analyzer TBF-300 was 
used.
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There are various techniques to measure percentage body fat; those with the greatest 
accuracy are more time consuming to carry out e.g. under water weighting. Bio-
electrical impedance provides a quick and simple way of calculating percentage body 
fat from total body water content. Participants are asked to stand bare foot on a set of 
scales similar in size to standard bathroom scales. A small alternating current is 
applied; the calculation is based on the assumption that only body water will conduct 
the current. Total body water content can then be predicted, and therefore fat free 
mass (Deurenberg et al. 1999). 
3.5.2 Driving performance
Driving incidents
Lane drifting is indicative of driver sleepiness, and was noted as a driving incident. Two 
types of driving incidents were recorded:
 Minor – when the wheels of the car touched a lane demarcation line.
 Major – when the car came out of the left hand driving lane.
At the end of the drive a computer printout detailed where the car was positioned on 
the road for each second of the drive. All incidents were then identified by the 
researcher. The incidents were identified on the video footage and classified visually 
by the investigator as one of two types:
 Sleep-related – i.e. the driver’s eyes were rolling, closed or staring vacantly.
 Non-sleep related – i.e. driver distraction, fidgeting or looking around
Only sleep-related incidents are considered in this thesis, when driving incidents are 
referred to in the context of the current work this should be taken to mean sleep-
related incidents. 
Standard deviation of road position
As well as departure from the driving lane, the simulator also records road position 
within the left hand driving lane. In some occasions of drifting due to sleepiness the 
participant will make corrections before a driving incident occurs. This behaviour can 
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be identified by calculating the standard deviation of road position; the greater the 
standard deviation, the greater the level of driver sleepiness. 
3.5.3 Subjective sleepiness
Subjective measures of sleepiness are used to assess the perceptions of participants of 
their own sleepiness levels. These measures can be divided into two categories:
1) Trait sleepiness, how sleepy a person feels in general 
2) State sleepiness, how sleepy a person feels at a specific time point
In the context of driver sleepiness trait sleepiness is important because if a person is 
consistently sleepy they may have greater difficulty maintaining alertness whilst 
driving than someone who is not. State sleepiness is important because people 
continue to drive based on their own perceptions of how sleepy they are and use this 
information to decide when they should stop. 
3.5.3.1 Trait sleepiness
Trait sleepiness is most commonly quantified using the Epworth Sleepiness Scale (ESS). 
The ESS measures average sleep propensity, an individual’s general level of sleepiness 
independent of the current situation (Shen et al. 2006). 
The ESS is a widely used 8 item self rating scale. Participants indicate the probability of
them falling asleep under different set circumstances. In each circumstance 
participants can choose 
0 = no chance of dozing
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
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Figure 3.5-1 Epworth Sleepiness Scale
The resulting scores are totalled ranging from 0 to 24 with scores over 12 suggesting 
excessive daytime sleepiness (Johns 1991). 
This scale is quick and easy to use so it popular in a clinical setting to assess for EDS in 
OSA patients. It has been shown to correlate with RDI (Johns 1993) and improves in 
OSA patients once started on CPAP treatment (Engleman et al. 1996). It is generally 
accepted as a good tool to identify OSA. However, some studies have not found 
significant correlation between ESS and OSA severity as measured by AHI and MSLT 
The Epworth Sleepiness Scale
How likely are you to fall asleep in the following situations? Please indicate, using the 
following scale, which is most appropriate given the situation.
0 = Would never doze
1 = Slight chance of dozing
2 = Moderate chance of dozing
3 = High chance of dozing
Situation Chance of Dozing
Sitting and Reading …………………..
Watching TV …………………..
Sitting inactive in a public place (e.g. theatre/meeting) …………………..
As a passenger in a car for an hour without a break …………………..
Lying down in the afternoon when circumstances permit …………………..
Sitting and talking to someone …………………..
Sitting quietly after lunch without alcohol …………………..
In a car, while stopped for a few minutes in the traffic …………………..
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(Chervin et al. 1997, Olson et al. 1998). Despite criticism; some studies have found 
correlations between ESS and MSLT (Johns 1991) though Johns does argue that the 
MSLT should not be considered the ‘gold standard’ measure of sleepiness (Johns 
2000a, Johns 2000b, Johns 1991). ESS has been found to correlate to inappropriate 
line crossings on a dual carriageway in OSA drivers and controls (Philip et al. 2008).
The ESS relies on honest self reporting of symptoms; as such it may be subject to 
misinterpretation and untruthful responses (Shen et al. 2006).  An example of these 
problems can be demonstrated by asking people to complete an ESS about their 
spouse, as one study has found bed partners give a higher ESS than the patients 
themselves (Walter et al. 2002b). However, another study has found close agreement 
between scores of spouses (Olson et al. 1998). 
In comparison to the equivalent objective measures, MSLT and MWT, the ESS is easier 
to use and much more cost effective. During the screening day, participants completed 
the ESS (appendix 2).
3.5.3.2 State sleepiness
The Karolinska Sleepiness Scale (KSS) is a widely used Likert scale to record sleepiness 
at a set time point (Akerstedt et al. 1990). It is quick and simple to complete allowing a 
participant to give an instant uniformed response to the question ‘How sleepy do you 
feel?’ Response is given as a number on a scale from 1 to 9.
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The KSS has been validated to EEG activity showing that EEG activity changes when a 
KSS of 7 is given by healthy individuals; this is predominantly linked to an increase in 
theta and alpha power (Akerstedt et al. 1990, Baulk et al. 2001, Kaida et al. 2006). KSS 
has also been found to correlate to actual inappropriate line crossings on a dual 
carriageway with both OSA drivers and controls (Philip et al. 2008).
KSS is a subjective measurement so it is possible that participants may not answer 
honestly, to try to eliminate this, the investigator built up a good relationship with 
participants during the approximately three hours spent with each participant before 
they completed a study drive.  The KSS has been validated against EEG, which has 
shown participants scoring 7 or higher on the KSS coinciding with EEG activity suggests 
sleepiness (Akerstedt et al. 1990). 
An alternative to the KSS is a Visual Analogue Scale (VAS). VAS requires participants to 
indicate on a line where their subjective sleepiness falls. It is suggested that VAS is 
more sensitive than KSS (Shen et al. 2006) but for the purpose of a driving simulator it 
is more practical to use a scale with a verbal response. 
Validation of the KSS to EEG shows that healthy people are able to tell when they are 
sleepy; in the case of driver sleepiness it is important that people recognise this and 
take action. They will only do this if they feel the sleepiness may impact on their 
The Karolinska Sleepiness Scale
1.  Extremely alert
2. Very alert
3. Alert
4. Rather alert
5. Neither alert nor sleepy
6. Some signs of sleepiness
7. Sleepy, but no effort to keep awake
8. Sleepy, some effort to keep awake
9. Very sleepy, great effort to keep awake, fighting sleep
Figure 3.5-2 Karolinska Sleepiness Scale
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chance of actually falling asleep. In order to assess this, a Likelihood of Falling Asleep 
(LHoFA) scale can be used in conjunction with the KSS (Reyner and Horne 1998b). 
Whereas the KSS can show if someone has insight into their level of sleepiness the 
LHoFA demonstrates if they perceive this to be a problem. For example if someone 
rates 9A they suggest they know they are very sleepy (very sleepy great effort to keep 
awake) but they believe they are very unlikely to fall asleep. 
Figure 3.5-3 The Likelihood of Falling Asleep scale
On all test days state sleepiness was recorded throughout the drives using the KSS and
rating the Likelihood of falling asleep in the next 5 minutes (LHoFA). The scales were
explained to participants at the screening day and they practiced using it during the 
test drive. Every 200 seconds of the drive is marked as a sleep check because a 
recorded voice asked “sleep check?” at these times, to which participants responded 
with a number from the KSS and a letter from the LHoFA scales. Responses to both 
these scales are reflective of how the participant is feeling at that particular point in 
time. 36 responses were collected for each participant in each 2 h drive. The scales
were constantly visible, presented on the dashboard of the car.  
Whereas the KSS can show if someone has insight into their level of sleepiness the 
LHoFA demonstrates if they perceive this to be a problem. For example if someone 
rates 9A they suggest they know they are very sleepy but they believe they are very 
unlikely to fall asleep. 
Likelihood of falling asleep in the next 5 minutes 
A Very unlikely
B Unlikely
C Neither 
D Likely
E Very likely
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For analysis subjective sleepiness scores are taken to represent the 100 seconds prior 
and post a “sleep check?”.
3.5.4 Sleep diary and actigraphy
Actigraphy is a technique used for measuring sleep quality based on movement during 
sleep. Participants were required to wear an actimeter © (CNT) for three nights prior 
to attending a study day. An actimeter is a movement sensor worn around the wrist. 
The actimeter was programmed to start recording 72 hours before the participant was 
due to arrive in the lab. Participants were instructed to put the actimeter on one hour 
before they intended to go to bed and take it off one hour after they woke in the 
morning. Participants were also instructed to remove it in situations where it may get 
wet, such as having a shower.  Movement data was stored every 30 seconds. The more 
a person moves in their sleep the more fragmented and light the sleep is deemed to 
be. Actigraphy is recognised as an accurate way to detect sleep in normal healthy 
populations (Littner et al. 2003), and can also be used as an indicator of OSA 
(Morgenthaler et al. 2007).
Participants were also required to keep a sleep diary (appendix 8). This detailed: the
time they went to bed, how long they thought they took to fall asleep, if they woke in 
the night and what time they got up in the morning. They were asked to write on the 
sleep diary times they had removed the actimeter.  
When participants arrived in the laboratory the actimeters were downloaded and the 
data visually inspected to verify that participants complied with the sleep 
requirements for the previous night. The data can be analysed using an algorithm 
which automatically scores the actigraph record (Sadeh et al. 2002).
Actimeters are small, light weight, portable devices which make them easy to use and 
appropriate for cases like this when sleep quality is assessed on a high level. Data 
collected from actimeters is of movement alone and cannot substitute the detailed 
recording of PSG. If details of sleep architecture are required PSG is a more 
appropriate measure to use. 
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3.5.5 Electroencephalography
Sleepiness can be measured by examining brain activity, recorded using electrodes 
attached to the scalp. These measure changes in electrical potential resulting from 
synaptic excitations of the dendrites in large populations of pyramidal neurons in the 
cerebral cortex. These are weak signals which need to be amplified for analysis (Teplan 
2002). 
EEG can also be recorded during wakefulness and spectrally analysed. EEG shows brain 
activity in terms of amplitude (voltage between the highest and lowest points of a 
wave, in microvolts) and frequency (the number of waves per second, in hertz).  
Spectral analysis describes the frequency of signal based on a set of criteria. The 
power spectrum displays the distribution of power over the particular frequency 
component of the signal. Differing frequencies have been found to correspond to 
differing sleepiness states:
<4 Hz = Delta, occurs during deep sleep
4 – 7 Hz = Theta, occurs in drowsiness and light sleep
8 – 11 Hz = Alpha, occurs in relaxed wakefulness
13 – 20 Hz = Beta, occurs when alert or anxious
Driver sleepiness is concerned with the transition from wake to sleep; as such it is 
power in alpha (8-11 Hz) and theta (4 – 7 Hz) bands that is of interest. The amount of 
alpha or theta a participant displays varies from person to person; therefore combined 
alpha and theta activity (4-11Hz) can be used to reflect increasing sleepiness (Horne et 
al. 1996, Reyner et al. 2000, Eoh et al. 2005).  
Although generally Beta activity has been shown to decrease with a prolonged 
attention task e.g. (Jap et al. 2009) it may also be of particular interest in the area of 
OSA and driver sleepiness. A recent driving simulator study comparing drivers with 
OSA and controls found beta activity to be higher in OSA group, which the authors 
suggest may be due to an increased effort on the part of the OSA drivers to remain 
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alert (Tassi et al. 2008).  Beta activity has also been shown to increase with increased 
sleep deprivation in OSA patients (Greneche et al. 2008). 
Daytime EEG equipment takes about 20 – 30 minutes to apply prior to the drive, so 
participants are required to be in the lab for longer than the drive period itself. 
Electrodes can be uncomfortable and are an additional variable which is not present in 
real life driving. It is also possible to accidently pull an electrode off thus interrupting 
the signal. 
In the current work Electroencephalography (EEG) signals were recorded using 
silverchloride coated electrodes for one channel of EEG (C3-A1 with C4-A2 as a 
backup; International 10-20 system; Rechtschaffen and Kales, (1986). 
Electrooculography (EOG) was recorded for both eyes to identify “eye rolling”. 
Electrodes were placed 1cm lateral to and 1cm below the left outer canthus and 1cm 
lateral to and 1cm above the right outer canthus, both were referenced to the 
forehead. Electrode resistance was measured using an impedance meter at application 
of the electrodes, resistance was <10kΩ for EOG and <5kΩ for EEG. Both EEG and EOG 
were collected using the Embla ambulatory system and recorded and analysed using 
Somnologica (flaga.hf).  
The EEG data was subject to high and low bandpass filtering at 20 and 4 Hz to remove 
slow eye movements and muscle artefact. All EEG was spectrally analysed using 
Somnologica (flaga.hf) in 4 second epochs for combined alpha and theta (4-11Hz) and 
beta (13-20Hz). EEG power in these ranges was averaged into 1 min epochs (after 
manual removal of any artefact) and standardised to the first 30 min of each 
individual’s normal sleep drive, thus removing individual difference in mean EEG 
power levels.  
Standardised value = difference from the mean of the first 30 minutes
                                  standard deviation of the first 30 minutes
Individual standardised values were then averaged for all participants in each 
condition.
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3.6 Statistical Analysis
The statistical analyses used in each chapter and noted in their individual method 
sections and which research questions they are addressing.  Statistical analysis in all 
cases was completed in SPSS 16.02 for Windows, (Rel 10/4/08. Chicago: SPSS Inc).
For chapters 5 to 10 the main statistical analysis technique used was analysis of 
variance (ANOVA). In all cases driving incidents, KSS, EEG and LHoFA results were
averaged into 30 min epochs per participant per condition. In cases where control and 
OSA participants were compared a mixed repeated measures analysis of variance 
(ANOVA) was completed, with two within subject factors:
Condition – 2 levels: normal sleep and sleep restriction
Time – 4 levels:  0-30 min, 30-60min, 60-90min and 90-120min
Additionally one between subjects factor:
OSA diagnosis – 2 levels: OSA patient and healthy control
Where only one group was investigated a two way (condition x time) repeated 
measures ANOVA was applied.  To clarify terminology used, groups, refers to OSA and 
control and conditions refers to normal night’s sleep and sleep restriction. 
In all cases data were first visually examined as hectograms to check the assumption of 
normal distribution was not violated. In the case of driving incidents this assumption 
was violated and a square root transformation was completed to correct for the 
skewed raw data. Huynh-Feldt (ε) adjustment was used if sphericity (Homogeneity of 
variance) could not be assumed. ε will always fall between 0.33 and 1, the higher the 
number the closer the data are to being spherical. All significance findings are
reported at p<0.05.
Additionally Chi-Squared, Pearsons correlation, Spearmans rho correlation and T tests 
are also used throughout the thesis and will be identified and explained at the relevant 
points. 
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Throughout this thesis means will be presented with standard deviation rather than 
standard error of the mean, as the variability within the study sample is considered to 
be of greater interest than level of uncertainty of how the study sample represents the 
underlying population (Hassani et al. 2010). Visualising standard deviation is important 
to understand the magnitude of variation within a group and how this variation differs 
between groups (OSA compared with control). Standard error is not appropriate as 
inferential statistics are not used (Nagele 2003). 
3.7 Pilot Work
The simulator set up used in the current work at Loughborough University is well 
tested with the method having been used previously under numerous different study 
protocols (Horne et al. 1996, Reyner and Horne 1998a, Reyner et al. 2000, Reyner et 
al. 2002, Horne et al. 2003). The simulator has also been validated as representative of
driving a real car, demonstrating it is a valid method of detecting driver sleepiness
(Baulk 2002). All of the previous studies have been completed by participants aged less 
than 30 years old. As the current work with OSA drivers would involve drivers aged 
over 50 it was necessary to assess the appropriateness of the simulator set up for this 
age group. Pilot drives were completed: three participants aged 63, 61 and 62 
completed the full study protocol as set out for the sleep restriction study.
3.7.1 Screening day measures
The screening day required participants to complete a questionnaire, hazard 
perception test and have anthropometric measurements taken. These measures were 
novel to the current research. There were no problems with the anthropometric
measurements taken or the hazard perception test but feedback from the first pilot 
participant led to the alteration of wording of one question and the addition of 
another question. 
3.7.2 The simulator
Initially, pilot participant 1 carried out a 30 minute test drive in the simulator where 3 
cars were presented to overtake (as is the case in the 2 hour drives of the study). At
the end of the test drive the participant was proficient at maintaining road position in 
the left hand lane so progressed to the main study day. During the 2 hour afternoon 
132
drive it was noted that the participant was still experiencing a learning curve of how to 
complete the overtaking manoeuvres. In response to this 10 cars were presented to 
overtake during the 30 minute test drive for pilot participants 2 and 3, allowing more 
practice at this aspect of the drive. Neither participant 2 or 3 had problems or showed 
a learning curve response with overtaking during the 2 hour drive. As such pilot 
participants 2 and 3 were included in the final data set and participant 1 excluded.      
Protocol was finalised and is described in section 3.4. 
3.7.3 Electroencephalogram (EEG) analysis
In the previous studies (Horne et al. 1996, Reyner, Horne 1998a, Reyner et al. 2000, 
Reyner et al. 2002, Horne et al. 2003) using the simulator, EEG was spectrally analysed 
in combined alpha and theta bands 4 – 11 Hz, an increase in power at this frequency
was found to reliably represent increased sleepiness. The participants in the current 
study differed from those in previous studies as they were older and half had OSA. 
Therefore on completion of the sleep restriction data collection, explorative analysis 
was conducted with the EEG recordings to investigate if 4 – 11Hz was most 
appropriate frequency band to complete spectral analysis on with this group. 5 
analysis sets were conducted at different hertz bands and compared to see which 
bands reliably indicated the increased sleepiness caused by sleep restriction. 
A bypass filter below 4 Hz and above 20 Hz was run over the EEG activity of 8 OSA and 
8 control participant’s EEG recordings before spectral analysis was conducted. In all 
cases EEG was standardised as described in section 3.5.5
Analysis was completed for Alpha (8 - 11Hz) and Theta (4 – 7 Hz) activity 
independently and combined (4 – 11 Hz). Alpha activity was also analysed in a 
narrower band width of 8.5 – 9 Hz as alpha activity frequency changes with age
(Greneche et al. 2008) and it has been suggested that in older people alpha activity 
falls in this specific narrower range and using the traditional 8 – 11Hz, therefore results 
in the analysis are missing most of the ‘real’ alpha (Klimesch 1999). Beta activity (13 –
20 Hz) was also analysed as this has been shown to be higher in untreated OSA 
participants than controls (Tassi et al. 2008).
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The different analyses results for each group individually (control n = 8 and OSA n = 8) 
were then used to compare the normal night sleep and sleep restriction condition, in 
order to identify the hertz band which most consistently distinguished between the 
two conditions. 
- Theta activity alone did not give clear results as there was an observable
difference between conditions for some participants but not for others. 
- There was little difference between the narrower and wider alpha ranges. In 
both OSA and control participants both measure of alpha activity were greater 
following sleep restriction. 
- For both the OSA and control group alpha and theta combined together (4 – 11 
Hz) showed the clearest difference between conditions. For this reason alpha
and theta combined, 4 – 11 Hz will be used for the final analysis.
- Beta activity did not increase as expected during the sleep restriction condition 
but it was higher in both conditions for the OSA group than the control group. 
Due to this disparity beta activity will also be used for the final analysis. 
In conclusion of this explorative analysis it was confirmed that combined alpha and 
theta activity (4-11 Hz) is the most appropriate frequency for assessing sleepiness with 
spectral analysis and that beta activity (13 – 20hz) may be of interest in comparing 
OSA and control participants.   
134
CHAPTER FOUR
Participant characteristics for the main driving simulator studies (not 
pilot work)
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4.1 Method
Following screening 40 participants were selected to complete the sleep restriction
study. The following chapter outlines the characteristics of the total study population, 
OSA n = 20, control n = 20. It is not designed to answer any hypothesis or research 
questions but provides back ground information of the two groups (OSA and control) 
being investigated by the simulator studies. 
4.1.1 Statistical analysis
Analysis is designed to identify any difference between the two experimental groups. 
Any differences found may be an underlying factor for differences at the driving 
simulator tasks. 
A Two tail independent T tests was used to compare the ages and total sleep time and 
sleep disturbance index of each group. Data were visually checked in histograms that 
the assumption of normal distribution was not violated. The assumption of 
homogeneity of variance was assessed using Levenes test and was not violated. 
BMI and % body fat are reported but not statistically compared as the control group 
was artificially selected to have a BMI under 28. 
4.2 Physical characteristics
Mean S.d.
OSA Age 63.8 7.7
Control Age 66.6 6.1
OSA BMI 34.5 6.5
Control BMI 25.5 1.7
OSA % body fat 32.4 5.5
Control % body 
fat
23.9 3.8
4.2-1 Age, BMI and percentage body fat of OSA and control groups
All participants were aged between 50 and 75, there was no significant difference 
between groups [t(37) = 1.22, p = 0.269]. As expected both BMI and percentage body 
fat were higher in the OSA group. The average BMI in the OSA group was obese at 
34.5; the average BMI in the control group was slightly overweight at 25.5. Control 
participants were screened not to have a BMI over 28 as there would then be at risk of 
136
then having undiagnosed OSA. BMI distribution can be seen in Figure 4.2-1. A man of 
average body weight would be expected to have 15 – 20% body fat, healthy range for 
50 – 75 years old is considered to be 13 – 25 %. 9 control and 18 OSA participants had 
a percent body fat above 25%.  
All participants were included in the study. Due to work commitments one OSA 
participant withdrew from the study before completion. The time commitment 
required for the study resulted in no other suitable participant volunteering. It is 
therefore stated in the methodology section of each chapter whether this participant 
is included (OSA n =20) in analysis for that chapter or not (OSA n = 19). 
Figure 4.2-1 BMI distribution
4.3 OSA
All of the OSA participants were being treated using CPAP from Leicester General 
Hospital and attend once a year for check up appointments. They had all been 
receiving CPAP since their diagnosis. For between 1 and 19 years (average = 7.46 
years). When asked if they ever slept without their CPAP 16 said they never would, 1 
person said they sleep without it once a month, 2 people once every two to three 
months and 1 person very occasionally. These participants reported not using their 
CPAP on occasion if they were away from home and there was no facility to plug it in, 
if they have a sore throat/nose they chose not to wear it, or if they fall asleep before 
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putting it on. However, one person who reported falling asleep before putting it on did 
comment that in this scenario they would then wake in the night and apply the mask. 
All the participants were happy with the CPAP and felt it was improving their quality of 
life. When asked what life was like before having a CPAP machine the most common 
complaints were falling asleep during the day, feeling stressed at work, struggling 
when driving and having a reduced social life, examples include:
“I had a restricted social life as I found it hard to go out in the evenings because I felt 
sleepy.”
“I was embarrassed to go on holiday with groups of people as my snoring would 
disturb them.”
“My performance at work was badly affected; I thought I couldn’t sleep well because I 
was stressed. It turned out I was stressed because I wasn’t sleeping well.”
“I left my job as I thought I was stressed so was unable to sleep properly.”
“I used to fall asleep in the daytime when I sat down.”
“I struggled to stay alert when driving long distances.”
“I was tired during the day and wanted to sleep all the time.”
4.4 Driving
OSA participants had held a UK driving licence for an average of 44.6 years, s.d. 7.2, 
with the least experienced driver having 32 years experience. Control participants had
held a UK driving licence for an average of 45.2 years, s.d. 6.9, with the least
experienced driver having 30 years experience. No participants were professional 
drivers. All participants drove for a minimum of 3 hours per week, the modal number 
of hours driven per week was 3- 5 hours (55% of OSA, 40% of controls). All participants 
drove at least 1000 miles per year with the modal response being 5000 – 10 000 miles 
(65% OSA, 40% control). 
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4.5 Trait sleepiness
All participants completed the Epworth Sleepiness Scale to assess for excessive 
daytime sleepiness (ESS >12). On average the OSA group had a slightly higher ESS (5.3 
s.d. 3.36) compared with controls (4.7 s.d. 2.56). One OSA participant reported EDS, 
during the 30 minute test drive of the simulator participants rated how sleepy they felt 
on the KSS every 200 seconds, and a mean over the 30 minutes was calculated. The 
OSA participant with EDS had an average KSS of 1 during the test drive and was 
included in the final study population. 
4.6 Habitual sleep
During screening participants were asked how long it took them to fall asleep in order 
to exclude anyone with insomnia. They were also asked if their bed partner currently 
reported anything unusual about their sleep. All control participants reported no loud 
snoring, choking or waking with a jolt in their sleep; all these signs would suggest 
undiagnosed OSA. 
Figure 4.6-1 Total sleep time with standard deviation
Each participant completed a sleep diary and wore an actiwatch to assess for 
compliance to sleep criteria prior to the study days. Four nights of baseline actiwatch 
data were collected as non study nights. Sleep diary and actimeter data were 
combined (Copyright Cambridge Neurotechnology Ltd. Version 7.22) and mean total 
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sleep time (TST) was calculated as time from initial sleep onset until final awakening 
for each participant, see Figure 4.6-1. On average both groups habitually slept a similar 
length (on non study days), controls slept for 7h 50min and OSA participants slept 7h 
37 min on average. There was no significant difference between the two groups 
average non study night SP [t (37) = 0.931, p = 0.358, two tailed]. 
The TST calculated for non study nights was used to assess if participants were 
compliant in the study conditions having either their usual night’s sleep or 5 hours 
sleep as appropriate.  
4.7 Actiwatch compliance check for the sleep restriction study
4.7.1 Total sleep time
Participants slept for the night before the study in their own homes, where actigraphy 
was used to assess their normal sleep behaviour and compliance to the 5 hours sleep 
restriction. 
Figure 4.7-1 Mean assumed sleep length in minutes, with standard deviation
All participants were compliant. The assumed sleep length, as calculated from the 
actiwatch software, sleep analysis 5 (Copyright Cambridge Neurotechnology Ltd. 
Version 7.22)
Assumed sleep = total sleep time – awake minutes
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This was compared for each condition (normal and restricted sleep) between the 
groups, Figure 4.7-1. There was no significant difference between sleep length after 
normal sleep; OSA (n=19) patients slept for 462.1 min, control (n=19) group slept 
477.3 min [t (36) = 1.09, p = 0.29, two tailed] and for sleep restriction the OSA group 
(n=19) slept 292.4 min and the control (n=20) 288.9 min [t (37) = 0.43, p = 0.67, two 
tailed]. n = 19 for control normal sleep due to a failure of one actiwatch recording. Any 
subsequent differences in performance during the driving task between groups is not 
because of differing sleep time. 
4.7.2 Sleep disturbance index
Sleep quality as well as sleep length can impact how sleepy a person feels during the 
day. Sleep disturbance index (SDI) can be calculated from actiwatch data using the 
following equation
SDI = number of wake minutes
          assumed length of sleep
The higher the SDI the poorer the sleep quality, therefore the sleepier a person may 
feel during the day. SDI was compared between groups for both conditions, and no 
significant difference was observed, Figure 4.7-2. 
Figure 4.7-2 Mean sleep disturbance index with standard deviation bars
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Following a normal night’s sleep the mean SDI was 9.08% for OSA participants and
7.32% for control participants, showing no significant difference [t (36) = 0.846, p = 
0.403, two tailed]. Following sleep restriction to 5 hours, sleep was more disturbed for 
both groups, the mean SDI was 14.81% for OSA participants and 19.45% for control 
participants, again showing no significant difference [t(37) = 0.762, p = 0.451, two 
tailed]. Any difference in performance during the task cannot be attributed to differing 
sleep quality the night before.   
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CHAPTER FIVE
Impact of sleep restriction on driving task performance
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5.1 Introduction
It has repeatedly been reported that an OSA patient’s performance at driving tasks 
improves following CPAP treatment; however the majority of studies follow up after
less than one year of treatment. It has not been demonstrated if performance at a 
driving task is still comparable to controls following long term treatment. Additionally,
previous research has not considered the ability to perform a driving task under the 
added pressure of sleep restriction. This chapter aims to address both of these issues 
by comparing performance at a driving simulator task using the primary outcome 
measure of task performance as assessed by driving incidents and standard deviation 
of road position. A comparison will be made between OSA participants treated with 
CPAP for a minimum of one year with healthy controls of a similar age, following their 
normal night’s sleep and sleep restriction to 5h.     
5.1.1 Key points from the literature review
Following the start of CPAP treatment the risk of RTI reduces in OSA patients to that of 
controls (George 2001).  Improvement at driving tasks has been reported in OSA 
participants following CPAP treatment also to levels comparable with controls, 
(Findley et al. 1989, George et al. 1997, Hack et al. 2000, Kingshott et al. 2000, Munoz 
et al. 2000, Mazza et al. 2006). In general these studies are carried out before and 
after the start of treatment: as such follow up periods tend to be within one year of
starting treatment. Additionally the research showing improvement in performance 
following CPAP treatment has predominantly been conducted using short duration 
tests. It is unknown if CPAP treated patients will have similar performance to controls 
at a long monotonous task, such as simulated motorway driving.  
Sleep restriction is known to impair driving performance in healthy individuals, 
resulting in a greater number of driving incidents over a monotonous two hour drive 
(Horne et al. 2004); it is not known if this effect differs with treated OSA participants. 
With untreated OSA participants total sleep deprivation (Desai et al. 2006) and sleep 
restriction to 4 hours (Vakulin et al. 2009) have be found to cause greater impairment 
at driving tasks than in healthy controls. No studies with treated OSA participants were 
identified to assess if this increased susceptibility to the effects of sleep restriction 
persists into treatment.
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5.1.2 Research aim and hypotheses
Aim: To evaluate the effect of sleep restriction in OSA-CPAP compliant patients 
compared with controls at a simulated driving task.
Hypotheses:
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by increased lane deviation 
after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation and 
shorter time to first incident after sleep restriction to 5h of treated sleep.
5.2 Method
Design: Repeated measures counterbalanced. Completing a 2h afternoon drive 
following a normal night’s sleep and following sleep restriction to 5h. Comparing 
treated OSA participants and healthy controls. 
Setting: Driving simulator
5.2.1 Participants
Participant characteristics can be found in chapter 4. 20 control participants and 19 
OSA participants are represented in the following chapter. 
5.2.2 Protocol
Study protocol was followed as detailed in chapter 3. The data presented here is for 
the simulator measures only, resulting from the repeated measures counterbalanced 
design comparing performance following a normal night’s sleep and sleep restriction 
to 5 h. 
5.2.3 Measures
Sleep-related minor and major driving incidents were scored from the driving 
simulator and video recording as detailed in chapter 3 and analysed in 30 min epochs. 
The standard deviation of road position was generated by the driving simulator. The
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standard deviation for the road position was calculated for each participant for each 2 
hour drive. The average of which was then compared between groups. 
5.2.4 Statistical analysis  
Incidents were analysed in three groups: minor incidents, major incidents and total 
incidents (minor + major). Incidents were totalled per participant then a mean taken 
for each group. As described in section 3.6, incidents were calculated in four 30 minute 
epochs and analysed using a mixed measures ANOVA, with two within subject factors:
condition (2 levels) and time (4 levels), and one between subjects factor, having OSA 
or not. 
A mixed measures ANOVA with one within subject factor, condition (2 levels) and one 
between subjects factor, having OSA or not, was used to analyse time to first incident 
and standard deviation of road position. 
In all cases raw data were visually examined in histograms to check the assumption of 
normal distribution, standard deviation of road position and time to first major 
incident were normal. Number of driving incidents (Minor, major and total) were not, 
to correct for this skewed data a square root transformation was completed prior to 
analysis. Huynh-Feldt (ε) adjustment was used where the assumption of homogeneity 
of variance was not met. 
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5.3 Results
5.3.1 Frequency of driving incidents
Figure 5.3-1 Mean number of total incidents occurring in 2 hours driving with standard deviation
Both groups experience more driving incidents following sleep restriction. In both 
conditions the OSA participants had more incidents than the controls, see Figure 5.3-1.
Figure 5.3-2 Minor incidents in 30 minute epochs with standard deviation
The number of minor incidents occurring is displayed in 30 minute epochs in Figure 
5.3-2. ANOVA demonstrates a significant effect of condition [F (1,37) = 22.29, p < 
0.001, ε = 1], with both groups having more minor incidents following sleep restriction 
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than a normal night’s sleep. There is a significant effect of time [F (2.03,75.16) = 26.92, 
p < 0.001, ε = 0.68] in general demonstrating an increase in incidents as the drive 
progressed. There was no significant difference between OSA and controls.
Figure 5.3-3 Major incidents in 30 minute epochs with standard deviation
The number of major incidents in each 30 minute epoch is shown in Figure 5.3-3 . For 
the first 30 min there is little difference in major incidents between groups; however 
for the following hour and a half the sleep restricted OSA participants had a greater 
number of incidents than the sleep restricted controls. 
There is a significant effect of condition on the number of major incidents [F (1,37) = 
20.78, p < 0.001, ε = 1] as both groups had more major incidents following sleep 
restriction. There is a significant effect of time [F (1.7,63) = 15.01, p <0.001, ε = 0.57] 
demonstrating a general increase in number of incidents across the drive. Sleep 
restriction affected OSA participants differently than controls as there is a significant 
condition, group interaction [F (1,37) = 9.37, p= 0.004, ε = 1]. This is demonstrated by
the interaction graph Figure 5.3-4, showing sleep restriction to have a greater effect 
on OSA participants than would be expected if sleep restriction resulted in the same 
increase in impairment as it does to control participants. The dotted line denotes the 
results that would be expected from OSA participants had they been affected by the 
intervention is the same way as the control group. 
0
5
10
15
20
25
0 - 30 min 30 - 60 min 60 - 90 min 90 - 120 min
M
aj
or
 in
ci
de
nt
s
OSA normal sleep
Control normal sleep
OSA sleep restriction
Control sleep restriction
148
Figure 5.3-4 Interaction condition and group for number of major driving incidents
5.3.2 Time to first major incident (safe driving time)
In a real road driving situation if a person drives out of their driving lane on any 
occasion it could result in serious consequences. To investigate this scenario the 
average time to first major incident was calculated. Those completing the drive 
without major incident were recorded as driving 120 minutes. Results are shown in 
Figure 5.3-5
Figure 5.3-5 Safe driving time with standard deviation
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After a normal night’s sleep the control participants successfully drove for a mean 
(s.d.) of 97.1 minutes (36.5) and the OSA group 88.9 minutes (29.0). Following sleep 
restriction this decreased to 91.1 minutes (38.6) for control and 65.0 minutes (42.0) 
for OSA. The effect of condition is close to significance [F(1,37) = 4.04, p = 0.052, ε = 1], 
suggesting that following sleep restriction both groups drove for a shorter time before 
having their first major incident. There is a significant condition, group interaction 
[F(1,37) = 4.16, p = 0.049, ε = 1], displayed in Figure 5.3-6, suggesting that sleep 
restriction has a greater impact in OSA participants safe driving time than would have 
been expected if sleep restriction resulted in the same difficulties experienced by 
controls. 
Figure 5.3-6 Interaction of condition and group for safe driving time
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5.3.3 Standard deviation of road position (drifting within the driving lane)
Figure 5.3-7 Standard deviation of road position for both groups in both conditions with standard 
deviation
The larger the standard deviation of road position the greater the movement of the 
vehicle from the required “straight” driving position; defined as ‘drifting within the 
driving lane’. Movement within driving lane is an indication of drowsiness, as alert 
drivers are expected to have better control and more accurately maintain driving 
position.  There is a significant effect of condition [F (1,37) = 6.91, p = 0.012, ε = 1], 
with both groups showing greater standard deviation of road position following sleep 
restriction. The impact of sleep restriction on road position was no different for the 
OSA group than controls as the group. 
5.4 Discussion
OSA participants have been found to be more affected by sleep restriction than 
controls. For both number of driving incidents and safe driving time the OSA 
participants were significantly more impaired after sleep restriction compared with 
the controls. When considering the total number of incidents over two hours, sleep 
restriction resulted in an increase of incidents of OSA participants more than twice 
that for controls.  A significant condition and group interaction for safe driving time 
demonstrates the differing effect of sleep restriction of OSA participants. If sleep 
restriction had the same effect on OSA participants as it did for controls it would be 
expected that they could drive safely for 18 minutes more than they actually did.  
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Major incidents demonstrate the strongest evidence for the impact of sleep 
restriction, where the significant condition and group interaction shows the total 
number of major incidents to be considerably higher than would be expected if the 
OSA participants had responded in the same manner as controls to the sleep 
restriction. The sleep restriction did significantly affect both groups resulting an 
increase in driving incidents and a near significant reduction in safe driving time.
When interpreting these results it is important to consider the nature of driving as a 
task. The question ‘should OSA patients drive when sleep restricted?’ does not have a 
simple yes/no answer. Although it is clear that OSA participants would suffer impaired 
driving performance if undertaking a long drive, for the first 30 minutes of driving the 
number of incidents is similar for the OSA and control groups. In fact OSA participants 
were able to drive without major incident for an average of 65 minutes following sleep 
restriction. It appears that OSA patients may only experience greater impairment from 
sleep restriction in a long duration task. No difference in sleep deprivation impairment 
between OSA and control participants was found in Desai et al. (2006): here the 
battery of tests completed were all short in duration, so it is likely the OSA participants 
were able to maintain performance to the level of controls in these short tests. 
However, had they been longer a difference in impairment severity would have been 
noted.   
No significant difference was found with standard deviation of road position. In real 
life, major driving incidents are more likely to result in RTI’s than minor incidents, and 
standard deviation of road position could represent movement within the designated 
driving lane. Therefore, major incidents are considered most important in assessing 
driving task performance and form the focus of the discussion. 
After a normal night’s sleep OSA participants had no significant difference in the 
number of either major or minor incidents compared to controls. There was also no 
significant difference in safe driving time. These results add to the evidence from many 
previous publications in finding no significant difference between the driving 
performances of CPAP treated OSA participants and healthy controls. (Findley et al. 
1989, George et al. 1997, Hack et al. 2000, Kingshott et al. 2000, Munoz et al. 2000, 
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Mazza et al. 2006). In addition, the current research provides unique confirmation that 
these results are still found in long term treated OSA participants.  With OSA 
participants demonstrating greater difficulty in the later stages of the drive it suggests
that they had greater difficulty with time on task than the control group.
Previous research has found untreated OSA participants to be more susceptible to the 
effects of sleep restriction (4h) than control drivers, (Vakulin et al. 2009). The current 
study is interesting compared with Vakulin et al. (2009) as it is a similar study design 
(though with different simulator) and with treated OSA participants. Commonly both 
the treated and untreated OSA participants suffered more from the sleep restriction 
than the control group, having more sleep-related incidents. Vakulin et al. (2009) 
found the standard deviation of road position to be 40% higher in OSA participants 
after the sleep restriction than the controls. No difference was found in the current 
work for this measure; this is possibly because of differing simulator set up, but a 
significant difference was found in the number of major incidents. It is possible that 
because of CPAP treatment sleep restriction related impairment is more manageable 
than in untreated sufferers. This enables participants to maintain their road position 
for the majority of the drive until the point they can’t maintain wakefulness any 
longer, having a major incident. CPAP treatment has been shown by many studies, 
including the current work, to result in driving performance of OSA participants to be 
no different from controls. It is interesting that the increased susceptibility to sleep 
restriction reported in untreated OSA participants is still apparent in the long term 
treated OSA participants. 
It is possible that untreated OSA participants are already sleep deprived so by reducing 
sleep length participants will experience greater sleep restriction than controls, 
putting them at a greater disadvantage. In the current research all OSA participants 
are successfully treated with CPAP, theoretically putting them at the same starting 
point as controls; demonstrated by a similar performance between groups following a 
normal night’s sleep. It is not possible to ascertain why OSA participants were less able 
to cope with sleep restriction than the control group from the current work, but it is 
possible that the time spent with untreated OSA may have resulted in some 
permanent brain damage. Imaging studies have found differences in grey matter in 
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untreated OSA sufferers and differences in some cognitive function studies between 
untreated OSA patients and controls (Joo et al. 2010). This may offer a possible 
explanation for being less able to cope with sleep restriction. To investigate this 
further it would be necessary to complete a longitudinal study investigating sleep 
restriction prior and post treatment with brain imaging. 
The UK Highway Code recommends taking a break from driving every 2 hours to avoid 
driver fatigue. In the current work the average safe driving time was approximately 90 
minutes for both the control and OSA participants following a normal night’s sleep. 
Even the healthy controls were not able to maintain performance for 2 hours, with 
35% of them unable to complete the drive without major incident. It may be more 
appropriate to recommend taking a break from driving every 90 minutes to avoid 
driver fatigue as this was the approximate safe driving time reached by both groups 
following a normal night’s sleep. All the participants were aged between 50 and 75 
years old so it may be that a short safe driving time is a reflection of age. If this were
the case it might be expected that the over 50s would feature highly in sleep-related 
crash statistics. In fact the most likely group to have srRTIs are the under 30s (Horne et 
al. 1995). This is likely due to the fact that older drivers will demonstrate less risky 
behaviour, i.e. less likely to drive without adequate prior sleep or in the early hours of 
the morning. It is also possible that older drivers would be taking breaks more 
frequently than 2 hours for reasons other than sleepiness, such as bathroom breaks, 
to stretch legs, or because they feel less pressure to complete their journey at speed
(Bhatti et al. 2008). Ultimately this reduces their sustained driving time and pre-empts
any difficulty due to driver sleepiness. 
The simulated road presented was designed to represent the type of driving condition 
where srRTIs are most likely to occur (Horne et al. 1995). It was therefore the intention 
of this study to present a ‘worst case scenario’ of a dull monotonous drive. As such it is 
acknowledged that in a ‘real world’ scenario participants may have been able to drive 
safely for longer than was found with the simulator. It is also possible that a larger 
volume of traffic on the road would have reduced the difference in performance 
between the OSA and control groups, as was found in a simulator of high traffic 
density in Tassi et al. (2008). 
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A greater variation in performance within the OSA group was found compared with 
control group.  For both total major and minor incidents the standard deviation is 
larger for the OSA group than the control group. This is true for both conditions but 
the difference is larger following sleep restriction, Table 5.4-1
Normal sleep Sleep restriction
Total minor incidents s.d. OSA 
20.03
Control
17.02
OSA
40.20
Control
25.13
Total major incidents s.d. OSA 
9.89
Control
2.91
OSA 
31.07
Control
8.77
Table 5.4-1 Standard deviation for total number of driving incidents in 2 hours
The greater individual difference within the OSA participants is of particular interest 
and will be investigated further in chapter 10. 
Primarily this study demonstrates the importance of getting a full night’s sleep before 
embarking on a long motorway journey, for both OSA drivers and healthy drivers. 
Advice should be aimed at this older age group in general, advising them to take a 
break from driving at least every 90 minutes and more often if they have had a poor 
night’s sleep. Health practitioners should emphasise to OSA patients that although 
they are safe to drive if using their CPAP correctly they should be aware that they may 
suffer greater impairment following sleep restriction than they would if they did not 
have OSA. It is now important to investigate if OSA participants know that they are 
sleepy as this would enable them to take appropriate action. Being sleepy while 
driving itself does not cause RTIs it is the inability to recognise or unwillingness to act 
on it that results in srRTIs; the ability to recognise sleepiness will be investigate in 
chapter 8. 
5.5 Conclusions 
- Following a normal night’s sleep with CPAP treatment OSA participants’
performance at a simulated driving task is not significantly different to that of 
healthy controls.
- Sleep restriction has a significantly greater impact on driving task performance 
for CPAP treated OSA participants than healthy controls.
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- Older drivers may benefit from taking a break from driving at least every 90 
minutes. This is more often than the 2 hours recommended in the Highway 
Code.  
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CHAPTER SIX
Impact of sleep restriction on subjective sleepiness while completing a 
driving task
157
6.1   Introduction
The focus of this chapter is state sleepiness while completing a simulated driving task. 
The previous chapter has shown OSA participants to have greater impairment due to 
sleep restriction compared with controls in terms of driving incidents; the current 
chapter assesses if this is reflected in subjective sleepiness.
6.1.1 Key points from the literature review
Subjective sleepiness will increase with time on task, particularly if the task is 
monotonous; even after a full night’s sleep participants may feel sleepier as the task 
progresses (Thiffault et al. 2003). Subjective driver sleepiness is most commonly 
investigated by recording subjective sleepiness before and after a driving task. 
However, this methodology means that sleepiness is not reported when the 
participant is completing the task, as such alertness may have improved or worsened
since the task environment has been removed. Also, any changes in alertness during 
the task will not be identified. The current study will record subjective sleepiness at 
regular intervals throughout a task to monitor changes while the task is being 
completed. The more often ratings are taken, the more detail of change in subjective 
state is obtained, however, the act of asking participants for a subjective rating itself 
has an alerting effect as it can produce stimuli in an otherwise monotonous 
environment. This is similar to the effect noted by conducting a reaction time test 
during a monotonous task (Baulk et al. 2001).   
CPAP treatment has been shown to improve daytime sleepiness in OSA patients 
(Hardinge et al. 1995, Ballester et al. 1999). It would therefore be expected that when 
OSA patients use their CPAP and have a full night’s sleep they would feel no sleepier 
than control participants at the start of a task and progress in sleepiness during the 
task in the same manner as controls. Previous research investigating subjective 
sleepiness in untreated OSA participants has recorded sleepiness periodically using the 
Stamford Sleepiness Scale, after total sleep deprivation compared with following a 
normal night’s sleep. Both groups reported feeling sleepier during total sleep 
deprivation but the untreated OSA participants did not report an increase in sleepiness 
to the same magnitude as control participants. (Desai et al. 2006). A similar finding has 
been reported using a visual analogue scale (Risser et al. 2000); here untreated OSA 
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and control participants rated sleepiness before and after completion of a 60 minute 
driving simulation. Both groups showed increased sleepiness at the end of the task, 
however, the OSA group had worse performance at the task but did not rate 
themselves as sleepier than controls. In both of these studies untreated OSA 
participants did not rate themselves as sleepy as would be expected from the 
magnitude of task performance impairment compared with controls. The current 
research will investigate if this is also apparent in treated OSA participants. 
6.1.2 Research aim and hypotheses 
AIM2: To evaluate the effect of sleep restriction in OSA-CPAP compliant patients 
compared with controls at a simulated driving task.
Hypotheses: 
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by subjective sleepiness 
measures (KSS and LHoFA) after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by subjective sleepiness measures 
(KSS and LHoFA) after sleep restriction to 5h of treated sleep.
To test the hypothesis that in both groups subjective measures of sleepiness will be 
correlated to each other (KSS vs LHoFA and KSS vs ESS). 
6.2 Method
Design: repeated measures counter balanced. Completing a 2h afternoon drive 
following a normal night’s sleep and following sleep restriction to 5h. Comparing 
treated OSA participants and healthy controls.
Setting: driving simulator
6.2.1 Participants
Participant characteristics can be found in chapter 4. 20 control participants and 19 
OSA participants are represented in the following chapter. 
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6.2.2 Protocol
Study protocol was followed as detailed in chapter 3. The data presented here is for 
the subjective sleepiness measures only, resulting from the repeated measures 
counterbalanced design comparing performance following a normal night’s sleep and 
sleep restriction to 5 h. 
6.2.3 Measures
During each 2 hour drive state sleepiness was recorded throughout using the KSS and
rating the Likelihood of falling asleep in the next 5 minutes (LHoFA). The scales were
explained to participants at the screening day and they practiced using it during the 
test drive. Every 200 seconds of the drive is marked as a sleep check because a 
recorded voice asked “sleep check?” at these times, to which participants responded 
with a number from the KSS (out of 9) and a letter from the LHoFA (out of 5) scales. 
Responses to both these scales are reflective of how the participant is feeling at that 
particular point in time. 36 responses were collected for each participant in each 2 h 
drive. The scales were constantly visible, presented on the dashboard of the car.  
All participants had previously completed an ESS measure of trait sleepiness at their 
screening day.
Full details of both scales can be found in chapter 3. Both scales were presented in 
clear view to participants throughout the drive. 
For analysis subjective sleepiness scores are taken to represent the 100 seconds prior 
and post a “sleep check?”.
6.2.4 Statistical analysis
The 36 subjective ratings taken in each drive were averaged across the participants in 
each group, for each condition. The mean response for each group in each condition 
was averaged into 30 minute epochs for statistical analysis using mixed measures 
ANOVA with two within subject factors; condition (2 levels) and time (4 levels), and 
one between subject factor, having OSA or not, as described in section 3.6
In all cases raw data were visually examined in histograms to check the assumption of 
normal distribution, KSS, LHoFA and the mean change in KSS (see below) showed 
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normal distribution. Huynh-Feldt (ε) adjustment was used where the assumption of 
homogeneity of variance was not met. 
The relationship between subjective sleepiness ratings was analysed with Spearman’s 
correlation coefficient (rs) comparing the mean KSS with LHoFA score for each 
participant over the 2 hours and KSS with ESS.
The mean percentage of the drive spent in each subjective score was calculated for 
both groups in both conditions and compared on percentage graphs. 
To assess change in state sleepiness over the drive the difference between the first 
and last KSS score was calculated for each participant determining the change in 
sleepiness state.
Change in sleepiness state = KSS second 7100 – KSS second 200
This was calculated to make comparisons to previous publications who recorded 
subjective sleepiness before and after a driving task. The mean change was calculated 
compared between groups using a repeated measures ANOVA, with one within 
subject factor, condition (2 levels) and one between subjects factor, having OSA or 
not.
6.3 Results
6.3.1 KSS
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by subjective sleepiness 
measures (KSS and LHoFA) after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by subjective sleepiness measures 
(KSS and LHoFA) after sleep restriction to 5h of treated sleep.
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Figure 6.3-1 Mean KSS every 200 seconds for OSA and Control participants following normal sleep and 
sleep restriction
The mean KSS scores are shown in Figure 6.3-1. In all cases KSS increased linearly from 
the beginning of the drive then plateaued after one hour. Both groups reported feeling 
sleepier following the sleep restriction.
For statistical analysis scores were averaged to 30 minute epochs, Figure 6.3-2. 
Figure 6.3-2 Mean KSS in 30 minute epochs with standard deviation 
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The effect of condition is significant [F (1,37) = 19.94, p < 0.001, ε = 1]. The effect of 
time was also significant, participants got sleepier as the drive went on [F (1.9, 72.1) = 
69.99, p < 0.001, ε = 0.649]. There was no group interaction effect. 
6.3.2 Change in sleepiness state
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by subjective sleepiness 
measures (KSS and LHoFA) after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by subjective sleepiness measures 
(KSS and LHoFA) after sleep restriction to 5h of treated sleep.
Figure 6.3-3 Mean change in KSS score from second 200 to second 7000 with standard deviation 
The change in reported sleepiness state is shown in Figure 6.3-3. There was a 
significant effect of condition [F(1,37) = 9.27, p = 0.004, ε = 1], both groups showing a 
greater change in subjective sleepiness from the beginning to the end of the task 
following sleep restriction. There was no significant group interaction; the sleep 
restriction did not affect the OSA participants any differently from the control 
participants. 
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6.3.3 LHoFA
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by subjective sleepiness 
measures (KSS and LHoFA) after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by subjective sleepiness measures 
(KSS and LHoFA) after sleep restriction to 5h of treated sleep.
Figure 6.3-4 Mean LHoFA score every 200 seconds for OSA and control participants following normal 
sleep and sleep restriction
LHoFA is displayed in Figure 6.3-4, the same trend is apparent as for KSS. Participants 
felt more likely to fall asleep following sleep restriction than following normal sleep, in 
all cases likelihood for falling asleep increased for the first hour then plateaued. Scores 
were averaged into 30 minute epochs for statistical analysis, Figure 6.3-5.
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Figure 6.3-5 Mean LHoFA scores in 30 minute epochs with standard deviation 
There is a significant effect of condition, participants felt more likely to fall asleep 
following sleep restriction [F (1,37) = 30.92, p < 0.001, ε = 1]. The effect of time was 
also significant as participants felt more likely to fall asleep as the drive progressed [F 
(1.8, 66.4) = 50.73, p < 0.001, ε = 0.60]. There was no significant interaction of group. 
6.3.4 Correlations between scales
To test the hypothesis that in both groups subjective measures of sleepiness will be 
correlated to each other (KSS vs LHoFA and KSS vs ESS). 
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Figure 6.3-6 Subjective sleepiness, LHoFA and KSS
Spearman’s correlation coefficient demonstrates that KSS and LHoFA have a significant 
positive relationship see in Figure 6.3-6, following both normal sleep [rs = 0.727, p < 
0.001] and sleep restriction [rs = 0.748, p < 0.001]. 
Figure 6.3-7 Subjective sleepiness, ESS and KSS
There was no correlation between ESS scores and KSS following a normal night’s sleep, 
shown in Figure 6.3-7 [rs = 0.153, p = 0.352] or sleep restriction [rs = 0.016, p = 0.331]. 
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The state sleepiness experienced during the task was not significantly related to trait 
sleepiness.
6.3.5 Prevalence of subjective sleepiness ratings
Figure 6.3-8 Mean percentage of the drive spent in each KSS score following a normal night’s sleep
Figure 6.3-9 Mean percentage of the drive spent in each KSS following sleep restriction
36 subjective sleepiness ratings were recorded for each participant in each drive, 
resulting in 720 data points per condition for control participants and 684 data points 
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per condition for OSA participants. The frequency of a particular subjective score was 
recorded per participant and a mean taken across participants for each point on both 
scales, displayed in Figure 6.3-8, Figure 6.3-9, Figure 6.3-10 and Figure 6.3-11. 
Following a normal sleep KSS 2 was most frequently reported by OSA drivers and KSS 3 
by control drivers. Following sleep restriction KSS 3, 8 and 9 were most frequently 
reported for both groups. 
Figure 6.3-10 Mean percentage of the drive spent in each LHoFA score after a normal sleep
Figure 6.3-11 Mean percentage of the drive spent in each LHoFA score after sleep restriction
After a normal sleep LHoFA 1 was the most frequently reported score by both OSA and 
control participants, with frequency of reporting decreasing up the scale, shown in 
Figure 6.3-10. Following sleep restriction LHoFA 2 was most frequently reported for 
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both groups. The variability between popularity of LHoFA scores after sleep restriction 
was less for OSA participants than control participants, displayed in Figure 6.3-11.
6.4 Discussion
Subjective sleepiness was recorded on the KSS and LHoFA scales throughout the drive, 
there was no significant group interaction for either scale in either condition. The OSA 
and control participants experienced comparable levels of sleepiness and likelihood of 
falling asleep in both conditions. For both groups participants felt significantly sleepier 
and significantly more likely to fall asleep following sleep restriction and in all cases 
the effect of time was significant.  
Sleep restriction had a significantly greater effect on driving task performance of the 
OSA participants than controls; therefore it would have been understandable for the 
OSA participants to feel significantly sleepier following sleep restriction than controls. 
However, the non significant difference in subjected sleepiness despite a significant 
difference in task performance is consistent with previous research, (Risser et al.
2000). In that study untreated OSA participants reported subjective sleepiness on a 
VAS before and after a 60 min simulated drive, no difference was found between OSA 
and control participants in the magnitude of sleepiness increase, despite worse 
performance by the OSA participants. Risser et al. (2000) recorded two subjective 
sleepiness scores and compared the difference between them, for comparison in the 
current work the mean change in KSS was also reported, again there was no significant 
difference between groups, despite the greater number of incidents by the OSA 
participants. Not feeling sleepier even though task performance is impaired may be 
indication of a lack of ability to identify sleepiness by the OSA participants; this is an 
area requiring further investigation and will be assessed in chapter 8.  
Ability to sustain attention has been shown to be impaired in untreated OSA sufferers 
and to improve to the same level as controls following 4 months of CPAP (Ferini-
Strambi et al. 2003). Subjective alertness over the two hours in the current work also 
shows the effect of time to be the same on controls and long term treated OSA 
participants. The OSA group did not show any more increased sleepiness with time on 
task than the controls, demonstrating this positive effect of CPAP to be sustained. 
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Analysis of RTI data depicts a small peak in srRTIs during the early afternoon despite 
this being a period of time with fewer cars on the roads (Horne et al. 1995). These 
afternoon srRTIs are more likely to be caused by older drivers, whereas early morning 
srRTIs are more likely to be caused by younger drivers (Horne et al. 1995) . The current 
study was conducted during the early afternoon, which, as a time noted for older 
drivers to have srRTIs it could be expected that these participants would experience 
day time sleepiness. However, it is noted that when compared with previous 
publications using this simulator the current participants felt more alert at the start of 
each drive than younger participants completing the same study protocol. The 
participants in the current study reporting an initial KSS of 2.6 after sleep restriction 
compared to KSS of 5 (Reyner et al. 2002), KSS of 4 (Horne et al. 2004) or KSS of 3 
(Horne et al. 2003) for younger participants. This was an unexpected difference and is 
further discussed in chapter 13. 
Following sleep restriction it was expected that the KSS scores denoting sleepiness (6-
9) would be more frequently reported that following normal sleep. However, KSS 6 
and 7 were less frequently reported following sleep restriction by both OSA and 
control participants than after normal sleep.  Following sleep restriction both groups 
most frequently reported KSS 3, 8 and 9. The low frequency of reporting KSS 6 and 7 is 
reflective of a fast transition from alert (KSS 1-4) to very sleepy (KSS8-9). With a short 
transition time from alert to sleepy there is a smaller window for participants to 
identify increasing sleepiness, as such it may be difficult to recognise if they are sleepy 
prior to a driving incident, and this will be investigated in chapter 8.     
It is beneficial to collect subjective sleepiness reports throughout the drive to reflect 
changes in sleepiness as they occur, yet, it is recognised that the act of asking “sleep 
check?” may promote artificial alertness in participants. Completing a secondary task 
during a monotonous main task has been shown to artificially increase alertness (Baulk 
et al. 2001) and the repeated request “sleep check?” may have had a similar effect. 
The KSS and LHoFA scales were found to be significantly correlated in both conditions, 
with approximately 85% of variance explained. It should be expected that as 
participants felt sleepier they would also feel more likely to fall asleep; nevertheless, 
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some younger drivers do not demonstrate this relationship (Reyner, Horne 1998b). It 
has been reported with younger participants that some will identify themselves as 
fighting sleep but not acknowledge any likelihood of falling asleep. Younger drivers are 
known to take more risks and have a greater sense of invincibility (Finn et al. 1986);
the high correlation between the two measures may be a reflection of the age of the 
participants.
There was no correlation between the state sleepiness measured by KSS and trait 
sleepiness measured by ESS. The ESS is commonly used in medical practice to monitor 
EDS in OSA patients. Having an ESS of less than 12 is an indication that patients have 
no EDS and may be used by a doctor as a basis for assessing fitness to drive. In the 
current study all participants had an ESS≤13 (one participant scored over 12) therefore 
none would be considered to have serious EDS. Even without EDS, it would be 
expected that trait sleepiness would be related to state sleepiness. Though it is 
possible that if participants with a wider range of ESS scores were studied a correlation 
maybe found with KSS, as it stands the higher end of the ESS scale is not represented. 
The lack of correlation between the trait sleepiness and state sleepiness whilst driving 
suggests that ESS may not be a reliable tool to assess fitness to drive.  
In chapter 5 larger standard deviation of number of driving incidents was reported 
within OSA participants compared with controls. This greater variation was not found 
with KSS and LHoFA scores, Table 6.4-1. 
Normal sleep Sleep restriction
Total KSS s.d. OSA 
1.46
Control
1.56
OSA
1.97
Control
1.69
Total LHoFA s.d. OSA 
0.69
Control
0.78
OSA 
0.83
Control
0.91
Table 6.4-1 Standard deviation of subjective scores
Sleep restriction resulted in larger standard deviations than normal sleep, reflecting 
individual difference in the ability to cope with sleep restriction. KSS following sleep 
restriction was the only measure showing a larger standard deviation in OSA than 
control participants.  Overall this also shows that there is little difference in subjective 
experience within treated OSA and control participants. 
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6.5 Conclusions
- Treated OSA drivers do not show the increase in subjective sleepiness that 
would be expected following sleep restriction when the increase in number of 
driving incidents is considered. 
- Both treated OSA participants and control participants feel sleepier and more 
likely to fall asleep while completing a driving task following sleep restriction 
compared to after a normal night’s sleep.
- Increasing time on task significantly increases subjective sleepiness for both 
treated OSA and control participants following normal sleep and sleep 
restriction.
- It is possible that older drivers experience a quick transition from alert to very 
sleepy.
- KSS and LHoFA are highly correlated; older drivers recognise that if they feel 
sleepy they are likely to fall asleep. 
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CHAPTER SEVEN
Impact of sleep restriction on EEG sleepiness while completing a driving 
task
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7.1 Introduction
The current chapter compares the EEG spectral components between treated OSA 
participants and control participants as they complete a two hour driving simulator 
task following a normal night’s sleep and sleep restriction (5h). It has already been 
shown that OSA participants have greater task impairment following sleep restriction 
(chapter 5) but suffer no higher subjective sleepiness compared with controls (chapter 
6). EEG spectral analysis provides a physiological indication of sleepiness which can be 
compared between groups.
7.1.1 Key points from the literature review
Increasing combined alpha and theta power has been demonstrated to be most 
representative of the transition between wake and sleep in healthy young participants 
during a driving simulator task (Horne et al. 1996). Beta activity occurs with increased 
effort to remain alert and has been shown to decrease with prolonged attention tasks 
(Jap et al. 2009). 
Beta activity is of particular interest in OSA participants as it has found to be higher in 
untreated patients during a driving task of medium traffic density compared to 
controls, suggestive of increased effort to remain alert (Tassi et al. 2008). Higher 
activity in the beta and theta power spectrum has also been observed during total 
sleep deprivation in untreated OSA participants compared with controls, suggesting 
greater sleepiness and greater effort to remain alert (Greneche et al. 2008). 
Very few EEG studies have been carried out in the area of OSA and driver simulation
and in particular none of longer duration. Risser et al. (2000) completed a driving 
simulator study for 60 min including EEG recording of untreated OSA participants 
compared with control participants. OSA participants were found to have more 
“attention lapses” in EEG activity than controls and these lapses became longer in 
duration as the task progressed for the OSA participants. Participants were asked to 
rate sleepiness subjectively before and after the task. Despite the greater amount of 
“attention lapses” in EEG, OSA participants showed parallel increase in subjective 
sleepiness to controls. This indicates that the EEG activity of untreated OSA 
participants differs to that of controls during a driving task, and that subjective 
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sleepiness in OSA may not be linked to EEG activity, however, this driving task was only 
60 minutes so it is unknown if the same result would be found with a longer task. No 
similar studies were identified with treated OSA participants. 
7.1.2 Research aim and hypotheses 
Aim: To evaluate the effect of sleep restriction in OSA-CPAP compliant patients 
compared with controls at a simulated driving task.
Hypotheses:
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
driver performance at a driving simulator task as reflected by increased beta and 
combined alpha theta activity after a normal night of treated sleep.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased beta and combined 
alpha theta activity after sleep restriction to 5h of treated sleep both overall and at the 
specific time of first incident for the OSA group.
7.2 Method
Design: repeated measures counter balanced. Completing a 2h afternoon drive 
following a normal night’s sleep and following sleep restriction to 5h. Comparing 
treated OSA participants and healthy controls.
Setting: driving simulator
7.2.1 Participants
Participant characteristics can be found in chapter 4. 20 control participants and 19 
OSA participants are represented in the following chapter.
7.2.2 Protocol
Full study protocol can be found in chapter 3. 
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7.2.3 Measures
Two channels of EEG activity were recorded, C3-A1 for analysis and C4-A2 as a backup. 
Resulting from exploratory analysis described in chapter 3, combined alpha and theta 
(4-11 Hz) and beta (13 – 20 Hz) bands were used for the final analysis. 
EEG data was recorded in 4 second epochs, power in the specific hertz bands was 
averaged into 1 minute epochs for each participant and standardised to the first 30 
minutes of the normal sleep drive, full details can be found in chapter 3. 
7.2.4 Statistical analysis
EEG activity is visually displayed in 1 minute epochs to show change in activity across 
the drive, each data point represents a mean for participants at that time point. These 
results were averaged into 30 minute epochs for statistical analysis using a mixed 
measures ANOVA, with 2 within subject factors; condition (2 levels) and time (4 
levels), and the between subjects factor, of having OSA or not, as described in section 
3.6.
In all cases raw data were visually examined in histograms both spectral analysis of 
EEG were slightly skewed, square root transformation of the data was completed but 
as this did not affect statistics the original data is presented here. Huynh-Feldt (ε) 
adjustment was used where the assumption of homogeneity of variance was not met. 
EEG at minute 65 of the drive is compared between groups using a 1 tail independent t 
test. This data is normally distributed, the assumption of homogeneity of variance was 
also met, tested using Levenes. 
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7.3 Results
7.3.1 Combined alpha and theta activity
Figure 7.3-1 Mean standardised EEG power (4 - 11Hz) in 1 min epochs, for both groups following 
normal sleep
Following a normal night’s sleep both control and OSA participants demonstrated an 
increase in alpha and theta power for the first hour of the drive before reaching a 
plateau in the second hour, see Figure 7.3-1. 
Figure 7.3-2 Mean standardised EEG power (4 - 11Hz) in 1 min epochs, for both groups following sleep 
restriction
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Following sleep restriction OSA participants show similar alpha and theta power to 
controls for the first 20 minutes. For the rest of the drive EEG power is higher for OSA 
participants. 
For statistical analysis scores were averaged to 30 minute epochs, see Figure 7.3-3.
Figure 7.3-3 Mean EEG power (alpha and theta) in 30 min epochs with standard deviation
Following one night sleep restriction to 5 hours there was no significant effect of 
condition [F(1,37) = 0.339, p = 0.635, ε = 1], participants showed no difference in EEG 
sleepiness despite feeling significantly subjectively sleepier and demonstrating 
significantly worse performance at the task. Although OSA participants showed greater 
EEG sleepiness than controls, the group interaction was not significant [F (1,37) = 
0.221, p = 0.641, ε = 1].
There was a significant effect of time [F (1.74, 64.23) = 35.05, p <0.001, ε = 0.58] 
showing an increase in EEG sleepiness as the drive progressed. There is also a 
significant time, group interaction [F (1.74, 64.23) = 4.27, p = 0.023, ε = 0.58] visualised 
in Figure 7.3-4. The OSA participants showed significantly greater alpha and theta 
power in the later 90 minutes of the drive than would be expected if time of task had 
the same effect as it did on controls.       
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Figure 7.3-4 Mean standardised EEG power (4-11Hz) across both conditions, for each group over time,
in 30 minute epochs
7.3.2 Beta activity
Figure 7.3-5 Mean standardised EEG activity (13-20Hz) in 1 min epochs, for both groups after a normal 
sleep
Following a normal night’s sleep beta activity was similar for both groups for the first 
40 minutes activity slightly higher in OSA participants than control participants for the 
remainder of the drive, see Figure 7.3-5.
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Figure 7.3-6 Mean standardised EEG power (13 - 20Hz) in 1 min epochs, for both groups following 
sleep restriction to 5 hours
Following sleep restriction EEG power in the beta spectrum was higher for most of the 
drive for the OSA participants compared with controls. 
For statistical analysis scores were averaged to 30 minute epochs, see Figure 7.3-7
Figure 7.3-7 Mean EEG power (beta) in 30 minute epochs with standard deviation
Condition had no significant effect on power in the beta range [F (1,37) = 0.08, p = 
0.777, ε = 1].  There was a significant effect of time, as beta power increases as the 
drive progressed [F (1.8, 65.6) = 5.8, p = 0.006, ε = 0.59].
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There was again a significant time, group interaction [F (1.78,65.6) = 4.91, p = 0.013, ε 
= 0.59]. The OSA group have significantly more power in the beta range in minutes 30 
to 120 than would be expected if beta activity followed the same pattern as for control 
participants, suggesting a greater effect of time on task on the OSA participants, this is 
visualised in Figure 7.3-8
Figure 7.3-8 Mean standardised EEG activity (13 -20Hz) combined for both groups over time for both 
conditions and expected power following sleep restriction, in 30 minute epochs
7.3.3 Sleep restriction: time at first major incident
Following sleep restriction control participants could drive for significantly longer 
before having their first major incident than OSA participants, 91.1 minutes (s.d. 38.6) 
compared to 65.0 minutes (s.d. 42.0), reported in chapter 5. The EEG activity at minute 
65 of the sleep restriction condition was selected to represent the time point where 
OSA participants were struggling with sleepiness and control participants were not (as 
measured by task performance). Comparison between the two groups at this point 
was completed using an independent t test (1 tail).
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Figure 7.3-9 Mean standardised EEG power at minute 65 of the sleep restriction condition, for both 
groups with standard deviation
At minute 65 of the sleep restriction condition there is a near significant trend for OSA 
participants to have higher beta power than the control group, suggesting greater 
effort to maintain alertness [t (37) = 1.49, p = 0.07].  There is a no significant difference 
between alpha and theta power between groups [t (37) = 0.97, p = 0.17]. 
7.4 Discussion
There was no significant effect of condition on either combined alpha theta EEG power 
(indicative of sleepiness) or beta EEG power (indicative of effort to remain alert). This 
was unexpected as sleep restriction had resulted in significantly more driving incidents 
and significantly greater subjective sleepiness, also sleep restriction has been reported 
to effect EEG activity in previous studies (Horne et al. 1996, Greneche et al. 2008). The 
lack of significant difference despite the trends in EEG activity is due to variation 
between participants. Large individual differences in EEG spectral activity are to be 
expected due to factors such as thickness of the skull, slight variation in electrode 
placement at study repetition and artefact due to muscle activity. For each participant 
recordings where standardised to the first 30 minutes of the drive following normal 
sleep to try to control for this variation. However, because driving (even under 
monotonous conditions) is not a constant experience, such as staring at a blank wall, 
fluctuation within the EEG signal is unavoidable. Individual difference as a topic is 
discussed in chapter 10. 
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It is also possible that significance was not found between conditions because 
participants did not reach a great enough sleepiness level to be apparent in the EEG. In 
the current study the average KSS score for both groups was less than 7 following 
sleep restriction, showing participants were not feeling sleepy and EEG activity has 
been shown to represent physiological changes due to sleepiness specifically when 
extreme sleepiness is encountered (Akerstedt et al. 1990), sleepiness may not have 
been extreme enough to effect EEG activity.
Sleep restriction was found to result in significantly more driving incidents for OSA 
participants than controls. Although there is no significant effect of group on EEG 
activity, the sleep restriction showed a trend for greater impact on OSA participants. 
Both combined alpha/theta and beta activity was similar between groups for the first 
30 minutes, then higher for OSA participants for the rest of the drive. Higher 
alpha/theta and beta activity has also been reported in untreated OSA participants 
compared with controls during sustained wake (Greneche et al. 2008), this is still 
apparent in treated OSA participants in the current study although not significant. The 
higher alpha/theta activity suggests the OSA participants were sleepier, and higher 
beta suggests they were putting in more effort to remain alert than controls. This 
would explain the significant difference in driving incidents between OSA and control 
participants. 
There was a significant effect of time on both beta and combined alpha and theta 
power, with participants getting sleepier and putting in more effort to remain alert as 
the drive progressed. In both cases the significant time, group interaction shows the 
OSA participants to be more affected by time on task than the control participants. 
This effect has also been demonstrated previously in (Eoh et al. 2005) but in this case 
the driving simulation task was only 50 minutes in duration which is short when 
investigating the effect of time on task. In the context of driving, treated OSA drivers 
may need to break from driving more often than control drivers, as they feel 
significantly sleepier with time on task.  
Previous research has shown untreated OSA participants to have greater EEG 
sleepiness during a driving task than controls (Risser et al. 2000); no significant 
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difference was identified in the current work between treated OSA participants and 
controls. It is possible that the CPAP treatment has eliminated any difference in EEG 
sleepiness between groups; however, these studies differ in their approach to EEG 
analysis. 
After sleep restriction the OSA participants were on average able to drive for 65 
minutes before having their first major incident, compared to 91 minutes for controls. 
EEG activity at minute 65 after sleep restriction showed OSA participants to have 
slightly higher EEG sleepiness than control participants (nsd) and putting in more effort 
to remain alert (nsd). Unfortunately, this effort was not effective as major driving 
incidents still occurred. A greater effort to remain alert by OSA participants than 
controls was also reported by Tassi et al. (2008). Here untreated OSA patients and 
controls completed 6, 25 min, driving simulations over 24 hours of sustained wake. 
The authors suggest the increase in beta activity can be used to maintain performance 
so long as the activity is not too monotonous or boring. The monotonous nature of the 
current task might explain why despite indication of higher beta activity task 
performance was not maintained.  
Normal sleep Sleep restriction
Total Alpha and theta  s.d. OSA 
0.93
Control
0.52
OSA
0.95
Control
0.48
Total Beta s.d. OSA 
0.68
Control
0.28
OSA 
0.66
Control
0.34
Table 7.4-1 Standard deviation of 1 min epoch EEG activity
For both of the EEG bands analysed in both conditions there is greater standard 
deviation within the OSA participants than the control participants, see Table 7.4-1. 
This greater variability within the OSA participants was also apparent in the number of 
driving incidents and will be discussed in chapter 10. 
7.5 Conclusions 
- Sleep restriction did not significantly affect EEG alpha and theta power or beta 
power in either group.
- Time on task resulted in significantly greater sleepiness and effort to remain 
alert in OSA participants compared with controls. 
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- OSA participants were sleepier than control participants as measured by alpha 
and theta EEG activity (nsd). Both after a normal night’s sleep and following 
sleep restriction.
- OSA participants appeared to put more effort into staying alert than control 
participants, as measured by beta activity (nsd). There is no difference in the 
amount of effort put in with and without sleep restriction. 
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CHAPTER EIGHT
Insight into sleepiness, the ability to recognise sleepiness prior to a 
major driving incident
186
8.1 Introduction
The following chapter investigates if treated OSA participants and older healthy 
controls can identify when they are sleepy (have insight into their sleepiness).  It is 
known that young participants have insight into sleepiness (Horne et al. 2004) with 
typically 45 minutes of feeling sleepy prior to a major driving incident occurring 
(Reyner and Horne 1998b). This has legal implications because drivers have prior 
warning of their sleepiness and therefore can be held responsible if a sleep-related 
incident occurs. In the situation of an OSA driver falling asleep at the wheel it has been 
argued that OSA renders the driver unable to identify sleepiness and will have no 
opportunity to cease driving prior to srRTI therefore they are not responsible. 
8.1.1 Key points from the literature review
Participants for Reyner and Horne (1998b) and Horne et al. (2004) were in their early 
twenties and were able to recognise that they were sleepy, with an average of 45.5 
minutes of declaring some level of sleepiness until first major incident, with 83% of 
major incidents happing in KSS 8 or 9. The current research allows for the same 
analysis to be completed on older healthy and OSA participants aged 50 to 75.  
The current research has shown treated OSA participants to be more affected by sleep 
restriction than controls in terms of total driving incidents and safe driving time. 
However, following a normal night’s sleep there is little difference in driving ability 
(measured by driving incidents) and no evidence that treated OSA patients should 
cease driving. The significant difference in safe driving time following sleep restriction 
is concerning, raising the question do OSA patients know when they are sleepy? If 
treated OSA patients are able to recognise sleepiness, they have full opportunity to 
stop driving and consequently should be held responsible for falling asleep at the 
wheel in the same manner as other road users.
Previous research investigating the ability to recognise sleepiness has been 
undertaken with untreated OSA sufferers. Desai et al. (2006) took subjective 
sleepiness ratings on the Stamford Sleepiness Scale periodically through the day 
comparing OSA and control participants during total sleep deprivation and then 
following a full night’s sleep. The authors report the increase in sleepiness from the 
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full night’s sleep to sleep deprivation as being significantly greater for controls than 
OSA participants, from which they suggest the OSA participants are not as good at 
recognising sleepiness as the controls. However, in practice the difference was small, 
with an increase just of 1.3 for OSA suffers, compared to 1.9 for controls. Conversely, 
Pizza et al. (2008) used a divided attention driving task periodically through the day to 
demonstrate that times where task performance was most impaired coincided with 
when OSA participants rated themselves as most sleepy, therefore suggesting OSA 
participants can recognise sleepiness.  
Subjective sleepiness and EEG (combined alpha and theta) sleepiness have been 
investigated separately in chapters 6 and 7; both increased as a result of sleep 
restriction (nsd for EEG). The relationship between subjective sleepiness and EEG 
sleepiness can be used to examine the extent to with drivers are aware of their 
sleepiness, which is positively correlated in young participants (Horne et al. 2004).  
Greneche et al. (2008) also investigated correlation of EEG and subjective sleepiness;
here during 24 h sustained wake in older participants. EEG was found to closely 
correlate to subjective sleepiness in control participants but not to OSA participants, 
suggesting OSA participants do not know when they were sleepy. This study was not 
associated with a performance task, so is not directly comparable to the current work 
as the perception of task performance may influence perception of sleepiness. 
However, it is of interest that the correlation was not identified in OSA participants. 
The previous studies with OSA participants identifying sleepiness have all been in 
untreated cases. Using CPAP has been shown to change an OSA patient’s perception of 
sleepiness (Engleman et al. 1997). In the study participants were asked to rate their 
sleepiness using the ESS before starting CPAP, then to retrospectively re-rate their ESS 
following treatment, this resulted in a significant increase in ESS score. This may 
suggest that the treated OSA participants in the current work will be able to identify 
sleepiness even though previous studies with untreated OSA patients report 
difficulties.  A possible explanation might be that sleepiness was common place before 
treatment so the severity was not recognised. Following treatment participants were 
then at an increased ability to recognise sleepiness and could more accurately re-
assess their ESS from before treatment. In this case, OSA patients may be better able 
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to identify sleepiness having experienced a severe case and subsequently been 
treated.  However, it is also possible that participants were unwilling to admit before 
treatment how sleepy they actually felt for fear of consequence, e.g. being told they 
are too sleepy to drive or that they now feel an obligation to demonstrate the CPAP is 
working.
8.1.2 Research aim and hypotheses
Aim: To evaluate the ability of OSA-CPAP compliant patients compared with controls 
at recognising sleepiness during a simulated driving task.
Hypotheses:
To test the hypothesis if OSA CPAP compliant participants show impaired ability to 
subjectively identify sleepiness at a driving simulator task as reflected by greater 
number of driving incidents while reporting not being sleepy, reporting feeling sleepy 
prior to first driving incident after sleep restriction to 5h.
To test the hypothesis that EEG will correlate to KSS in both treated OSA and control 
participants after sleep restriction to 5h.
To test the hypothesis that fleeing sleepy will be associated with being likely to fall 
asleep for OSA CPAP treated patients during a driving task following sleep restriction 
to 5h. 
8.2 Method
Design: single condition, completing a 2h drive following sleep restriction to 5h. 
Comparing treated OSA participants and healthy controls.
Setting: driving simulator
8.2.1 Participants
Participant’s characteristics can be found in chapter 4. 20 control participants and 19 
OSA participants are represented in the following chapter.
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8.2.2 Protocol
Study protocol was followed as detailed in chapter 3. The data presented here is the 
results following the sleep restriction condition only, in order that participants were 
likely to experience some sleepiness. 
8.2.3 Measures
Driving incidents, subjective sleepiness and EEG were recorded and analysed as 
detailed in chapter 3.
8.2.4 Statistical analysis
Subjective sleepiness ratings were recorded every 200 seconds throughout each drive, 
resulting in 36 recordings per 2h. Each score was taken to represent the 100 seconds 
preceding and following the time it was given. The number of major and minor driving 
incidents coinciding with each subjective score were totalled for each participant and 
averaged across each group. 
The frequency of LHoFA score was reported for each KSS rating. Throughout the drive 
36 subjective sleepiness scores are recorded, giving a total of 720 responses for 
controls (n=20) and 684 responses for OSA (n=19) participants. The frequency of each 
combination of KSS and LHoFA is displayed as a percentage in area graphs for each 
group. 
In the case of the specific analysis of subjective sleepiness prior to major incidents, 
only those participants who had a major incident could be included, control n = 9, OSA 
n = 14. This is presented as a percentage of participants reporting sleepiness prior to 
major incident. 
Mean subjective sleepiness score at first major incident are compared between groups 
by independent t test. The subjective scores data was normally distributed and met 
the assumption of homogeneity of variance, assed by Levenes test. 
Pearson’s r (r) is also reported for EEG and KSS correlation as although the KSS 
produces categorical data the scale is well validated and widely used with parametric 
statistics. The correlation of EEG and KSS is compared between participants reporting 
sleepiness prior to incident and those not reporting sleepiness prior to incident. 
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Spearman’s rho (rs) is used to assess correlation between EEG and LHoFA in those 
participants who had a major incident (control n = 9, OSA n = 14).
8.3 Results 
8.3.1 Driving incidents per subjective score
To test the hypothesis if OSA CPAP compliant participants show impaired ability to 
subjectively identify sleepiness at a driving simulator task as reflected by greater 
number of driving incidents while reporting not being sleepy, reporting feeling sleepy 
prior to first driving incident after sleep restriction to 5h.
Figure 8.3-1 Mean minor and major driving incidents per KSS for OSA and control participants with 
standard deviation
Figure 8.3-1 displays major (solid colour) and minor (hatched colour) incidents for the 
2 h drive occurring at each KSS rating for control and OSA participants. Few minor and 
major incidents occur for both groups in KSS ratings 1 to7, with no increase in 
frequency at the start of signs of sleepiness (6 to 7). OSA participants had a greater 
number of driving incidents at KSS 8 than control drivers, but this is a reflection of OSA 
participants having a total greater number of incidents overall.
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Figure 8.3-2 Mean major and minor incidents for each LHoFA sleep rating in OSA participants with 
standard deviation
Figure 8.3-2 shows major (solid colour) and minor (hatched colour) incidents for the 2 
h drive within each LHoFA rating for control and OSA participants. The OSA 
participants have few minor and major incidents for LHoFA 1 to 3, followed by an 
increase for both in LHoFA 4 and 4. Control participants did not show increase in 
driving incidents until LHoFA 5. 
8.3.2 Association of sleepiness with likelihood of falling asleep
To test the hypothesis that fleeing sleepy will be associated with being likely to fall 
asleep for OSA CPAP treated patients during a driving task following sleep restriction 
to 5h. 
To assess if feeling sleepy (KSS 8 and 9) is associated with being likely to fall asleep 
(LHoFA 4 and 5) the percent of LHoFA responses in each KSS was recorded. 
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Figure 8.3-3 The percentage of KSS rating spent in each LHoFA score for control participants
(1) Extremely alert
(2) Very alert
(3) Alert
(4) Rather alert
(5) Neither
(6) Some signs of sleepiness
(7) Sleepy but no effort to stay awake
(8) Sleepy but some effort to stay 
awake
(9) Very sleepy, great effort to stay
awake
Table 8.3-1 Percentage of total time in each KSS rating, subdivided into categories of likelihood of 
falling asleep for control participants
Figure 8.3-3 and Table 8.3-
combination for control parti
participants did not feel it likely they 
spent in KSS categories 7 to 9. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Very 
unlikely Unlikely Possibly
0.9 0.3 0.0
4.0 9.1 0.0
8.2 10.8 2.0
2.3 5.3 1.6
2.7 3.5 2.2
2.2 4.2 2.9
0.4 0.0 4.2
3.0 0.3 11.4
0.0 0.0 0.4
1 show the percentage of time spent in each KSS and LHoFA 
cipants. While scoring KSS 8 on 3.3% of occasions control 
would fall asleep. 36.5% of total drive time was 
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Likely
Very 
likely 
0.0 0.0
0.0 0.0
0.3 0.0
0.4 0.0
0.1 0.0
0.6 0.0
0.9 0.0
2.4 0.1
2.9 10.4
Very likely 
Likely
Possibly
Unlikely
Very unlikely
Figure 8.3-4 The percentage of KSS rating spent in each LHoFA score for OSA participants
(1) Extremely alert
(2) Very alert
(3) Alert
(4) Rather alert
(5) Neither
(6) Some signs of sleepiness
(7) Sleepy but no effort to stay awake
(8) Sleepy but some effort to stay 
awake
(9) Very sleepy, great effort to stay 
awake
Table 8.3-2 Percentage of total time in each KSS rating, subdivided into categories of likelihood of 
falling asleep for OSA participants
Figure 8.3-4 and Table 8.3-
LHoFA combination for OSA participants. 
falling asleep was always seen as at least possible. 
KSS categories 7 to 9. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Very 
unlikely Unlikely Possibly
10.8 0.0 0.0
7.1 2.4 0.3
3.5 9.4 3.3
1.5 5.2 3.6
0.6 3.3 1.7
0.5 3.5 3.2
0.0 1.5 3.2
0.0 0.0 2.0
0.0 0.0 0.0
2 show the percentage of total time spent in each KSS and 
For OSA participants when scoring KSS 8 
20.8% of drive time was spent in 
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Likely
Very 
likely 
0.0 0.0
0.0 0.0
0.2 0.0
0.2 0.0
0.0 0.0
0.8 0.0
1.8 0.0
9.6 2.0
2.7 16.2
Very likely 
Likely
Possibly
Unlikely
Very unlikely
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8.3.3 Major incidents and subjective scores
To test the hypothesis if OSA CPAP compliant participants show impaired ability to 
subjectively identify sleepiness at a driving simulator task as reflected by greater 
number of driving incidents while reporting not being sleepy, reporting feeling sleepy 
prior to first driving incident after sleep restriction to 5h.
Control Participants
- 44.4% (4/9) identified sleepiness on the KSS (6+) prior to first major incident: the 4 
participants had an average of 65.0 minutes sleepiness prior to incident. 
- 44.4% (4/9) participants identified some chance of falling asleep on LHoFA prior to 
first major incident: the 4 participants felt likely to fall asleep an average 34.1 minutes 
prior to incident. 
- In total 84 major incidents occurred: 48.8% of these occurred in KSS 8 and 9. 45.2% 
occurred in KSS 1 – 5. 
- 45.2% of major incidents occurred in LHoFA 4 and 5. 
OSA Participants
- 71.4% (10/14) participants identified sleepiness on the KSS (6+) prior to first major 
incident: the 10 participants had an average of 15.3 minutes sleepiness prior to 
incident.
- 50% (7/14) participants identified some chance of falling asleep on LHoFA prior to first 
major incident: the 7 participants felt likely to fall asleep an average of 19.2 minutes 
prior to incident.
- In total 323 major incidents occurred, 90.7% of these occurred in KSS 8 and 9. 4.9% 
occurred in KSS 1 – 5. 
- 90.7% of major incidents occurred in LHoFA 4 and 5.
Table 8.3-3 Perception of sleepiness
During the drive 9 control participants and 14 OSA participants had a major driving 
incident. 44.4% of control participants identified sleepiness prior to major incident and 
did so an average of 65 minutes prior to the major incident. 71.4% of OSA participants 
identified sleepiness prior to major incident though with less warning, having an 
average of 15.3 minutes awareness of sleepiness before an incident occurred. 
44.4% of control participants felt likely to fall asleep prior to major incident, though for 
a shorter time (34.1 minutes) than they had felt sleepy for. 50% of OSA participants 
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reported likelihood of falling asleep prior to major incident giving a longer warning 
time (19.2 minutes) than KSS. 
90.7% of major incidents for OSA participants occurred while reporting KSS 8 and 9 
compared with only 48.8% of control participants major incidents occurring in KSS 8 
and 9. 
Figure 8.3-5 Mean subjective sleepiness score at first major incident with standard deviation
There was no significant difference between mean KSS or LHoFA score at first major 
incident for OSA or control participants, see Figure 8.3-5. At the time of first major 
incident neither group was identifying them self as sleepy or having a possibility of 
falling asleep. 
8.3.4 EEG and subjective sleepiness
To test the hypothesis that EEG will correlate to KSS in both treated OSA and control 
participants after sleep restriction to 5h.
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Figure 8.3-6 Mean change in EEG power (4 - 11Hz) in 2 min epochs and KSS in 200 s epochs during a 2 
hour drive for control participants
Figure 8.3-7 Mean change in EEG power (4 - 11Hz) in 2 min epochs and KSS in 200 s epochs during a 2 
hour drive for OSA participants
Figure 8.3-6 and Figure 8.3-7 display combined alpha and theta power in 2 minute 
epochs and subjective sleepiness in 200 second epochs for the participants who had 
major incidents. The two measures are significantly correlated for both groups but a 
greater amount of variance is explained for OSA [r = 0.89, p<0.001] participants 
compared with controls [r = 0.75, p<0.001]. The same can be said for the correlation 
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between EEG sleepiness and LHoFA for OSA [rs = 0.75, p <0.001] and control 
participants [rs = 0.51, p <0.001], not graphically displayed.
8.3.5 Comparison of those with and without insight
As detailed above, 44.4% of controls and 71.4% of OSA participants identified 
sleepiness (by KSS) prior to having a major incident. It can be hypothesised that those 
who identified sleepiness may be able to do this because they have greater subjective 
awareness of their physiological sleepiness. If this were the case a stronger correlation 
between EEG sleepiness and subjective sleepiness would be expected. Those 
participants reporting sleepiness prior to incident are said to have “insight” into 
sleepiness. 
KSS Pearsons LHoFA Spearmans rho 
Control EEG with insight n 
=4
.88 p = <0.01 .76 p = <0.01
Control EEG without insight 
n = 5
.19 p =0.13 .06 p = 0.37
OSA EEG with insight n = 10 .83 p = <0.01 .60 p = <0.01
OSA EEG without insight n = 
4
.82  p = <0.01 .69 p = <0.01
Table 8.3-4 EEG and subjective sleepiness correlation in those with and without insight into sleepiness
In control participants correlation of EEG sleepiness and subjective sleepiness appears 
to be linked to ability to recognise sleepiness. In those control participants without 
insight into sleepiness no correlation was found between the two types of measure.  
Both sub groups of OSA participants showed significant correlation between EEG 
sleepiness and subjective sleepiness; however, only between 36% and 56% of 
variability is explained. 
KSS at first major incident With insight Without insight
Control 8.8 3.2
OSA 7.1 2.5
Table 8.3-5 Mean KSS score at first major incident of those with and without insight into sleepiness
Mean KSS score at first major incident for both groups as a whole suggested that 
participants did not to feel sleepy at this time. However, when split into those with
insight and those without in Table 8.3-5 it is apparent that participants with insight 
into sleepiness knew they were sleepy prior to first major incident and those without 
insight did not. 
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8.4 Discussion 
The ability to identify sleepiness while driving gives drivers opportunity to cease 
driving before having a srRTI. This is an important skill which can mean the difference 
between life and death. Overall OSA participants were found to be more likely to 
recognise sleepiness prior to incident, more likely to report feeling sleepy at the time 
of major incidents and were more likely to acknowledge sleepiness may result in 
falling asleep than control participants. It is possible that their experience of having 
and being treated for a sleep disorder improves insight into sleepiness. It has 
previously been shown than perception of ESS changes following CPAP treatment in
OSA patients (Engleman et al. 1997). It is possible that prior experience of extreme 
sleepiness results in more of the OSA participants being able to accurately identify 
increasing sleepiness than control participants. 
73.7% of participants in the current work identified some sleepiness prior to having a 
major driving incident; less than the 100% reported in younger participants (Reyner
and Horne 1998b). In that study younger participants were reported to have a 45.5 
minute window of knowledge of sleepiness prior to their first major incident. In the 
current study control participants also had a long window of opportunity between 
identification of sleepiness and first major incident. Although the OSA participants 
were more likely to identify sleepiness they did so with an average 19 minutes (LHoFA) 
warning prior to the incident. In relative terms this could make it harder to find a safe 
place to stop before an incident occurs. In practice 15 minutes travelling at 70 mph on
a motorway equates to 17.8 miles travelled, a distance at which it is likely a driver 
would come across a junction off the motorway in order to find a safe stopping place. 
On real roads with more traffic and a more stimulating environment it is probable that 
the window of opportunity to stop would be longer than in the simulator scenario. 
Greater stimulus from the environment makes the transition from slightly sleepy to 
very sleepy likely to increase in duration. It is also probable that in this study more 
incidents occurred than would do on the real roads due to the monotonous 
environment and a lack of consequence allowing drivers to be more complacent. In a 
real environment with more traffic on the road and the awareness of danger it is 
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probable fewer incidents would have occurred. Subsequently the time to first incident 
from identifying sleepiness is likely to be longer in practice. 
Overall, neither group felt sleepy or likely to fall asleep at the time of first incident, 
despite a major sleep-related incident occurring. However, when both groups are 
divided into those with insight (reporting sleepiness prior to first major incident) and 
without insight, those with insight were reporting feeling sleepy prior to the first major 
incident.  It appears if participants can identify sleepiness then they do so well. This 
has serious connotations in the real world, as although the signs may be there that a 
person is sleepy if they are unable to recognise them they will not be able to act. 
Education in identification of sleepiness may help; this could be investigated by 
repeating the study protocol with another group who had first received training to 
identify sleepiness. 
Recognition of feedback from task performance appears to be particularly important 
as participants have difficulty identifying when they are likely to fall asleep if
completing the MWT (Herrmann et al. 2010). Also correlation between EEG and 
subjective sleepiness is not apparent with untreated OSA participants during sustained 
wakefulness and no performance task (Greneche et al. 2008). 
In previous work all young drivers were able to identify sleepiness prior to a major 
incident (Reyner and Horne 1998b). The lesser ability of these older drivers to identify 
sleepiness may be explained by a weaker correlation association between subjective 
sleepiness and EEG alpha and theta power. The correlation between EEG and KSS in 
young people explains between 77.4 and 86.5% of the variability (Horne et al. 2004)
compared to between 56.3% and 79.2% of the variability in the current study, 
demonstrating that younger participants are more aware of EEG sleepiness changes 
than the older participants. It should be noted that in Horne et al. (2004) EEG activity 
was reported in 200 second epochs and in the current work is reported in 120 second 
epochs. Another consideration is that in the current work all the older drivers are male 
and the studies of Horne and Reyner with younger drivers had a mix of male and 
female participants. It has been shown that women are better at identifying increased 
sleepiness with alcohol consumption (Barrett et al. 2004b); it is therefore possible that
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if women are better at identifying sleepiness this would have improved the overall 
performance of the younger group. 
There is a distinct difference between feeling sleepy and recognising the likelihood of 
falling asleep. The older drivers in the current work were all accurately able to identify 
that one would lead to another. On the whole, younger participants recognised that 
being sleepy could result in falling asleep, however, 18% of responses KSS 8 were
reported with unlikely to fall asleep (Reyner and Horne 1998b). There is a clear 
distinction in attitude to sleepiness with only 3.3% of the older control participants 
reporting KSS 8 believing they were unlikely to fall asleep. The OSA participants appear 
more willing to accept that sleepiness means a possibility to fall asleep than control’s 
because they all felt likely to fall asleep in KSS 8. With age perception of risk changes 
(Finn et al. 1986), it is probable that the older drivers are more willing to recognise 
consequence to feeling sleepy, and not harbour a belief of invincibility. As a result, 
analysis of LHoFA and KSS produce results similar to each other.  
Younger drivers have been reported to spend 60% of the drive time in KSS 7 to 9, 
completing a similar protocol (Reyner and Horne 1998b) compared to 36.5 % for older 
control participants and 20.8% for OSA participants. This is likely due to the higher 
impact of sleep restriction on younger people than older people (Adam et al. 2006). 
The percentage of major incidents occurring in KSS 8 and 9 demonstrates ability to 
recognise sleepiness; with this measure the OSA participants again appeared better 
able to recognise sleepiness than control participants as when 90% of driving incidents 
occurred OSA participants were reporting KSS 8 and 9. 
Having insight into sleepiness is improved by ability to recognise changes in EEG 
sleepiness in control participants, as those without insight into sleepiness showed a 
non significant correlation between EEG and subjective scores. These participants 
were unaware of their physiological level of sleepiness. For OSA participants the 
correlation between EEG and subjective ratings for those with insight and those 
without is very similar. Difference in ability to recognise sleepiness here is more subtle;
possibly participants are recognising an increase in sleepiness but not quick enough to 
know that they are sleepy before an incident occurs. 
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If a participant is reporting KSS 9, defined as fighting sleep, it is probable that in a real 
life situation they would be performing a countermeasure to “fight” sleep, i.e. opening 
a window or talking to a passenger. Undertaking any such act demonstrates an 
awareness of sleepiness, in order to consciously take action. In addition all participants 
were asked if they had ever felt sleepy when driving, 100% of OSA participants and 
85% of control participants said they had (chapter 12). In order to remember having 
felt sleepy they must have been aware of feeling sleepy at the time. Implementing an 
effective counter measure at this time is particularly important for OSA patients as in 
the current work they were found to have a short time period from identifying 
sleepiness to first major incident. Choice of countermeasure is investigated in chapter 
12.  
8.5 Conclusions
- The majority of older participants (73.7%) did have insight into sleepiness.
- A greater proportion of OSA participants had insight into sleepiness than 
control drivers.
- Of participants with insight into sleepiness, control drivers had an average of 
65 minutes warning and OSA drivers an average 19.2 minutes warning of 
sleepiness prior to incident. 
- All OSA participants and the majority of control participants associated 
sleepiness with a likelihood of falling asleep. 
- OSA participants were better at identifying sleepiness than control participants 
as a greater percentage of major incidents for OSA occurred in KSS 8 and 9 than 
for control participants. 
- EEG activity is correlated with subjective sleepiness scores except in control 
participants who do not have insight into sleepiness. 
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CHAPTER NINE
Impact of one night CPAP withdrawal
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9.1 Introduction
The participants in the sleep restriction study were all compliant CPAP users however, 
on rare occasions they did report one night withdrawal of CPAP treatment. As part of 
the characteristics questionnaire given to all participants in the sleep restriction study, 
OSA participants were asked, “Do you ever sleep without your CPAP?” 4 out of 20
participants said they did very occasionally, stating reasons such as “if I have a cold” 
and “if I am away from home and there is no plug socket near the bed”.  
There is limited existing research in this area; consequently the sleep restriction study 
was extended and all OSA participants were invited to complete the simulated drive a 
third time following their normal length of sleep having not used their CPAP treatment
for one night. 
9.1.1 Key points from the literature review
Withdrawal of CPAP in compliant long term users results in immediate resumption of 
sleep disordered breathing and when treatment is resumed there is immediate 
recovery (Grunstein et al. 1996, Yang et al. 2006a). There have been limited studies 
investigating the impact of CPAP withdrawal on task performance and subjective 
sleepiness; all have been with participants on CPAP for one year or less and results are 
conflicting.  
Turkington et al. (2004) used a divided attention driving task, CPAP was found to 
improve task performance compared to prior treatment performance. Following two
weeks of CPAP the treatment was stopped, although task performance decreased it 
never returned to the same level as before treatment.   Yang et al. (2006) also 
withdrew CPAP from compliant users; here participants felt sleepier after one night of 
withdrawal but were able to maintain performance at a battery of cognitive tasks 
including PVT. The residual effect of treatment after it had been withdrawn is 
unexpected as sleep disordered breathing is likely to have returned. However, it is
likely that participants were able to maintain performance despite the increased 
sleepiness due to the simple nature of the task. The PVT is a short duration test and 
the divided attention driving task used in Turkington et al. (2004) was only 20 minutes 
in duration. This is too short to give an indication of ability to drive.
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In contrast Kribbs et al. (1993a) also withdrew CPAP treatment for 1 night but reported 
that all participants had impaired subjective sleepiness and PVT performance 
compared with when undergoing treatment. Similarly the MSLT has been shown to be
significantly affected by one night’s CPAP withdrawal, although in this case 
participants did not suffer from greater subjective sleepiness (Sforza et al. 1995).  
9.1.2 Research aim and hypotheses
Aim: To evaluate the ability of OSA-CPAP compliant patients during a simulated driving 
task following CPAP withdrawal for one night compared with after a normal night on 
treatment and treated sleep restricted to 5h. 
Hypotheses: 
To test the hypothesis that sleep quality will be impaired with CPAP withdrawal in OSA 
CPAP compliant participants.
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation, 
subjective sleepiness, EEG activity, successful drive completion and shorter time to 
first incident after treatment withdrawal than either normal treated sleep or sleep 
restriction to 5h of treated sleep.
To test the hypothesis that treatment withdrawal from OSA CPAP compliant 
participants with not affect ability to recognise sleepiness as reflected by KSS at first 
major incident and reporting feeling sleepy prior to first driving incident (KSS6+, LHoFA 
4+).
9.2 Method
Design: repeated measures. Completing a 2h afternoon drive following a normal 
night’s sleep, sleep restriction to 5h and a normal length of sleep without CPAP 
treatment. OSA participants only. 
Setting: driving simulator
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9.2.1 Participants 
All participants had completed the sleep restriction study. Details of recruitment and 
selection can be found in chapter 3. The 19 OSA participants who completed the sleep 
restriction study were invited to take part in a CPAP withdrawal night, 11 participated.
There was no significant difference in characteristics between the 11 who participated 
and the 8 who did not, see Table 9.2-1. However, all those who reported on occasion 
as not using CPAP treatment declined to participate. 
Participated (n=11) Did not participate (n=8)
Age (years) 65.6 (s.d. 7.7) 62.8 (s.d. 7.1)
BMI 33.1 (s.d. 6.1) 36.2 (s.d. 7.5)
Driving experience (years) 45.9 (s.d. 6.6) 44.1 (s.d. 7.8)
CPAP treatment  (years) 7.7 (s.d. 5.8) 7.7 (s.d. 4.0)
ESS 5.2 (s.d. 2.3) 5.5 (s.d. 4.8)
Report occasionally missing a 
night’s treatment
0/11 4/8
Have insight into sleepiness 75% (6/8) 66.6%(4/6)
Table 9.2-1 Participant characteristics of those who participated and who did not participate in CPAP 
withdrawal
9.2.2 Protocol
The study protocol was the same as the sleep restriction study detailed in chapter 3. 
On the additional study night prior to attending the lab, participants slept at home for 
their usual length of sleep without using the CPAP treatment. Ethical approval was 
obtained from Loughborough University Ethics Committee following a letter from Dr 
Chris Hanning, see appendix 7.
As treatment was being stopped there was an additional ethical implication because 
this is something prescribed by a doctor and a medical doctor was not present during 
the withdrawal.  To address this Dr Chriss Hanning provided a statement for the 
university ethics committee clarifying that there is no risk to patients with 
discontinuing treatment for one night and that this is a situation experienced by many 
patients on occasion. The withdrawal of CPAP was suspected to cause increased day 
time sleepiness, this issue was addressed by providing transport to and from the 
university and instructing participants not to drive or operate machinery until they had 
slept using their CPAP. An additional suspected issue was that participants may have 
felt uncomfortable in the night when sleeping without the machine. All participants 
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were informed that if they had any noticeable problems breathing during the 
withdrawal night they were to resume treatment then phone the investigator in the 
morning to confirm they were unable to participate. No participants had such a 
problem.  
9.2.3 Measures
As with the sleep restriction study actigraphy was used to verify sleep length and sleep 
disturbance index (SDI) was calculated using the below formula,
SDI = actual awake time (min) / assumed total sleep (min)
SDI was compared between OSA participants with CPAP and without CPAP and 
compared with 11 healthy controls, chosen at random from the 20 who completed the 
sleep restriction study. 
During the simulator task driving incidents, subjective sleepiness and EEG were 
recorded in accordance with the procedures in chapter 3.  
9.2.4 Statistical analysis
SDI was compared between OSA with CPAP and controls using a 2 tail independent T 
test. OSA participants with and without CPAP were compared using 1 tail repeat 
measures T test.  In all cases data were visually checked in histograms for normal 
distribution and Levenes test was used to assess for homogeneity of variance. 
Driving incidents, subjective sleepiness and EEG were calculated in 30 min epochs and 
analysed using a factorial repeat measures ANOVA for comparison of OSA participants 
for condition (3 levels) and time (4 levels). In all cases data were visually checked in 
histograms for normal distribution. Due to a positive skew on the driving incident data,
a square root transformation was completed prior to analysis. EEG data is slightly 
skewed but the original data is still presented. Huynh-Feldt adjustment was used the 
assumption of homogeneity of variance is violated.  
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9.3 Results
9.3.1 Actiwatch 
To test the hypothesis that sleep quality will be impaired with CPAP withdrawal in OSA 
CPAP compliant participants.
Figure 9.3-1 Mean sleep length (min) and mean SDI for OSA participants with and without CPAP and 
control participants, with standard deviation
Actigraphy showed no significant differences between mean actual sleep time, OSA 
with CPAP = 436 min (s.d. 44.6) Control = 435.8 min (s.d. 45.2) OSA without CPAP = 
403.1 min (s.d. 39.4). There was no significant difference between SDI of OSA with 
CPAP (7.9) and controls (9.5) [t (19) = 0.891, p =0.423].  However, withdrawal of CPAP 
treatment significantly increased SDI in OSA patients, from 7.9 to 13.8 [t (10) = 3.510, p 
=0.003] see Figure 9.3-1.
9.3.2 Driving Incidents
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation, 
subjective sleepiness, EEG activity, successful drive completion and shorter time to 
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first incident after treatment withdrawal than either normal treated sleep or sleep 
restriction to 5h of treated sleep.
Figure 9.3-2 Mean major and minor incidents in the 2 hour drive with standard deviation
Figure 9.3-2 shows mean incidents over the total drive. Sleep restriction results in 
increased incidents compared with normal sleep (with CPAP). Withdrawal of CPAP also 
increases incidents but not to the same extent as sleep restriction. 
Figure 9.3-3 Mean number of minor incidents in 30 minute epochs with standard deviation
There is a significant effect of condition [F (2,20) = 7.82, p = 0.003] and time [F (3,30) = 
15.95, p < 0.001] on minor incidents. There is also a significant condition, time 
interaction [F (6,60) = 2.66, p = 0.02]. On both occasions using CPAP the number of 
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minor incidents peaks in minutes 60-90, without the CPAP the peak in minor incidents 
occurs in minutes 30-60.
Figure 9.3-4 Mean number of major incidents in 30 minute epochs, with standard deviation
The same significant effects are found with major incidents for condition [F (2,20) = 
7.0, p =0.005], time [F (1.5,30.3) = 9.95, p = 0.003, ε = 0.51] and condition, time 
interaction [F (6,60) = 3.40, p = 0.006]. For the first hour major incidents are more 
prevalent when CPAP is withdrawn, in the second hour major incidents are more 
prevalent when sleep is restricted and CPAP is used. 
9.3.3 Successful drive completion (without major incident) and time to first major 
incident 
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation, 
subjective sleepiness, EEG activity, successful drive completion and shorter time to 
first incident after treatment withdrawal than either normal treated sleep or sleep 
restriction to 5h of treated sleep.
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Figure 9.3-5 Percent of successful drive completion (without major incident)
Following a normal night’s sleep 45.5% of participants completed the 2 h drive without 
major incident, 27.3% successfully completed after sleep restriction while only 18.2% 
of participants successfully completed the drive after CPAP withdrawal. 
Figure 9.3-6 Average minute driven prior to first major incident with standard deviation
There was a significant effect of condition on safe driving time [F (2,20) = 8.8, p = 
0.002]. After having the same length of sleep the participants drove without major 
incident for an average of 38.8 minutes longer when using CPAP than without. 
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9.3.4 Subjective sleepiness
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation, 
subjective sleepiness, EEG activity, successful drive completion and shorter time to 
first incident after treatment withdrawal than either normal treated sleep or sleep 
restriction to 5h of treated sleep.
Figure 9.3-7 Mean KSS recorded every 200 seconds for each condition
Figure 9.3-8 Mean LHoFA recorded every 200 seconds for each condition
Figure 9.3-7 and Figure 9.3-8 show mean subjective sleepiness across the drive. 
Without CPAP the participants feel sleepier in the first half of the drive than in the 
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other two conditions. In the second hour subjective sleepiness is similar to that after 
sleep restriction, in both cases, greater sleepiness was experienced than after a 
normal night with CPAP. 
Figure 9.3-9 Mean KSS in 30 min epochs with standard deviation 
Figure 9.3-9 shows KSS in 30 min epochs, there is a significant effect of condition [F 
(2,20) = 10.04, p = 0.001], time [F (1.96,19.58) = 98.31, p < 0.001, ε = 0.65] and 
condition, time interaction [F (3.94,39.41) = 3.39, p = 0.018, ε = 0.66]. These findings 
are similar to that of incidents, for the first hour KSS is highest in the condition without 
CPAP, then similar for without CPAP and sleep restriction in the second hour. 
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Figure 9.3-10 Mean LHoFA in 30 min epochs with standard deviation 
Figure 9.3-10 shows mean LHoFA in 30 min epochs. LHoFA again followed the same 
pattern as KSS, showing a significant effect of condition [F (2,20) = 13.16, p <0.001], 
time [F (2.1, 21.0) = 57.58, p <0.001, ε = 0.70] and condition, time interaction [F 
(2.8,20.3) = 6.21, p = 0.003, ε = 0.47].
9.3.5 EEG 
To test the hypothesis that OSA CPAP compliant participants will show impaired driver 
performance at a driving simulator task as reflected by increased lane deviation, 
subjective sleepiness, EEG activity, successful drive completion and shorter time to 
first incident after treatment withdrawal than either normal treated sleep or sleep 
restriction to 5h of treated sleep.
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Figure 9.3-11 Standardised EEG power (alpha and theta) over time
Following the CPAP withdrawal EEG alpha and theta power was higher throughout the 
drive than in either condition with the CPAP, see Figure 9.3-11.
Figure 9.3-12 Standardised EEG power (alpha and theta) in 30 min epochs with standard deviation
Although there is higher EEG activity after CPAP withdrawal there is no significant 
effect of condition [F (1.37,13.71) = 1.76, p = 0.21, ε = 0.69]. There is a significant 
effect of time [F (2.19,21.84) = 8.18, p = 0.002, ε = 0.73]. There was no significant 
condition, time interaction [F (3.58,35.81) = 1.71, p = 0.18, ε = 0.60]. 
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Figure 9.3-13 Standardised EEG power (beta) over time
Beta power to be higher throughout the drive following CPAP withdrawal than for 
either condition with CPAP, see Figure 9.3-13.
Figure 9.3-14 Standardised EEG power (beta) in 30 min epochs with standard deviation
Figure 9.3-14 shows beta activity in 30 min epochs. There is a near significant effect of 
condition [F (1.17, 11.69) = 3.87, p = 0.07, ε = 0.59], a significant effect of time [F (1.96, 
19.59) = 4.75, p = 0.02, ε = 0.65] but no significant condition, time interaction [F (2.45, 
24.53) = 0.79, p = 0.491, ε = 0.41].
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9.3.6 Insight into sleepiness
To test the hypothesis that treatment withdrawal from OSA CPAP compliant 
participants with not affect ability to recognise sleepiness as reflected by KSS at first 
major incident and reporting feeling sleepy prior to first driving incident (KSS6+, LHoFA 
4+).
Figure 9.3-15 Mean KSS at first major incident with standard deviation
Without CPAP participants on average were feeling sleepier at the time of first major 
incident than on either occasion when CPAP had been used (nsd). 
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OSA Participants normal sleep with CPAP
- 50% (3/6) identified sleepiness on the KSS (6+) prior to first major incident
- Those who were reported sleepiness prior to incident did so on average 22.14 min
prior to major incident. 
- In total 36 major incidents occurred, 11.1% occurred in KSS 8 and 9. 75% occurring in 
KSS 6 – 9.
OSA Participants sleep restriction with CPAP
- 75% (6/8) identified sleepiness on the KSS (6+) prior to first major incident
- Those who were reported sleepiness prior to incident did so on average 20.09 min
prior to major incident.
- In total 195 major incidents occurred, 91.8% occurred in KSS 8 and 9. 98.9% occurring 
in KSS 6 – 9.
OSA Participants without CPAP
- 55.5% (5/9) identified sleepiness on the KSS (6+) prior to first major incident
- Those who were reported sleepiness prior to incident did so on average 19.48 min 
prior to major incident.
- In total 172 driving incidents occurred, 73.8% occurred in KSS 8 and 9. 94.8% occurring 
in KSS 6 -9. 
Table 9.3-1 Perception of sleepiness in each condition
Major incidents occurred for 6 participants after normal sleep; 8 after sleep restriction 
and 9 after CPAP withdrawal. Participants were most likely to identify sleepiness prior 
to major incident following sleep restriction. Identification of sleepiness prior to 
incident was similar after a normal nights’ sleep with and without CPAP. In sleep 
restriction and CPAP withdrawal the majority of major incidents occurred while 
participants were feeling very sleepy, reporting KSS 8 and 9. When participants have 
insight into their sleepiness they have approximately 20 min knowledge of sleepiness 
prior to major driving incident.  
9.4 Discussion 
Withdrawal of CPAP for just one night with compliant CPAP users resulted in a 
significant increase in driving incidents and subjective sleepiness compared with the 
same participants obtaining the same length of sleep using CPAP treatment.  
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There was a significant condition, time interaction on both incidents and subjective
sleepiness where impairment was found earlier in the drive for the CPAP withdrawal 
night than following sleep restriction. Overall a greater number of incidents occurred 
following sleep restriction than following normal sleep or CPAP withdrawal suggesting 
that sleep restriction has greater consequences than missing treatment. However, the 
significant condition time interaction demonstrates the two scenarios to have differing 
implications. During the first hour the number of driving incidents were more 
numerous following CPAP withdrawal than following sleep restriction. Subjective 
sleepiness was also greater in CPAP withdrawal for the first hour and EEG activity 
shows a non-significant trend for greater sleepiness and increased effort to remain 
alert. Additionally, safe driving time before first major incident was shorter following 
CPAP withdrawal than following sleep restriction. 
In terms of driving the differing effect of sleep restriction and CPAP withdrawal is of 
great importance as any major incident on a real road could be fatal. Following a 
normal sleep with CPAP OSA participants were safe to drive for approximately 90 min 
(comparable with controls see chapter 5) but without the CPAP there was a dramatic 
fall in safe driving time to less than 1h. This is an important message for OSA patients 
to consistently use CPAP, because even if they are compliant generally, there is no
residual effect on driving performance if treatment is missed. 
An explanation for these findings is that EEG sleepiness levels are greater following 
CPAP withdrawal than following sleep restriction. Although not significant, in the first 
30 min epoch alpha/theta levels and beta levels are similar following normal sleep and 
sleep restriction but are notably higher following CPAP withdrawal. Without CPAP,
participants start sleepier and therefore have difficulties in task performance earlier
on. As the effect of condition on beta power is near significance it is also possible that 
because of the extra effort participants were putting in following CPAP withdrawal 
overall incidents were fewer compared with sleep restriction. 
Treated OSA patients are obtaining quality sleep when using CPAP and no disparity in 
sleep quality (SDI) was found compared with healthy controls and as a result task 
performance and subjective sleepiness are comparable, as detailed in chapters 5 and 
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6. However, withdrawal of treatment for one night caused sleep quality to deteriorate 
significantly. Without full PSG it is not possible to say if SDB was resumed but the 
higher SDI suggests this is likely to have occurred, which would be consistent with 
existing research (Grunstein et al. 1996, Yang et al. 2006a).  
The resumption of sleep disordered breathing in cases of CPAP withdraw is 
consistently found, but impact on task performance and subjective sleepiness vary 
between studies from immediate impairment (Kribbs et al. 1993a) to maintained 
higher than expected performance for up to 7 days without treatment (Turkington et 
al. 2004a, Yang et al. 2006b). The current study found task performance to be 
impaired and subjective sleepiness to be increased with one night CPAP withdrawal. 
This is in contrast to Yang et al. (2006) who found no impairment in a cognitive task 
battery following 1 night CPAP withdrawal. The tasks used by Yang were fairly short, 
the current study uses a long sustained attention task, and it is possible that short 
term concentration is not affected by CPAP withdrawal but longer sustained attention 
is. 
The case of 7 days without treatment reported by Turkington et al. (2004) appears 
contradictory to the current work where task performance was reportedly maintained. 
However, the main focus of that study was to investigate improvements in 
performance when CPAP is started compared with OSA sufferers who do not receive 
treatment. The maintained task performance with 7 days withdrawal reported is in 
comparison with those participants who had never received treatment. On inspection 
of the graphs impairment in performance following 1 nights’ withdrawal is shown but 
this is not commented on by the authors. 
There was a significant effect of condition on subjective sleepiness, with CPAP 
withdrawal resulting in higher KSS scores than sleep restriction in all but the final 
epoch. However, participants only rated themselves more likely to fall asleep for the 
first hour (comparing CPAP withdrawal and sleep restriction). Participants were 
recognising an increased sleepiness but not acknowledging an increased likelihood of 
sleep. Following sleep restriction 75% of participants recognised they were sleepy 
prior to having a major incident. Following a normal length of sleep both with and 
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without CPAP frequency of identifying sleepiness fell to approximately 50% of 
participants. For both sleep restriction and CPAP withdrawal the majority of major 
incidents occurred in KSS 8 and 9, so for the most part participants knew when they 
are sleepy. However, the transition into sleepiness was less frequently identified 
following CPAP withdrawal. In all conditions those who could identify sleepiness did so 
with approximately 20 minutes notice prior to major incident, which in practice should 
allow time to get off the road as long as it is acted on immediately. 
As CPAP withdrawal did appear to reduce the occurrence of insight into sleepiness, 
this study highlights the importance of treatment compliance.  It is possible that the 
act of restricting sleep may increase acceptance of possibility of falling asleep, as in 
order to restrict sleep a participant must be out of bed at a time when they are usually 
asleep. This act provides a memory cue as to why it might be possible to fall asleep so 
participants may be looking out for impaired task performance more. Fewer major 
incidents occurred while participants were sleepy after a normal sleep than after CPAP 
withdrawal. Similarly the withdrawal of CPAP is a physical action which may result in 
actively looking for impairment. With CPAP withdrawal the participant knows they 
were in bed for an adequate length of time and therefore may perceive themselves to 
be at less risk of falling asleep than if they have restricted their sleep time, but more at 
risk than if they have used the CPAP.
The nature of the study design meant that the CPAP withdrawal night was not 
completed in a counterbalanced routine. However, there is no improvement in task 
performance so there were no beneficial effects of additional learning time. It is also 
acknowledged that the 11 participants were self selecting after all 19 participants 
completing the sleep restriction study were asked. No significant differences in 
characteristics between those who participated and those who did not were 
identified. However, Yang et al. (2006) stated “Individuals who are compliant CPAP 
users may be reluctant to volunteer for this type of research if they have previously 
experienced marked negative symptoms with CPAP withdrawal.” This could be 
applicable to the current research as all those reporting occasional CPAP withdrawal 
declined to take part. This is encouraging in terms of compliance to treatment, as 
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those who have experienced the effects of CPAP withdrawal do not want to repeat it. 
Also baseline data prior to initial CPAP treatment was not available for comparison.
OSA patients need to know that even short-term non-compliance with CPAP 
treatment significantly impairs sleep quality, leading to excessive sleepiness and 
impaired performance at a monotonous task such as driving. Importantly task 
performance is impaired from earlier on and there is a reduced ability to recognise 
sleepiness compared with sleep restriction. No residual effects of the CPAP treatment 
were found.
9.5 Conclusions
- CPAP withdrawal results in impairment earlier in the task than sleep restriction. 
- CPAP withdrawal results in a greater number of driving incidents than following 
a normal night’s sleep with CPAP, but less than sleep restriction with CPAP.
- Following CPAP withdrawal participants feel sleepier than following a normal 
sleep with CPAP and sleep restriction. However, they do not always associate 
this with being more likely to fall asleep than following sleep restriction.
- One night withdrawal of CPAP results in increased sleep disturbance and 
reduced sleep efficiency, compared with a night using CPAP.
- Insight into sleepiness was more common following sleep restriction than CPAP 
withdrawal.
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CHAPTER TEN
OSA participants’ individual difference in susceptibility to sleep 
restriction
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10.1 Introduction
The standard deviations of the primary outcome measures of the sleep restriction 
study are reported in the discussions of chapters 5, 6 and 7. Higher standard 
deviations are found following sleep restriction for the OSA participants compared 
with control participants for all measures, except LHoFA. In particular the standard 
deviation for number of driving incidents following sleep restriction was considerably 
greater in OSA participants than controls. This is of interest as it suggests some OSA 
participants may not have been as affected by sleep restriction despite the overall 
results showing greater impairment in the OSA group than controls. This idea is 
investigated in the following chapter. 
10.1.1 Key points from the literature review
The ability to maintain performance when sleep deprived varies greatly between 
individuals (Van Dongen et al. 2004). Some degree of variability at the driving 
simulator task, when sleep restricted, was therefore expected in both the control and 
treated OSA group.
Driving simulator studies have shown there to be great individual difference between 
untreated OSA participants, with many studies showing an overlap with performance 
of the control group (George et al. 1996b, Findley et al. 1999, Juniper et al. 2000, 
Findley 1995, Ayalon et al. 2009). This greater variability appears to be maintained 
following CPAP treatment (Findley et al. 1989, Hack et al. 2001). With large individual 
difference it is important to find out what the predictor of driving impairment is, as 
OSA may not be the only factor affecting driving performance, because some
participants appear able to perform driving tasks to the same level as controls and 
some cannot. Knowing what predicts impaired driving performance would help 
doctors make the decision about fitness to drive. 
With previous studies it has not been possible to demonstrate what factor predicts 
which OSA participants will have impaired performance. ESS, AHI and MWT have all 
been unsuccessful at consistently predicting poor task performance (Mazza et al. 2005,
Kingshott et al. 1998, Orth et al. 2005, Sagaspe et al. 2007b, Turkington et al. 2001).  
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Many of the studies mentioned use short duration driving performance tasks. It is 
therefore not known if the same variability cross over in performance level with 
controls will be apparent during a long duration driving task. 
10.1.2 Research aim and hypotheses
Aim: To evaluate the individual difference of the effect of sleep restriction in OSA-
CPAP compliant patients at a simulated driving task.
To test the hypothesis that there will be great individual difference in OSA CPAP 
compliant participants driver performance at a driving simulator task as reflected by 
lane deviation incidents in comparison to controls after sleep restriction to 5h. 
To test the hypothesis that those OSA CPAP compliant participants with greater 
vulnerability to sleep restriction will have impaired driver performance at a driving 
simulator task as reflected by land deviation incidents, time to first incident, greater 
subjective and EEG sleepiness in comparison to OSA CPAP complaint participants not 
vulnerable to sleep restriction. 
To test the hypothesis that those OSA CPAP compliant participants who are older and 
those with higher ESS will have greater impaired driver performance at a driving 
simulator task. 
To test the hypothesis that in those OSA CPAP compliant participants who have 
greater vulnerability to sleep restriction there will be no difference in insight into 
sleepiness than those who are not vulnerable, as reflected by subjective score at first 
major incident. 
10.2 Method
Design: repeated measures counter balanced. Completing a 2h afternoon drive 
following a normal night’s sleep and following sleep restriction to 5h. OSA participants 
only.
Setting: driving simulator
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10.2.1 Participants
The focus of this analysis will be on the OSA participants. The 19 OSA participants were 
classified into 2 subgroups
- More affected by sleep restriction than control participants (affected)
- Affected by sleep restriction the same as control participants (not affected)
The division of the OSA group was based on the average increase in incidents being 
greater than the mean plus 1 standard deviation of control participants (17.85 + 29.41 
= 47.26). 5 OSA participants were identified as having been more affected by sleep 
restriction (highlighted in yellow) than the control group, (Table 10.2-11).  
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OSA2 17 72 55 Con1 3 49 46
OSA3 23 76 53 Con2 3 27 24
OSA4 8 28 20 Con3 12 18 6
OSA5 1 0 -1 Con5 5 38 33
OSA7 44 200 156 Con6 20 49 29
OSA8 27 18 -9 Con7 85 57 -28
OSA9 4 45 41 Con8 4 13 9
OSA10 11 28 17 Con9 11 24 13
OSA11 54 54 0 Con10 5 7 2
OSA12 2 6 4 Con11 43 77 34
OSA13 1 2 1 Con13 17 30 13
OSA14 1 2 1 Con14 10 36 26
OSA16 0 0 0 Con15 1 5 4
OSA17 20 13 -7 Con16 22 30 8
OSA18 27 141 114 Con17 17 139 122
OSA19 41 87 46 Con18 18 27 9
OSA20 11 40 29 Con19 1 9 8
OSA6 22 15 -7 Con20 8 6 -2
OSA21 124 242 118 Con21 1 2 1
Con22 0 0 0
Average 33.21 Average 17.85
S.d. 48.12 S.d. 29.41
Table 10.2-1 Identification of OSA participants affected by sleep restriction by increase in driving 
incidents.
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10.2.2 Participant characteristics 
Affected 
mean 
(n=5)
Affected 
s.d.
Not 
affected 
mean 
(n=14)
Not 
affected 
s.d.
Independent 
t test 
p value
(2 tail)
Age 59.8 10.13 66.00 5.82 1.68 0.11
ESS 4.40 3.05 5.64 3.63 0.68 0.51
BMI 34.62 8.27 34.31 6.43 0.09 0.93
% body fat 31.08 6.95 33.92 5.37 0.61 0.55
Years of CPAP 
treatment
5.85 7.42 8.36 3.99 0.96 0.35
Driving 
experience 
years
42.20 9.39 46.21 5.98 1.11 0.28
Hazard 
perception 
score
55.6 4.28 47.36 8.83 1.98 0.06
Table 10.2-2 Comparison of participant characteristics by independent t test between those who were 
affected by sleep research and those not affected
Table 10.2-2 shows there is no significant difference between those OSA participants 
who were affected by sleep restriction and those who were not in terms of age, ESS, 
BMI, % body fat, years of CPAP treatment and driving experience. Those who were 
affected by sleep restriction had near significantly higher hazard perception scores, 
though the mean of both groups is over the 44 pass mark, for more details on hazard 
perception test please see chapter 11. 
10.2.3 Protocol 
The results from the 5 OSA participants affected by sleep restriction were compared 
with the results from the remaining OSA participants (n = 14). Those OSA participants 
not affected by sleep restriction will then be compared with the control group. 
10.2.4 Measures
Number of driving incidents, subjective sleepiness and EEG activity were recorded and 
analysed as detailed in chapter 3.    
10.2.5 Statistical analysis
Results for number of driving incidents, subjective sleepiness and EEG were calculated 
in 30 min epochs and analysed using a repeated measures ANOVA form comparison of 
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the two sub types of OSA participants for condition (2 levels), time (4 levels) and 1 
between subject level (affected or not affected). 
A repeated measures ANOVA was also used to compare OSA participants not affected 
by sleep restriction and controls also with data in 30 minute epochs for condition (2 
levels), time (4 levels) and 1 between subject level (not affected OSA or control). 
Due to a positive skew on driving incident data a square root transformation was 
completed prior to analysis. Subjective sleepiness was normally distributed. EEG is 
slightly skewed, the original data is presented. Huynh-Feldt adjustment was used 
where the assumption of homogeneity of variance was violated. 
Prevalence of participant characteristics (including total sleep time) was compared 
between the two OSA sub groups by independent t test (two tailed). Data were 
normally distributed, visually checked using histograms and did not violate the 
assumption of homogeneity of variance, assessed by Levenes test. Correlation 
between increase in total number of driving incidents following sleep restriction with
age and hazard perception score were assessed using one tailed Pearson’s r. 
Correlation of ESS and annual mileage with increase in driving incidents was assessed 
using one tailed Spearmans rho. 
10.3 Results
10.3.1 Sleep time
Actiwatch data was used to asses total sleep time for non study days, the normal sleep 
condition and the sleep restriction condition. It would be possible for the difference in 
driving performance between the two OSA sub groups to be caused by difference in 
habitual sleep time or difference in compliance to the 5 h sleep restriction. In order to 
eliminate this as a possible confounding variable, comparison was made between 
those OSA participants affected by sleep restriction and those not affected to 
eliminate reduced sleep time as a cause of higher impact of sleep restriction. 
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Figure 10.3-1 Total sleep time for OSA participants affected and not affected by sleep restriction
Figure 10.3-1 shows no significant difference in sleep length on either of the study 
days or on non study days. Comparing total sleep time of the normal nights’ sleep and 
sleep restriction nights showed those affected by sleep restriction lost an average of 2 
h 43 min sleep and those not affected lost an average of 2 h 50 min sleep. Therefore, 
the difference in performance cannot be explained by differing sleep times.   
10.3.2 Driving incidents
To test the hypothesis that there will be great individual difference in OSA CPAP 
compliant participants driver performance at a driving simulator task as reflected by 
lane deviation incidents in comparison to controls after sleep restriction to 5h. 
To test the hypothesis that those OSA CPAP compliant participants with greater 
vulnerability to sleep restriction will have impaired driver performance at a driving 
simulator task as reflected by land deviation incidents, time to first incident, greater 
subjective and EEG sleepiness in comparison to OSA CPAP complaint participants not 
vulnerable to sleep restriction. 
00:00
01:12
02:24
03:36
04:48
06:00
07:12
08:24
09:36
Non study normal sleep sleep restriction
affected
not affected
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Figure 10.3-2 Minor driving incidents over time with standard deviation
Figure 10.3-3 Major driving incidents over time with standard deviation
Figure 10.3-2 and Figure 10.3-3 show the number of minor and major incidents 
occurring in 30 minute epochs. The OSA group were sub divided by number of 
incidents, as expected there was a significant condition, group interaction showing 
those who were affected by sleep restriction had significantly more minor [F(1,17) = 
17.758, p = 0.001] and major [F(1,17) = 25.142, p < 0.001] incidents than those who 
were not affected. In comparison with control participants those with OSA who were 
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not affected by sleep restriction showed no significant difference in major incidents [F 
(1,32) = 0.219, p = 0.643] or minor incidents [F (1,32) = 3.146, p = 0.086].
Figure 10.3-4 Mean time driven prior to first major incident with standard deviation
Following sleep restriction those OSA participants who were not affected by sleep 
restriction could drive safely for significantly longer than those who were affected by 
sleep restriction [t (16.309) = 4.516, p < 0.001] and showed no significant difference in 
safe driving time to the control participants [t (32) = 0.890, p = 0.380], this can be seen 
in Figure 10.3-4. 
10.3.3 Subjective sleepiness
To test the hypothesis that those OSA CPAP compliant participants with greater 
vulnerability to sleep restriction will have impaired driver performance at a driving 
simulator task as reflected by land deviation incidents, time to first incident, greater 
subjective and EEG sleepiness in comparison to OSA CPAP complaint participants not 
vulnerable to sleep restriction. 
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Figure 10.3-5 Mean KSS score over time following sleep restriction
Figure 10.3-6 Mean KSS in 30 min epochs with standard deviation following sleep restriction
KSS can be seen in Figure 10.3-5 and Figure 10.3-6. There was no significant condition, 
group interaction between OSA participants who were and were not affected by sleep 
restriction [F(1,17) = 0.22, p = 0.883] and the not affected group showed no significant 
difference to controls [F(1,32) = 0.004, p = 0.953]. 
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Figure 10.3-7 Mean LHoFA over time following sleep restriction
Figure 10.3-8 Mean LHoFA in 30 min epochs with standard deviation following sleep restriction
Using the LHoFA scale (Figure 10.3-7 and Figure 10.3-8) the OSA group who were not 
affected by sleep restriction felt significantly less likely to fall asleep than those who 
were affected [F(1,17) = 6.374, p = 0.022] and those not affected showed no significant 
difference to controls [F(1,32) = 0.015, p = 0.903]. In all cases participants fell sleepier 
and more likely to fall asleep as the drive progressed. 
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10.3.4 EEG
To test the hypothesis that those OSA CPAP compliant participants with greater 
vulnerability to sleep restriction will have impaired driver performance at a driving 
simulator task as reflected by land deviation incidents, time to first incident, greater 
subjective and EEG sleepiness in comparison to OSA CPAP complaint participants not 
vulnerable to sleep restriction.
Figure 10.3-9 Standardised alpha and theta EEG power over time following sleep restriction
Figure 10.3-10 Standardised alpha and theta EEG power in 30 min epochs with standard deviation
following sleep restriction
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Combined alpha and theta activity are shown in Figure 10.3-9 and Figure 10.3-10. The 
OSA participants affected by sleep restriction showed a significantly higher 
standardised power, suggesting increased level of sleepiness than those not affected, 
[F(1, 17) = 7.374, p = 0.033]. There is no significant difference between OSA 
participants not affected by sleep restriction and controls [F (1,32) = 0.436, p = 0.514].
Figure 10.3-11 Standardised beta EEG power over time following sleep restriction
Figure 10.3-12 Standardised beta EEG power in 30 min epochs with standard deviation following sleep 
restriction
Those OSA participants who were affected by sleep restriction had higher standardised 
beta power, suggesting that those participants were putting in more effort to remain 
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alert than those who were not affected, this was a non significant difference [F(1,17) = 
2.399, p = 0.140]. However there is a significant condition, time group interaction 
[F(3,51) = 3.202, p = 0.31] and again there is no significant difference between those 
who were not affected and controls [F(1,32) = 0.230, p = 0.635].
10.3.5 Correlations
To test the hypothesis that those OSA CPAP compliant participants who are older and 
those with higher ESS will have greater impaired driver performance at a driving 
simulator task. 
Pearsons r P value
Age -0.54 0.018*
Hazard perception score 0.37 0.122
Years driving experience -0.43 0.069
Spearmans rho P value
ESS -0.039 0.876
Annual millage -0.307 0.201
*significant p <0.05
Table 10.3-1 Correlations to increase in driving incidents between a normal nights sleep and sleep 
restriction
Table 10.3-1 shows the results of correlation between the change in number of driving 
incidents from the normal sleep to the sleep restriction condition and various 
participant characteristics. The only significant correlation was age, demonstrated in 
Figure 10.3-13.
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Figure 10.3-13 Change in driving incidents for OSA participants with age
There is a significant negative correlation with older drivers being less affected by 
sleep restriction. In practice two younger drivers, aged 50 and 51 both had greater 
than 150 increase in number of incidents; it is likely that the significant correlation is
due to these two participants. 
10.3.6 Insight into sleepiness
To test the hypothesis that in those OSA CPAP compliant participants who have 
greater vulnerability to sleep restriction there will be no difference in insight into 
sleepiness than those who are not vulnerable, as reflected by subjective score at first 
major incident. 
OSA Participants affected by sleep restriction
- 100% (5/5) identified sleepiness on the KSS (6+) prior to first major incident an 
average of 7.4 minutes prior to the incident.
OSA Participants not affected by sleep restriction
- 55.6% (5/9) identified sleepiness on the KSS (6+) prior to first major incident an 
average of 23.2 minutes prior to the incident. 
Table 10.3-2 Perception of sleepiness
All of the participants affected by sleepiness reported feeling sleepy prior to their first 
major incident. However, they only had 7.4 minutes notice of sleepiness prior to 
incident. On average the first major incident occurred 26 minutes into driving so there 
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was not a large opportunity to rate sleepiness. Just over half of those not affected by 
sleep restriction identified sleepiness prior to first major incident with a longer 
awareness period of 23 minutes. 
10.4 Discussion 
Although individual differences in ability to cope with sleep restriction is to be 
expected (Van Dongen et al. 2004, Philip et al. 2006) the magnitude of variation found 
was higher within OSA participants than control participants. This is consistent with 
previous research reporting some OSA participants to have similar levels of 
performance to controls (George et al. 1996a, Findley et al. 1999, Juniper et al. 2000). 
Therefore, it may not be appropriate to offer blanket advice on the fitness to drive of 
all treated OSA patients. 
As discussed in previous chapters OSA participants are found to have no significant 
impairment in driving performance after a normal night’s sleep compared with
controls. However, if sleep is disturbed by a reduce sleep length or withdrawal of 
CPAP, driving performance is significantly affected. When driving performance 
following sleep restriction is analysed in greater depth two distinct groups become 
apparent within OSA participants. Some OSA participants have impairment (measured 
by driving incidents) greater than control participants (higher than 1 standard 
deviation from the mean). These OSA participants were significantly affected by sleep 
restriction by such a magnitude as to create an overall significant difference in driving 
incidents between OSA and control groups when the group was considered as a whole, 
as discussed in chapter 5. Those who are not affected by sleep restriction performed
no differently to controls. OSA participants who were affected also appeared to have 
greater difficulty with prolonged time on task as even after a normal sleep this sub 
group had a shorter safe driving time than the unaffected OSA sub group and controls. 
Interestingly, by creating the two sub groups of OSA participants using driving
incidents significant differences are also found between them with subjective 
sleepiness and EEG. The overall findings between OSA and control participants for 
subjective sleepiness and EEG reported in chapter 6 and 7 were not significant. 
However, when separated, these two OSA sub groups are significantly different to 
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each other and those not affected are no different to controls. This further adds to the 
evidence in chapter 8 that OSA patients do have insight into their sleepiness as here 
the group with higher standardised power in alpha/theta (greater EEG sleepiness)
reported feeling significantly more likely to fall asleep.  In chapter 8, 71.4% of OSA 
participants were found to have insight into their sleepiness compared with 44.4% of 
control participants. All of those OSA participants affected by sleep restriction had 
insight into sleepiness compared with 55.5% of those who were not affected by sleep 
restriction. Even though some OSA participants were significantly affected by sleep 
restriction these were the participants who were much more likely to identify when 
they are sleepy. Providing they act appropriately on this knowledge they should pose 
no more danger on the road than any other group of drivers.
It is really important that all drivers are aware of how to recognise when they are 
sleepy and what to do about it, particularly with OSA drivers. Those OSA participants 
who were affected by sleep restriction only drove for an average of 26 minutes before 
having a major driving incident and only felt sleepy on average 7 minutes before this 
incident occurred. Encouragingly, all of the OSA participants affected by sleep 
restriction were able to identify they were sleepy prior to major incident, so should be 
able to implement a countermeasure to driver sleepiness as long as they act straight 
away. Promoting awareness of the dangers of driver sleepiness and what effective 
countermeasures should be taken if a driver does feel sleepy should enable those 
most affected to take action before an incident occurs. In particular medical 
practitioners of OSA patients should explain the increased susceptibility faced by some 
OSA patients to sleep restriction. Awareness of effective countermeasure to driver 
sleepiness is discussed in chapter 12. 
No difference was found between the total sleep time of those OSA participants 
affected or not affected by the sleep restriction. As such differences during the day are 
as a result of two distinct phenotypes: affected and not affected by sleep restriction. 
As in previous studies no predictor has been found to suggest which OSA participants 
will be affected by sleep restriction and which will not. A significant negative 
correlation with age was identified, but in practice two younger OSA drivers had a 
large increase in number of incidents, if these were removed as outliers the 
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correlation would probably not be significant. The mean ESS was slightly higher in 
those who were affected by sleep restriction, but not significantly. This adds to a large 
number of previous studies finding no predictor of which OSA participants will have 
impaired driving performance (George et al. 1996b, Kingshott et al. 1998, Turkington 
et al. 2001, Mazza et al. 2005, Sagaspe et al. 2007a). Those OSA participants affected 
by sleep restriction did score higher at the hazard perception test than those not 
affected, perhaps suggesting some ability to compensate for negative effects of time 
on task and sleep restriction in a stimulating environment.
Without a reliable predictor medical practitioners have nothing to base fitness to drive 
recommendations on. ESS is often used in a clinical setting to assess fitness to drive, 
but in the current work the ESS of those participants affected and not affected by 
sleep restriction were within normal range. As such, it is possible that ESS is an 
appropriate tool for assessing day time sleepiness under normal sleep conditions 
because there was no significant difference between driving performance of these 
OSA participants and controls following normal sleep, but as some OSA participants 
are susceptible to sleep restriction it would be appropriate for treated patients to 
undergo a sleep restriction study to assess performance. Those who suffer from a 
greater susceptibility could then receive targeted advice. The current driving simulator 
set up would not be appropriate for clinical use due to its long nature; further research 
in this area is needed to identify a shorter test sensitive to the affects of sleep 
restriction which could be used in a clinical setting. Hopefully a 30 min test would be 
appropriate as on average the affected group had the first major incident in 26 
minutes.
The clear distinction between the two types of OSA participant can be seen in this 
study population of 19 OSA participants. With smaller study populations this 
distinction may not have been identified, because of these findings studies with very 
small sample sizes should be accepted with caution. When making comparative 
statements between OSA participants and control participants care is needed as to 
which sub group of OSA participants are represented. 
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10.5 Conclusion 
- 26.3% of OSA participants were affected by sleep restriction, having 
significantly more driving incidents and shorter safe driving time than controls.
- OSA participants affected by sleep restriction had significantly higher EEG 
power in alpha/theta and LHoFA scores than those not affected.
- OSA participants not affected by sleep restriction showed no significant 
difference compared with controls in terms of driving incidents, subjective 
sleepiness or EEG activity. 
- No predictor as to which OSA participants would be affected by sleep 
restriction was identified.
- OSA participants who were more affected by sleep restriction were more likely 
to have insight into sleepiness. 
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CHAPTER ELEVEN
Hazard perception test
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11.1 Introduction 
Hazard perception is a skill enabling drivers to identify potentially dangerous situations 
in time to take evasive action if necessary.  Passing (scoring 44 or more out of 75) a 
hazard perception test has been compulsory for obtaining a UK driving licence since its 
introduction in 2002. The participants in this research all obtained their driving licence 
prior to this date so were not required to pass such a test. The hazard perception test 
provides a specific driving context in which to assess cognitive function.  
11.1.1 Key points from the literature review
Despite not having taken this test before it could be expected that as all participants 
are experienced drivers they would pass. Experienced drivers perform better at hazard 
perception tests than inexperienced drivers (Smith et al. 2009), with age and annual 
mileage being strong predictors of hazard perception test performance (Grayson et al. 
2002). Poor hazard perception has been linked to increased RTI risk (Grayson et al. 
2002) although training in hazard perception has not conclusively been seen to reduce 
RTI risk (Horswill et al. 2004).
Hazard perception will be presented as a novel task for all participants. Untreated OSA 
participants have been reported to have poorer cognitive task performance on initial 
exposure to a task, though improvement can be seen with practice (Rouleau et al. 
2002); it is not known if this is still the cases when treated with CPAP. 
Hazard perception is cognitively demanding (Horswill et al. 2004, Smith et al. 2009).
OSA patients have been shown to be at greater risk of RTI (Ellen et al. 2006) and to 
have reduced cognitive function (Mathieu et al. 2008). It is possible that one factor 
causing the increased RTI risk in OSA patients is poor hazard perception.  
11.1.2 Research aim and hypotheses
Aim: To evaluate the ability of OSA-CPAP compliant patients at a hazard perception 
test specifically related to driving compared with healthy controls.
Hypotheses:
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To test the hypothesis that OSA CPAP compliant participants will show no difference in 
hazard perception performance at a computer based task compared with controls, 
following a normal treated night’s sleep, as reflected by test score and pass rate.
To test the hypothesis that ESS and Age will be negatively correlated with hazard 
perception score in both OSA CPAP compliant participants and controls. 
To test the hypothesis that driving experience will be positively correlated with hazard 
perception score in both OSA CPAP compliant participants and controls. 
11.2 Method
Design: each participant completed the hazard perception test once following a 
normal night’s sleep. Comparing OSA and control participants. 
Setting: computer based test.
11.2.1 Participants
The data presented in this chapter are for 20 OSA and 20 control participants. Details 
of recruitment can be found in chapter 3 and participant characteristics in chapter 4. 
11.2.2 Protocol
The PC hazard perception test (Driving Test Success 2007) was completed during the 
screening day following a normal night’s sleep. The test consists of a series of video 
clips requiring participants to click the mouse button when they see a developing 
hazard. The video is filmed from a camera mounted on the interior windscreen of a car 
driven in various situations. Participants were alone in a room with no distractions 
while completing the test.
11.2.3 Measures
The hazard perception test consists of 14 video clips presenting 15 hazards. For each 
hazard a mark is given from 0 to 5, the earlier the hazard is identified the more points 
will be scored, if the hazard is missed a score of 0 is given. Tests are scored out of 75, 
the pass mark is 44.
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11.2.4 Statistical analysis 
The average hazard perception score of OSA and control participants was compared 
with independent t test (2 tailed). Data was normally distributed (assessed visually on 
a histogram) and did not violate the assumption of homogeneity of variance (assessed 
using (Levenes test). Association between having OSA or not and passing the hazard 
perception test is assessed using chi-square test.  
Correlation between age and driving experience with hazard perception score was 
assessed using one tailed Pearson’s r (r). Correlation between ESS and annual mileage 
with the hazard perception score was assessed using one tailed Spearmans rho (rs) for 
each group individually. 
11.3 Results
11.3.1 Test score and pass rate
To test the hypothesis that OSA CPAP compliant participants will show no difference in 
hazard perception performance at a computer based task compared with controls, 
following a normal treated night’s sleep, as reflected by test score and pass rate.
The computer programme automatically graded each video clip giving participants a 
score out of 75. Overall 72.5% of participants passed the test.
245
Figure 11.3-1 Mean hazard perception score for the two groups with standard deviation
There was no significant difference between mean score for OSA participants 
compared with controls [t (38) = 1.29, p = 0.21], shown in Figure 11.3-1. 
Figure 11.3-2 Hazard perception pass rate by group
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85% of the OSA participants passed compared with 60% of controls, pass rate can be 
seen in Figure 11.3-2. There was no significant association between having OSA and 
passing [X² (1) = 3.14, p = 0.077].
11.3.2 Correlations
To test the hypothesis that ESS and Age will be negatively correlated with hazard 
perception score in both OSA CPAP compliant participants and controls. 
To test the hypothesis that driving experience will be positively correlated with hazard 
perception score in both OSA CPAP compliant participants and controls. 
Age, driving experience and annual mileage has no correlation to hazard perception 
score as shown inTable 11.3-1
OSA Control 
Pearson’s 
r
Significance 
(one tailed)
Pearson’s r Significance 
(one tailed)
Age and hazard perception 
score
-0.25 0.148 -0.29 0.109
Driving experience and 
hazard perception score
-0.07 0.382 0.08 0.371
Table 11.3-1 Parametric correlation statistics
OSA Control 
Spearmans 
rho
Significance 
(one tailed)
Spearmans 
rho
Significance 
(one tailed)
ESS and hazard perception 
score
0.06 0.409 - 0.52 0.009**
Annual mileage and hazard 
perception score
0.07 0.379 0.17 0.237
** signifies significance at 0.001 level
Table 11.3-1 Non parametric correlation statistics
In control participants ESS was negatively correlated to hazard perception score 
visualised in Figure 11.3-3
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Figure 11.3-3 Hazard perception score by ESS for control participants
11.4 Discussion
There was no significant difference of hazard perception score or pass rate between 
OSA and control participants and no suggestion that treated OSA drivers are not fit to 
drive, despite previous studies finding impaired cognitive function in OSA participants.
A limitation of cognitive function research is that a wide variety of tests are used, 
these measure cognitive function in different ways, presenting a problem when 
comparing them. The hazard perception test is a cognitive function test tailored to 
assess the very specific skill of identifying hazards while driving. So while there is some 
evidence of cognitive impairment in OSA participants it is has not been found using 
this specific test. 
One explanation for cognitive impairment in untreated OSA participants is that any 
impairment found is due to varying tolerance levels to sleep deprivation (Yaouhi et al. 
2009) and that treatment with CPAP removes any impairment previously reported 
(Alchanatis et al. 2005). This would provide an explanation for why no impairment was 
reported in these treated OSA participants. However, participants did not complete 
the hazard perception test prior to starting CPAP treatment so it is not possible to tell 
if CPAP has removed any previous impairment in these particular participants. 
It has been reported that untreated OSA participants struggle with novel tasks but 
given time to practice, any impaired ability is removed (Rouleau et al. 2002). In the 
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current study the task was novel to all participants and in fact more OSA participants 
passed the test than healthy controls, indicating no impaired ability in treated OSA 
participants. 
It was expected that as participants had a minimum of 30 years driving experience 
they would score highly on the test as experienced drivers have been shown to be 
better at hazard perception tests (Smith et al. 2009). However, 27.5% of participants 
failed the test, scoring lower than 44/75. This is possibly because participants were 
given no opportunity to practice prior to completion of the task. Prior to an actual 
driving test the hazard perception test can be practiced, the PC programme used for 
this study is a commercially available aid designed for this purpose. The participants in 
this study are therefore in an unusual situation that they did not get to practice before 
hand. If they had done the pass rate may have been higher.
The hazard perception test used has been designed specifically to assess fitness to 
drive in new drivers. Although cognitive function is assessed it has not been designed 
specifically with this in mind. The focus of the current thesis is not on cognitive 
function but because this test forms part of the UK driving test it was felt appropriate 
for participants to complete it, as this is the actual measure used to asses driving 
ability in the UK.  
ESS was significantly negatively correlated to hazard perception score for control 
participants but not OSA participants. It might be expected that people with trait 
sleepiness may find it harder to maintain concentration through the 15 minute test 
and therefore have a lower score. However, Smith et al. (2009) found experienced 
drivers not to be affected by sleepiness when completing the hazard perception test. 
Although this correlation is significant in practice only 27% of the variability in hazard 
perception score of control participants can be explained by ESS. 
The test is known to be easier to pass for experienced than non experienced drivers 
Smith et al. (2009); however in the current work driving experience was not found to 
correlate to hazard perception score. In Smith et al. (2009) the experienced drivers 
were aged 28 – 36 years much younger than the 50 – 75 year olds in the current study. 
This suggests the effect of increasing driver experience is gained from experience in 
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earlier years of driving. With all participants having over 30 years experience it was not 
an impacting factor on hazard perception ability. Driving experience in terms of annual 
mileage was also investigated and again no correlation was found with hazard 
perception score.  
The study population was specifically chosen to be older experienced drivers. The 
hazard perception test is aimed at inexperienced drivers and therefore may not be 
sensitive enough to identify any impairment in these experienced drivers. The test is 
the government standard for the UK so in having the ability to pass a person would be 
eligible to take their practical driving test to gain their driving licence. It is concerning 
that not all drivers could pass the test despite them all having a driving licence, but it is 
possible with further practice they would all pass. Importantly there was no difference 
between OSA and control participants. 
11.5 Conclusion
- There is no cognitive impairment as measured by hazard perception test in CPAP 
treated OSA patients compared with healthy controls. 
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CHAPTER TWELVE
Countermeasures to driver sleepiness: is the message getting through?
Findings reported from all groups studied: HGV drivers and OSA car 
drivers 
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12.1 Introduction 
Any actions taken by a driver to prevent sleepiness occurring or to reduce sleepiness
at the time are countermeasures.  Whether or not an effective countermeasure is 
used is dependent on recognition of sleepiness, knowledge of countermeasures and 
driver choice. Chapter 8 reported that the majority of participants in the simulator
study were able to recognise when they are sleepy. Following recognition of sleepiness 
a driver can only make an appropriate choice if they are educated in which 
countermeasures are effective and will only make that choice if they are motivated to 
do so by the perception of the danger to themselves and others.
The data presented in this chapter is from questionnaire responses of the 148 HGV 
drivers surveyed in chapter 2, the 20 OSA car drivers and 20 Control car drivers who 
participated in the simulator studies. The chapter is located after the HGV and 
simulator chapters as it relates to all the participant groups previously studied.  
12.1.1 Key points from the literature review
Studies in Norway and Sweden surveying the general public have reported good 
awareness of the dangers of driver sleepiness and generally good knowledge of 
effective countermeasures, however, despite this knowledge appropriate measures 
are not necessarily utilised (Nordbakke et al. 2007, Anund et al. 2008). The only similar 
UK study identified was conducted prior to the change in advice for sleepy drivers in 
the UK Highway Code, the survey results for “choice of countermeasure” reflected the 
advice published at the time (Maycock 1996).   
The UK Highway Code currently offers good advice in dealing with driver sleepiness
stating to take a break every 2 hours and if a driver feels sleepy to stop for a 
caffeinated drink and a nap, see Figure 1.3-1. Prior to 1999 stopping to stretch legs 
was advised.  
Young participants know when they are sleepy (Horne et al. 2004) and feel sleepy for
approximately 45 minutes before having an incident (Reyner and Horne 1998b). 
Healthy older participants in the current study reported 65 minutes of sleepiness prior 
to driving incident. This is sufficient time to implement a countermeasure and avoid an
RTI. It is possible that on real roads drivers do not assess their sleepiness levels as 
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often, as when in a regulated study, so may not realise they are sleepy until they are 
fighting sleep. The UK motorway signs, “tiredness kills take a break” provide a prompt 
for people on long journeys to assess their sleepiness, and the accurate information in 
the Highway Code means UK drivers are well facilitated in making good 
countermeasure choices. A key question is, now ten years after the change to the 
Highway Code advice, are experienced drivers choosing effective countermeasures?  In 
particular because OSA participants only had approximately 20 minutes between 
feeling sleepy and having a major incident it is important that they utilise an effective 
countermeasure quickly. 
All new drivers in the UK are required to be familiar with the Highway Code; however,
experienced drivers are required to keep up to date on their own volition. It is possible 
therefore, that drivers passing their test before 1999 would choose to stretch their 
legs if they felt sleepy while driving as this was the advice at the time. 
As a subgroup, professional drivers (driving long distances for long hours) and OSA
patients (with a shorter window on which to act when feeling sleepy) may be more 
likely to experience driver sleepiness than control car licence holders. As such these 
groups may have actively sought out advice on driver sleepiness countermeasures or 
received it from their employer or doctor, which may result in making effective 
choices.    
12.1.2 Research aim and hypotheses 
Aim: To evaluate the choice of countermeasure to driver sleepiness in two groups 
susceptible to driver sleepiness, HGV drivers and OSA drivers. 
Hypotheses: 
To test the hypothesis that HGV and OSA drivers will be more likely to choose 
appropriate countermeasures to driver sleepiness than controls.
To test the hypothesis that participants who have prior experience of falling asleep at 
the wheel will be more likely to choose appropriate countermeasures than those that 
have not.  
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To test the hypothesis that the countermeasures listed in the highway code (caffeine, 
nap and break from driving every 2h) will be most popular for all respondents.
To test the hypothesis that OSA CPAP treated participants will be more likely to 
identify driver sleepiness as a problem than controls. 
12.2 Method
Design: cross-sectional questionnaire, completed once by all participants. Comparing 
HGV drivers, OSA car drivers and control car drivers.
Setting: HGV drivers - A UK HGV rest stop as described in chapter 2. Participants 
completed the questionnaire independently with the investigator available to help if 
required. 
Car drivers (OSA and control) – University Sleep Centre. Participants completed the 
questionnaire with the investigator prior to participanting in the simulator studies of 
chapters 5 – 10. 
12.2.1 Participants 
Three groups of participants were recruited
(1) 148 HGV drivers on UK roads surveyed in a truck stop as detailed in chapter 2. 
(2) 20 CPAP treated OSA car drivers who participated in the driving simulator study 
details of recruitment and participant characteristics can be found in chapter 3 
and 4. 
(3) 20 healthy car drivers who participated in the driving simulator study details of 
recruitment and participant characteristics can be found in chapter 3 and 4.
12.2.2 Protocol
The HGV drivers completed a self administered questionnaire following the protocol in 
chapter 2, as part of the questionnaire (appendix 1) questions was asked about driver 
sleepiness and countermeasures to sleepiness, the results of which were not discussed 
in chapter 2.
254
The OSA and control drivers completed the screening questionnaires (appendix 6 and 
7) with the researcher. These included questions about driver sleepiness and 
countermeasures to sleepiness. 
12.2.3 Measures 
The following questions were asked:
Have you ever felt sleepy while driving? Yes No
Have you ever fallen asleep while driving? Yes No
How long are you happy to drive for without taking a break?
If you felt sleepy while driving what are you most likely to 
do? (you may choose more than one)
Stretch your legs 
Open a window 
Have a caffeine 
containing drink
Turn the radio up
Stop for a nap
Keep going
12.2.4 Statistical analysis
Responses to each question are reported in percentages. 
Comparison is made using chi-squared test for independence between the two groups 
of car drivers (OSA and Control) and drivers with and without experience of falling 
asleep at the wheel, separately for professional and non professional drivers. Odds 
ratios are not reported as no Chi-squared tests were significant.   
The two groups of healthy drivers (HGV and Control) were visually compared without 
statistics due to be large difference in sample size. 
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12.3 Results
12.3.1 Experience of driver sleepiness
Figure 12.3-1 Percentage of OSA, Control and HGV drivers who have felt sleepy and fallen asleep 
while driving
All of the OSA participants had prior experience of feeling sleepy while driving 
compared with 85% of controls (nsd). Significantly more OSA participants (85%) 
admitted falling asleep while driving compared with controls (40%) [X² = 6.82, p = 
0.009]. 
35% of cases of OSA participants falling asleep at the wheel were reported after having
started their CPAP treatment. Following CPAP treatment it might be expected that 
OSA drivers have the same experience as controls but actually incidence of falling 
asleep at the wheel is less than controls (40%). 
62.56% of HGV drivers reported having felt sleepy at some time whilst driving with 
18.92% admitting having fallen asleep at the wheel. This is less in both cases than the 
control non professional drivers.
12.3.2 Choice of countermeasure
To test the hypothesis that HGV and OSA drivers will be more likely to choose 
appropriate countermeasures to driver sleepiness than controls.
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To test the hypothesis that the countermeasures listed in the highway code (caffeine, 
nap and break from driving every 2h) will be most popular for all respondents.
Figure 12.3-2 Preference for driver sleepiness countermeasure for OSA and control drivers
The most popular countermeasure for all three groups was to open a window and 
stretching legs, in all cases the least popular was to keep going, see Figure 12.3-2.
Having OSA had no effect on preference of any countermeasure compared with
healthy controls, keeping going [X² = 1.03, p = 0.31], having a nap [X² = 0, p = 1], 
turning the radio up [X² = 2.57, p =0.109], having a caffeine drink [X² = 0, p = 1], 
opening a window [X² = 0.108, p = 0.298] and stretching legs [X² = 0.450, p = 0.502].
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Figure 12.3-3 Percentage of car driving participants preferring to stop driving and not stop driving 
within the suggested 2 hours
When asked how long they would be happy to drive for without taking a break more 
OSA drivers responded with an answer of ≤2 hours than control participants, [X² = 
0.468, p = 0.494], Figure 12.3-3.
Figure 12.3-4 Preference of driving time for HGV drivers
The majority of HGV drivers are willing to drive for longer than the recommended 2 
hours for private drivers in the Highway Code. This is not unexpected as the maximum 
legal drive time without a break for HGV drivers is 4.5 hours, see Figure 12.3-4. 
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12.3.3 Prior experience of driver sleepiness and effect on choice of countermeasure 
To test the hypothesis that participants who have prior experience of falling asleep at 
the wheel will be more likely to choose appropriate countermeasures than those that 
have not.  
62.5% of the private car drivers surveyed reported previous experience of falling 
asleep at the wheel. Data was compared between drivers who had experience of
driver sleepiness (n = 25, OSA = 17) and those who had not (n = 15, OSA = 3). 18.9% of 
HGV drivers reported previously falling asleep while driving, the HGV data was also 
analysed to compare those with driver sleepiness experience (n = 28) and those 
without (n = 120). Data was analysed separately for professional and non professional 
drivers. 
Figure 12.3-5 Percentage of non professional drivers preferring to stop or not stop driving within the 
suggested 2 hours, split by prior experience of falling asleep at the wheel
Prior experience of driver sleepiness had no significant effect on choice of driving 
duration for non professional drivers [X² = 0.716, p = 0.397]. More participants who 
had fallen asleep at the wheel before would drive for longer than the recommended 2 
hours (nsd), see Figure 12.3-5.   
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Figure 12.3-6 Preference of countermeasure between non professional drivers who did and did not 
have prior experience of driver sleepiness
The preferred countermeasure to driver sleepiness for both groups of non professional 
drivers was opening a window. Having a caffeine containing drink was more popular 
among those with no experience of driver sleepiness (nsd). Having prior experience of 
driver sleepiness had no significant effect on choice of any countermeasure, keep 
going [X² = 0, p = 1], have a nap [X² = 0, p =1], turn the radio up [X² = 0.2, p = 0.887], 
have a caffeinated drink [X² = 0.689, p = 0.406], open a window [X² = 0, p = 1], stretch 
legs [X² = 0.014, p = 0.906], see Figure 12.3-6.   
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Figure 12.3-7 HGV drivers preference for countermeasure comparing those who do and do not have 
prior experience of driver sleepiness
The most popular countermeasure for both groups of professional drivers was 
stretching legs, followed by having a nap and opening a window, see Figure 12.3-7. 
Prior experience of driver sleepiness has no significant effect on preference of 
countermeasure for HGV drivers. Keep going [X² = 0.226, p = 0.635], have a nap [X² = 0, 
p = 1], turn the radio up [X² = 1.016, p = 0.313], have a caffeinated drink [X² = 0.278, p 
= 0.598], open a window [X² = 0, p = 1], stretch legs [X² = 0.45, p = 0.832].   
12.3.4 Attitudes to driver sleepiness
To test the hypothesis that OSA CPAP treated participants will be more likely to 
identify driver sleepiness as a problem than controls. 
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Figure 12.3-8 Percentage of drivers believing sleepiness can affect ability to drive safely
When asked if being sleepy can affect their ability to drive safely all of the OSA drivers 
thought it could compared with 90% of control drivers and 87.2% of HGV drivers, see 
Figure 12.3-8. 
Perception of ability to drive safely when sleepy may be influenced by prior 
experience. When the group is split by experience of driver sleepiness, car drivers who 
had previously fallen asleep at the wheel all thought that sleepiness affected their 
ability to drive safely. However, 25% of HGV drivers who had prior experience of driver 
sleepiness did not believe it could affect their ability to drive safely, see Figure 12.3-9.
Figure 12.3-9 Percentage of drivers believing driver sleepiness does not affect ability to drive safely by 
prior experience of driver sleepiness
0
10
20
30
40
50
60
70
80
90
100
yes no
Pe
rc
en
t
OSA
Control
HGV 
0
5
10
15
20
25
30
experience of driver 
sleepiness
no experience of 
driver sleepiness
experience of driver 
sleepiness
no experience of 
driver sleepiness
HGV Car drivers
Pe
rc
en
t
262
12.4 Discussion 
The UK government is providing valid advice on counteracting driver sleepiness. 
Despite being introduced in 1999 this advice is not being followed; instead of selecting 
caffeine and a nap drivers are still choosing to open a window and stretch their legs
which follows the advice in the “Highway Code” before 1999, when all participants 
took their driving tests. Two groups of drivers at increased susceptibility to driver 
sleepiness, HGV drivers and OSA patients, are no better at choosing effective 
countermeasures to driver sleepiness than controls. Having previously fallen asleep 
while driving does not result in increased likelihood of choosing an effective 
countermeasure. 
Significantly more OSA participants had fallen asleep while driving than control 
participants. This is likely to be due to driver sleepiness prior to starting treatment as
the number of OSA participants reporting falling asleep while driving post treatment is 
very similar to reports from control participants. 
It might be expected that OSA and HGV participants would be more likely to choose 
effective countermeasures than controls because they would have had access to 
accurate information about driver sleepiness from either their company, occupational 
health or medical practitioner, however, there was no difference in preference for 
each countermeasure option. Having a nap was rated more highly by HGV drivers than 
non professionals, this is possibly because many HGVs are designed for drivers to sleep 
in them overnight whereas cars are not. Despite this, only half of the HGV drivers 
stated a nap was a countermeasure they would use if they felt sleepy. 
The majority of drivers would take some action, with only 5% of OSA drivers and 7% of 
HGV drivers saying they would keep going. The low popularity of keeping going may be 
a reflection of participant age, as it has been shown that older drivers (aged > 45) are 
more likely to sacrifice journey time for a sleepiness countermeasure than young 
drivers (Anund et al. 2008). However, the HGV drivers were surveyed in a truck stop so 
by the nature of the experimental protocol any drivers choosing to keep going would 
not be available for survey. 
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The most popular choices are not effective at reducing sleepiness and are not in line 
with government advice. The most popular countermeasure for OSA and HGV drivers 
was to stretch their legs and for control drivers was to open a window. These findings 
are comparable to large studies in Sweden and Norway (Nordbakke et al. 2007, Anund 
et al. 2008). In Sweden a survey of 3135 drivers reported their most popular 
countermeasures as stop for a walk (54%), turn on the radio (52%) and open a window 
(47%) (Anund et al. 2008). In Norway 1513 drivers reported their most popular 
countermeasures as open a window (52%), stop to get out of the car (50%) and put 
music on (36%) (Nordbakke et al. 2007). Stopping for a walk and opening a window are 
in all cases popular choices of countermeasure despite being ineffective (Reyner et al 
1998a, Horne et al 1996). It is likely opening a window is particularly popular because 
it does not increase journey time. 
Previous research in the UK prior to the change in Highway Code advice reported only
35.1% of people to take a break from driving every 2 hours (Maycock 1996). The 
current research reports nearly 60% of non professional drivers stating that they 
would take a break from driving every 2 hours. This greater percentage is encouraging 
and could suggest an improvement in public awareness. However, Maycock (1996) 
had a much larger sample size of 4621 and a younger average age of 47.7 years 
compared to the average age of participants in this study, 65 years. Being willing to 
take a break may be influenced by age. 
It was hypothesised that previous experience of falling asleep while driving may cause 
a person to seek out accurate information on how to deal with driver sleepiness there 
by putting themselves in a position better equipped to deal with the situation should it 
happen again. A larger proportion of non professional drivers had previously fallen 
asleep at the wheel than HGV drivers. Drivers who had not fallen asleep while driving 
were more likely to report taking a break from driving at least every 2 hours (nsd). The 
act of regularly stopping may be why these participants were less likely to have fallen 
asleep while driving. There was no effect of prior experience of driver sleepiness on 
any countermeasure choice, with the most popular for both sub groups being open a
window and stretch legs. Those who had experienced falling asleep were no more 
likely to choose a nap and caffeine than those who had.
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A factor in choice of countermeasure is whether a person perceives driver sleepiness 
to be a problem. All drivers were asked if they think driving while sleepy affects their
ability to drive safely. This demonstrated that the majority of respondents do know 
that sleepiness affects ability to drive safely, so initial recognition of the problem is 
there, along with the desire to do something (keeping going being the least popular 
countermeasure). One particular subset of interest are HGV drivers who had fallen 
asleep while driving, 25% of these drivers reported driver sleepiness not to affect their 
ability to drive safely. It is possible that if they have fallen asleep and there have been 
no consequences they do not perceive the possible danger. This group in particular 
may benefit from targeted advice because they have got away with it once. They are 
less concerned and therefore may not bother to implement any countermeasures.   
This current study has a small sample size, but despite this a consistent preference for 
opening a window and stretching legs has been reported, which is in line with research 
in other European countries (Nordbakke et al. 2007, Anund et al. 2008).  The question 
of ‘why?’ cannot be answered from the data here, but participant response follows
outdated advice in the Highway Code so it is possible that experienced drivers are not 
aware of the new advice. 
The choice of countermeasures question used in this survey asked drivers what they 
would do if they felt sleepy, it does not ask what they think is most effective
countermeasure. Nordbakke and Sagberg (2007) in Norway found that 70% of 
respondents thought that a nap would be the most effective countermeasure but 
when asked what they do only 8% said they would nap. It would be interesting to see 
if there was similar disparity in the UK. The current work could be extended to
investigate if non professional drivers and professional drivers who passed their 
driving test after 1999 were better at indentifying effective countermeasures. 
An awareness campaign is needed to provide experienced drivers with accurate 
information on how best to deal with sleepiness. Key dissemination points could be 
HGV employers and OSA medical practitioners. However, although training in driver 
sleepiness is known to improve knowledge, this knowledge is not necessarily followed 
(Gander et al. 2005). UK drivers currently have access to accurate information about 
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countermeasures to driver sleepiness but the message does not appear to be getting 
through.  
12.5 Conclusion
- The most effective countermeasures to driver sleepiness (caffeine and a nap) are 
not the most popular choice for UK drivers.
- Prior experience of driver sleepiness does not promote effective choice of 
countermeasures.
- Being part of a susceptible group (OSA and HGV drivers) does not result in more 
effective choice of countermeasure.
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CHAPTER THIRTEEN
Comparison of driving simulator performance of the current older 
participants with previous publications of young participants
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13.1 Introduction 
Years of driver sleepiness research at Loughborough University have shown that 
driving performance is impaired following sleep restriction and that participants are 
aware when they are sleepy (Reyner, Horne 1998b, Horne et al. 2004). It has been 
shown that caffeine and a 20min nap combined are the most effective 
countermeasures to driver sleepiness (Horne et al. 1996, Reyner et al. 1997, Reyner
and Horne 1998a,  Reyner et al. 2000, Horne et al. 2001, Reyner et al. 2002) and low 
levels of alcohol worsen performance when combined with sleep restriction (Horne et 
al. 2003, Barrett et al. 2004a, Barrett et al. 2004b, Barrett et al. 2005). 
All of these previous studies have been conducted in young (under 30 years) healthy 
participants. The current research uses healthy older participants (aged 50 – 75 years) 
as a control group for comparison with OSA participants in the same age range. 
Although not the focus of this research it was observed that sleep restriction affects 
task performance of young people in the previous publications than for the older 
participants in the current work. Interestingly, as shown in chapter 8, it was also
identified that these older participants did not show as great frequency of insight into 
sleepiness as younger participants (Reyner and Horne 1998b, Horne et al. 2004).
In order to put these findings of the current work into context this chapter provides a 
brief comparison between the current research and previous results with younger 
participants using the same simulator set up as previous publications by Loughborough 
University.
13.1.1 Research questions
- Do older participants differ in ability at a driving simulator task, in terms of driving 
incidents compared with younger participants?
- Do older participants show the same pattern of increasing sleepiness as younger 
participants during a driving simulator task?  
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13.2 Method
Design: Repeated measures counterbalanced. Completing a 2h afternoon drive 
following a normal night’s sleep and following sleep restriction to 5h. Comparing 
healthy older (50 – 75y) and younger (<30y) participants. 
Setting: driving simulator
13.2.1 Selection of younger participants
All driving simulator publications from Loughborough University were assessed to 
identify those most relevant for comparison with the current work. The most relevant 
for comparison was: 
Horne JA, Reyner LA, Barrett PR (2003) Driving impairment due to sleepiness is 
exacerbated by low alcohol intake.
This paper was selected because it matched the current study in that;
- The study contained 2 h drive times between 2pm and 4pm
- All participants were male, n = 12 (aged under 30)
- Results reported a baseline (normal night’s sleep) condition and a sleep 
restriction to 5 h condition.
Although insight into sleepiness has already been discussed in chapter 8, in the current 
chapter comparison will be made between the older control group and the 
unpublished data from the younger participants in Horne et al. (2003). 
13.2.2 Protocol
Details of full study protocols can be found in chapter 3 of this thesis and in the 
publication of Horne et al. (2003).
13.2.3 Measures
The number of major driving incidents and KSS were recorded and analysed as 
detailed in chapter 3. EEG activity was not compared as age related changes to the 
signal present a confounding variable. Minor incidents and LHoFA were not recorded 
in Horne et al. (2003).
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13.2.4 Statistical analysis
Results for the number of driving incidents and subjective sleepiness were calculated 
in 30 minute epochs and compared between the younger participants and older 
control group using a repeated measure ANOVA for 2 within subject factors,  condition 
(2 levels), time (4 levels) and 1 between subjects factor (age group) as described in 
section 3.6. 
In all cases raw data were visually examined in histograms to check the assumption of 
normal distribution, standard deviation of road position and time to first major 
incident were normal. Number of driving incidents were not normally distributed, to 
correct for this skewed data a square root transformation was completed prior to 
analysis. Subjective sleepiness data was normally distributed. In all cases the 
assumption of homogeneity of variance was met so Huynh-Feldt (ε) adjustment was 
not used.
Results from OSA participants are presented for visual comparison on the same graph 
but are not included in the ANOVA as they have been compared with the control 
group. 
13.3 Results
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13.3.1 Major driving incidents
Figure 13.3-1 Major driving incidents after a normal night’s sleep with standard deviation
Figure 13.3-2 Major driving incidents after sleep restriction with standard deviation
Figure 13.3-1 and Figure 13.3-2 shows major driving incidents in young healthy 
controls and both older groups following a normal night’s sleep and sleep restriction 
to 5 hours. There is a significant condition, group interaction, in both conditions the
control older participants had less driving incidents than the younger participants [F 
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(1,30) = 8.38, p = 0.007]. OSA participants appear more similar to young participants 
during the later stages of both drives than older control participants.
13.3.2 Subjective sleepiness
Figure 13.3-3 Mean KSS following a normal night's sleep for all three groups
Figure 13.3-4 Mean KSS following sleep restriction for all three groups
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Figure 13.3-3 and Figure 13.3-4 show mean KSS over a 2 h drive for young participants,
older control participants and OSA participants. For both conditions the younger 
participants start the drive feeling sleepier than the older participants. For statistical 
analysis results were averaged to 30 minute epochs, shown in  Figure 13.3-5 and 
Figure 13.3-6. 
Figure 13.3-5 KSS in 30 min epochs following a normal night's sleep with standard deviation
Figure 13.3-6 KSS in 30 min epochs following sleep restriction with standard deviation
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older healthy participants. 
13.3.3 Insight into sleepiness
Figure 13.3-7 The percentage of each KSS spent in each LHoFA score
Table 13.3-1 Percentage of total time in each KSS rating, subdivided into categories of likelihood of 
falling asleep for young participants
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13.3-2 are repeated from chapter 8
Figure 13.3-8 The percentage of each KSS spent in each LHoFA for older healthy participants
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(7) Sleepy but no effort to stay awake
(8) Sleepy but some effort to stay 
awake
(9) Very sleepy, great effort to stay 
awake
Table 13.3-2 Percentage of total time in each KSS rating, subdivided into categories of likelihood of 
falling asleep for older participants
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3.7% of epochs for older participants. Demonstrating that young participants are more 
likely to think that sleepiness is not a problem to them.   
13.4 Discussion
Older male participants have fewer major driving incidents while completing this 2 h 
driving simulator task than younger male participants, both after a normal night’s 
sleep and sleep restriction to 5 hours. Older participants also appeared to feel less 
sleepy than younger participants (nsd). The greater number of incidents in younger 
males reflects UK RTI data where 38% of sleep-related RTIs are caused by drivers 
under 30 compared to approximately 14% by drivers aged 50+ (Flatley et al. 2004).  
The smaller increase in driving incidents in the healthy older participants is to be 
expected as sleep restriction has previously been shown to have greater impact on 
younger participants (Adam et al. 2006). It was also anticipated that older drivers 
would be more aware that feeling sleepy meant they had a possibility of falling asleep, 
as risk perception has been show to change with age (Finn et al. 1986).
Although comparison of this data shows older drivers to be at less risk of sleep-related 
incidents than young drivers it is important to remember the findings of chapter 8, 
which showed the older participants were not as reliable at recognising sleepiness as 
the younger participants had been. OSA participants have better insight into 
sleepiness than control participants of a similar age; however, neither are as likely to 
recognise that they are sleepy prior to driving incident as young participants. As older 
drivers represent a lower proportion of srRTIs than younger drivers (Flatley et al. 2004)
it is possible that older drivers do not put themselves in situations where they may be 
sleepy while driving, in contrast to younger drivers.
OSA participants have a similar number of driving incidents as young healthy drivers 
for the second hour of the drive following normal sleep and the later 90 minutes of the 
drive following sleep restriction. In light of these findings it should be considered when 
assessing an OSA patient’s fitness to drive that these patients are not only OSA 
sufferers but also represent a predominantly older aged group. When evaluating if an 
OSA patient is fit to drive assessment should be made in the context of drivers as a 
whole. Although OSA participants have significantly more driving incidents than 
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controls of the same age, these older controls have significantly fewer driving 
incidents than healthy young drivers. Although OSA participants have impaired driving 
performance compared with controls (following sleep restriction) when this is put into 
context with other road users, treated OSA drivers may be no worse than younger 
sleep restricted drivers. 
This highlights the vulnerability of all road users to driver sleepiness and demonstrates 
the need for wide spread education in identifying driver sleepiness and effective 
countermeasures. As long as all drivers know how to identify when they are sleepy and 
what they should do about it potential risk of RTI could be lowered. 
13.5 Conclusions
- Healthy older participants have fewer major driving incidents during a 2 h 
simulated driving task than healthy younger participants, following both a 
normal night’s sleep and sleep restriction.
- Older participants increase in sleepiness rating across a 2 h drive in a similar 
pattern to younger participants; however, the younger participants start at a 
higher level of sleepiness and are more affected by sleep restriction.  
- Young participants are more likely to rate themselves as unlikely to fall asleep 
when they feel sleepy than older participants. 
- OSA participants appear to suffer the impact of sleep restriction to a similar 
level as healthy young participants. 
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CHAPTER FOURTEEN
General Discussion
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14.1 Discussion
It has been repeatedly shown by numerous authors that untreated OSA drivers are 
more likely to have RTIs (George et al. 1999, Ellen et al. 2006, Vakulin et al. 2009) and 
that CPAP treatment reduces RTI risk (Juniper et al. 2000, Yamamoto et al. 2000, 
George 2001). However, a lack of research investigating long term CPAP treated OSA 
patients, the impact of sleep restriction and one night of CPAP withdrawal was 
identified. Prevalence of OSA diagnosis is increasing and now CPAP treatment is 
recommended on the NHS for moderate and severe cases, the number of CPAP 
treated OSA patients driving on UK roads will also increase from current levels. It is 
important for further investigations into driving ability when on treatment to be 
conducted, demonstrating no difference in performance between controls and OSA 
participants if CPAP is fully adhered to. Despite the increasing occurrence of OSA, 
research with commercial drivers has found participants to be reluctant to volunteer 
for screening (Vennelle et al. 2010). If it is widely accepted that treated OSA drivers 
are as safe as healthy drivers more commercial drivers may volunteer for screening, 
reducing the number of tragic srRTIs in undiagnosed OSA sufferers like those listed in 
the preface to this thesis.
In some of these cases, OSA itself has been stated as a defence that the driver was not 
able to identify that they were sleepy because of the disorder; however, the literature 
review identified no scientific research to substantiate this claim. This is particularly 
important when considering that approximate 10% of HGV drivers were found to have 
suspected undiagnosed OSA. 
This thesis aimed to address the research questions posed in section 1.14, spanning 7
areas: 
1. Prevalence of undiagnosed OSA in heavy goods vehicle (HGV) drivers.
2. Impact of sleep restriction on long term CPAP treated OSA participants, 
comparing driving to healthy controls. 
3. Ability of OSA participants to identify sleepiness. 
4. The impact of one night’s CPAP withdrawal. 
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5. Individual difference in driving performance in long term CPAP treated OSA 
participants. 
6. Ability at hazard perception.
7. Choice of countermeasures to driver sleepiness.
Research was conducted using three approaches, questionnaires, a computer based 
hazard perception test and a driving simulator protocol. The questionnaire was 
designed to be succinct and straightforward for participants to complete. Three 
versions of the questionnaire were used; all were based around the same core 
questions.
1. For HGV drivers
2. For OSA car drivers, participants of the driving simulator study
3. For control car drivers, participants of the driving simulator study
The questionnaire included anthropometric measures and questions on driving habits, 
attitudes to driver sleepiness, health, countermeasure preference and OSA where 
applicable. The questionnaire was also used for screening purposes for the simulator 
study. 
The hazard perception test was completed by all participants in the driving simulator 
study; this computer based task represented that used in the UK driving test (Driving 
Test Success 2007). 
The driving simulator protocol was completed by 19 OSA participants and 20 control 
participants; procedure was the same on each occasion apart from the change in test 
condition; (i) normal night’s sleep, (ii) sleep restriction to 5 h, (iii) CPAP withdrawal for 
one night. The research conducted using the driving simulator focused on a realistic 
scenario that the majority of the general public could find themselves in at some point
and something that they would not consider particularly risky to do: driving on a 
motorway after 5 h sleep or following one night of missed CPAP treatment. 
14.1.1 Prevalence of OSA in HGV drivers
 Is undiagnosed OSA prevalent in HGV drivers on UK roads?
 Are OSA risk factors and symptoms associated with falling asleep at the wheel?
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Nearly 10% of the HGV population surveyed may be suffering from undiagnosed OSA. 
HGV drivers as a subgroup were found to have greater prevalence of risk factors 
associated with OSA than the general population including: male gender, obesity, aged 
over 40 years, larger neck circumference and higher average ESS. This is slightly less 
than studies in Sweden (17%) and Australia (15.8%) using overnight PSG (Carter et al. 
2003, Howard et al. 2004). This difference may in part be because the main criteria for 
suspected OSA in the current study were witnessed apnoeas by a bed partner and 
22.3% of participants reported not having a bed partner therefore no ability to identify
apnoeas. This is the first impartial study to our knowledge in the UK with HGV drivers.
Undiagnosed OSA may be a big problem in HGV drivers as those with suspected OSA 
were significantly more likely to have EDS. 36% of the suspected OSA cases were in 
participants not obliged to have regular medicals as they were under 45 years old, this 
demonstrates possible benefit to medical examination at a younger age. However, the 
remainder of suspected OSA sufferers were of an age to be receiving medicals and 
they had not been diagnosed.
Sleep-related RTIs involving HGV’s can be devastating due to the size of the vehicle.
This simple survey shows it is easy to identify people who may be at risk, therefore 
haulage companies have the opportunity/responsibility to monitor their drivers and 
recommend seeing a doctor if necessary.   
14.1.2 Sleep restriction
 Do long term CPAP treated drivers have impaired driving performance at a 
simulator compared to control drivers following a normal night’s sleep?
 Do long term CPAP treated drivers have a greater impaired ability at a 
simulated driving task following one night’s sleep restriction compared to a 
control group?
At baseline, following a normal night’s sleep there was no significant difference in 
driving performance at the simulator task between the CPAP treated OSA participants 
and healthy non professional control drivers. Restricting sleep to 5 hours resulted in 
both groups having significantly more driving incidents, shorter safe driving time and 
higher subjective sleepiness. The short safe driving time is of particular concern as the 
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UK Highway Code recommends drivers take a break every 2 hours to avoid driver 
fatigue. The healthy older drivers in this study were only able to safely drive for 
approximately 90 minutes. For this age group it is perhaps more appropriate to 
recommend taking a break from driving every 90 minutes.
It is also possible that older participants experience a quicker transition from alert to 
sleepy than younger participants as the mid range of the KSS is reported with a low 
frequency. The quick transition may make it harder for individuals to identify when 
sleepy. The KSS and LHoFA scales were found to be highly correlated, demonstrating 
older participants know that there is likelihood they will fall asleep when they are 
sleepy. The KSS and ESS were not correlated suggesting ESS may not be a suitable tool 
to assess fitness to drive. 
The OSA participants were significantly more affected by the sleep restriction than the 
controls in terms of driving incidents. For the first 30 minutes performance was 
comparable between groups but for the remaining 90 minutes OSA participants had 
more major driving incidents than the control participants. However, there was no 
similar difference in subjective sleepiness or EEG activity between groups. As a result 
OSA patients may be unaware of their increased susceptibility to driving impairment,
because they do not feel any sleepier than controls and for the first 30 minutes driving 
performance is the same as after a normal nights’ sleep. 
The OSA participants were also found to have greater difficulty with time on task than 
control participants, with a shorter time to first major incident and a greater increase 
in subjective sleepiness from the beginning to the end of the sleep restriction drive. 
Time had a significantly different effect on OSA participants than controls, with an
earlier increase in EEG sleepiness and effort required to remain alert. 
14.1.3 Insight into sleepiness
 Do treated OSA drivers have impaired insight into their sleepiness levels?
The majority of participants were able to identify that they were sleepy prior to having 
a major incident. However, not all participants could, this is in contrast to 100% of
younger participants who could identify sleepiness prior to a major incident (Reyner
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and Horne 1998b). A greater proportion of OSA participants had insight into sleepiness 
than control drivers, suggesting that despite the greater susceptibility to driving 
incidents following sleep restriction, the OSA participants show increased ability to 
recognise sleepiness, therefore they should have opportunity to stop driving. On 
average, OSA participants have 19 minutes warning of sleepiness prior to major 
incident. 15 minutes at 70 mph on a motorway equates to 17.8 miles travelled, in 
which time it is likely the driver would reach a safe place to stop. However, this 
requires the driver to take action as soon as they are aware of sleepiness. Not all 
participants had insight into sleepiness; in particular the poor insight in control drivers 
may is explained by the lack of no correlation between KSS and EEG activity.  
Training in how to recognise sleepiness could be beneficial. These older participants 
were more likely to recognise that they might fall asleep when sleepy than younger 
participants (Reyner and Horne 1998b), demonstrating a wiliness to accept the 
dangers of driver sleepiness. 
14.1.4 CPAP withdrawal
 What is the effect of missing one night’s CPAP treatment on simulated driving 
performance in the longer term treated?
CPAP withdrawal for one night results in significantly increased sleep disturbance 
index, suggesting the resumption of sleep disordered breathing. Despite having a 
normal sleep length, not using CPAP resulted in significantly more driving incidents, 
reduced safe driving time and feeling sleepier compared with a normal night’s sleep. 
CPAP withdrawal resulted in impairment earlier in the drive than sleep restriction;
participants started the drive feeling sleepier and had more major incidents in the first 
hour.
In real world terms of driving, the earlier impairment and heightened sense of 
sleepiness experienced without CPAP could pose a greater danger on roads than sleep 
restriction. Additionally insight into sleepiness was more common following sleep 
restriction than CPAP withdrawal. It is possible that the act of restricting sleep 
provided a cue to participants that heightened their awareness of sleepiness, whereas 
without CPAP they felt they had received their usual 8 hours they did not notice when 
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they became sleepy. OSA patients need to be educated to the dangers of not using 
CPAP. 
14.1.5 Individual difference
 Is there a larger individual difference in effect of sleep restriction on simulated 
driving performance of long term CPAP treated OSA participants? 
 If so which OSA participants are more susceptible?
A great variation in OSA driving performance following sleep restriction was reported 
in chapter 5, 6 and 7. The OSA group was divided into those who had been affected by 
sleep restriction more than the control group and those who had not. Those who had 
not been affected by sleep restriction show no significant difference to controls at the 
driving task, subjective sleepiness or EEG activity. Those who were affected had 
significantly worse performance at the task, felt significantly more likely to fall asleep
and showed greater EEG sleepiness than those OSA participants not affected.
No predictor was found to suggest which OSA participants would be affected by sleep 
restriction. ESS is often used in a clinical setting to assess fitness to drive; however, 
there was no significant difference between groups using this scale. It may be 
appropriate to have a sleep restriction test in clinics to identify those OSA participants 
susceptible to sleep restriction. Those affected by sleep restriction were more likely to 
have insight into sleepiness and therefore could benefit from targeted advice in how 
to deal with driver sleepiness.
14.1.6 Hazard perception
 Do long term CPAP treated OSA drivers have impaired cognitive performance 
as measured by a hazard perception test?
There was no difference in hazard perception score or pass rate between OSA and 
control participants. Driving experience and age were also not correlated to test 
performance. ESS and hazard perception test score were significantly correlated for 
control participants but not for OSA participants. In practice this correlation only 
explains 27% of variability. Not all participants passed the test but it is possible with 
further practice they would. 
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14.1.7 Countermeasures to driver sleepiness
 What is the opinion of HGV drivers in the UK on driver sleepiness and 
countermeasures?
 Is there a difference in preference of countermeasures to driver sleepiness 
between OSA and control participants?
 Do long term CPAP treated drivers have different attitudes to driver sleepiness 
than control drivers of a similar age?
 Do UK drivers with prior experience of sleepiness at the wheel choose more 
effective countermeasures?
The UK government is providing valid advice on counteracting driver sleepiness; 
despite being introduced in 1999 this advice is still not being followed. The three 
groups investigated showed greatest preference for opening a window and stretching
their legs (advice in the Highway Code before 1999) as a countermeasure to driver 
sleepiness. Experienced drivers did not appear to be aware of the change of advice. 
OSA drivers and HGV drivers may be at increased susceptibility to driver sleepiness but 
are no better at choosing effective sleepiness countermeasures than controls. Also 
having prior experience of driver sleepiness also does not promote effective choice of 
countermeasure. 
The majority of drivers recognised that driver sleepiness can affect their ability to drive 
safely, and very few reported to keep going as a preferred countermeasure. This 
suggests that the majority of drivers want to take some action; however, they are not 
making effective choices.  Particularly concerning was the 25% of HGV drivers who had 
fallen asleep while driving but did not think that driver sleepiness affects their ability 
to drive safely. 
14.1.8 Comparison with younger participants
Although not an original aim of this thesis, it became apparent that there were clear 
differences between the older participants in current work and young participant in 
previous publications. Thus it was appropriate to compare the current findings with 
previous findings using the same driving simulator protocol. 
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Healthy older control participants were found to have fewer driving incidents 
compared with the younger participants both after a normal sleep and sleep 
restriction. Younger participants started both drives feeling sleepier than older 
controls. These findings provide some suggestion as to why sleep-related RTIs are 
more commonly caused by younger drivers, as not only do younger drivers have more 
driving incidents but they are also more likely to believe that despite their sleepiness,
they will not fall asleep. This provides context in which to assess OSA drivers, because
although this thesis found greater impairment with sleep restriction for the patient 
group, realistically, driving simulator performance in the patient group is similar to 
young participants.  
14.2 Implication of findings
14.2.1 The law
Overall, these findings suggest that current UK law, allowing OSA patients to continue 
driving when successfully treated, is appropriate. In all cases of comparison between 
the normal night’s sleep condition there was no significant difference between OSA 
participants and healthy controls.  
However, untreated OSA sufferers are known to have increased risk of RTI. Despite 
numerous studies on the dangers of untreated OSA and the number of miles travelled 
in large vehicles there is no mandatory screening of HGV drivers. Approximately 10% 
of those surveyed showed signs of undiagnosed OSA. Screening of all HGV drivers 
would be costly and unnecessary. However a simple questionnaire screening could
identify those drivers most likely to be suffering from OSA, resulting in a smaller sub 
group which would be more efficient to complete sleep studies on. Having a legal 
requirement to screen drivers if certain risk factors for OSA are met would reduce the 
number of untreated OSA sufferers on the roads and danger to the public. 
The preface to the thesis list several court cases where the defendant used OSA in 
their defence stating they were unable to identify they were tired due to their 
undiagnosed OSA. The evidence in this thesis suggests that treated OSA patients are 
not less likely to identify sleepiness than healthy controls either with or without CPAP
treatment. Although, further work in this area is required it is probable that untreated 
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OSA sufferers would also not have impaired ability in recognising when they are 
sleepy, rendering OSA as a mitigating circumstance inappropriate.  
14.2.2 Education
Although the law does appear to be appropriate this thesis has highlighted several 
areas requiring an improvement in education.
Currently the UK Highway Code recommends for drivers to take a break from driving 
every 2 hours to avoid driver fatigue. The current research found that even after a 
normal night’s sleep the healthy older participants were only able to drive for 90 
minutes without incident. Therefore it may be more appropriate to suggest taking a 
break every 90 minutes for older drivers to avoid driver fatigue. 
Further research is needed comparing CPAP treated HGV drivers and healthy HGV 
driver controls; it is likely that there would be no difference between these groups. If 
haulage companies are aware that treated drivers are safe they may be more willing to 
screen those most at risk, identifying cases of undiagnosed OSA in the knowledge that 
with successful treatment they do not need to lose employees. 
A widespread campaign to raise awareness of a caffeinated drink combined with a nap 
as an effective countermeasure is needed. Although this information is in the Highway 
Code it does not appear to be accepted by the majority of drivers surveyed. In 
particular, HGV employers could be key information dissemination points. Doctors 
with OSA patients should also be providing advice on what to do if they get sleepy 
while driving, as OSA patients appear to be more susceptible to sleep restriction than 
healthy adults. 
Sleep restriction posed a problem for both groups in the simulator study; as such a 
general awareness campaign into the dangers of driving when sleepy would be useful. 
However, this would be costly so perhaps an intermediate measure such as targeting 
those most at risk such as OSA patients would be more valid. When a person is 
diagnosed with OSA time should be spent explaining the dangers of driver sleepiness. 
In particular the importance of not missing CPAP treatment because this causes a 
significant impairment in driving ability and is arguably more dangerous than sleep 
287
restriction as the impairment happens earlier on. It has been shown that OSA patients 
can recognise when they are sleepy but they do not have a large time window to act 
on it. Information on countermeasures to driver sleepiness should be disseminated; so 
that OSA patients know as soon as they feel sleepy they should find somewhere safe 
to stop.  
Medical practitioners treating OSA patients should be aware that some patients will 
have greater susceptibility to sleep restriction than others. When assessing fitness to 
drive, examining treated patients following sleep restriction would hopefully identify 
the susceptible sub group and aid doctors in their decision. 
14.3 Limitations 
The present study, as with any other, has a number of limitations to be acknowledged 
to allow the findings to be put into context. Firstly the main simulator studies were 
carried out with OSA participants who were all members of a patient association 
group. This specialised recruitment allowed for easy access to the patients who were 
most likely to be happy and compliant with CPAP treatment. It was a requirement of 
the study to have participants who were compliant with the treatment and, because it 
was not possible to check CPAP compliance with patients’ CPAP machines, using this 
sub group of patients hopefully reduced the chance of non-compliant patients
participating. However in doing so, participants were recruited from a self selecting 
population, meaning they cannot be representative of the general treated OSA 
population. Similarly for the HGV survey, by conducting it in a “truck stop” the very 
nature of the protocol meant all participants were from a self selected group who had 
decided to stop at that safe location, any drivers wishing to keep going were not
represented. 
The sample size of 40 for the driving simulator study could be considered small, 
however, within the context of driving simulator studies this is a fairly large group. 
Simulator studies are very costly both in time and money as such they often have small 
sample sizes. Again with HGV drivers a sample size of 148 for a survey may also be 
considered small. Due to funding and time constraints it was only possible to conduct 
the survey at one “truck stop” which resulted in repeat encounters with customers 
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over the period of data collection. Ideally additional funding would allow the survey to 
be completed at multiple “truck stops” across the UK therefore testing a cross section 
of the HGV driver community and not the regulars of one stop. 
The majority of the current work was carried out in the controlled environment of a 
driving simulator. Although this is not a study limitation, applying findings to real world 
scenarios should be done with caution due to various uncontrollable factors in the real 
world environment. It is likely that the driving simulator represents a worst case 
scenario, as real roads usually offer more stimulation and as such fewer driving 
incidents might be expected. 
Within the simulator study protocol itself, it would have been useful to have an 
additional subjective measure for participants to report if at any point they would take 
a break from driving (although the protocol would not have actually allowed them to 
do so). This would create an assessment of which KSS rating would need to be reached 
before a person would stop driving. 
14.4 Directions for further research
On completion of the research within this thesis a number of potential areas for future 
research have been identified. These are outlined below. 
14.4.1 Perception of sleepiness
The current research recognised that not all participants were able to identify that
they were sleepy prior to a major driving incident. Participants with OSA were more 
likely to report sleepiness prior to major incident but with less warning than control 
participants. No factor was identified as a predictor of which participants would report 
sleepiness and which would not as the current research was designed to assess if 
perception of sleepiness occurred, not investigate why it might not. In particular it was 
interesting to note that for those control participants who did not report sleepiness 
prior to major incident EEG activity and KSS were not correlated. A more vigorous 
study protocol incorporating a greater number of background questions, daytime 
sleepiness scales and perception of sleepiness during other sustained vigilance tasks 
may be able to identify why some participants cannot identify they are sleepy. This 
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could then be followed by an intervention to educate participants on identification of 
sleepiness and see if it subsequently improves.  
It would also be interesting to conduct a similar study with untreated OSA suffers. 
Although it is widely reported that prior to treatment driving performance is impaired 
in OSA suffers, there is little research examining if these participants know that they 
are sleepy when driving. This would have strong legal implications as undiagnosed OSA 
has been stated as a reason that drivers causing RTIs as they were not able to stop 
before falling asleep; they suggest they didn’t know they had the condition and were 
unable to tell that they might fall asleep. As the majority of treated OSA participants 
did report sleepiness prior to major incident it could by hypothesised that untreated 
OSA participants would do the same. 
14.4.2 Impact of variance of CPAP compliance
All OSA participants in the current research were compliant CPAP users. In general 
CPAP adherence rates are low with as many as 50% of patients rejecting the treatment 
outright or taking it off part way through the night (Engleman et al. 2003, Weaver et 
al. 2008). The current research showed that withdrawal of CPAP for one night, and 
reducing sleep to 5 hours with CPAP, both had significant effects on driving 
performance. It is reported that many OSA patients will use their CPAP for only part of 
a night, i.e. sleep for 8 hours but only use the CPAP for 4 (Kribbs et al. 1993b). It would 
be interesting to know what the impact of this partial CPAP use is on driving 
performance, as this may represent a more realistic scenario.  
14.4.3 Individual difference in susceptibility to sleep restriction
Great individual difference between untreated OSA participants driving ability has 
been reported by previous studies (George et al. 1996, Findley et al. 1999, Juniper et 
al. 2000). The current research found this to also be true of treated OSA participants. 
Although various factors were investigated no predictors of which OSA participants 
would be affected were identified. Again a more extensive study protocol would be 
beneficial in measuring other possible predicting factors. This information would be 
very useful for doctors, who have to assess patients’ fitness to drive; also if they knew 
which patients will suffer from sleep restriction their advice could be targeted.  
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14.4.4 Comparison of older and younger drivers
Although not a main topic of the current research, it became apparent that there were 
differences in driving performance between these older participants and findings 
reported in previous publications on younger participants. Now this is known a full 
study protocol could be designed using four groups, older and younger drivers with 
and without OSA. It would be interesting to see if older age contributes to fewer 
driving incidents in an OSA group. 
14.5 Conclusions
This thesis aimed to investigate the area of obstructive sleep apnoea and daytime 
driver sleepiness. The objective was to provide evidence about the driving ability of 
treated OSA participants and consider factors which may impair ability (sleep 
restriction and CPAP withdrawal), whilst assessing the impact of OSA on driving. 
Fortunately driving ability following a normal night’s sleep was found to be no 
different than for a healthy control group, however, OSA participants were more 
affected by sleep restriction than control participants. In particular missing one night’s
CPAP treatment is very dangerous as driving impairment occurred earlier on than 
following sleep restriction and sleepiness was not as well identified by participants. 
Ultimately it is medical practitioners who decide if treated OSA patients are fit to drive 
and provide patients with advice in living with their condition. Based on this thesis the 
following advice would be offered: 
1. ESS should not be used alone, as there was no correlation between ESS and 
driving simulator performance. 
2. Express to patients that they are only fit to drive if they adhere to treatment. 
3. Some treated patients will be particularly sensitive to sleep restriction, because 
of this it would be useful to assess participants following sleep restriction, 
regardless of their ESS. 
4. Inform all patients that they may be susceptible to driver sleepiness if they do 
not get adequate, CPAP treated, sleep. In order to reduce the risk of RTI they 
should take a break from driving every 2 hours and if they feel sleepy while 
driving stop, have a high caffeine content drink and a 20 min nap. 
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The discovery of a potential 10% of HGV drivers suffering from undiagnosed OSA is 
particularly worrying. Although the UK system provides good treatment for OSA 
patients a greater awareness and understanding is needed in the haulage industry to 
allow screening of drivers, without the worry of job losses. It is also vital that doctors 
and OSA patients are aware of the dangers of sleep restriction and CPAP withdrawal 
and doctors pass this message on to patients along with advice on effective 
countermeasures. 
Ultimately, untreated OSA sufferers pose a danger on the roads which would be 
reduced with increased diagnosis. People who suspect they have OSA are not going to 
come forward if they feel it may be at the expense of their driving licence. Research 
like the current work demonstrating the ability of treated OSA drivers will aid 
acceptance of the condition and hopefully increase willingness to be tested. However, 
it must be remembered that getting a full night’s sleep and treatment compliance are 
vital.         
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         QUESTIONNAIRE   
     Loughborough Sleep Research Centre  
**Confidential**
Would you mind taking part in this Questionnaire, which is completed by the 
participant with the Investigator present.                      Age (Years):    ...................
                                      Weight (Kg or Lb):    …………….
                                 Height (cm or inc):    ……………
                                                Collar size (cm or inc):    ……………
Please tick the boxes which apply most to you:
1) How many years have you held a HGV licence?        ......................................
2) On average how many miles do you drive a year?     ......................................
3) On average how many hours do you drive for a week?.....................................
4) Are you a smoker?
              Yes No
5) Have you ever been diagnosed with Sleep Apnoea?
Yes No
6) How many cups of coffee do you usually drink a day?
None 5-6
1-2 Over 6
3-4 Don’t know
7) How many drinks of high caffeine content other than coffee e.g. Red Bull do you 
usually drink?
None 1-2 a week
1- 2 a month 3-5 a week
3-4 a month More than 5 a week
Don’t know
8) Would you ever drink high caffeine content drinks or coffee with the sole purpose 
to remain alert during monotonous tasks?
Never Yes sometimes Yes often
9) How often do you nap during the day whilst working?  
Never 2-3 times a week
Twice or more a day Once per week
Every day Sometimes, less than once a week
10) How long are you happy to drive for before you want to stop and take a break?  
Less than 2hours 2-4 hours 4 - 5 hours
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5-6 hours 6-7 hours More than 7 hours
11) How long do you actually drive for before you stop and take a break?
Less than 2hours 2-4 hours 4 - 5 hours
5-6 hours 6-7 hours More than 7 hours
12) Have you ever felt sleepy when driving? 
Yes No
If so, please describe under what circumstances this occurred/did you have to stop 
driving?……………………………………………………………….............................................................
..............................................................................................................
13) Do you ever think you have fallen asleep when driving?
Yes No
14) Do you think that driving whilst drowsy affects your ability to drive safely?
Yes No
15) If you felt drowsy whilst driving which statements best describe what you are most 
likely to do. (You many answer more than one)
(a) Keep going to reach your destination as soon as possible
(b) Stop at a service station and have a nap
(a) Turn  the radio up
(b) Stop at a service station and have a high caffeine content 
drink
(c) Open a window
(d) Stop at services and stretch your legs
(e) Other  (please give details)  ……………………………………
…………………………………………………………………...
16) How long does it usually take you to get to sleep? 
Less than 5 min 5-10 min
10 – 20 min Over 20min
17) On average how many hours do you sleep for a night?
On a working day On a non working day 
18) Does your bed partner report anything unusual about your sleep?
Occasional loud 
snoring
Frequent loud snoring Holding breath in 
your sleep
N/A
Choking None of these Other (please specify 
below)
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Please Complete the Following:
How likely are you to fall asleep in the following situations? Please indicate, 
using the following scale, which is most appropriate given the situation.
0 = Would never doze
1 = Slight chance of dozing
2 = Moderate chance of dozing
3 = High chance of dozing
Situation Chance of Dozing
Sitting and Reading …………………..
Watching TV …………………..
Sitting inactive in a public place (e.g. theatre/meeting) …………………..
As a passenger in a car for an hour without a break …………………..
Lying down in the afternoon when circumstances permit …………………..
Sitting and talking to someone …………………..
Sitting quietly after lunch without alcohol …………………..
In a car, while stopped for a few minutes in the traffic …………………..
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Participant information sheet
Written Explanation of Experimental Procedure For 
Participants
If you are willing to take part you will be asked to attend an 
initial familiarisation session which will last approximately 2 
hours between 10 and 12 on a week day morning.  
Following on from this you will visit the Driver Sleepiness 
Laboratory on two other occasions, on week day afternoons 
between 1 and 4.20pm.  
Before your first visit, we will ask you to do the following:
 Drink no alcohol or caffeine containing drinks (coffee, 
tea, coke) from 10pm the evening prior to the study 
day.
 Go to bed at your normal time, and get your normal 
night’s sleep.
 Have your normal breakfast.
 Please arrive well hydrated. I would suggest drinking 
about a pint of non caffeine containing liquid about an 
hour and a half before you arrive at the sleep centre. 
This is because the percent body fat measure is 
sensitive to dehydration. 
 Please wear light weight, unrestrictive clothes
On your arrival you will have an informal talk with the 
investigator for approximately 30 minutes about your 
general health, general sleep and your driving. You will 
then be measured and weighed. We will also calculate your 
percentage body fat, this is done using scales similar to 
weighing scales, and you must stand on these with bare 
feet. A small electric pulse is then sent up your body, you 
are not able to feel this and the scales will instantly 
calculate percentage of body fat, all jewellery should be 
removed and you must inform the investigator if you have a 
pacemaker. 
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You will then be asked to complete a hazard perception 
test, similar to that currently required for the UK driving test. 
This is computer based test where you will see a series of 
14 video clips of car journey’s and be asked to press the 
left mouse button if you see a hazard. This takes about 20 
minutes. How to complete the test will be explained fully on 
the day.
Finally you will be invited to drive the simulator for 30 
minutes. This is a stationary car in a laboratory, a road 
scene is projected in front of the car. The car’s steering, 
accelerator and brake affect its position on the simulated 
road. The road is a dual carriageway, you will be asked to 
keep in the left-hand lane at all times unless overtaking.  
During the drive there will be opportunities to overtake, 
these occur at random times.  When you see another car, 
you must overtake as you would in a normal car and not 
“hang around” behind the other vehicle.
Before your second visit we will ask you to
 Put on the wrist actimeter provided, the evening before 
the drive one hour before going to bed, and keep 
wearing it until you arrive at the lab at 1pm the next 
day.  With the exception of when showering or anytime 
when the actimeter may come into contact with water, 
and also if the actimeter is likely to get banged or 
knocked, e.g. when playing sport.
 Drink no alcohol or caffeine containing drinks (coffee, 
tea, coke) from 10pm the evening prior to the study 
day.
 Go to bed at 1am and get up at 6am so that you have 
had 5 hours sleep. 
 Have your normal breakfast but please don’t eat 
anything after 10am until you arrive in the lab and will 
be provided with a light lunch. 
 On the morning of this visit we would like you to wash 
your hair.  This is so that the application of the 
electrodes is easier.
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 A pre paid taxi will be provided to get you to and from 
the university. Because of sleep restriction you are not 
allowed to drive or cycle on the morning of the 
experiment.
On arrival your actimeter data will be checked to confirm 
you were in bed for the required 5 hours. You will then be 
given two cheese rolls and a drink of water which must be 
consumed within 15 minutes. An alternative meal will be 
provided if you have food allergies or intolerances. Please 
inform the investigator of this at your first visit.
There will be eight electrodes placed on your scalp and 
face, these monitor your brain activity and eye movements.  
The substances used to attach the electrodes are not 
harmful to either your skin or hair.  When connected to the
machines, these electrodes are isolated from the main 
power supply (they do not send any input into the brain, 
and only monitor its activity).  The electrodes are removed 
at the end of the visit, and any traces of adhesive removed, 
although we recommend that you wash your hair after the 
visit as sometimes small particles can be accidentally 
missed.  
At 2pm, you will begin driving in the car simulator for 2 
hours.  The simulator and road layout will be exactly the 
same as for the previous 30minute drive. 
Throughout the drive an investigator will be present in the 
laboratory.  Your head and shoulder’s will be shown on a 
monitor in the recording area behind the simulator, this 
image is videoed throughout.  The data collected on video 
will not be used for any purpose not associated with the 
experiment unless you have given your written consent.
Every 200 seconds you will be asked for a “sleep check,” 
which you must respond to using the 2 scales presented in 
front of you on the dashboard of the car.  Before each drive 
you will be given time to familiarise yourself with the scales.
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When the 2 hour drive is over the electrodes will be 
removed.  The investigator will escort you to a taxi, which 
will take you home.  You must not drive, cycle or do 
anything to endanger yourself or others until you have 
slept, and for at least 2 hours after finishing the trial.
The third day of the trial will be exactly the same as the 
second day except that you will have your normal night’s
sleep on the night preceding the study day. 
You may withdraw from the experiment at any time, and are 
under no obligation to give reason for your withdrawal if you 
do not wish to do so. You must understand that you may 
feel sleepy throughout the experiment, and that you must 
undertake to obey the instructions of the investigator 
present whilst in the lab regarding safety.
All information you provide about yourself is treated as 
confidential information by the investigator(s). 
You will be paid £10 for the first session, £15 for the second 
session and £15 for the third session.
If you have any questions please do not hesitate to contact 
me.
Ashleigh Filtness
Sleep Research Centre
Department of Human Sciences
Loughborough University
Loughborough
Leics, LE11 3TU
A.J.Filtness@lboro.ac.uk
01509 228225
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Sleep Research Centre: Consent Form
Consent of Participant to be included in research trial:
I ……..………………….……………………………………………………………….
 Consent to taking part in a Sleep Research Laboratory experiment.  An 
explanation of the nature and purpose of the procedure has been given 
to me by Ashleigh Filtness.
 I understand that I may withdraw from the experiment at any time, and 
that I am under no obligation to give reasons for such withdrawal.  I 
understand also that I may feel sleepy during some parts of the 
experiment and undertake to obey the instructions of the experimenter 
for safety purposes.
 I understand that any information about myself that I have given will be 
treated as confidential by the experimenter.  
 I have had the opportunity to ask for further information and details.
 I understand that my percentage body fat will be measured using a set 
of scales which will send a very small eclectic pulse through my body 
and I have informed the experimenter if I have a pace maker. 
Signed
………..………………………………Date.……………………………...……
Signature of experimenter…………….………………………………………………
A.J.Filtness@lboro.ac.uk
Sleep Research Centre, Department of Human Sciences
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Sleep Research Centre: Use of Video Material Consent Form
Consent of Participant regarding use of videotaped material:
I …………………………………………………………………………………..
am / am not* willing to allow the use of extracts of my video recordings which 
have been taken whilst I participated in an experimental study for the Sleep 
Research Centre, Department of Human Sciences, Loughborough University, 
to be used for:
Scientific meetings/conferences*
Television documentary programmes and other media outlets e.g. newspaper 
articles *
Signed ……………………………………….………
Date ……………………………………………….
Signature of experimenter ……………………………………………….
* Please delete as appropriate
A.J.Filtness@lboro.ac.uk
Sleep Research Centre, Department of Human Sciences
Appendix 6
325
The following questionnaire to be completed in the form of a structured 
interview with the participant and experimenter. The experimenter will fill in the 
answers.
Age: .........................................
Sex: .........................................
Weight (Kg or Lb): .........................................
Height (cm or inc): .........................................
Occupation: .........................................
Do you work shifts: …… ……………………….
           Collar size (cm or inc): .........................................
Years held a UK driving licence        ………...…………………..
GENERAL QUESTIONS
1. How many cups of coffee do you usually drink in a day?
None
1-2 
3-4
5-6
Over 6
Don’t Know
2. How many drinks of high caffeine content e.g., Red Bull 
    do you usually drink? 
None
1-2 a month
3-4 a month
1-2 a week 
3-5 a week
More than 5 a week
Don’t Know
3. Would you ever drink high caffeine content drinks or coffee with
    the sole purpose to remain alert during monotonous tasks?
Never
Yes some times
Yes often
4. Do you smoke?
Yes often
Yes Sometimes
No
5. If yes often, How many cigarettes per day?
0-5
5 or more
Don’t Know
SLEEP SCREENING 
QUESTIONNAIRE
Loughborough Sleep Research Centre 
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HEALTH QUESTIONS
6. In general would you say your health is:
Excellent
Very Good
Good
Fair
Poor
7. Have you ever experienced any of the following medical conditions, and if so when?
No = 1 Yes in the past = 2
Yes, sometimes = 3 Yes, at present = 4
(a) Obstructive sleep apnoea .......... (o) Hay fever ..........
(b) Eczema .......... (p) Allergies ..........
(c) Thyroid Problems .......... (q) Undue anxiety ..........
(d) Sleepwalking .......... (r) Loud snoring ..........
(e) Nightmares .......... (s) Bruxism ……...
(f) Difficulty reading/writing ......... (t) Arthritis/Rheumatism ..........
(g) Depression .......... (u) Heart attack ..........
(h) Stomach problems .......... (v) Waking up with a jolt ..........
(i) Waking up excessively early .......... (w) Difficulty falling asleep..........
(j) Stress/anxiety at home/work .......... (x) Epilepsy ..........
(k) Migraine .......... (y) Morning headaches ..........
(l) Hearing Problems …….. (z) Diabetes ..........
(m) Stroke .......... (aa) Hypertension ..........
(n) Irregular heart rhythms …….. (bb) Asthma ……...
7a) Do you currently suffer from any medical conditions not mentioned, if so please 
give details below? Including high cholesterol. 
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
8. Do you regularly take pills or medicines from the chemist or
by prescription? Including sleeping pills and herbal remedies. 
Yes
No
Don’t Know
If so can you tell me what they are? 
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
GENERAL SLEEP QUESTIONS
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9. What time do you normally go to bed? ……………………………
10. What time do you normally get up? ……………………………
11. How long does it normally take you to fall asleep?
0-5 minutes
5-10 Minutes
10-20 Minutes
20-30 Minutes
Over 30 Minutes
Don’t know
12. Do you ever miss a night’s sleep or have a shorter nights 
      sleep than usual?
No
Yes, sometimes
Yes, regularly
Don’t know
12a) If yes, can you tell me what the reason is for this, work/social?
…………………………………………………………….…………………………..…………
……………………………………………………………………………………………..
…………………………………………………………….…………………………..…………
……………………………………………………………………………………………..
13. How many times on average do you wake in the night?
Never
More than twice a night
Twice a night
Once a night
Not every night but at 
least once a week
Not every night but at 
least once a month
Don’t know
13a) If you wake up:
How long does it take you to get back to sleep again?
Less than 10 minutes
10 – 30 Minutes
30 – 60 Minutes
Over 60 Minutes
Don’t know
14. Are you a Morning Person or Evening Person?
Morning
Evening
Neither
Don’t know
15. If you currently have a bed partner, does s/he report any
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       unusualness about your sleep? And did they used to?
Yes
No
15a) If yes please can you give details of what s/he reports
Loud snoring
Moderate snoring
Choking 
Other -please detail below
………………………………………………………………………………………………….…
……………………………………………………………………………………………….
16. Do you ever nap during the day?
Yes
No
Don’t Know
16a) If yes, how often on average?
Twice or more a day
Every Day
2-3 Times per week
Once per week
Occasionally but less than 
once per week
Don’t know
16b) what time do you usually nap?
………………………………………………………………………………………………….
SLEEP APNOEA QUESTIONS
17. When was your sleep apnoea first diagnosed? .............................
18. When did you start to receive treatment for sleep apnoea? ………................... 
19. Are you currently receiving treatment for sleep apnoea?
Yes
No
19a) If yes what treatment are you currently receiving?.................................................
19b) How long have you been receiving this treatment?...............................................
20. Have you previously received any different treatment for sleep apnoea?
Yes
No
Don’t remember
20a) If yes please can you give details below of previous treatments and why you 
changed to a different treatment including any surgery? 
..........................................................................................................................................
..........................................................................................................................................
..........................................................................................................................................
..............................................................................................................................
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21. Before knowing you had sleep apnoea do you now think you had to make any life 
style changes because of the condition? Since being diagnosed with sleep apnoea 
have you made any life style changes e.g. losing weight, increasing weekly exercise, 
reduced social life, restricted number or nights away from home etc. 
..........................................................................................................................................
..........................................................................................................................................
..........................................................................................................................................
..........................................................................................................................................
...........................................................................................................................
22. If you are using a CPAP machine for treating sleep apnoea:
a) How often do you sleep at night without using your CPAP
Never
Once or twice a week
Once or twice a month
Once every two to three 
months
Very occasionally 
b) If you do sleep without your CPAP do you do so through 
    choice or due to circumstance?
Choice
Circumstance 
If you choose not to use the CPAP what is your usually reason for doing so?
..........................................................................................................................................
....................................................................................................................................
c) How much does the noise and vibration from the CPAP 
    machine effect the quality of your sleep?
Very much
Moderately
Slightly
Not at All
Don’t Know
23. If known, during sleep how many apnoeas do you have an hour –
23a) what is your current Apnoea/Hypopnoea Index (AHI)? 
.......................................................................................................................................
23b) what was your Apnoea/Hypopnoea Index (AHI) prior to treatment?
24. How regularly are your appointments with the sleep clinic?.....................................
DRIVING QUESTIONS
25. On average how many hours do you drive for a week?
Less than 3 hours
3-5 hours
5 -10 hours
10–15 hours
15-20 hours
20-25hours
Over 25 hours
Don’t know
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26. Do you drive as part of your job?
Yes
Yes I used to 
No 
27. On average how many miles do you drive a year?
Less than 1000 miles
1000 – 5000 miles
5000 – 10 000miles
10 000 – 15 000miles
15 000 – 20 000miles
20 000 – 30 000 miles
Over  30 000 miles
Don’t know
28. If you are undertaking a long journey on average how long would you feel happy to 
drive before you take a break?
………………………………………………………………………………………………….
29. Have you ever felt sleepy while driving?
Yes
No
29a) If yes was this before or after first receiving treatment for sleep apnoea
Before
After
Both before and after
30. Have you ever had to pull over and stop driving due to sleepiness?
Yes
No
30a) If yes was this before or after first receiving treatment for sleep apnoea
Before
After
Both before and after
31. Have you ever fallen asleep whilst driving?
Yes
No
31a) If yes was this before or after first receiving treatment for sleep apnoea
Before
After
Both before and after
32. Do you think that driving whilst sleepy affects your ability to drive safely?
Yes
No
32a) Do you think that driving whilst drowsy affects your ability to drive safely more or 
less than:
- Bad weather conditions More/Less
- Legal alcohol consumption 80mg alcohol per 100ml blood 
(About 2 pints of beer for the average man) More/Less
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33. If you felt drowsy whilst driving which statements best describe what you are most 
likely to do. (You may tick more than one)
(a) Keep going to reach your destination as soon as possible ……………
(b) Stop at a service station and have a nap ……………
(c) Turn the radio up ……………
(d) Stop at a service station and have a high caffeine content drink ……………
(e) Open a window ……………
(f) Stop at services and stretch your legs ……………
(g) If there is else you would do not covered above please give details 
..........................................................................................................................................
....................................................................................................................................
34. Do you feel having sleep apnoea currently affects your driving?
Yes
No
35. Do you feel your driving was affected by sleep apnoea 
      prior to receiving treatment? 
Yes
No
34/35a) If yes to either question 35 or 36 in what way was/is your driving effected?
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
36. Do you feel you have changed your driving habits as a result 
      of your sleep apnoea diagnosis? 
Yes
No
36a) If yes in what have you changed your driving habits?
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
37. In the 3 years prior to receiving treatment for sleep apnoea 
      how many car accidents resulting in greater than £250 damage
      or personal injury to you or another did you have?
0
1
2
3
More than 3
38. In the last 3 years while you have been receiving treatment for sleep apnoea (or 
the total time you have been receiving treatment for sleep apnoea if this is less than 3 
years) how many car accidents resulting in greater than £250 damage or personal 
injury to you or another have you had?
0
1
2
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3
More than 3
39. Do you think you are greater risk while driving than some 
      one without sleep apnoea?
Not at all
Slightly 
Moderately
Very
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The following questionnaire to be completed in the form of a structured interview with 
the participant and experimenter. The experimenter will fill in the answers.
Age: .........................................
Sex: .........................................
Weight (Kg or Lb): .........................................
Height (cm or inc): .........................................
Occupation: .........................................
Do you work shifts: …… ……………………….
           Collar size (cm or inc): .........................................
Years held a UK driving licence        ………...…………………..
GENERAL QUESTIONS
1. How many cups of caffeinated coffee do you usually drink in a day?
None
1-2 
3-4
5-6
Over 6
Don’t Know
2. How many drinks of high caffeine content other than coffee e.g., Red Bull 
    do you usually drink? 
None
1-2 a month
3-4 a month
1-2 a week 
3-5 a week
More than 5 a week
Don’t Know
3. Would you ever drink high caffeine content drinks or coffee with
    the sole purpose to remain alert during monotonous tasks?
Never
Yes some times
Yes often
4. Do you smoke?
Yes often
Yes Sometimes
No
5. If yes often, How many cigarettes per day?
0-5
5 or more
Don’t Know
SLEEP SCREENING 
QUESTIONNAIRE
Loughborough Sleep Research Centre 
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HEALTH QUESTIONS
6. In general would you say your health is:
Excellent
Very Good
Good
Fair
Poor
7. Have you ever experienced any of the following medical conditions, and if so when?
No = 1 Yes in the past = 2
Yes, sometimes = 3 Yes, at present = 4
(a) Obstructive sleep apnoea .......... (o) Hay fever ..........
(b) Eczema .......... (p) Allergies ..........
(c) Thyroid Problems .......... (q) Undue anxiety ..........
(d) Sleepwalking .......... (r) Loud snoring ..........
(e) Nightmares .......... (s) Bruxism ……...
(f) Difficulty reading/writing ......... (t) Arthritis/Rheumatism ..........
(g) Depression .......... (u) Heart attack ..........
(h) Stomach problems .......... (v) Waking up with a jolt ..........
(i) Waking up excessively early .......... (w) Difficulty falling asleep..........
(j) Stress/anxiety at home/work .......... (x) Epilepsy ..........
(k) Migraine .......... (y) Morning headaches ..........
(l) Hearing Problems …….. (z) Diabetes ..........
(m) Stroke .......... (aa) Hypertension ..........
(n) Irregular heart rhythms …….. (bb) Asthma ……...
7a) Do you currently suffer from any medical conditions not mentioned, if so please 
give details below? Including high cholesterol. 
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
8. Do you regularly take pills or medicines from the chemist or
by prescription? Including sleeping pills and herbal remedies. 
Yes
No
Don’t Know
If so can you tell me what they are? 
…………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
…………………………………………………………….………………………………………
………………………………………………………………………………………………
9. Do you have any family history of Obstructive Sleep Apnoea?
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Yes
No
Don’t Know
GENERAL SLEEP QUESTIONS
10. What time do you normally go to bed? ……………………………
11. What time do you normally get up? ……………………………
12. How long does it normally take you to fall asleep?
0-5 minutes
5-10 Minutes
10-20 Minutes
20-30 Minutes
Over 30 Minutes
Don’t know
13. Do you ever miss a night’s sleep or have a shorter nights 
      sleep than usual?
No
Yes, sometimes
Yes, regularly
Don’t know
13a) If yes, can you tell me what the reason is for this, work/social?
…………………………………………………………….…………………………..…………
……………………………………………………………………………………………..
…………………………………………………………….…………………………..………
14. How many times on average do you wake in the night?
Never
More than twice a night
Twice a night
Once a night
Not every night but at 
least once a week
Not every night but at 
least once a month
Don’t know
14a) If you wake up:
How long does it take you to get back to sleep again?
Less than 10 minutes
10 – 30 Minutes
30 – 60 Minutes
Over 60 Minutes
Don’t know
15. Are you a Morning Person or Evening Person?
Morning
Evening
Neither
Don’t know
16. If you currently have a bed partner, does s/he report any
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       unusualness about your sleep? 
Yes
No
16a) If yes please can you give details of what s/he reports
Loud snoring
Moderate snoring
Choking 
Other -please detail below
………………………………………………………………………………………………….…
……………………………………………………………………………………………….
………………………………………………………………………………………………….…
……………………………………………………………………………………………….
17. Do you ever nap during the day?
Yes
No
Don’t Know
17a) If yes, how often on average?
Twice or more a day
Every Day
2-3 Times per week
Once per week
Occasionally but less than 
once per week
Don’t know
17b) what time do you usually nap?
………………………………………………………………………………………………….
DRIVING QUESTIONS
18. On average how many hours do you drive for a week?
Less than 3 hours
3-5 hours
5 -10 hours
10–15 hours
15-20 hours
20-25hours
Over 25 hours
Don’t know
19. Do you drive as part of your job?
Yes
Yes I used to 
No 
20. On average how many miles do you drive a year?
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Less than 1000 miles
1000 – 5000 miles
5000 – 10 000miles
10 000 – 15 000miles
15 000 – 20 000miles
20 000 – 30 000 miles
Over  30 000 miles
Don’t know
21. If you are undertaking a long journey on average how long would you feel happy to 
drive before you take a break?
………………………………………………………………………………………………….
22. Have you ever felt sleepy while driving?
Yes
No
22a) If yes what were the circumstances
………………………………………………………………………………………………….
………………………………………………………………………………………………….
23. Have you ever had to pull over and stop driving due to sleepiness?
Yes
No
23a) If yes what were the circumstances
………………………………………………………………………………………………….
………………………………………………………………………………………………….
24. Have you ever fallen asleep whilst driving?
Yes
No
24a) If yes what were the circumstances
………………………………………………………………………………………………….
………………………………………………………………………………………………….
25. Do you think that driving whilst sleepy affects your ability to drive safely?
Yes
No
25a) Do you think that driving whilst drowsy affects your ability to drive safely more or 
less than:
- Bad weather conditions More/Less
- Legal alcohol consumption 80mg alcohol per 100ml blood 
(About 2 pints of beer for the average man) More/Less
26. If you felt drowsy whilst driving which statements best describe what you are most 
likely to do. (You may tick more than one)
(a) Keep going to reach your destination as soon as possible ……………
(b) Stop at a service station and have a nap ……………
(c) Turn the radio up ……………
(d) Stop at a service station and have a high caffeine content drink ……………
(e) Open a window ……………
(f) Stop at services and stretch your legs ……………
(g) If there is else you would do not covered above please give details 
....................................................................................................................................... 
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27. In the past 3 years how many car accidents resulting in greater than £250 
      damage or personal injury to you or another have you had?
0
1
2
3
More than 3
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Ref No: R08-P22
LOUGHBOROUGH UNIVERSITY
ETHICAL ADVISORY COMMITTEE
RESEARCH PROPOSAL 
INVOLVING HUMAN PARTICIPANTS
______________________________________________________________________
Title: Investigation into the effect of obstructive sleep apnoea (OSA) in 
subjects being treated with continuous positive airway pressure 
(CPAP) on driving errors in a driving simulator and subjective 
awareness of tiredness
Applicant: Dr L Rayner, A Filtness
Department: Human Sciences
Date of clearance: 12 February 2008
Comments of the Committee:
The Committee agreed to issue clearance to proceed subject to the following conditions:
That confirmation was provided as to whether participants would need to be able to drive 
a manual transmission car, and if so, that this was included on the Participant Information 
Sheet.
That the Participant Information Sheet was checked for spelling and grammatical 
mistakes, that the term ‘investigator’ was used in place of ‘experimenter’ and that the 
term ‘participants’ was used in place of ‘subjects.’
That an alternative meal was available to those with allergies and intolerances.
That the Participant Information Sheet stated that the drink to be consumed 1 ½ hours 
prior to the study should not contain caffeine.
That the Sleep Screening Questionnaire was amended so that 
Question 1 referred to caffeinated coffee, if appropriate.
Question 2 stated high caffeine drinks other than coffee, if appropriate.
Question 9 was removed.
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Dr CD Hanning. BSc, MB, BS, MD, FRCA
Consultant in Sleep Disorders Medicine
Home Address Consulting Rooms
11 Old Forge Road Holmfield Consulting Rooms
Ashby Magna No 1 Holmfield Court
Leicester LE17 5NL 3 Holmfield Road
Tel: 01455 202274 Leicester LE2 1SD
Tel: 0116 270 6841
Dear Ashleigh,
Studies on driving ability in patients with Obstructive Sleep Apnoea
The Leicester Sleep Disorders Service has always been delighted to support the research 
undertaken under Professor Horne’s auspices into driving ability and obstructive sleep 
apnoea. This has been both while I was the senior clinician and subsequently, since my 
retirement, when Dr Andrew Hall has been in charge. We recognise that an increased 
road accident rate is a major source of concern with these patients and research benefits 
not just the patients themselves but also the general public.
We were thus very supportive of the members of the Leicester Sleep Apnoea Patients 
Association who agreed to volunteer for this research. We reviewed the protocols and 
were happy with the procedures for ensuring that subjects did not drive while sleepy after 
their studies. There is no risk to the patients in discontinuing CPAP for a single night. As 
your own questions have confirmed, a large proportion of patients decide not to use their 
CPAP machines on a fairly regular basis, perhaps when they are away from home or 
travelling. It is probably true to say that virtually all longer standing CPAP users have slept 
at least one night without their machines, either voluntarily or because of machine failure. 
We only provide a 9-5, weekday only, replacement service, accepting that it does patients 
no harm to sleep without their machines for 2-3 nights over a weekend. The only 
consequence is sleepiness which is covered by your existing protocols.
In summary, I am happy to reassure your Ethics Committee that I have no objection to the 
addition to your protocol as it poses no risk to the patients. The patients are all well 
briefed on their condition and are able to give informed consent to the studies.
Yours sincerely,
Dr CD Hanning
Honorary Consultant in Sleep Medicine, University Hospitals of Leicester NHS Trust
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This shortened sleep diary will enable us to gain a picture of how you slept over the 
three nights. This information will be linked with the actiwatch data, please put the 
actiwatch on one hour before you go to bed and take it off one hour after you get 
up.
Please fill each day as appropriate. 
QUESTION Night 1 Night 2 Night 3 
Last night I went to bed at…
This morning I woke up at….
This morning I got out of bed 
at…..
Last night, I slept for a total of 
…. hours
Last night, I fell asleep in…. 
minutes
Last night, I woke up…. times
Last night my sleep was 
disturbed by….
I did/did not sleep with my 
partner
Please note below any times when you remove
the actiwatch and why:
BASIC SLEEP DIARY
Loughborough Sleep Research Centre 
SUBJECT NUMBER:
Any queries please contact:
Ashleigh Filtness,
Sleep Research Centre,
Department of Human Sciences,
Loughborough University.
a.j.filtness@lboro.ac.uk
01509 228225
